data_5j2r_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5j2r _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.5 Cg_endo . . . . . 0 N--CA 1.455 -0.77 0 CA-C-O 120.504 0.127 . . . . 2.8599999999999999 112.034 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.6 pp -139.87 161.16 26.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.908 0.385 . . . . 2.3500000000000001 110.948 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.6 t -125.32 117.8 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.297 -0.631 . . . . 2.3599999999999999 109.297 170.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.63 103.69 12.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.438 0.637 . . . . 4.0300000000000002 110.51 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.413 HG12 ' CD1' ' A' ' 181' ' ' LEU . 77.1 t -92.54 116.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.071 -0.968 . . . . 1.3999999999999999 111.507 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 4.1 m-85 -77.32 103.71 7.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.076 0.941 . . . . 2.79 109.641 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.576 HD12 ' HB ' ' A' ' 167' ' ' THR . 3.7 mt -70.53 166.68 33.23 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.067 -1.424 . . . . 2.6200000000000001 110.677 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 85.3 Cg_exo -50.81 154.25 7.2 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.566 2.177 . . . . 2.27 111.954 172.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 15.1 m120 69.06 23.92 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 3.75 110.905 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 60.81 31.35 20.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.666 -0.697 . . . . 5.0 112.684 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.88 178.85 5.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.396 -0.965 . . . . 3.9199999999999999 108.396 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -148.95 140.01 23.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 3.75 111.148 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -130.43 136.45 49.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.309 -0.859 . . . . 2.2000000000000002 108.724 169.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.28 140.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.023 -0.671 . . . . 2.6200000000000001 110.091 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.442 ' HA ' ' HZ1' ' A' ' 183' ' ' LYS . 3.3 p -123.4 123.08 26.58 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.952 -0.567 . . . . 2.2000000000000002 109.476 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 7.5 Cg_endo -50.71 129.59 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.632 2.221 . . . . 2.27 110.954 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -60.0 107.6 0.65 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.501 0.667 . . . . 2.2799999999999998 109.595 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.2 mmp_? -90.51 112.24 23.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.048 -0.978 . . . . 4.3799999999999999 110.512 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.16 122.49 28.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 3.77 110.396 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.51 11.31 60.96 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.228 -1.149 . . . . 3.48 110.228 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 172' ' ' ARG . 94.8 t -123.62 143.08 38.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.92 -0.64 . . . . 3.0699999999999998 109.616 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 36.7 p -91.92 168.99 11.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.783 -0.644 . . . . 3.0 109.508 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.656 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 17.7 t -56.09 -31.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.185 -0.672 . . . . 2.46 109.185 173.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 15.8 tpt180 -52.67 -53.81 42.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.347 -0.842 . . . . 4.9100000000000001 112.581 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -74.64 -44.47 50.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.645 0.736 . . . . 2.8700000000000001 110.966 -174.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 p -64.51 -52.39 58.08 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.966 -1.015 . . . . 2.3100000000000001 110.584 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -68.41 -23.64 64.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.318 -0.856 . . . . 1.75 111.599 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.43 -44.33 72.36 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.381 -0.6 . . . . 3.3999999999999999 109.381 176.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.501 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 27.4 ttpt -64.01 -47.8 78.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.313 -0.555 . . . . 3.0899999999999999 109.991 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.09 -52.25 45.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.431 -0.804 . . . . 1.4299999999999999 112.026 -175.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.33 -48.75 66.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.71 0.29 . . . . 2.1600000000000001 110.789 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -29.38 68.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.792 . . . . 2.4900000000000002 113.14 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 41.6 mtm -70.15 -29.75 66.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 2.5 110.26 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.587 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 2.5 mmp_? -83.74 -13.97 52.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.682 . . . . 5.0599999999999996 110.48 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.53 14.48 47.18 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.425 -0.807 . . . . 2.4900000000000002 111.281 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.17 173.72 6.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.934 0.397 . . . . 2.8399999999999999 110.424 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.4 140.94 34.97 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.937 -0.574 . . . . 2.5499999999999998 111.085 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.79 -4.31 14.84 Favored 'Trans proline' 0 CA--C 1.526 0.114 0 C-N-CA 122.892 2.394 . . . . 2.0800000000000001 112.296 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.38 -52.17 29.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 3.3199999999999998 110.753 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.2 m -100.37 27.62 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.205 -0.907 . . . . 3.3399999999999999 111.267 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.611 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.0 m -128.32 151.72 48.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 1.9099999999999999 109.88 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.492 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -121.53 151.91 39.79 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.47 0.176 . . . . 1.8799999999999999 111.043 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.551 HG11 HD13 ' A' ' 208' ' ' ILE . 44.3 t -110.73 122.99 66.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 2.0099999999999998 110.859 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.444 ' CD2' ' HG3' ' A' ' 225' ' ' GLU . 11.4 m-85 -126.29 157.45 38.31 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.674 -1.148 . . . . 3.2200000000000002 109.745 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.576 ' HD2' HD11 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -142.56 144.84 33.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 120.542 -0.463 . . . . 3.1200000000000001 110.203 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.679 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 47.7 mm -86.81 122.89 39.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.609 -0.723 . . . . 2.75 110.175 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.9 tt0 -104.23 -138.92 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.658 -1.238 . . . . 3.5499999999999998 107.658 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.18 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.02 0.528 . . . . 4.0199999999999996 112.214 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.33 8.43 9.11 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.184 -0.462 . . . . 3.6699999999999999 113.24 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -137.17 -179.38 5.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.452 0.626 . . . . 3.48 112.049 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.679 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -106.92 136.98 45.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 2.9700000000000002 111.515 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 199' ' ' ARG . 34.8 mmtp -125.7 117.8 24.45 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 114.68 -1.146 . . . . 3.54 108.766 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.39 136.37 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.092 1.861 . . . . 2.6800000000000002 112.171 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' A' ' 199' ' ' ARG . 43.6 mt -102.05 152.65 5.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.637 -0.71 . . . . 1.9099999999999999 111.543 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 145.41 17.68 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.008 -0.837 . . . . 2.4700000000000002 111.008 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.658 ' O ' ' HB ' ' A' ' 176' ' ' THR . 98.4 m95 -69.76 -17.53 63.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.059 0.392 . . . . 2.3999999999999999 112.059 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.1 4.03 54.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.906 0.384 . . . . 3.79 110.956 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.0 m -75.42 128.91 36.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.015 -0.538 . . . . 2.6099999999999999 110.418 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' A' ' 215' ' ' SER . 16.0 t70 -62.43 115.47 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 3.4700000000000002 109.849 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 214' ' ' ILE . 5.0 tt -66.81 -15.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.946 -0.57 . . . . 2.02 112.043 -173.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.522 ' HB2' ' OD2' ' A' ' 213' ' ' ASP . 17.0 m -75.84 -9.93 59.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.951 -0.468 . . . . 3.1899999999999999 111.876 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -81.32 -27.95 34.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 5.5099999999999998 109.64 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.81 5.63 39.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.022 -0.99 . . . . 2.5600000000000001 111.9 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.463 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.2 m -58.45 151.51 19.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.877 0.37 . . . . 2.2000000000000002 110.273 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.66 -9.99 57.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.844 -0.693 . . . . 2.1400000000000001 112.997 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -106.35 155.44 19.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.896 0.379 . . . . 2.6099999999999999 111.185 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -102.55 124.5 48.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.659 -0.867 . . . . 3.0600000000000001 108.659 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.444 ' HG ' ' CG1' ' A' ' 157' ' ' VAL . 46.5 mt -96.49 172.18 8.09 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.642 -0.708 . . . . 1.9199999999999999 109.912 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 16.8 p80 -153.15 136.38 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.499 -0.556 . . . . 4.0999999999999996 109.499 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.611 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 86.6 t -102.39 135.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.362 0.601 . . . . 1.5800000000000001 111.266 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 5.5 mm-40 -108.18 120.48 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.079 -0.964 . . . . 2.7400000000000002 109.31 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.316 -0.869 0 C-N-CA 120.375 -0.53 . . . . 3.0099999999999998 111.593 -178.247 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.462 -0.374 0 CA-C-O 120.884 0.285 . . . . 2.8599999999999999 112.001 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.465 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -136.09 162.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.875 0.369 . . . . 2.3500000000000001 111.004 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 218' ' ' THR . 26.0 t -126.69 127.59 70.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.017 -0.735 . . . . 2.3599999999999999 109.017 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 86.0 mtm180 -88.79 107.62 19.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.357 0.599 . . . . 4.0300000000000002 110.244 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.85 122.95 46.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.265 -0.879 . . . . 1.3999999999999999 111.433 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 4.4 m-85 -87.22 102.91 14.93 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.61 -0.436 . . . . 2.79 110.226 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -63.21 167.79 5.95 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 2.6200000000000001 110.432 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 75.5 Cg_exo -50.52 158.24 2.84 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.101 1.868 . . . . 2.27 110.919 168.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 t30 70.31 13.08 7.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.392 0.615 . . . . 3.75 110.361 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.69 40.39 16.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.356 -0.838 . . . . 5.0 112.941 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 3.4 mt-30 -98.96 174.2 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.635 -0.876 . . . . 3.9199999999999999 108.635 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.5 ptt180 -139.44 130.27 26.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.892 0.769 . . . . 3.75 111.916 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 184' ' ' ALA . 0.5 OUTLIER -128.67 136.1 50.18 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.993 -1.003 . . . . 2.2000000000000002 108.479 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 156' ' ' ILE . 3.9 t -94.46 144.79 9.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.616 -0.434 . . . . 2.6200000000000001 110.681 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.436 ' HA ' ' HZ1' ' A' ' 183' ' ' LYS . 6.2 p -137.56 124.72 13.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.048 -0.524 . . . . 2.2000000000000002 110.009 175.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 8.5 Cg_endo -50.88 133.33 39.68 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.097 2.531 . . . . 2.27 112.234 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -61.45 110.58 1.49 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.2799999999999998 109.546 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.4 mmp_? -98.98 112.02 24.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.537 -0.756 . . . . 4.3799999999999999 111.428 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.9 p -76.5 135.93 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.779 -0.646 . . . . 3.77 110.321 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 15.21 78.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.99 -0.844 . . . . 3.48 110.99 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.507 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 86.7 t -128.11 143.86 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.228 -0.656 . . . . 3.0699999999999998 109.228 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 71.1 p -94.78 169.68 9.98 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.919 -0.771 . . . . 3.0 108.919 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -60.65 -22.88 27.16 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.753 -0.832 . . . . 2.46 108.753 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 38.2 tpt85 -62.31 -41.55 98.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 112.116 0.413 . . . . 4.9100000000000001 112.116 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.506 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 6.7 t70 -77.48 -51.91 9.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.816 0.817 . . . . 2.8700000000000001 109.957 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.451 ' OG ' HG23 ' A' ' 214' ' ' ILE . 47.6 m -63.64 -45.54 89.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 2.3100000000000001 111.101 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.747 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -72.25 -27.12 62.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.071 -0.513 . . . . 1.75 111.718 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.689 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 1.0 OUTLIER -55.32 -43.22 74.69 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.27 -0.572 . . . . 3.3999999999999999 109.841 178.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.436 ' HZ1' ' HA ' ' A' ' 169' ' ' VAL . 22.5 ttpt -65.57 -46.88 77.73 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.412 -0.515 . . . . 3.0899999999999999 109.995 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -50.82 -49.62 58.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.446 -0.797 . . . . 1.4299999999999999 111.569 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.14 -53.4 30.96 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.671 -0.695 . . . . 2.1600000000000001 110.61 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.06 65.31 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.902 0.704 . . . . 2.4900000000000002 112.902 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 43.1 mtm -66.22 -35.1 79.54 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.528 -0.469 . . . . 2.5 110.789 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -90.92 -0.23 57.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.251 0.548 . . . . 5.0599999999999996 111.431 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.19 66.96 Favored Glycine 0 C--N 1.314 -0.654 0 CA-C-N 115.146 -0.934 . . . . 2.4900000000000002 111.679 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.51 160.58 16.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.199 -0.5 . . . . 2.8399999999999999 109.661 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 193' ' ' GLU . 44.5 pt -126.44 141.37 39.84 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.507 . . . . 2.5499999999999998 111.56 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.71 -10.23 24.81 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 123.188 2.592 . . . . 2.0800000000000001 112.471 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' A' ' 191' ' ' ILE . 32.7 mt-10 -64.63 -35.36 80.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.958 -0.564 . . . . 3.3199999999999998 111.322 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 58.7 m -118.26 16.47 13.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.316 0.487 . . . . 3.3399999999999999 112.316 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 63.6 m -124.49 164.34 19.95 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.576 -0.45 . . . . 1.9099999999999999 110.896 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.523 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -129.14 154.52 46.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 116.474 -0.33 . . . . 1.8799999999999999 111.424 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 208' ' ' ILE . 43.4 t -112.8 129.03 69.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.652 0.739 . . . . 2.0099999999999998 111.329 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -128.92 162.2 28.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.714 -1.13 . . . . 3.2200000000000002 110.099 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.95 134.49 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.669 -0.493 . . . . 3.1200000000000001 109.669 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -92.26 122.86 44.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.393 0.616 . . . . 2.75 110.863 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.9 tt0 -102.04 -141.15 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.436 -0.949 . . . . 3.5499999999999998 108.436 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.54 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.184 0.594 . . . . 4.0199999999999996 111.822 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.48 6.03 7.56 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.52 -0.309 . . . . 3.6699999999999999 112.757 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 16.6 pt-20 -120.16 -178.72 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.074 0.464 . . . . 3.48 111.301 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.59 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 39.2 mtpt -123.54 141.97 51.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.9700000000000002 110.635 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.63 120.69 23.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.747 -0.834 . . . . 3.54 108.747 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.21 130.94 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.968 1.779 . . . . 2.6800000000000002 112.217 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.575 HD13 HG11 ' A' ' 197' ' ' VAL . 65.6 mt -99.76 157.4 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.324 -0.853 . . . . 1.9099999999999999 111.484 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.11 147.33 18.54 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.146 -1.181 . . . . 2.4700000000000002 110.146 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.532 ' HA ' HG21 ' A' ' 177' ' ' VAL . 91.5 m95 -69.93 -13.37 62.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.312 0.556 . . . . 2.3999999999999999 112.064 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.42 8.31 45.03 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 120.952 0.406 . . . . 3.79 110.622 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -76.63 129.26 36.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.07 -0.513 . . . . 2.6099999999999999 110.328 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.86 110.44 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 3.4700000000000002 110.377 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.451 HG23 ' OG ' ' A' ' 180' ' ' SER . 3.4 tt -62.29 -17.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 2.02 111.127 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 8.0 p -66.29 -16.32 63.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.067 -0.515 . . . . 3.1899999999999999 112.185 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -86.17 -31.19 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 5.5099999999999998 110.702 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 217' ' ' LEU . 1.1 mm? -86.58 15.02 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.214 -0.448 . . . . 2.5600000000000001 111.766 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.459 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -56.81 151.64 13.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 2.2000000000000002 110.451 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.65 -1.5 72.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.067 -0.587 . . . . 2.1400000000000001 112.96 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -115.27 165.51 12.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.012 0.434 . . . . 2.6099999999999999 111.069 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.6 mp0 -113.23 124.79 53.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.768 -0.651 . . . . 3.0600000000000001 109.388 172.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.97 167.91 10.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.568 -0.742 . . . . 1.9199999999999999 110.439 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.84 129.34 24.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.293 -0.632 . . . . 4.0999999999999996 109.293 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 196' ' ' ALA . 89.8 t -104.58 136.7 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.329 0.585 . . . . 1.5800000000000001 110.383 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.56 171.1 7.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.725 -1.213 . . . . 2.7400000000000002 107.725 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 61.8 t . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 109.409 -0.589 . . . . 3.0099999999999998 109.409 170.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 82.9 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 N-CA-C 111.595 -0.194 . . . . 2.8599999999999999 111.595 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 1.7 pp -142.89 152.57 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.178 0.513 . . . . 2.3500000000000001 111.79 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.4 t -118.95 123.13 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.303 -0.999 . . . . 2.3599999999999999 108.303 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.493 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 68.4 mtm180 -86.31 101.65 13.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.602 0.715 . . . . 4.0300000000000002 110.687 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.91 121.24 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.803 -1.09 . . . . 1.3999999999999999 111.795 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.8 m-85 -84.63 102.72 13.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.312 0.577 . . . . 2.79 109.813 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.639 ' CD1' ' HD2' ' A' ' 188' ' ' ARG . 15.0 mt -66.2 163.59 37.39 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.933 -1.031 . . . . 2.6200000000000001 111.366 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -45.18 145.6 3.33 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.179 2.586 . . . . 2.27 113.0 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.416 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 93.6 m-20 64.03 43.52 5.12 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.567 -0.742 . . . . 3.75 111.442 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.5 mppt? 57.68 32.56 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.27 -1.332 . . . . 5.0 112.238 168.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.501 ' OE1' ' HD3' ' A' ' 188' ' ' ARG . 33.0 mt-30 -94.31 172.8 7.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.653 -0.703 . . . . 3.9199999999999999 109.186 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.1 ptt180 -148.99 137.87 21.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.567 0.699 . . . . 3.75 112.122 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.557 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -139.74 133.89 31.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.615 -1.175 . . . . 2.2000000000000002 108.337 172.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -97.67 137.11 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.258 -0.645 . . . . 2.6200000000000001 109.258 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.87 130.6 24.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.836 -0.431 . . . . 2.2000000000000002 109.836 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 6.6 Cg_endo -50.21 129.2 24.8 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.905 2.403 . . . . 2.27 111.738 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -70.8 77.98 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.36 -0.836 . . . . 2.2799999999999998 110.303 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.664 ' O ' HG13 ' A' ' 175' ' ' VAL . 6.8 mtm180 -59.32 133.56 56.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.402 -1.272 . . . . 4.3799999999999999 110.664 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 2.8 p -95.54 135.66 36.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.342 -0.39 . . . . 3.77 110.748 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.49 22.31 70.45 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.65 -0.786 . . . . 3.48 111.433 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 172' ' ' ARG . 2.9 p -123.34 171.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.655 -0.498 . . . . 3.0699999999999998 109.655 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 43.3 p -105.43 160.24 15.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.594 -0.521 . . . . 3.0 109.594 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 7.3 t -53.59 -33.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.962 -0.755 . . . . 2.46 108.962 171.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -55.15 -49.9 70.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.652 -0.704 . . . . 4.9100000000000001 112.62 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.528 ' HB3' HG21 ' A' ' 175' ' ' VAL . 15.3 t70 -71.46 -47.49 55.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.866 0.841 . . . . 2.8700000000000001 110.514 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 m -65.13 -47.89 75.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.118 -0.946 . . . . 2.3100000000000001 111.026 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.6 mm? -68.58 -25.22 64.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.486 -0.325 . . . . 1.75 111.565 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.03 -39.09 68.78 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.427 -0.583 . . . . 3.3999999999999999 109.427 175.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.664 ' HE3' ' SD ' ' A' ' 187' ' ' MET . 33.5 tttp -67.39 -48.36 67.62 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.575 -0.45 . . . . 3.0899999999999999 110.27 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.556 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -49.98 -55.58 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.553 -0.749 . . . . 1.4299999999999999 112.097 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.411 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 1.1 mm? -63.17 -53.09 58.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 2.1600000000000001 110.657 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.4 mmt -58.17 -27.83 64.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.543 0.942 . . . . 2.4900000000000002 113.543 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.664 ' SD ' ' HE3' ' A' ' 183' ' ' LYS . 58.7 mtm -67.86 -22.2 65.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.513 -0.475 . . . . 2.5 111.285 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.639 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 45.1 mtt-85 -112.81 16.28 19.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.741 0.781 . . . . 5.0599999999999996 111.713 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.54 25.34 75.6 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.419 -1.264 . . . . 2.4900000000000002 111.892 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.411 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.6 mt -96.18 163.51 13.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.629 -0.878 . . . . 2.8399999999999999 108.629 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.8 138.26 32.51 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.964 0.411 . . . . 2.5499999999999998 111.058 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.32 -8.49 23.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.036 2.49 . . . . 2.0800000000000001 112.634 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.154 0.502 . . . . 3.3199999999999998 110.301 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 61.5 m -101.73 21.52 14.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.598 -0.728 . . . . 3.3399999999999999 111.184 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.565 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 69.4 m -129.59 149.31 51.41 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.893 -0.323 . . . . 1.9099999999999999 110.929 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -125.39 155.9 39.63 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.329 -0.396 . . . . 1.8799999999999999 110.608 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.566 HG11 HD13 ' A' ' 208' ' ' ILE . 36.2 t -115.15 124.97 72.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.162 -0.615 . . . . 2.0099999999999998 111.66 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.84 164.52 18.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.014 -0.994 . . . . 3.2200000000000002 110.095 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -141.78 131.82 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.733 -0.469 . . . . 3.1200000000000001 109.733 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.624 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -90.63 122.16 41.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.147 -0.479 . . . . 2.75 110.655 -175.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 203' ' ' GLY . 5.6 tt0 -103.0 -137.07 0.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.494 -0.928 . . . . 3.5499999999999998 108.494 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.45 78.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.435 0.694 . . . . 4.0199999999999996 112.117 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.57 10.19 16.41 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.421 -0.354 . . . . 3.6699999999999999 112.255 -177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 17.0 pt-20 -120.56 179.29 4.37 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 121.183 0.516 . . . . 3.48 111.398 -172.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 40.9 mtpt -124.96 137.42 54.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.317 -0.856 . . . . 2.9700000000000002 110.488 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -121.17 117.26 30.71 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.408 -0.814 . . . . 3.54 108.983 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.76 133.84 19.17 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 121.931 1.754 . . . . 2.6800000000000002 111.932 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.566 HD13 HG11 ' A' ' 197' ' ' VAL . 72.2 mt -105.84 154.34 7.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 1.9099999999999999 112.097 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 151.43 19.48 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.63 -0.988 . . . . 2.4700000000000002 110.63 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.656 ' O ' ' HB ' ' A' ' 176' ' ' THR . 95.8 m95 -74.97 -13.04 60.47 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.684 0.624 . . . . 2.3999999999999999 112.684 -172.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.466 ' HA ' HG21 ' A' ' 176' ' ' THR . 3.2 p30 -102.11 9.44 40.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.161 0.505 . . . . 3.79 110.874 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -69.76 136.76 51.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.702 -0.681 . . . . 2.6099999999999999 109.292 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.74 107.07 3.32 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.809 -0.441 . . . . 3.4700000000000002 109.809 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.468 ' HA ' HD21 ' A' ' 217' ' ' LEU . 1.0 OUTLIER -58.66 -17.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 2.02 111.23 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 5.7 p -66.48 -8.74 28.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.101 -0.499 . . . . 3.1899999999999999 111.989 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -90.21 -34.53 15.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.026 0.441 . . . . 5.5099999999999998 110.629 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 217' ' ' LEU . 1.4 mm? -85.82 13.77 6.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.064 -0.517 . . . . 2.5600000000000001 112.066 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -51.97 150.08 4.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.502 . . . . 2.2000000000000002 111.617 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.1 -31.61 2.04 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.485 -0.78 . . . . 2.1400000000000001 113.208 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.87 163.04 25.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.575 0.702 . . . . 2.6099999999999999 111.672 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 22.6 mt-10 -105.36 114.96 29.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.958 -1.019 . . . . 3.0600000000000001 108.703 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.83 155.83 16.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.811 -0.811 . . . . 1.9199999999999999 108.811 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.84 120.08 29.55 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.614 -0.513 . . . . 4.0999999999999996 109.614 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 75.4 t -100.66 133.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.402 0.62 . . . . 1.5800000000000001 110.172 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -107.23 159.8 16.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.717 -1.129 . . . . 2.7400000000000002 108.68 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 122.201 1.0 . . . . 3.0099999999999998 110.603 -179.152 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 111.583 -0.199 . . . . 2.8599999999999999 111.583 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.4 pp -138.37 160.23 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.967 0.413 . . . . 2.3500000000000001 111.152 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -134.51 127.3 49.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.566 0.698 . . . . 2.3599999999999999 109.122 170.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.471 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 66.6 mtm180 -88.88 107.84 19.22 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.997 -1.001 . . . . 4.0300000000000002 111.238 -171.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.427 HG11 HD13 ' A' ' 161' ' ' LEU . 56.7 t -97.2 122.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.757 -1.11 . . . . 1.3999999999999999 111.62 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 4.3 m-85 -90.73 102.8 15.55 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 122.027 -0.421 . . . . 2.79 110.396 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 167' ' ' THR . 0.0 OUTLIER -67.95 169.89 8.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 2.6200000000000001 111.166 -175.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 54.4 Cg_exo -52.72 154.97 11.28 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.087 1.858 . . . . 2.27 110.095 165.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 162' ' ' PRO . 9.5 t30 78.2 10.86 1.93 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.676 0.75 . . . . 3.75 109.912 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 62.23 32.95 17.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.277 -0.874 . . . . 5.0 112.8 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -102.11 -178.73 3.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.462 -0.569 . . . . 3.9199999999999999 109.462 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 21.6 ptt180 -139.57 137.59 35.51 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.652 0.739 . . . . 3.75 111.343 175.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.629 ' N ' HD23 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -129.51 127.54 41.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.963 -1.495 . . . . 2.2000000000000002 106.963 170.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.471 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -94.86 135.48 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.883 -0.784 . . . . 2.6200000000000001 108.883 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.01 128.68 25.82 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.878 -0.416 . . . . 2.2000000000000002 109.878 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 9.4 Cg_endo -51.81 132.58 42.39 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.832 2.355 . . . . 2.27 110.944 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -64.1 88.4 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.641 -0.708 . . . . 2.2799999999999998 110.371 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 42.8 mmt180 -68.09 111.28 4.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.993 -1.003 . . . . 4.3799999999999999 110.939 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 12.8 p -77.88 130.75 37.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.045 -0.525 . . . . 3.77 109.882 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.63 4.54 87.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.607 -0.806 . . . . 3.48 111.228 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 1.6 t -118.66 144.18 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.371 0.605 . . . . 3.0699999999999998 110.041 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 10.9 p -93.8 173.22 7.79 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.378 -0.828 . . . . 3.0 109.265 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 44.9 t -50.47 -33.81 11.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.512 -0.551 . . . . 2.46 109.512 171.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.618 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 12.1 tpt180 -48.98 -62.68 1.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.404 -0.816 . . . . 4.9100000000000001 112.934 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.681 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 10.6 t70 -75.78 -36.5 59.78 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.513 0.673 . . . . 2.8700000000000001 111.493 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 p -65.63 -49.93 66.88 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.669 0.747 . . . . 2.3100000000000001 110.105 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.6 mm? -68.71 -22.23 64.36 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.303 -0.862 . . . . 1.75 111.601 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.1 mtpt -48.52 -51.12 28.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.311 -0.625 . . . . 3.3999999999999999 109.311 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 187' ' ' MET . 24.7 tttp -59.88 -51.44 69.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.655 -0.418 . . . . 3.0899999999999999 110.729 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.75 -49.23 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.741 -0.663 . . . . 1.4299999999999999 112.132 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -47.4 54.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.106 -0.497 . . . . 2.1600000000000001 111.076 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.403 ' HA ' ' CE ' ' A' ' 186' ' ' MET . 0.3 OUTLIER -59.19 -27.72 65.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.391 0.515 . . . . 2.4900000000000002 112.391 -177.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 42.3 mtm -73.14 -32.91 65.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.71 -0.396 . . . . 2.5 110.352 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.45 ' CG ' ' HG ' ' A' ' 161' ' ' LEU . 14.2 mmm180 -74.77 -22.6 58.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.214 0.531 . . . . 5.0599999999999996 110.76 171.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.51 12.84 37.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.661 -0.7 . . . . 2.4900000000000002 111.401 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.4 mp -106.28 176.78 5.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 2.8399999999999999 110.54 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.467 HD12 ' SG ' ' A' ' 194' ' ' CYS . 46.2 pt -124.97 144.49 47.2 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 121.09 0.472 . . . . 2.5499999999999998 110.514 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.27 -3.8 12.43 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 123.352 2.701 . . . . 2.0800000000000001 112.796 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.415 ' HB2' HD11 ' A' ' 191' ' ' ILE . 19.7 mt-10 -86.2 -28.12 24.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.094 -0.503 . . . . 3.3199999999999998 110.773 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.467 ' SG ' HD12 ' A' ' 191' ' ' ILE . 74.6 m -111.66 18.98 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 3.3399999999999999 111.267 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 68.9 m -131.35 163.8 27.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.547 -0.538 . . . . 1.9099999999999999 109.547 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -129.65 146.27 51.45 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 111.24 0.089 . . . . 1.8799999999999999 111.24 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.631 ' CG2' ' HB ' ' A' ' 208' ' ' ILE . 1.3 m -111.21 130.67 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.449 1.119 . . . . 2.0099999999999998 111.421 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -123.69 164.99 18.0 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.489 -1.687 . . . . 3.2200000000000002 109.82 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 199' ' ' ARG . 2.8 ptm180 -147.2 133.44 19.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.108 -0.701 . . . . 3.1200000000000001 109.108 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.57 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -83.91 118.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.255 0.55 . . . . 2.75 110.524 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.6 tt0 -101.45 -140.86 0.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.585 -1.265 . . . . 3.5499999999999998 107.585 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.15 81.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.552 0.575 . . . . 4.0199999999999996 112.552 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.62 7.65 16.38 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.163 -0.471 . . . . 3.6699999999999999 113.06 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 12.7 pt-20 -131.1 -179.39 5.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 117.346 0.573 . . . . 3.48 111.324 -174.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 27.8 mtpt -114.05 138.08 50.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.502 -0.772 . . . . 2.9700000000000002 110.611 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.69 111.22 39.64 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.376 -0.829 . . . . 3.54 109.619 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.73 121.71 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.85 1.7 . . . . 2.6800000000000002 111.462 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.631 ' HB ' ' CG2' ' A' ' 197' ' ' VAL . 13.2 mt -93.75 158.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.494 -0.776 . . . . 1.9099999999999999 111.361 -171.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -92.22 144.23 17.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 2.4700000000000002 110.935 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.527 ' O ' ' HB ' ' A' ' 176' ' ' THR . 92.8 m95 -72.77 -14.88 61.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 111.955 0.354 . . . . 2.3999999999999999 111.955 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -98.72 20.26 13.33 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.423 0.63 . . . . 3.79 110.397 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -85.26 127.07 34.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.367 -0.833 . . . . 2.6099999999999999 109.874 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.31 109.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 3.4700000000000002 109.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.7 tt -67.23 -14.35 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 2.02 112.247 -170.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 173' ' ' CYS . 22.7 t -69.27 -13.81 62.6 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.051 -0.406 . . . . 3.1899999999999999 110.673 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -90.35 -14.07 33.84 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.44 0.638 . . . . 5.5099999999999998 110.271 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.623 ' N ' HD11 ' A' ' 217' ' ' LEU . 6.5 mp -101.74 17.88 21.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 2.5600000000000001 111.645 -176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 m -60.51 153.51 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 2.2000000000000002 111.074 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.29 -29.17 1.68 Allowed Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.982 -0.554 . . . . 2.1400000000000001 113.911 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.459 ' O ' HG21 ' A' ' 157' ' ' VAL . 16.3 mm-40 -70.2 164.13 24.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.15 0.5 . . . . 2.6099999999999999 111.351 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.3 mt-10 -112.85 118.71 35.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.037 -0.727 . . . . 3.0600000000000001 109.037 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.3 mt -95.91 160.18 14.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.127 -0.942 . . . . 1.9199999999999999 110.16 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.72 117.86 18.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.315 -0.624 . . . . 4.0999999999999996 109.315 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 64.9 t -101.72 134.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.724 0.774 . . . . 1.5800000000000001 111.355 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.298 -1.319 . . . . 2.7400000000000002 107.712 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 97.2 t . . . . . 0 C--N 1.309 -1.171 0 C-N-CA 121.056 -0.258 . . . . 3.0099999999999998 110.608 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 CA-C-O 120.663 0.193 . . . . 2.8599999999999999 112.131 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -132.04 161.93 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 2.3500000000000001 111.596 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.42 HG23 HD23 ' A' ' 217' ' ' LEU . 47.1 t -132.44 125.02 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.923 -0.769 . . . . 2.3599999999999999 108.923 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.404 ' HG2' ' CG2' ' A' ' 168' ' ' VAL . 77.5 mtm-85 -87.45 104.98 16.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 4.0300000000000002 110.391 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.9 t -93.3 114.97 31.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.317 -0.856 . . . . 1.3999999999999999 111.476 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.58 103.62 7.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.534 0.683 . . . . 2.79 109.583 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.553 HD12 ' HB ' ' A' ' 167' ' ' THR . 2.3 mt -72.09 168.25 24.63 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.568 -1.197 . . . . 2.6200000000000001 110.975 -175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 71.1 Cg_exo -52.68 156.11 9.43 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.393 2.062 . . . . 2.27 111.299 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 18.4 m120 70.29 19.81 6.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.147 0.499 . . . . 3.75 110.479 -175.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 58.75 31.26 21.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.242 -0.89 . . . . 5.0 112.493 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.4 179.21 5.74 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.844 -0.799 . . . . 3.9199999999999999 108.844 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -148.02 129.84 15.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 118.418 0.554 . . . . 3.75 111.689 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.553 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -121.04 137.62 54.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.572 -0.899 . . . . 2.2000000000000002 108.572 172.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.404 ' CG2' ' HG2' ' A' ' 158' ' ' ARG . 6.1 t -92.84 144.42 9.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.093 -0.706 . . . . 2.6200000000000001 109.093 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.89 130.89 14.35 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 108.713 -0.847 . . . . 2.2000000000000002 108.713 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.7 Cg_endo -50.02 135.8 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.687 2.258 . . . . 2.27 111.757 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -68.06 82.37 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 2.2799999999999998 109.427 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.584 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 41.0 mmt180 -64.47 111.12 2.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.878 -1.056 . . . . 4.3799999999999999 111.291 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.32 125.17 31.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 3.77 109.95 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.12 71.58 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.496 -1.041 . . . . 3.48 110.496 -174.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.584 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 88.5 t -118.71 152.16 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.852 -0.674 . . . . 3.0699999999999998 109.451 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 33.8 p -97.09 163.76 12.8 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.671 -0.492 . . . . 3.0 109.671 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 18.7 t -52.17 -32.18 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.548 -0.538 . . . . 2.46 109.548 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.4 tpt180 -53.05 -53.56 48.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.371 -0.831 . . . . 4.9100000000000001 112.454 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.512 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 2.0 t70 -74.53 -43.15 57.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.516 0.674 . . . . 2.8700000000000001 110.669 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.522 ' OG ' HG23 ' A' ' 214' ' ' ILE . 41.1 m -67.2 -49.85 63.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.359 -0.837 . . . . 2.3100000000000001 111.318 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -68.02 -23.67 65.02 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.98 0.363 . . . . 1.75 111.98 173.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.07 -43.21 77.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.057 -0.72 . . . . 3.3999999999999999 109.057 176.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 187' ' ' MET . 23.1 tttp -63.28 -48.44 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 3.0899999999999999 110.079 173.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -52.54 -50.31 63.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 1.4299999999999999 111.82 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -52.57 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.391 -0.368 . . . . 2.1600000000000001 110.633 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.44 62.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.796 0.665 . . . . 2.4900000000000002 112.796 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.512 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 45.6 mtm -69.42 -40.77 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.646 -0.422 . . . . 2.5 109.877 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 2.2 mmp_? -74.83 -20.55 59.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.879 -0.6 . . . . 5.0599999999999996 111.025 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.55 15.55 22.57 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.041 -0.599 . . . . 2.4900000000000002 111.752 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' A' ' 195' ' ' CYS . 9.2 mp -104.53 177.43 4.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.294 . . . . 2.8399999999999999 110.267 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 193' ' ' GLU . 12.8 pt -133.42 145.74 57.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.209 0.528 . . . . 2.5499999999999998 110.606 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.71 -9.87 12.66 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 124.015 3.143 . . . . 2.0800000000000001 113.531 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' A' ' 191' ' ' ILE . 27.2 mt-10 -83.41 -25.72 31.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.846 0.355 . . . . 3.3199999999999998 110.541 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 69.7 m -112.14 36.25 3.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.504 . . . . 3.3399999999999999 111.412 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.493 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 89.6 m -152.96 162.74 40.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.143 -0.481 . . . . 1.9099999999999999 109.876 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.49 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -129.8 149.62 51.47 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 110.452 -0.203 . . . . 1.8799999999999999 110.452 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 208' ' ' ILE . 55.6 t -108.1 127.96 63.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.791 -0.764 . . . . 2.0099999999999998 111.307 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.43 168.94 15.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.425 -1.261 . . . . 3.2200000000000002 109.946 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.408 ' HG2' HD11 ' A' ' 208' ' ' ILE . 11.7 ptm180 -147.17 132.76 18.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.852 -0.613 . . . . 3.1200000000000001 109.695 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.584 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -90.46 123.18 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.388 0.613 . . . . 2.75 110.44 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 21.8 mt-30 -106.08 -146.79 0.39 Allowed 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.294 -0.867 . . . . 3.5499999999999998 109.094 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 39.0 t70 -49.12 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.579 0.751 . . . . 4.0199999999999996 112.812 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.85 9.02 11.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.246 -0.434 . . . . 3.6699999999999999 113.303 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.56 -178.34 4.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.364 0.582 . . . . 3.48 111.923 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 40.8 mtpt -122.47 142.11 50.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.251 -0.886 . . . . 2.9700000000000002 110.692 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.424 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 70.8 mmtt -125.31 113.29 25.91 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.56 -0.746 . . . . 3.54 109.334 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.67 131.92 19.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.252 1.968 . . . . 2.6800000000000002 112.025 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.546 HD13 HG11 ' A' ' 197' ' ' VAL . 42.9 mt -103.46 154.8 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.42 -0.809 . . . . 1.9099999999999999 111.476 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.62 148.84 19.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.128 -0.789 . . . . 2.4700000000000002 111.128 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.534 ' O ' ' HB ' ' A' ' 176' ' ' THR . 94.9 m95 -77.78 -15.09 59.35 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.575 -0.368 . . . . 2.3999999999999999 111.946 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.425 ' O ' HG21 ' A' ' 176' ' ' THR . 3.7 p30 -93.75 3.75 54.97 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.231 0.538 . . . . 3.79 110.641 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 67.8 m -73.83 130.45 39.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.444 -0.798 . . . . 2.6099999999999999 110.509 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 216' ' ' TRP . 16.6 t70 -60.81 114.17 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.37 -0.604 . . . . 3.4700000000000002 109.37 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.637 ' O ' HG12 ' A' ' 214' ' ' ILE . 2.8 tt -77.35 2.41 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.36 0.6 . . . . 2.02 112.136 -170.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 35.5 t -76.2 -7.23 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.255 -0.903 . . . . 3.1899999999999999 109.148 170.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -65.27 -57.54 8.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.254 -0.885 . . . . 5.5099999999999998 111.202 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.595 ' H ' HD21 ' A' ' 217' ' ' LEU . 0.0 OUTLIER -88.33 31.07 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.968 0.729 . . . . 2.5600000000000001 112.968 -172.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.1 m -57.36 146.69 28.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.353 0.597 . . . . 2.2000000000000002 111.111 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 67.75 6.15 42.1 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.149 -0.932 . . . . 2.1400000000000001 113.361 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 217' ' ' LEU . 43.0 mt-10 -115.22 165.51 12.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.886 0.343 . . . . 2.6099999999999999 110.486 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.38 126.61 55.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.298 0.571 . . . . 3.0600000000000001 110.508 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 29.2 mt -96.45 166.8 11.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.9199999999999999 110.866 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -137.23 123.41 20.47 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.373 -0.603 . . . . 4.0999999999999996 109.373 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 52.2 t -106.05 140.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.283 0.564 . . . . 1.5800000000000001 110.924 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.33 174.47 5.85 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.797 -1.186 . . . . 2.7400000000000002 107.797 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 4.1 t . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 121.096 0.474 . . . . 3.0099999999999998 109.851 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.2 Cg_endo . . . . . 0 N--CA 1.451 -1.007 0 CA-C-O 120.646 0.186 . . . . 2.8599999999999999 111.711 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.0 pp -142.07 144.55 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.739 0.304 . . . . 2.3500000000000001 110.602 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.9 t -110.66 119.55 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.851 -0.796 . . . . 2.3599999999999999 108.851 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.573 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 8.0 mtp85 -87.88 104.19 16.37 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.447 0.641 . . . . 4.0300000000000002 111.365 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 222' ' ' LEU . 85.2 t -88.74 138.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 1.3999999999999999 111.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.4 m-85 -96.95 104.84 16.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.532 0.682 . . . . 2.79 109.891 171.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.555 HD12 ' HB ' ' A' ' 167' ' ' THR . 15.3 mt -64.69 160.16 55.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.596 -1.184 . . . . 2.6200000000000001 110.778 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.98 154.11 13.97 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.539 2.16 . . . . 2.27 112.441 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.33 30.51 4.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.659 -0.701 . . . . 3.75 110.43 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 55.56 47.85 19.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.11 -0.95 . . . . 5.0 112.716 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 165' ' ' GLN . 0.9 OUTLIER -109.08 178.17 4.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.643 -0.873 . . . . 3.9199999999999999 108.643 174.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 31.5 ptt180 -148.44 134.82 19.54 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.563 0.697 . . . . 3.75 112.61 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.555 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.7 OUTLIER -134.58 132.62 39.29 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.712 -1.131 . . . . 2.2000000000000002 108.794 173.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.573 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -95.08 150.31 4.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.284 -0.635 . . . . 2.6200000000000001 109.284 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.77 126.81 14.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.54 -0.541 . . . . 2.2000000000000002 109.54 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.4 Cg_endo -49.71 134.27 33.82 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.207 2.605 . . . . 2.27 112.211 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -62.72 95.19 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.2799999999999998 109.748 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.54 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 40.1 mmt180 -76.17 110.73 10.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.986 -1.006 . . . . 4.3799999999999999 110.391 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 2.1 p -81.82 117.77 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.58 . . . . 3.77 110.834 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.39 19.61 41.14 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.755 -0.938 . . . . 3.48 110.755 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 81.4 t -131.07 148.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.402 . . . . 3.0699999999999998 110.271 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.479 HG21 ' HA ' ' A' ' 211' ' ' ASP . 19.9 p -84.83 157.55 20.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.413 -0.958 . . . . 3.0 108.413 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.756 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 14.6 p -59.51 -22.42 23.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.817 -0.809 . . . . 2.46 108.817 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.9 tpt180 -57.51 -51.64 68.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.915 -0.584 . . . . 4.9100000000000001 112.408 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.586 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 11.0 t70 -69.42 -49.93 50.48 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.81 0.814 . . . . 2.8700000000000001 110.412 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -61.1 -53.89 51.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.334 -1.303 . . . . 2.3100000000000001 110.677 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.1 mm? -69.43 -20.17 63.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.7 -0.682 . . . . 1.75 112.237 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.9 -44.8 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.23 -0.656 . . . . 3.3999999999999999 109.23 173.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.498 ' HE3' ' HE2' ' A' ' 187' ' ' MET . 27.8 tttp -63.07 -49.87 72.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.609 -0.436 . . . . 3.0899999999999999 110.226 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.526 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.4 -52.48 45.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.264 -0.88 . . . . 1.4299999999999999 111.373 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.684 HD22 ' SG ' ' A' ' 195' ' ' CYS . 8.5 tp -71.1 -35.94 72.0 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.359 -0.837 . . . . 2.1600000000000001 110.711 -175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -20.71 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 2.4900000000000002 111.722 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.498 ' HE2' ' HE3' ' A' ' 183' ' ' LYS . 38.9 mtt -64.76 -44.03 91.36 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.697 -0.853 . . . . 2.5 108.697 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.539 ' CD ' HD13 ' A' ' 161' ' ' LEU . 11.1 mmm180 -69.49 -24.72 63.81 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.389 -1.278 . . . . 5.0599999999999996 110.454 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.32 19.13 26.56 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.595 -0.73 . . . . 2.4900000000000002 111.572 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.484 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . 11.3 mp -105.6 171.08 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.191 -0.3 . . . . 2.8399999999999999 110.191 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.53 ' C ' HD23 ' A' ' 185' ' ' LEU . 34.9 pt -123.66 135.24 25.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 2.5499999999999998 111.774 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.71 -3.75 7.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.784 2.989 . . . . 2.0800000000000001 113.518 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.423 ' HB2' HD11 ' A' ' 191' ' ' ILE . 32.3 mt-10 -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.857 0.36 . . . . 3.3199999999999998 110.605 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 31.6 t -110.02 14.7 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 3.3399999999999999 111.7 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.684 ' SG ' HD22 ' A' ' 185' ' ' LEU . 35.3 m -127.84 169.26 14.11 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.905 -0.497 . . . . 1.9099999999999999 110.358 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.447 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -139.46 149.46 44.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 111.75 0.278 . . . . 1.8799999999999999 111.75 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 208' ' ' ILE . 1.9 m -110.85 134.36 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.423 1.106 . . . . 2.0099999999999998 111.582 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 225' ' ' GLU . 13.1 m-85 -122.63 173.18 7.87 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.671 -1.604 . . . . 3.2200000000000002 109.525 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.4 ptm180 -151.48 127.86 10.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.735 -0.666 . . . . 3.1200000000000001 109.651 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.632 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -84.53 122.72 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.517 0.675 . . . . 2.75 109.84 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 31.9 tt0 -111.19 -136.5 0.37 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.807 -1.182 . . . . 3.5499999999999998 107.807 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.94 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.616 0.766 . . . . 4.0199999999999996 112.882 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 6.45 7.39 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 116.018 -0.537 . . . . 3.6699999999999999 113.474 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 10.5 pt-20 -137.07 -179.25 5.6 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 117.776 0.788 . . . . 3.48 111.991 -172.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.632 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 43.0 mtpt -112.16 139.83 47.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.304 -0.862 . . . . 2.9700000000000002 111.098 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -122.75 110.57 31.65 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 3.54 109.483 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.51 131.38 18.7 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.035 1.823 . . . . 2.6800000000000002 112.028 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.603 HD13 HG21 ' A' ' 197' ' ' VAL . 17.0 mt -103.12 160.78 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.154 -0.475 . . . . 1.9099999999999999 111.525 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -98.16 144.61 17.36 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.953 -0.859 . . . . 2.4700000000000002 110.953 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -66.19 -13.75 60.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.357 0.873 . . . . 2.3999999999999999 113.357 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.479 ' HA ' HG21 ' A' ' 176' ' ' THR . 4.1 p-10 -103.3 11.51 36.66 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.04 -0.412 . . . . 3.79 111.313 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.9 m -73.06 122.0 21.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 2.6099999999999999 109.474 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 175' ' ' VAL . 9.9 t0 -60.99 117.27 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.256 -0.646 . . . . 3.4700000000000002 109.256 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.433 HG23 HD11 ' A' ' 214' ' ' ILE . 4.4 tt -68.82 -15.17 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 2.02 112.41 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.531 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 95.1 p -71.4 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.781 -0.574 . . . . 3.1899999999999999 111.702 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -90.13 -11.68 40.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.313 0.577 . . . . 5.5099999999999998 110.216 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.644 ' N ' HD11 ' A' ' 217' ' ' LEU . 6.3 mp -102.02 11.85 37.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.579 -0.737 . . . . 2.5600000000000001 111.709 -174.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.429 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.7 m -56.7 153.24 10.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.283 0.563 . . . . 2.2000000000000002 111.607 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.03 -19.57 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.511 -0.768 . . . . 2.1400000000000001 113.12 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.26 151.89 19.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.109 0.481 . . . . 2.6099999999999999 111.131 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 53.0 mt-10 -100.0 126.04 46.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.92 -0.77 . . . . 3.0600000000000001 108.92 170.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 35.9 mt -94.46 167.3 11.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.667 -0.697 . . . . 1.9199999999999999 110.206 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -140.18 122.46 15.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.357 -0.608 . . . . 4.0999999999999996 109.357 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.62 135.78 36.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.456 0.646 . . . . 1.5800000000000001 111.407 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 198' ' ' TYR . 2.1 mm-40 -108.85 167.99 9.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.209 -1.404 . . . . 2.7400000000000002 107.209 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 21.7 t . . . . . 0 C--N 1.307 -1.253 0 C-N-CA 120.308 -0.557 . . . . 3.0099999999999998 110.211 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 120.895 0.289 . . . . 2.8599999999999999 112.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.517 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -137.29 163.13 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.855 0.359 . . . . 2.3500000000000001 111.062 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 218' ' ' THR . 35.3 t -126.93 122.8 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.337 -0.616 . . . . 2.3599999999999999 109.337 171.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 91.4 mtt180 -80.6 106.12 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.812 -0.44 . . . . 4.0300000000000002 109.812 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.62 107.78 20.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.836 -0.62 . . . . 1.3999999999999999 110.959 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 m-85 -71.63 103.23 2.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.807 0.813 . . . . 2.79 110.438 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 167' ' ' THR . 14.4 mt -63.61 159.73 49.68 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.241 -1.345 . . . . 2.6200000000000001 111.051 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.64 148.25 21.67 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.487 2.125 . . . . 2.27 111.825 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.426 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 15.0 m120 69.95 36.06 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.505 0.669 . . . . 3.75 110.755 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HD3' ' C ' ' A' ' 163' ' ' ASN . 0.0 OUTLIER 58.49 33.27 22.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 5.0 113.281 169.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -98.35 -179.99 4.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.0 -0.741 . . . . 3.9199999999999999 109.0 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.1 ptt180 -149.93 132.96 16.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 3.75 112.011 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.608 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -121.56 136.92 54.92 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.637 -0.875 . . . . 2.2000000000000002 108.637 170.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.517 HG13 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -92.6 141.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.324 -0.621 . . . . 2.6200000000000001 109.324 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.95 123.51 15.95 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.425 -0.583 . . . . 2.2000000000000002 109.425 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 10.5 Cg_endo -51.17 138.51 44.78 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.348 2.699 . . . . 2.27 111.675 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -65.3 87.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.507 -0.77 . . . . 2.2799999999999998 110.324 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 37.3 mmt180 -66.82 113.04 4.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.527 -1.215 . . . . 4.3799999999999999 111.542 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 20.7 p -76.34 131.23 39.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 3.77 110.651 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.27 79.8 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.052 -0.819 . . . . 3.48 111.052 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.613 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 89.0 t -129.06 144.95 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.661 -0.496 . . . . 3.0699999999999998 109.661 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.8 p -93.3 170.81 9.34 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.074 -0.713 . . . . 3.0 109.074 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.2 m -60.83 -21.31 23.66 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 108.995 -0.743 . . . . 2.46 108.995 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -53.04 -61.22 2.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.013 -0.54 . . . . 4.9100000000000001 111.883 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.613 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 10.3 t70 -66.38 -48.12 71.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.722 0.773 . . . . 2.8700000000000001 110.786 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 p -61.57 -53.13 60.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.908 -1.042 . . . . 2.3100000000000001 110.658 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -65.94 -24.98 66.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.669 -0.696 . . . . 1.75 112.101 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -40.34 71.52 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.679 -0.489 . . . . 3.3999999999999999 109.679 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 187' ' ' MET . 38.1 tttp -68.7 -46.2 69.61 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.322 -0.551 . . . . 3.0899999999999999 109.945 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.7 -55.9 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 1.4299999999999999 111.945 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -49.08 75.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 2.1600000000000001 111.227 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -23.38 66.11 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.356 0.502 . . . . 2.4900000000000002 112.356 -175.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 44.1 mtm -76.06 -31.45 58.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 2.5 110.505 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.537 ' CD ' HD13 ' A' ' 161' ' ' LEU . 12.0 mmm180 -72.99 -25.72 61.09 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.187 0.518 . . . . 5.0599999999999996 110.478 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.75 16.56 25.96 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.374 -0.83 . . . . 2.4900000000000002 111.063 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.33 172.35 6.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.873 0.368 . . . . 2.8399999999999999 110.246 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.46 140.52 28.34 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 2.5499999999999998 110.291 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.12 -4.22 12.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.049 2.5 . . . . 2.0800000000000001 112.7 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -73.99 -47.29 38.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 3.3199999999999998 110.578 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 86.0 m -102.01 37.74 1.79 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.902 -0.59 . . . . 3.3399999999999999 111.113 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 72.7 m -143.31 162.67 35.07 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.379 -0.6 . . . . 1.9099999999999999 109.379 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -133.73 156.68 47.52 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.444 0.164 . . . . 1.8799999999999999 111.274 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 208' ' ' ILE . 35.9 t -113.81 126.66 71.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.769 0.795 . . . . 2.0099999999999998 111.258 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -129.13 161.84 29.14 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.499 -1.228 . . . . 3.2200000000000002 109.547 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -145.84 154.93 42.54 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.645 -0.502 . . . . 3.1200000000000001 109.645 168.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.754 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 40.2 mm -104.54 129.31 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 2.75 110.81 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 32.5 tt0 -113.34 -138.96 0.38 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.089 -1.078 . . . . 3.5499999999999998 108.089 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.413 ' H ' ' HG2' ' A' ' 201' ' ' GLN . 14.3 t70 -56.3 78.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.471 0.708 . . . . 4.0199999999999996 112.248 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.11 11.12 17.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.397 -0.43 . . . . 3.6699999999999999 112.309 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.78 178.63 6.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 3.48 111.296 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.754 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 54.7 mtpt -118.78 139.5 51.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.159 -0.928 . . . . 2.9700000000000002 111.17 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -120.84 108.86 36.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.789 -1.096 . . . . 3.54 108.513 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.32 128.91 15.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.615 1.543 . . . . 2.6800000000000002 110.967 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.517 HD13 HG11 ' A' ' 197' ' ' VAL . 20.5 mt -99.49 153.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.725 -0.671 . . . . 1.9099999999999999 111.381 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.3 147.5 18.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.215 -0.754 . . . . 2.4700000000000002 111.215 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 85.8 m95 -74.28 -13.75 60.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.016 0.376 . . . . 2.3999999999999999 112.016 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -106.88 20.42 19.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.197 0.523 . . . . 3.79 110.339 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.7 m -83.77 128.49 34.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.489 -0.778 . . . . 2.6099999999999999 109.942 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -65.15 114.43 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 3.4700000000000002 109.531 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.27 -15.16 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.066 -0.515 . . . . 2.02 111.948 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 91.8 p -73.07 -8.96 58.1 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.064 -0.654 . . . . 3.1899999999999999 111.075 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -88.8 -26.15 21.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.341 0.591 . . . . 5.5099999999999998 110.084 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.58 18.43 7.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.395 -0.82 . . . . 2.5600000000000001 112.293 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.408 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.4 m -59.47 153.27 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.168 0.508 . . . . 2.2000000000000002 111.353 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.66 5.3 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.718 -0.673 . . . . 2.1400000000000001 112.933 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.4 ' O ' HG11 ' A' ' 157' ' ' VAL . 27.5 mm-40 -81.34 145.9 30.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.937 0.399 . . . . 2.6099999999999999 110.951 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 50.2 mt-10 -101.53 114.16 27.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 3.0600000000000001 108.698 167.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.64 171.73 8.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.32 -0.855 . . . . 1.9199999999999999 109.441 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -148.53 134.15 18.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.898 -0.408 . . . . 4.0999999999999996 109.898 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.97 139.81 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.577 0.703 . . . . 1.5800000000000001 111.103 -174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -107.84 169.27 8.71 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.523 -1.288 . . . . 2.7400000000000002 107.523 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 77.8 t . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 120.601 -0.44 . . . . 3.0099999999999998 110.817 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.462 -0.324 0 CA-C-O 120.987 0.328 . . . . 2.8599999999999999 112.074 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.5 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -138.58 165.5 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.989 -0.551 . . . . 2.3500000000000001 110.195 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 220' ' ' GLU . 44.6 t -128.44 120.76 53.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.61 -0.515 . . . . 2.3599999999999999 109.61 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -83.09 104.07 13.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.877 -0.601 . . . . 4.0300000000000002 110.192 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.411 HG12 ' CD1' ' A' ' 181' ' ' LEU . 60.1 t -95.66 119.7 44.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.169 -0.923 . . . . 1.3999999999999999 111.337 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 5.3 m-85 -79.05 102.8 8.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.656 0.741 . . . . 2.79 109.931 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.531 HD12 ' HB ' ' A' ' 167' ' ' THR . 14.3 mt -64.27 159.2 59.95 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.759 -1.109 . . . . 2.6200000000000001 110.246 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.524 ' HD2' ' CD1' ' A' ' 190' ' ' LEU . 41.5 Cg_exo -56.63 142.24 90.83 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.702 2.268 . . . . 2.27 111.18 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.4 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 64.6 t30 75.87 43.97 0.16 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.126 0.965 . . . . 3.75 110.424 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 164' ' ' LYS . 1.3 mppt? 53.01 32.5 12.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.743 -1.571 . . . . 5.0 113.378 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -101.12 173.7 6.34 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.933 -0.766 . . . . 3.9199999999999999 108.933 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -148.47 137.73 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.166 0.508 . . . . 3.75 111.948 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -130.54 139.24 50.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.035 -0.984 . . . . 2.2000000000000002 108.958 174.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -95.22 142.57 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.265 -0.643 . . . . 2.6200000000000001 109.265 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.19 125.64 13.63 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 109.332 -0.618 . . . . 2.2000000000000002 109.332 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 6.8 Cg_endo -49.79 137.35 34.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.284 2.656 . . . . 2.27 112.252 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -67.72 85.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.338 -0.846 . . . . 2.2799999999999998 109.889 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 175' ' ' VAL . 23.6 mmm180 -71.13 112.18 7.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.055 -0.975 . . . . 4.3799999999999999 111.694 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 31.6 m -72.29 131.8 43.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.742 -0.663 . . . . 3.77 110.323 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.05 12.15 84.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 3.48 111.351 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 172' ' ' ARG . 67.6 t -118.49 150.0 20.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.115 0.483 . . . . 3.0699999999999998 109.902 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 211' ' ' ASP . 22.0 p -85.02 151.46 24.15 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.596 -0.89 . . . . 3.0 108.596 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.753 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 12.6 p -58.33 -22.65 20.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.484 -0.932 . . . . 2.46 108.484 170.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -58.1 -50.62 72.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.959 -0.564 . . . . 4.9100000000000001 112.044 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 7.7 t70 -67.23 -52.13 44.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.12 0.962 . . . . 2.8700000000000001 110.152 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.445 ' OG ' HG23 ' A' ' 214' ' ' ILE . 60.0 m -63.18 -45.63 90.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.446 -1.252 . . . . 2.3100000000000001 111.132 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.0 OUTLIER -75.71 -21.69 57.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.615 0.598 . . . . 1.75 112.615 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 9.6 pttt -60.3 -37.8 81.66 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.535 -0.866 . . . . 3.3999999999999999 108.96 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 187' ' ' MET . 15.5 tttp -63.15 -52.9 60.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.522 -0.471 . . . . 3.0899999999999999 109.824 170.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.556 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -48.52 -53.92 16.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 1.4299999999999999 111.673 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 79.6 mt -66.98 -51.06 59.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.694 -0.685 . . . . 2.1600000000000001 111.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -23.23 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 2.4900000000000002 112.878 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 41.8 mtm -64.61 -44.62 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 2.5 110.285 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.555 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -71.18 -26.03 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.553 0.692 . . . . 5.0599999999999996 111.331 171.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.38 21.45 9.33 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 114.744 -1.116 . . . . 2.4900000000000002 111.163 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 188' ' ' ARG . 26.1 mt -94.87 159.06 15.21 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.899 -0.651 . . . . 2.8399999999999999 109.981 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 193' ' ' GLU . 48.8 pt -120.28 135.39 24.43 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.153 0.501 . . . . 2.5499999999999998 111.524 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.2 -4.74 14.94 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.144 2.563 . . . . 2.0800000000000001 112.474 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' A' ' 191' ' ' ILE . 26.1 tt0 -61.22 -49.97 74.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.789 -0.641 . . . . 3.3199999999999998 111.548 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.89 -1.22 22.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 3.3399999999999999 111.286 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 49.9 m -109.25 161.15 15.52 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.289 -0.257 . . . . 1.9099999999999999 110.519 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.431 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -133.06 154.29 50.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 116.478 -0.328 . . . . 1.8799999999999999 110.237 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 208' ' ' ILE . 2.2 m -104.49 135.78 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.24 1.019 . . . . 2.0099999999999998 110.851 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.654 ' CD2' ' HB3' ' A' ' 225' ' ' GLU . 9.2 m-85 -129.48 167.04 18.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.839 -1.528 . . . . 3.2200000000000002 109.795 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -149.92 131.98 15.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.122 -0.49 . . . . 3.1200000000000001 110.226 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -92.34 121.27 42.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.522 0.677 . . . . 2.75 110.375 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.2 tt0 -103.76 -137.66 0.35 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.976 -1.12 . . . . 3.5499999999999998 107.976 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.81 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.392 0.515 . . . . 4.0199999999999996 112.392 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.47 6.25 14.83 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.125 -0.489 . . . . 3.6699999999999999 112.764 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.5 pt-20 -127.7 -179.52 4.98 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 117.318 0.559 . . . . 3.48 111.866 -172.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 51.8 mtpt -118.78 140.97 49.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.374 -0.83 . . . . 2.9700000000000002 111.042 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -124.93 113.6 26.71 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.152 -0.931 . . . . 3.54 108.652 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 198' ' ' TYR . 54.6 Cg_endo -76.71 127.94 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.891 1.727 . . . . 2.6800000000000002 111.799 175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.587 HD13 HG21 ' A' ' 197' ' ' VAL . 8.5 mt -100.79 156.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.932 -0.576 . . . . 1.9099999999999999 110.988 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -94.78 146.85 18.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.139 -0.784 . . . . 2.4700000000000002 111.139 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CE3' ' HA ' ' A' ' 178' ' ' ARG . 67.1 m95 -66.09 -20.2 66.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.325 0.861 . . . . 2.3999999999999999 113.325 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.432 ' HA ' HG21 ' A' ' 176' ' ' THR . 4.0 p-10 -103.28 15.59 28.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.281 -0.567 . . . . 3.79 110.809 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 42.0 m -73.68 131.4 41.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.338 -0.846 . . . . 2.6099999999999999 109.756 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 9.8 t70 -62.81 109.92 1.59 Allowed 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.363 0.414 . . . . 3.4700000000000002 109.948 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.494 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.4 tt -64.4 -18.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.381 . . . . 2.02 111.689 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.589 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 38.2 t -69.42 -11.64 60.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.924 -0.31 . . . . 3.1899999999999999 111.307 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -90.01 -25.56 20.78 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.106 -0.371 . . . . 5.5099999999999998 110.525 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 217' ' ' LEU . 1.4 mm? -87.6 16.93 5.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 111.928 0.344 . . . . 2.5600000000000001 111.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 m -55.33 149.07 13.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 2.2000000000000002 110.095 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.9 -8.28 37.78 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 121.06 -0.59 . . . . 2.1400000000000001 113.128 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 157' ' ' VAL . 52.3 mm-40 -101.67 137.99 39.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.816 0.308 . . . . 2.6099999999999999 110.557 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.24 118.78 30.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.873 -0.788 . . . . 3.0600000000000001 108.873 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.44 174.3 6.74 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.435 -0.802 . . . . 1.9199999999999999 109.816 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 5.9 p80 -156.11 149.89 25.05 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.671 -1.233 . . . . 4.0999999999999996 107.671 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.44 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.1 t -100.65 123.52 53.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 122.032 0.92 . . . . 1.5800000000000001 111.106 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.654 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 0.0 OUTLIER -109.64 120.44 42.51 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.666 -1.606 . . . . 2.7400000000000002 109.276 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 64.1 t . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 115.421 -0.809 . . . . 3.0099999999999998 112.03 -171.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 111.457 -0.247 . . . . 2.8599999999999999 111.457 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -137.84 165.53 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.177 0.513 . . . . 2.3500000000000001 111.017 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 220' ' ' GLU . 1.1 p -139.43 123.1 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.409 -0.814 . . . . 2.3599999999999999 109.559 173.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -81.22 109.37 15.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 4.0300000000000002 110.711 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -98.7 110.81 26.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.095 -0.957 . . . . 1.3999999999999999 111.485 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.5 m-85 -75.48 103.63 5.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.336 0.589 . . . . 2.79 109.986 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.534 HD12 ' HB ' ' A' ' 167' ' ' THR . 16.1 mt -62.54 161.03 29.77 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.973 -1.012 . . . . 2.6200000000000001 111.362 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.457 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.02 148.7 37.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.762 2.308 . . . . 2.27 111.491 175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.6 m120 72.94 23.64 2.74 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.724 0.64 . . . . 3.75 110.894 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 67.38 34.06 4.98 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.537 0.94 . . . . 5.0 113.537 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -98.08 -179.35 4.36 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.598 -0.89 . . . . 3.9199999999999999 108.598 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 2.9 ptt180 -149.51 139.58 22.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.585 0.629 . . . . 3.75 111.666 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.534 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -132.35 138.94 47.94 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.698 -0.852 . . . . 2.2000000000000002 108.698 170.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 156' ' ' ILE . 3.5 t -93.08 140.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.16 -0.616 . . . . 2.6200000000000001 110.057 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 180' ' ' SER . 20.0 t -119.28 122.51 29.41 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.295 -0.411 . . . . 2.2000000000000002 110.424 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.555 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 9.7 Cg_endo -52.96 123.34 12.9 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.343 2.029 . . . . 2.27 109.971 168.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -60.42 101.13 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 2.2799999999999998 110.49 -173.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 23.9 mmm180 -82.57 119.14 23.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.562 -1.199 . . . . 4.3799999999999999 111.415 -172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.7 t -85.03 136.07 33.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 3.77 109.527 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.32 75.51 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.053 -1.219 . . . . 3.48 110.053 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 172' ' ' ARG . 23.3 t -132.79 136.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.651 -0.774 . . . . 3.0699999999999998 110.318 -174.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 23.4 p -89.37 167.03 13.35 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.663 -0.699 . . . . 3.0 109.683 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 24.2 t -53.02 -34.17 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.261 -0.644 . . . . 2.46 109.261 171.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -53.28 -56.53 15.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.848 -1.069 . . . . 4.9100000000000001 112.812 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.483 ' HB3' HG11 ' A' ' 175' ' ' VAL . 9.1 t70 -72.52 -43.62 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 2.8700000000000001 110.926 -173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 169' ' ' VAL . 1.3 m -65.21 -50.24 66.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.423 -0.808 . . . . 2.3100000000000001 111.104 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -70.51 -21.12 62.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.625 -0.43 . . . . 1.75 111.968 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.548 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.53 -47.05 73.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.933 -0.765 . . . . 3.3999999999999999 108.933 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.548 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 25.5 ttpt -63.4 -46.61 85.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.984 -0.553 . . . . 3.0899999999999999 110.041 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.33 -54.13 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.707 -0.679 . . . . 1.4299999999999999 111.865 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.42 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -65.11 -51.94 58.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 2.1600000000000001 110.752 178.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.437 ' HE1' ' O ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -62.41 -21.55 65.48 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.257 0.836 . . . . 2.4900000000000002 113.257 -172.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 45.6 mtm -71.87 -28.17 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.497 -0.481 . . . . 2.5 110.914 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -96.82 -8.47 30.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 5.0599999999999996 110.896 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.58 35.5 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.502 -0.772 . . . . 2.4900000000000002 112.433 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.437 ' O ' ' HE1' ' A' ' 186' ' ' MET . 7.9 mp -95.19 176.8 6.08 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.933 -0.395 . . . . 2.8399999999999999 109.933 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.9 pt -132.61 143.53 49.13 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.159 0.504 . . . . 2.5499999999999998 111.08 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.17 -3.74 6.62 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 123.7 2.933 . . . . 2.0800000000000001 112.46 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -76.03 -49.89 16.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.49 0.662 . . . . 3.3199999999999998 110.724 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.405 ' O ' HG11 ' A' ' 226' ' ' VAL . 63.5 m -103.66 38.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.938 -1.028 . . . . 3.3399999999999999 112.363 -172.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 98.1 m -145.78 162.62 37.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.258 -0.276 . . . . 1.9099999999999999 110.375 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -132.13 140.36 48.77 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.496 -0.187 . . . . 1.8799999999999999 110.496 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.6 ' CG2' ' HB ' ' A' ' 208' ' ' ILE . 1.3 m -105.35 130.22 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 122.633 1.206 . . . . 2.0099999999999998 111.541 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.27 165.17 14.6 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.605 -1.634 . . . . 3.2200000000000002 109.622 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.426 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 10.8 ptm180 -144.58 145.28 31.72 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.868 -0.605 . . . . 3.1200000000000001 109.7 172.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.559 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -98.38 121.92 49.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.729 . . . . 2.75 110.52 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.9 tt0 -99.41 -142.11 0.32 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.62 -1.173 . . . . 3.5499999999999998 108.115 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.23 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.193 0.597 . . . . 4.0199999999999996 112.321 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.96 7.65 8.94 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.619 -0.324 . . . . 3.6699999999999999 112.313 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -123.76 -175.74 3.29 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.887 0.375 . . . . 3.48 110.686 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.8 mtpt -123.21 149.23 44.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.958 -0.565 . . . . 2.9700000000000002 111.162 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -136.22 117.72 11.62 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 114.74 -1.118 . . . . 3.54 108.807 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.33 131.08 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.206 1.937 . . . . 2.6800000000000002 111.494 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.6 ' HB ' ' CG2' ' A' ' 197' ' ' VAL . 19.5 mt -98.02 156.83 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.573 . . . . 1.9099999999999999 111.738 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -98.36 145.8 17.91 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.084 -0.806 . . . . 2.4700000000000002 111.084 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.506 ' O ' ' HB ' ' A' ' 176' ' ' THR . 88.1 m95 -68.48 -13.19 62.14 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.868 0.692 . . . . 2.3999999999999999 112.868 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.471 ' HA ' HG21 ' A' ' 176' ' ' THR . 1.4 p30 -105.66 14.26 28.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.531 . . . . 3.79 111.211 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.5 m -75.56 128.49 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.723 -0.671 . . . . 2.6099999999999999 109.352 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.447 ' HB3' ' CE3' ' A' ' 216' ' ' TRP . 15.9 t70 -65.89 114.09 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.282 -0.636 . . . . 3.4700000000000002 109.282 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 214' ' ' ILE . 5.7 tt -69.6 -11.15 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 2.02 112.03 -170.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 34.3 t -70.48 -14.49 62.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.835 -0.541 . . . . 3.1899999999999999 110.634 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 213' ' ' ASP . 13.2 m0 -92.25 -1.77 56.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.932 0.396 . . . . 5.5099999999999998 110.567 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.83 9.33 34.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.402 -0.363 . . . . 2.5600000000000001 110.81 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 153.38 18.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.078 0.466 . . . . 2.2000000000000002 111.189 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 75.13 -7.36 23.12 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.636 -0.711 . . . . 2.1400000000000001 113.697 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.641 ' O ' HG21 ' A' ' 157' ' ' VAL . 12.3 mm-40 -99.62 149.32 23.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.044 0.422 . . . . 2.6099999999999999 110.253 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -95.68 119.8 34.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.475 0.655 . . . . 3.0600000000000001 109.447 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 70.6 mt -98.21 167.33 10.93 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.85 -1.068 . . . . 1.9199999999999999 109.252 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -149.7 144.08 25.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.324 -0.621 . . . . 4.0999999999999996 109.324 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 21.3 t -114.42 141.09 32.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.749 0.785 . . . . 1.5800000000000001 111.507 -171.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.01 179.38 4.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.02 -1.445 . . . . 2.7400000000000002 107.774 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 87.0 t . . . . . 0 C--N 1.314 -0.958 0 CA-C-O 121.272 0.558 . . . . 3.0099999999999998 110.064 172.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.457 -0.667 0 CA-C-O 120.974 0.322 . . . . 2.8599999999999999 112.23 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.493 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -137.28 162.77 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.272 -0.422 . . . . 2.3500000000000001 110.813 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -135.04 120.63 30.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.315 0.578 . . . . 2.3599999999999999 109.985 170.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 168' ' ' VAL . 99.3 mtt180 -74.71 119.97 19.62 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.312 -0.858 . . . . 4.0300000000000002 110.26 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.08 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.749 -1.114 . . . . 1.3999999999999999 111.277 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.4 m-85 -73.28 103.45 3.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.566 0.698 . . . . 2.79 109.664 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.531 HD12 ' HB ' ' A' ' 167' ' ' THR . 12.7 mt -64.98 161.64 45.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.511 -1.222 . . . . 2.6200000000000001 111.077 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.431 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 78.4 Cg_exo -51.63 150.45 16.53 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.511 2.141 . . . . 2.27 111.272 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 164' ' ' LYS . 21.6 t-20 63.89 36.98 9.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.408 1.099 . . . . 3.75 110.237 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.7 mppt? 57.64 28.7 16.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.407 -1.724 . . . . 5.0 114.167 164.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.578 ' NE2' ' HD2' ' A' ' 188' ' ' ARG . 5.5 mt-30 -93.34 -179.07 4.94 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.028 -0.731 . . . . 3.9199999999999999 109.028 169.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 34.3 ptt180 -147.62 135.05 20.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 3.75 111.511 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.531 ' HB ' HD12 ' A' ' 161' ' ' LEU . 2.8 t -111.38 -177.76 3.28 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.909 -1.145 . . . . 2.2000000000000002 107.909 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.493 HG13 ' HB ' ' A' ' 156' ' ' ILE . 4.6 t -135.75 132.36 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.178 -1.045 . . . . 2.6200000000000001 108.178 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.88 123.51 26.19 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.735 -0.386 . . . . 2.2000000000000002 110.014 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 6.5 Cg_endo -50.71 134.17 40.2 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.095 2.53 . . . . 2.27 111.786 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -61.27 117.69 5.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.761 . . . . 2.2799999999999998 109.482 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 3.4 mmp_? -105.37 111.78 24.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.075 -0.966 . . . . 4.3799999999999999 110.823 -173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.6 p -81.2 122.43 27.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.099 -0.501 . . . . 3.77 110.379 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.99 67.32 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.743 -0.943 . . . . 3.48 110.743 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 59.2 t -122.33 140.66 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.239 -0.481 . . . . 3.0699999999999998 109.742 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 178' ' ' ARG . 44.3 p -86.78 168.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.054 -0.721 . . . . 3.0 109.054 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.712 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -59.53 -24.93 29.9 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 N-CA-C 108.703 -0.851 . . . . 2.46 108.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.418 ' HB3' ' OG1' ' A' ' 176' ' ' THR . 9.5 tmm_? -56.19 -60.57 3.31 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.516 0.561 . . . . 4.9100000000000001 112.516 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.53 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 1.9 t70 -64.52 -48.51 74.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.152 0.977 . . . . 2.8700000000000001 110.607 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.62 ' OG ' HG23 ' A' ' 214' ' ' ILE . 1.3 m -61.31 -50.82 71.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.268 -1.333 . . . . 2.3100000000000001 110.496 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.712 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.9 mm? -68.82 -24.25 64.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.677 -0.692 . . . . 1.75 111.594 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 186' ' ' MET . 0.0 OUTLIER -54.94 -41.93 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.642 -0.503 . . . . 3.3999999999999999 109.642 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 187' ' ' MET . 19.9 tttt -65.07 -52.21 56.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.648 -0.421 . . . . 3.0899999999999999 110.155 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 167' ' ' THR . . . -47.52 -52.4 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 1.4299999999999999 111.683 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 91.0 mt -69.33 -54.34 15.07 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.263 -0.881 . . . . 2.1600000000000001 110.919 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 5.2 mmt -62.54 -21.36 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.683 0.994 . . . . 2.4900000000000002 113.683 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 47.1 mtm -67.93 -28.85 67.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.5 110.225 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.578 ' HD2' ' NE2' ' A' ' 165' ' ' GLN . 22.9 mtp180 -95.44 -2.69 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.265 0.555 . . . . 5.0599999999999996 111.204 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.13 15.76 64.17 Favored Glycine 0 C--N 1.315 -0.583 0 CA-C-N 115.319 -0.855 . . . . 2.4900000000000002 111.731 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 185' ' ' LEU . 16.6 mt -86.11 159.78 19.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.324 -0.438 . . . . 2.8399999999999999 109.985 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.65 143.15 37.42 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 2.5499999999999998 111.564 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.37 -4.51 15.14 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.113 2.542 . . . . 2.0800000000000001 112.628 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -71.5 -39.71 70.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.999 -0.546 . . . . 3.3199999999999998 111.035 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.62 37.5 4.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.285 -0.416 . . . . 3.3399999999999999 111.466 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 86.1 m -136.86 163.51 30.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.512 -0.551 . . . . 1.9099999999999999 109.512 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.9 139.73 41.8 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 111.195 0.072 . . . . 1.8799999999999999 111.195 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.581 HG21 HD13 ' A' ' 208' ' ' ILE . 1.3 m -102.48 129.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.323 1.058 . . . . 2.0099999999999998 111.075 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -120.81 170.53 9.37 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.74 -1.573 . . . . 3.2200000000000002 110.059 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -150.88 131.1 13.58 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.526 -0.761 . . . . 3.1200000000000001 109.295 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -83.57 124.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.353 0.597 . . . . 2.75 110.167 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.4 tt0 -111.25 -139.45 0.38 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.508 -1.294 . . . . 3.5499999999999998 107.508 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.17 82.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.702 0.63 . . . . 4.0199999999999996 112.702 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 7.99 10.6 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 113.578 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.69 -179.02 5.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 117.463 0.632 . . . . 3.48 111.895 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.9 mtpt -111.96 140.13 46.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.181 -0.918 . . . . 2.9700000000000002 111.064 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.83 115.51 33.46 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.372 -0.831 . . . . 3.54 109.417 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.46 123.46 6.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.87 1.714 . . . . 2.6800000000000002 111.739 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 197' ' ' VAL . 16.0 mt -94.04 159.33 2.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 1.9099999999999999 111.301 -173.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -92.39 151.27 20.56 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.985 -0.846 . . . . 2.4700000000000002 110.985 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.519 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 80.5 m95 -76.98 -12.95 60.01 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.506 0.558 . . . . 2.3999999999999999 112.506 -172.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.74 12.56 36.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.08 0.467 . . . . 3.79 110.574 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.9 m -79.23 131.48 36.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.868 -0.606 . . . . 2.6099999999999999 110.316 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 17.5 t70 -61.71 117.9 6.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 3.4700000000000002 109.921 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.62 HG23 ' OG ' ' A' ' 180' ' ' SER . 5.8 tt -74.11 -16.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.455 . . . . 2.02 111.889 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 20.7 t -67.54 -18.61 65.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.461 0.648 . . . . 3.1899999999999999 109.94 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 20.0 t90 -77.83 -18.21 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.839 -0.618 . . . . 5.5099999999999998 110.385 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.1 mt -102.79 14.04 32.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.091 -0.504 . . . . 2.5600000000000001 111.211 -171.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 m -60.96 153.31 25.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 2.2000000000000002 110.435 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.72 24.63 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.977 -0.556 . . . . 2.1400000000000001 113.576 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.571 ' O ' HG21 ' A' ' 157' ' ' VAL . 16.0 mm-40 -99.44 166.12 11.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.13 -0.322 . . . . 2.6099999999999999 110.13 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.92 126.61 55.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.065 -0.717 . . . . 3.0600000000000001 109.065 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.74 156.4 16.35 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.491 -0.777 . . . . 1.9199999999999999 109.571 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -132.65 117.25 17.66 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.036 -0.728 . . . . 4.0999999999999996 109.036 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 45.9 t -101.31 133.37 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.585 0.707 . . . . 1.5800000000000001 110.895 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.3 174.4 5.89 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.326 -1.306 . . . . 2.7400000000000002 108.033 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 16.4 t . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 110.276 -0.268 . . . . 3.0099999999999998 110.276 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.895 -0.409 . . . . 7.3300000000000001 109.895 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.84 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.671 2.248 . . . . 5.8700000000000001 111.748 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -65.76 131.84 47.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.798 -0.637 . . . . 5.2400000000000002 110.493 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.45 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -120.16 105.58 42.07 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 4.8099999999999996 110.108 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 55.5 Cg_endo -88.18 134.28 3.0 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.691 2.927 . . . . 2.8599999999999999 112.034 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.6 pp -139.87 161.16 26.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.908 0.385 . . . . 2.3500000000000001 110.948 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.6 t -125.32 117.8 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.297 -0.631 . . . . 2.3599999999999999 109.297 170.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -82.63 103.69 12.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.438 0.637 . . . . 4.0300000000000002 110.51 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.413 HG12 ' CD1' ' A' ' 181' ' ' LEU . 77.1 t -92.54 116.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.071 -0.968 . . . . 1.3999999999999999 111.507 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 4.1 m-85 -77.32 103.71 7.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.076 0.941 . . . . 2.79 109.641 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.576 HD12 ' HB ' ' A' ' 167' ' ' THR . 3.7 mt -70.53 166.68 33.23 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.067 -1.424 . . . . 2.6200000000000001 110.677 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 85.3 Cg_exo -50.81 154.25 7.2 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.566 2.177 . . . . 2.27 111.954 172.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 15.1 m120 69.06 23.92 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 3.75 110.905 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 60.81 31.35 20.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.666 -0.697 . . . . 5.0 112.684 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.88 178.85 5.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.396 -0.965 . . . . 3.9199999999999999 108.396 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -148.95 140.01 23.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 3.75 111.148 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -130.43 136.45 49.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.309 -0.859 . . . . 2.2000000000000002 108.724 169.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 1.3 m -99.28 140.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.023 -0.671 . . . . 2.6200000000000001 110.091 178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.442 ' HA ' ' HZ1' ' A' ' 183' ' ' LYS . 3.3 p -123.4 123.08 26.58 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.952 -0.567 . . . . 2.2000000000000002 109.476 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 7.5 Cg_endo -50.71 129.59 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.632 2.221 . . . . 2.27 110.954 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -60.0 107.6 0.65 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.501 0.667 . . . . 2.2799999999999998 109.595 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.2 mmp_? -90.51 112.24 23.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.048 -0.978 . . . . 4.3799999999999999 110.512 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.16 122.49 28.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 3.77 110.396 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.51 11.31 60.96 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.228 -1.149 . . . . 3.48 110.228 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 172' ' ' ARG . 94.8 t -123.62 143.08 38.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.92 -0.64 . . . . 3.0699999999999998 109.616 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.658 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 36.7 p -91.92 168.99 11.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.783 -0.644 . . . . 3.0 109.508 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.656 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 17.7 t -56.09 -31.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.185 -0.672 . . . . 2.46 109.185 173.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 15.8 tpt180 -52.67 -53.81 42.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.347 -0.842 . . . . 4.9100000000000001 112.581 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -74.64 -44.47 50.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.645 0.736 . . . . 2.8700000000000001 110.966 -174.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 p -64.51 -52.39 58.08 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.966 -1.015 . . . . 2.3100000000000001 110.584 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -68.41 -23.64 64.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.318 -0.856 . . . . 1.75 111.599 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.501 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.43 -44.33 72.36 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.381 -0.6 . . . . 3.3999999999999999 109.381 176.333 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.501 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 27.4 ttpt -64.01 -47.8 78.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.313 -0.555 . . . . 3.0899999999999999 109.991 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.09 -52.25 45.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.431 -0.804 . . . . 1.4299999999999999 112.026 -175.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.33 -48.75 66.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.71 0.29 . . . . 2.1600000000000001 110.789 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -29.38 68.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.792 . . . . 2.4900000000000002 113.14 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 41.6 mtm -70.15 -29.75 66.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 2.5 110.26 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.587 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 2.5 mmp_? -83.74 -13.97 52.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.682 . . . . 5.0599999999999996 110.48 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.53 14.48 47.18 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.425 -0.807 . . . . 2.4900000000000002 111.281 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.17 173.72 6.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.934 0.397 . . . . 2.8399999999999999 110.424 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.4 140.94 34.97 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.937 -0.574 . . . . 2.5499999999999998 111.085 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.79 -4.31 14.84 Favored 'Trans proline' 0 CA--C 1.526 0.114 0 C-N-CA 122.892 2.394 . . . . 2.0800000000000001 112.296 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.38 -52.17 29.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 3.3199999999999998 110.753 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.2 m -100.37 27.62 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.205 -0.907 . . . . 3.3399999999999999 111.267 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.611 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.0 m -128.32 151.72 48.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 1.9099999999999999 109.88 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.492 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -121.53 151.91 39.79 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.47 0.176 . . . . 1.8799999999999999 111.043 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.551 HG11 HD13 ' A' ' 208' ' ' ILE . 44.3 t -110.73 122.99 66.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 2.0099999999999998 110.859 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.444 ' CD2' ' HG3' ' A' ' 225' ' ' GLU . 11.4 m-85 -126.29 157.45 38.31 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.674 -1.148 . . . . 3.2200000000000002 109.745 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.576 ' HD2' HD11 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -142.56 144.84 33.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 120.542 -0.463 . . . . 3.1200000000000001 110.203 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.679 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 47.7 mm -86.81 122.89 39.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.609 -0.723 . . . . 2.75 110.175 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.9 tt0 -104.23 -138.92 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.658 -1.238 . . . . 3.5499999999999998 107.658 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.18 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.02 0.528 . . . . 4.0199999999999996 112.214 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.33 8.43 9.11 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.184 -0.462 . . . . 3.6699999999999999 113.24 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -137.17 -179.38 5.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.452 0.626 . . . . 3.48 112.049 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.679 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -106.92 136.98 45.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 2.9700000000000002 111.515 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.425 ' O ' ' HD3' ' A' ' 199' ' ' ARG . 34.8 mmtp -125.7 117.8 24.45 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 114.68 -1.146 . . . . 3.54 108.766 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.39 136.37 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.092 1.861 . . . . 2.6800000000000002 112.171 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.576 HD11 ' HD2' ' A' ' 199' ' ' ARG . 43.6 mt -102.05 152.65 5.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.637 -0.71 . . . . 1.9099999999999999 111.543 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 145.41 17.68 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.008 -0.837 . . . . 2.4700000000000002 111.008 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.658 ' O ' ' HB ' ' A' ' 176' ' ' THR . 98.4 m95 -69.76 -17.53 63.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.059 0.392 . . . . 2.3999999999999999 112.059 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.1 4.03 54.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.906 0.384 . . . . 3.79 110.956 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.0 m -75.42 128.91 36.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.015 -0.538 . . . . 2.6099999999999999 110.418 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.522 ' OD2' ' HB2' ' A' ' 215' ' ' SER . 16.0 t70 -62.43 115.47 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 3.4700000000000002 109.849 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 214' ' ' ILE . 5.0 tt -66.81 -15.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.946 -0.57 . . . . 2.02 112.043 -173.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.522 ' HB2' ' OD2' ' A' ' 213' ' ' ASP . 17.0 m -75.84 -9.93 59.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.951 -0.468 . . . . 3.1899999999999999 111.876 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -81.32 -27.95 34.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 5.5099999999999998 109.64 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -87.81 5.63 39.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.022 -0.99 . . . . 2.5600000000000001 111.9 -174.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.463 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.2 m -58.45 151.51 19.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.877 0.37 . . . . 2.2000000000000002 110.273 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.66 -9.99 57.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.844 -0.693 . . . . 2.1400000000000001 112.997 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -106.35 155.44 19.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.896 0.379 . . . . 2.6099999999999999 111.185 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -102.55 124.5 48.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.659 -0.867 . . . . 3.0600000000000001 108.659 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.444 ' HG ' ' CG1' ' A' ' 157' ' ' VAL . 46.5 mt -96.49 172.18 8.09 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.642 -0.708 . . . . 1.9199999999999999 109.912 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 16.8 p80 -153.15 136.38 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.499 -0.556 . . . . 4.0999999999999996 109.499 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.611 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 86.6 t -102.39 135.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.362 0.601 . . . . 1.5800000000000001 111.266 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.444 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 5.5 mm-40 -108.18 120.48 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.079 -0.964 . . . . 2.7400000000000002 109.31 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.7 m -70.35 113.31 6.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.375 -0.53 . . . . 3.0099999999999998 111.593 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 196' ' ' ALA . 6.8 mt -83.96 93.61 8.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.251 -0.648 . . . . 3.1899999999999999 109.251 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.17 94.96 7.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.135 0.493 . . . . 4.2699999999999996 110.749 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -135.93 43.59 2.54 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.278 -0.873 . . . . 6.0199999999999996 109.201 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.8 m -70.23 146.03 94.14 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.474 -1.239 . . . . 6.8799999999999999 111.017 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 69.39 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.938 2.425 . . . . 8.5800000000000001 111.752 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 tt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.361 -0.828 . . . . 10.369999999999999 108.898 -177.767 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.685 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.214 -0.291 . . . . 7.3300000000000001 110.214 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.02 -40.09 74.26 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.134 2.556 . . . . 5.8700000000000001 112.54 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -104.64 103.51 13.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.384 -0.371 . . . . 5.2400000000000002 110.049 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -98.39 110.88 58.33 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.199 -0.455 . . . . 4.8099999999999996 110.429 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.22 129.14 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.382 2.055 . . . . 2.8599999999999999 112.001 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.465 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -136.09 162.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.875 0.369 . . . . 2.3500000000000001 111.004 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.459 HG22 ' HA ' ' A' ' 218' ' ' THR . 26.0 t -126.69 127.59 70.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.017 -0.735 . . . . 2.3599999999999999 109.017 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 86.0 mtm180 -88.79 107.62 19.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.357 0.599 . . . . 4.0300000000000002 110.244 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.6 t -94.85 122.95 46.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.265 -0.879 . . . . 1.3999999999999999 111.433 -176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 4.4 m-85 -87.22 102.91 14.93 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.61 -0.436 . . . . 2.79 110.226 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -63.21 167.79 5.95 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 2.6200000000000001 110.432 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 75.5 Cg_exo -50.52 158.24 2.84 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.101 1.868 . . . . 2.27 110.919 168.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 t30 70.31 13.08 7.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.392 0.615 . . . . 3.75 110.361 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.69 40.39 16.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.356 -0.838 . . . . 5.0 112.941 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 3.4 mt-30 -98.96 174.2 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.635 -0.876 . . . . 3.9199999999999999 108.635 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.5 ptt180 -139.44 130.27 26.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.892 0.769 . . . . 3.75 111.916 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 184' ' ' ALA . 0.5 OUTLIER -128.67 136.1 50.18 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.993 -1.003 . . . . 2.2000000000000002 108.479 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 156' ' ' ILE . 3.9 t -94.46 144.79 9.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.616 -0.434 . . . . 2.6200000000000001 110.681 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.436 ' HA ' ' HZ1' ' A' ' 183' ' ' LYS . 6.2 p -137.56 124.72 13.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.048 -0.524 . . . . 2.2000000000000002 110.009 175.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.485 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 8.5 Cg_endo -50.88 133.33 39.68 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.097 2.531 . . . . 2.27 112.234 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.487 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -61.45 110.58 1.49 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.2799999999999998 109.546 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.635 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.4 mmp_? -98.98 112.02 24.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.537 -0.756 . . . . 4.3799999999999999 111.428 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.9 p -76.5 135.93 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.779 -0.646 . . . . 3.77 110.321 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 15.21 78.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.99 -0.844 . . . . 3.48 110.99 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.507 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 86.7 t -128.11 143.86 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.228 -0.656 . . . . 3.0699999999999998 109.228 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.514 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 71.1 p -94.78 169.68 9.98 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.919 -0.771 . . . . 3.0 108.919 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.747 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -60.65 -22.88 27.16 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.753 -0.832 . . . . 2.46 108.753 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 38.2 tpt85 -62.31 -41.55 98.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 112.116 0.413 . . . . 4.9100000000000001 112.116 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.506 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 6.7 t70 -77.48 -51.91 9.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.816 0.817 . . . . 2.8700000000000001 109.957 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.451 ' OG ' HG23 ' A' ' 214' ' ' ILE . 47.6 m -63.64 -45.54 89.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 2.3100000000000001 111.101 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.747 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -72.25 -27.12 62.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.071 -0.513 . . . . 1.75 111.718 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.689 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 1.0 OUTLIER -55.32 -43.22 74.69 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.27 -0.572 . . . . 3.3999999999999999 109.841 178.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.436 ' HZ1' ' HA ' ' A' ' 169' ' ' VAL . 22.5 ttpt -65.57 -46.88 77.73 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.412 -0.515 . . . . 3.0899999999999999 109.995 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -50.82 -49.62 58.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.446 -0.797 . . . . 1.4299999999999999 111.569 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.14 -53.4 30.96 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.671 -0.695 . . . . 2.1600000000000001 110.61 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.06 65.31 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.902 0.704 . . . . 2.4900000000000002 112.902 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 43.1 mtm -66.22 -35.1 79.54 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.528 -0.469 . . . . 2.5 110.789 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -90.92 -0.23 57.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.251 0.548 . . . . 5.0599999999999996 111.431 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.19 66.96 Favored Glycine 0 C--N 1.314 -0.654 0 CA-C-N 115.146 -0.934 . . . . 2.4900000000000002 111.679 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.51 160.58 16.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.199 -0.5 . . . . 2.8399999999999999 109.661 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 193' ' ' GLU . 44.5 pt -126.44 141.37 39.84 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.507 . . . . 2.5499999999999998 111.56 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.71 -10.23 24.81 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 123.188 2.592 . . . . 2.0800000000000001 112.471 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.492 ' HB2' HD11 ' A' ' 191' ' ' ILE . 32.7 mt-10 -64.63 -35.36 80.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.958 -0.564 . . . . 3.3199999999999998 111.322 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 58.7 m -118.26 16.47 13.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.316 0.487 . . . . 3.3399999999999999 112.316 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 63.6 m -124.49 164.34 19.95 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.576 -0.45 . . . . 1.9099999999999999 110.896 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.523 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -129.14 154.52 46.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 116.474 -0.33 . . . . 1.8799999999999999 111.424 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.575 HG11 HD13 ' A' ' 208' ' ' ILE . 43.4 t -112.8 129.03 69.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.652 0.739 . . . . 2.0099999999999998 111.329 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -128.92 162.2 28.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.714 -1.13 . . . . 3.2200000000000002 110.099 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -139.95 134.49 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.669 -0.493 . . . . 3.1200000000000001 109.669 172.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -92.26 122.86 44.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.393 0.616 . . . . 2.75 110.863 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.9 tt0 -102.04 -141.15 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.436 -0.949 . . . . 3.5499999999999998 108.436 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.54 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.184 0.594 . . . . 4.0199999999999996 111.822 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.48 6.03 7.56 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.52 -0.309 . . . . 3.6699999999999999 112.757 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 16.6 pt-20 -120.16 -178.72 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.074 0.464 . . . . 3.48 111.301 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.59 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 39.2 mtpt -123.54 141.97 51.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.9700000000000002 110.635 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.63 120.69 23.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.747 -0.834 . . . . 3.54 108.747 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.21 130.94 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.968 1.779 . . . . 2.6800000000000002 112.217 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.575 HD13 HG11 ' A' ' 197' ' ' VAL . 65.6 mt -99.76 157.4 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.324 -0.853 . . . . 1.9099999999999999 111.484 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.11 147.33 18.54 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.146 -1.181 . . . . 2.4700000000000002 110.146 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.532 ' HA ' HG21 ' A' ' 177' ' ' VAL . 91.5 m95 -69.93 -13.37 62.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.312 0.556 . . . . 2.3999999999999999 112.064 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.42 8.31 45.03 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 120.952 0.406 . . . . 3.79 110.622 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -76.63 129.26 36.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.07 -0.513 . . . . 2.6099999999999999 110.328 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.86 110.44 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 3.4700000000000002 110.377 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.451 HG23 ' OG ' ' A' ' 180' ' ' SER . 3.4 tt -62.29 -17.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 2.02 111.127 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.487 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 8.0 p -66.29 -16.32 63.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.067 -0.515 . . . . 3.1899999999999999 112.185 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -86.17 -31.19 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 5.5099999999999998 110.702 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.533 HD22 ' H ' ' A' ' 217' ' ' LEU . 1.1 mm? -86.58 15.02 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.214 -0.448 . . . . 2.5600000000000001 111.766 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.459 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -56.81 151.64 13.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 2.2000000000000002 110.451 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.65 -1.5 72.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.067 -0.587 . . . . 2.1400000000000001 112.96 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -115.27 165.51 12.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.012 0.434 . . . . 2.6099999999999999 111.069 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.425 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.6 mp0 -113.23 124.79 53.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.768 -0.651 . . . . 3.0600000000000001 109.388 172.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.97 167.91 10.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.568 -0.742 . . . . 1.9199999999999999 110.439 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.84 129.34 24.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.293 -0.632 . . . . 4.0999999999999996 109.293 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.523 HG11 ' O ' ' A' ' 196' ' ' ALA . 89.8 t -104.58 136.7 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.329 0.585 . . . . 1.5800000000000001 110.383 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.56 171.1 7.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.725 -1.213 . . . . 2.7400000000000002 107.725 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 61.8 t -115.01 129.79 70.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.409 -0.589 . . . . 3.0099999999999998 109.409 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.17 81.12 3.68 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.169 0.509 . . . . 3.1899999999999999 110.183 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -99.29 115.73 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.667 -0.697 . . . . 4.2699999999999996 111.06 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.3 m120 56.58 53.54 8.4 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.517 0.675 . . . . 6.0199999999999996 111.454 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.2 m -87.57 154.34 53.52 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.022 -0.99 . . . . 6.8799999999999999 109.729 175.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.08 65.88 2.58 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.06 2.506 . . . . 8.5800000000000001 112.058 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.531 -0.747 . . . . 10.369999999999999 109.412 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.673 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.164 -0.31 . . . . 7.3300000000000001 110.164 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.08 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.774 2.316 . . . . 5.8700000000000001 111.305 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.98 123.5 19.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.393 -0.367 . . . . 5.2400000000000002 111.077 -174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 118.81 70.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 4.8099999999999996 110.912 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 82.9 Cg_endo -76.88 147.95 27.73 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.813 2.342 . . . . 2.8599999999999999 111.595 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 1.7 pp -142.89 152.57 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.178 0.513 . . . . 2.3500000000000001 111.79 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.4 t -118.95 123.13 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.303 -0.999 . . . . 2.3599999999999999 108.303 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.493 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 68.4 mtm180 -86.31 101.65 13.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.602 0.715 . . . . 4.0300000000000002 110.687 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 74.8 t -91.91 121.24 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.803 -1.09 . . . . 1.3999999999999999 111.795 -173.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.8 m-85 -84.63 102.72 13.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.312 0.577 . . . . 2.79 109.813 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.639 ' CD1' ' HD2' ' A' ' 188' ' ' ARG . 15.0 mt -66.2 163.59 37.39 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.933 -1.031 . . . . 2.6200000000000001 111.366 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -45.18 145.6 3.33 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.179 2.586 . . . . 2.27 113.0 173.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.416 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 93.6 m-20 64.03 43.52 5.12 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.567 -0.742 . . . . 3.75 111.442 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.482 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.5 mppt? 57.68 32.56 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.27 -1.332 . . . . 5.0 112.238 168.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.501 ' OE1' ' HD3' ' A' ' 188' ' ' ARG . 33.0 mt-30 -94.31 172.8 7.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.653 -0.703 . . . . 3.9199999999999999 109.186 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.1 ptt180 -148.99 137.87 21.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.567 0.699 . . . . 3.75 112.122 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.557 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -139.74 133.89 31.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.615 -1.175 . . . . 2.2000000000000002 108.337 172.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -97.67 137.11 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.258 -0.645 . . . . 2.6200000000000001 109.258 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 6.5 p -123.87 130.6 24.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.836 -0.431 . . . . 2.2000000000000002 109.836 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 155' ' ' PRO . 6.6 Cg_endo -50.21 129.2 24.8 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.905 2.403 . . . . 2.27 111.738 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -70.8 77.98 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.36 -0.836 . . . . 2.2799999999999998 110.303 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.664 ' O ' HG13 ' A' ' 175' ' ' VAL . 6.8 mtm180 -59.32 133.56 56.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.402 -1.272 . . . . 4.3799999999999999 110.664 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 2.8 p -95.54 135.66 36.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.342 -0.39 . . . . 3.77 110.748 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.49 22.31 70.45 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.65 -0.786 . . . . 3.48 111.433 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.664 HG13 ' O ' ' A' ' 172' ' ' ARG . 2.9 p -123.34 171.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.655 -0.498 . . . . 3.0699999999999998 109.655 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.656 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 43.3 p -105.43 160.24 15.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.594 -0.521 . . . . 3.0 109.594 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 7.3 t -53.59 -33.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.962 -0.755 . . . . 2.46 108.962 171.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -55.15 -49.9 70.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.652 -0.704 . . . . 4.9100000000000001 112.62 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.528 ' HB3' HG21 ' A' ' 175' ' ' VAL . 15.3 t70 -71.46 -47.49 55.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.866 0.841 . . . . 2.8700000000000001 110.514 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 m -65.13 -47.89 75.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.118 -0.946 . . . . 2.3100000000000001 111.026 -177.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.6 mm? -68.58 -25.22 64.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.486 -0.325 . . . . 1.75 111.565 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.03 -39.09 68.78 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.427 -0.583 . . . . 3.3999999999999999 109.427 175.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.664 ' HE3' ' SD ' ' A' ' 187' ' ' MET . 33.5 tttp -67.39 -48.36 67.62 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.575 -0.45 . . . . 3.0899999999999999 110.27 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.556 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -49.98 -55.58 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.553 -0.749 . . . . 1.4299999999999999 112.097 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.411 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 1.1 mm? -63.17 -53.09 58.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 2.1600000000000001 110.657 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.4 mmt -58.17 -27.83 64.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.543 0.942 . . . . 2.4900000000000002 113.543 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.664 ' SD ' ' HE3' ' A' ' 183' ' ' LYS . 58.7 mtm -67.86 -22.2 65.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.513 -0.475 . . . . 2.5 111.285 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.639 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 45.1 mtt-85 -112.81 16.28 19.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.741 0.781 . . . . 5.0599999999999996 111.713 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.54 25.34 75.6 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.419 -1.264 . . . . 2.4900000000000002 111.892 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.411 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.6 mt -96.18 163.51 13.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.629 -0.878 . . . . 2.8399999999999999 108.629 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.8 138.26 32.51 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.964 0.411 . . . . 2.5499999999999998 111.058 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.32 -8.49 23.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.036 2.49 . . . . 2.0800000000000001 112.634 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.154 0.502 . . . . 3.3199999999999998 110.301 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 61.5 m -101.73 21.52 14.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.598 -0.728 . . . . 3.3399999999999999 111.184 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.565 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 69.4 m -129.59 149.31 51.41 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.893 -0.323 . . . . 1.9099999999999999 110.929 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -125.39 155.9 39.63 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.329 -0.396 . . . . 1.8799999999999999 110.608 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.566 HG11 HD13 ' A' ' 208' ' ' ILE . 36.2 t -115.15 124.97 72.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.162 -0.615 . . . . 2.0099999999999998 111.66 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.84 164.52 18.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.014 -0.994 . . . . 3.2200000000000002 110.095 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -141.78 131.82 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.733 -0.469 . . . . 3.1200000000000001 109.733 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.624 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -90.63 122.16 41.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.147 -0.479 . . . . 2.75 110.655 -175.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 203' ' ' GLY . 5.6 tt0 -103.0 -137.07 0.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.494 -0.928 . . . . 3.5499999999999998 108.494 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.45 78.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.435 0.694 . . . . 4.0199999999999996 112.117 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.57 10.19 16.41 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.421 -0.354 . . . . 3.6699999999999999 112.255 -177.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 17.0 pt-20 -120.56 179.29 4.37 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 121.183 0.516 . . . . 3.48 111.398 -172.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.624 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 40.9 mtpt -124.96 137.42 54.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.317 -0.856 . . . . 2.9700000000000002 110.488 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -121.17 117.26 30.71 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.408 -0.814 . . . . 3.54 108.983 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.76 133.84 19.17 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 121.931 1.754 . . . . 2.6800000000000002 111.932 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.566 HD13 HG11 ' A' ' 197' ' ' VAL . 72.2 mt -105.84 154.34 7.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 1.9099999999999999 112.097 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 151.43 19.48 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.63 -0.988 . . . . 2.4700000000000002 110.63 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.656 ' O ' ' HB ' ' A' ' 176' ' ' THR . 95.8 m95 -74.97 -13.04 60.47 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.684 0.624 . . . . 2.3999999999999999 112.684 -172.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.466 ' HA ' HG21 ' A' ' 176' ' ' THR . 3.2 p30 -102.11 9.44 40.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.161 0.505 . . . . 3.79 110.874 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -69.76 136.76 51.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.702 -0.681 . . . . 2.6099999999999999 109.292 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.74 107.07 3.32 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.809 -0.441 . . . . 3.4700000000000002 109.809 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.468 ' HA ' HD21 ' A' ' 217' ' ' LEU . 1.0 OUTLIER -58.66 -17.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 2.02 111.23 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 5.7 p -66.48 -8.74 28.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.101 -0.499 . . . . 3.1899999999999999 111.989 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -90.21 -34.53 15.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.026 0.441 . . . . 5.5099999999999998 110.629 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 217' ' ' LEU . 1.4 mm? -85.82 13.77 6.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.064 -0.517 . . . . 2.5600000000000001 112.066 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.465 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -51.97 150.08 4.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.502 . . . . 2.2000000000000002 111.617 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.1 -31.61 2.04 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.485 -0.78 . . . . 2.1400000000000001 113.208 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.87 163.04 25.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.575 0.702 . . . . 2.6099999999999999 111.672 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 22.6 mt-10 -105.36 114.96 29.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.958 -1.019 . . . . 3.0600000000000001 108.703 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.83 155.83 16.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.811 -0.811 . . . . 1.9199999999999999 108.811 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.84 120.08 29.55 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.614 -0.513 . . . . 4.0999999999999996 109.614 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 75.4 t -100.66 133.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.402 0.62 . . . . 1.5800000000000001 110.172 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -107.23 159.8 16.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.717 -1.129 . . . . 2.7400000000000002 108.68 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.52 109.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.201 1.0 . . . . 3.0099999999999998 110.603 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' A' ' 196' ' ' ALA . 15.7 mt -78.54 81.07 4.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.344 -1.298 . . . . 3.1899999999999999 111.012 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -82.15 96.86 7.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.905 -0.589 . . . . 4.2699999999999996 109.52 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -113.63 61.28 0.65 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.547 . . . . 6.0199999999999996 110.535 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.4 m 38.35 70.28 1.32 Allowed Pre-proline 0 N--CA 1.468 0.437 0 O-C-N 124.716 1.26 . . . . 6.8799999999999999 112.937 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.18 148.8 92.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.554 2.169 . . . . 8.5800000000000001 111.692 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.571 -0.728 . . . . 10.369999999999999 110.118 -179.238 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.668 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.984 -0.376 . . . . 7.3300000000000001 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.58 104.81 0.23 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.834 2.356 . . . . 5.8700000000000001 111.848 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -104.48 99.58 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 5.2400000000000002 109.612 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -90.55 120.19 68.97 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 116.232 -0.44 . . . . 4.8099999999999996 110.278 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.83 140.38 12.82 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.468 2.112 . . . . 2.8599999999999999 111.583 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.4 pp -138.37 160.23 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.967 0.413 . . . . 2.3500000000000001 111.152 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -134.51 127.3 49.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.566 0.698 . . . . 2.3599999999999999 109.122 170.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.471 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 66.6 mtm180 -88.88 107.84 19.22 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.997 -1.001 . . . . 4.0300000000000002 111.238 -171.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.427 HG11 HD13 ' A' ' 161' ' ' LEU . 56.7 t -97.2 122.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.757 -1.11 . . . . 1.3999999999999999 111.62 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 4.3 m-85 -90.73 102.8 15.55 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 122.027 -0.421 . . . . 2.79 110.396 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 167' ' ' THR . 0.0 OUTLIER -67.95 169.89 8.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 2.6200000000000001 111.166 -175.472 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 54.4 Cg_exo -52.72 154.97 11.28 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.087 1.858 . . . . 2.27 110.095 165.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 162' ' ' PRO . 9.5 t30 78.2 10.86 1.93 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.676 0.75 . . . . 3.75 109.912 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 62.23 32.95 17.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.277 -0.874 . . . . 5.0 112.8 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -102.11 -178.73 3.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.462 -0.569 . . . . 3.9199999999999999 109.462 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 21.6 ptt180 -139.57 137.59 35.51 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.652 0.739 . . . . 3.75 111.343 175.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.629 ' N ' HD23 ' A' ' 161' ' ' LEU . 0.4 OUTLIER -129.51 127.54 41.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.963 -1.495 . . . . 2.2000000000000002 106.963 170.619 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.471 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -94.86 135.48 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.883 -0.784 . . . . 2.6200000000000001 108.883 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.01 128.68 25.82 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.878 -0.416 . . . . 2.2000000000000002 109.878 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.479 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 9.4 Cg_endo -51.81 132.58 42.39 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.832 2.355 . . . . 2.27 110.944 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -64.1 88.4 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.641 -0.708 . . . . 2.2799999999999998 110.371 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 42.8 mmt180 -68.09 111.28 4.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.993 -1.003 . . . . 4.3799999999999999 110.939 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.464 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 12.8 p -77.88 130.75 37.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.045 -0.525 . . . . 3.77 109.882 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.63 4.54 87.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.607 -0.806 . . . . 3.48 111.228 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 1.6 t -118.66 144.18 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.371 0.605 . . . . 3.0699999999999998 110.041 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 10.9 p -93.8 173.22 7.79 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.378 -0.828 . . . . 3.0 109.265 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 44.9 t -50.47 -33.81 11.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.512 -0.551 . . . . 2.46 109.512 171.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.618 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 12.1 tpt180 -48.98 -62.68 1.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.404 -0.816 . . . . 4.9100000000000001 112.934 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.681 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 10.6 t70 -75.78 -36.5 59.78 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.513 0.673 . . . . 2.8700000000000001 111.493 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 p -65.63 -49.93 66.88 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.669 0.747 . . . . 2.3100000000000001 110.105 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.6 mm? -68.71 -22.23 64.36 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.303 -0.862 . . . . 1.75 111.601 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.1 mtpt -48.52 -51.12 28.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.311 -0.625 . . . . 3.3999999999999999 109.311 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 187' ' ' MET . 24.7 tttp -59.88 -51.44 69.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.655 -0.418 . . . . 3.0899999999999999 110.729 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.572 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.75 -49.23 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.741 -0.663 . . . . 1.4299999999999999 112.132 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -47.4 54.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.106 -0.497 . . . . 2.1600000000000001 111.076 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.403 ' HA ' ' CE ' ' A' ' 186' ' ' MET . 0.3 OUTLIER -59.19 -27.72 65.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.391 0.515 . . . . 2.4900000000000002 112.391 -177.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 42.3 mtm -73.14 -32.91 65.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.71 -0.396 . . . . 2.5 110.352 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.45 ' CG ' ' HG ' ' A' ' 161' ' ' LEU . 14.2 mmm180 -74.77 -22.6 58.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.214 0.531 . . . . 5.0599999999999996 110.76 171.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.51 12.84 37.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.661 -0.7 . . . . 2.4900000000000002 111.401 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.4 mp -106.28 176.78 5.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 2.8399999999999999 110.54 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.467 HD12 ' SG ' ' A' ' 194' ' ' CYS . 46.2 pt -124.97 144.49 47.2 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 121.09 0.472 . . . . 2.5499999999999998 110.514 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.27 -3.8 12.43 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 123.352 2.701 . . . . 2.0800000000000001 112.796 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.415 ' HB2' HD11 ' A' ' 191' ' ' ILE . 19.7 mt-10 -86.2 -28.12 24.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.094 -0.503 . . . . 3.3199999999999998 110.773 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.467 ' SG ' HD12 ' A' ' 191' ' ' ILE . 74.6 m -111.66 18.98 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 3.3399999999999999 111.267 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 68.9 m -131.35 163.8 27.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.547 -0.538 . . . . 1.9099999999999999 109.547 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.6 ' HB2' ' CD2' ' A' ' 227' ' ' LEU . . . -129.65 146.27 51.45 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 111.24 0.089 . . . . 1.8799999999999999 111.24 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.631 ' CG2' ' HB ' ' A' ' 208' ' ' ILE . 1.3 m -111.21 130.67 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.449 1.119 . . . . 2.0099999999999998 111.421 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -123.69 164.99 18.0 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.489 -1.687 . . . . 3.2200000000000002 109.82 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 199' ' ' ARG . 2.8 ptm180 -147.2 133.44 19.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.108 -0.701 . . . . 3.1200000000000001 109.108 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.57 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -83.91 118.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.255 0.55 . . . . 2.75 110.524 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.6 tt0 -101.45 -140.86 0.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.585 -1.265 . . . . 3.5499999999999998 107.585 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.15 81.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.552 0.575 . . . . 4.0199999999999996 112.552 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.62 7.65 16.38 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.163 -0.471 . . . . 3.6699999999999999 113.06 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 12.7 pt-20 -131.1 -179.39 5.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 117.346 0.573 . . . . 3.48 111.324 -174.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.57 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 27.8 mtpt -114.05 138.08 50.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.502 -0.772 . . . . 2.9700000000000002 110.611 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.69 111.22 39.64 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.376 -0.829 . . . . 3.54 109.619 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.73 121.71 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.85 1.7 . . . . 2.6800000000000002 111.462 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.631 ' HB ' ' CG2' ' A' ' 197' ' ' VAL . 13.2 mt -93.75 158.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.494 -0.776 . . . . 1.9099999999999999 111.361 -171.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.487 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -92.22 144.23 17.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 2.4700000000000002 110.935 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.527 ' O ' ' HB ' ' A' ' 176' ' ' THR . 92.8 m95 -72.77 -14.88 61.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 111.955 0.354 . . . . 2.3999999999999999 111.955 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -98.72 20.26 13.33 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.423 0.63 . . . . 3.79 110.397 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.8 m -85.26 127.07 34.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.367 -0.833 . . . . 2.6099999999999999 109.874 176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.31 109.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 3.4700000000000002 109.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.435 HG22 ' O ' ' A' ' 175' ' ' VAL . 6.7 tt -67.23 -14.35 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 2.02 112.247 -170.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 173' ' ' CYS . 22.7 t -69.27 -13.81 62.6 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.051 -0.406 . . . . 3.1899999999999999 110.673 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -90.35 -14.07 33.84 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.44 0.638 . . . . 5.5099999999999998 110.271 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.623 ' N ' HD11 ' A' ' 217' ' ' LEU . 6.5 mp -101.74 17.88 21.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 2.5600000000000001 111.645 -176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 m -60.51 153.51 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 2.2000000000000002 111.074 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.29 -29.17 1.68 Allowed Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.982 -0.554 . . . . 2.1400000000000001 113.911 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.459 ' O ' HG21 ' A' ' 157' ' ' VAL . 16.3 mm-40 -70.2 164.13 24.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.15 0.5 . . . . 2.6099999999999999 111.351 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.3 mt-10 -112.85 118.71 35.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.037 -0.727 . . . . 3.0600000000000001 109.037 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 32.3 mt -95.91 160.18 14.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.127 -0.942 . . . . 1.9199999999999999 110.16 -176.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.72 117.86 18.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.315 -0.624 . . . . 4.0999999999999996 109.315 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 64.9 t -101.72 134.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.724 0.774 . . . . 1.5800000000000001 111.355 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.298 -1.319 . . . . 2.7400000000000002 107.712 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 97.2 t -114.05 133.39 60.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 121.056 -0.258 . . . . 3.0099999999999998 110.608 173.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.6 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 4.0 mm? -77.05 81.98 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.467 -0.568 . . . . 3.1899999999999999 109.467 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.77 97.2 2.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.073 0.463 . . . . 4.2699999999999996 109.794 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.34 64.3 7.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.527 0.68 . . . . 6.0199999999999996 110.25 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.472 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 4.7 m -59.52 135.25 88.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.84 -1.073 . . . . 6.8799999999999999 110.446 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 10.5 Cg_exo -70.52 86.79 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.67 2.247 . . . . 8.5800000000000001 112.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.558 -0.734 . . . . 10.369999999999999 109.662 178.194 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.698 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.072 -0.344 . . . . 7.3300000000000001 110.072 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.12 131.67 31.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.236 2.624 . . . . 5.8700000000000001 112.955 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.433 ' OE1' ' HA ' ' A' ' 153' ' ' GLN . 14.9 mm-40 -103.1 99.61 9.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 5.2400000000000002 110.828 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -103.9 106.75 54.31 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.634 -0.712 . . . . 4.8099999999999996 109.526 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -77.04 129.36 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.578 2.185 . . . . 2.8599999999999999 112.131 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.531 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -132.04 161.93 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 2.3500000000000001 111.596 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.42 HG23 HD23 ' A' ' 217' ' ' LEU . 47.1 t -132.44 125.02 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.923 -0.769 . . . . 2.3599999999999999 108.923 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.404 ' HG2' ' CG2' ' A' ' 168' ' ' VAL . 77.5 mtm-85 -87.45 104.98 16.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 4.0300000000000002 110.391 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.9 t -93.3 114.97 31.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.317 -0.856 . . . . 1.3999999999999999 111.476 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.58 103.62 7.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.534 0.683 . . . . 2.79 109.583 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.553 HD12 ' HB ' ' A' ' 167' ' ' THR . 2.3 mt -72.09 168.25 24.63 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.568 -1.197 . . . . 2.6200000000000001 110.975 -175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 71.1 Cg_exo -52.68 156.11 9.43 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.393 2.062 . . . . 2.27 111.299 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 18.4 m120 70.29 19.81 6.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.147 0.499 . . . . 3.75 110.479 -175.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 58.75 31.26 21.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.242 -0.89 . . . . 5.0 112.493 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.4 179.21 5.74 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.844 -0.799 . . . . 3.9199999999999999 108.844 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -148.02 129.84 15.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 118.418 0.554 . . . . 3.75 111.689 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.553 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -121.04 137.62 54.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.572 -0.899 . . . . 2.2000000000000002 108.572 172.253 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.441 ' H ' ' H9O' ' A' ' 301' ' ' 6FS . 6.1 t -92.84 144.42 9.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.093 -0.706 . . . . 2.6200000000000001 109.093 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.89 130.89 14.35 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 108.713 -0.847 . . . . 2.2000000000000002 108.713 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.7 Cg_endo -50.02 135.8 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.687 2.258 . . . . 2.27 111.757 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -68.06 82.37 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 2.2799999999999998 109.427 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.584 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 41.0 mmt180 -64.47 111.12 2.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.878 -1.056 . . . . 4.3799999999999999 111.291 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.32 125.17 31.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 3.77 109.95 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.12 71.58 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.496 -1.041 . . . . 3.48 110.496 -174.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.584 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 88.5 t -118.71 152.16 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.852 -0.674 . . . . 3.0699999999999998 109.451 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 33.8 p -97.09 163.76 12.8 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.671 -0.492 . . . . 3.0 109.671 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.52 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 18.7 t -52.17 -32.18 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.548 -0.538 . . . . 2.46 109.548 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.4 tpt180 -53.05 -53.56 48.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.371 -0.831 . . . . 4.9100000000000001 112.454 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.512 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 2.0 t70 -74.53 -43.15 57.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.516 0.674 . . . . 2.8700000000000001 110.669 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.522 ' OG ' HG23 ' A' ' 214' ' ' ILE . 41.1 m -67.2 -49.85 63.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.359 -0.837 . . . . 2.3100000000000001 111.318 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -68.02 -23.67 65.02 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.98 0.363 . . . . 1.75 111.98 173.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.07 -43.21 77.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.057 -0.72 . . . . 3.3999999999999999 109.057 176.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.512 ' O ' ' HG3' ' A' ' 187' ' ' MET . 23.1 tttp -63.28 -48.44 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 3.0899999999999999 110.079 173.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -52.54 -50.31 63.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 1.4299999999999999 111.82 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.87 -52.57 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.391 -0.368 . . . . 2.1600000000000001 110.633 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.44 62.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.796 0.665 . . . . 2.4900000000000002 112.796 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.512 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 45.6 mtm -69.42 -40.77 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.646 -0.422 . . . . 2.5 109.877 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.431 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 2.2 mmp_? -74.83 -20.55 59.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.879 -0.6 . . . . 5.0599999999999996 111.025 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.55 15.55 22.57 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.041 -0.599 . . . . 2.4900000000000002 111.752 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.417 HD23 ' SG ' ' A' ' 195' ' ' CYS . 9.2 mp -104.53 177.43 4.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.294 . . . . 2.8399999999999999 110.267 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.452 HD11 ' HB2' ' A' ' 193' ' ' GLU . 12.8 pt -133.42 145.74 57.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.209 0.528 . . . . 2.5499999999999998 110.606 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.71 -9.87 12.66 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 124.015 3.143 . . . . 2.0800000000000001 113.531 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' A' ' 191' ' ' ILE . 27.2 mt-10 -83.41 -25.72 31.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.846 0.355 . . . . 3.3199999999999998 110.541 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 69.7 m -112.14 36.25 3.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.504 . . . . 3.3399999999999999 111.412 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.493 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 89.6 m -152.96 162.74 40.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.143 -0.481 . . . . 1.9099999999999999 109.876 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 227' ' ' LEU . . . -129.8 149.62 51.47 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 110.452 -0.203 . . . . 1.8799999999999999 110.452 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.546 HG11 HD13 ' A' ' 208' ' ' ILE . 55.6 t -108.1 127.96 63.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.791 -0.764 . . . . 2.0099999999999998 111.307 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.43 168.94 15.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.425 -1.261 . . . . 3.2200000000000002 109.946 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.408 ' HG2' HD11 ' A' ' 208' ' ' ILE . 11.7 ptm180 -147.17 132.76 18.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.852 -0.613 . . . . 3.1200000000000001 109.695 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.584 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -90.46 123.18 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.388 0.613 . . . . 2.75 110.44 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.478 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 21.8 mt-30 -106.08 -146.79 0.39 Allowed 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.294 -0.867 . . . . 3.5499999999999998 109.094 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 39.0 t70 -49.12 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.579 0.751 . . . . 4.0199999999999996 112.812 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.85 9.02 11.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.246 -0.434 . . . . 3.6699999999999999 113.303 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.56 -178.34 4.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.364 0.582 . . . . 3.48 111.923 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 40.8 mtpt -122.47 142.11 50.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.251 -0.886 . . . . 2.9700000000000002 110.692 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.424 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 70.8 mmtt -125.31 113.29 25.91 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.56 -0.746 . . . . 3.54 109.334 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.67 131.92 19.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.252 1.968 . . . . 2.6800000000000002 112.025 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.546 HD13 HG11 ' A' ' 197' ' ' VAL . 42.9 mt -103.46 154.8 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.42 -0.809 . . . . 1.9099999999999999 111.476 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.62 148.84 19.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.128 -0.789 . . . . 2.4700000000000002 111.128 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.534 ' O ' ' HB ' ' A' ' 176' ' ' THR . 94.9 m95 -77.78 -15.09 59.35 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.575 -0.368 . . . . 2.3999999999999999 111.946 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.425 ' O ' HG21 ' A' ' 176' ' ' THR . 3.7 p30 -93.75 3.75 54.97 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.231 0.538 . . . . 3.79 110.641 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 67.8 m -73.83 130.45 39.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.444 -0.798 . . . . 2.6099999999999999 110.509 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 216' ' ' TRP . 16.6 t70 -60.81 114.17 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.37 -0.604 . . . . 3.4700000000000002 109.37 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.637 ' O ' HG12 ' A' ' 214' ' ' ILE . 2.8 tt -77.35 2.41 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.36 0.6 . . . . 2.02 112.136 -170.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 35.5 t -76.2 -7.23 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.255 -0.903 . . . . 3.1899999999999999 109.148 170.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.555 ' HB3' HD12 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -65.27 -57.54 8.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.254 -0.885 . . . . 5.5099999999999998 111.202 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.595 ' H ' HD21 ' A' ' 217' ' ' LEU . 0.0 OUTLIER -88.33 31.07 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.968 0.729 . . . . 2.5600000000000001 112.968 -172.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.1 m -57.36 146.69 28.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.353 0.597 . . . . 2.2000000000000002 111.111 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 67.75 6.15 42.1 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.149 -0.932 . . . . 2.1400000000000001 113.361 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.412 ' OE2' ' HA ' ' A' ' 217' ' ' LEU . 43.0 mt-10 -115.22 165.51 12.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.886 0.343 . . . . 2.6099999999999999 110.486 -177.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -112.38 126.61 55.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.298 0.571 . . . . 3.0600000000000001 110.508 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 29.2 mt -96.45 166.8 11.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.9199999999999999 110.866 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -137.23 123.41 20.47 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.373 -0.603 . . . . 4.0999999999999996 109.373 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 52.2 t -106.05 140.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.283 0.564 . . . . 1.5800000000000001 110.924 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.33 174.47 5.85 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.797 -1.186 . . . . 2.7400000000000002 107.797 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 4.1 t -100.0 110.03 26.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.096 0.474 . . . . 3.0099999999999998 109.851 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.582 HD11 ' O ' ' A' ' 227' ' ' LEU . 0.0 OUTLIER -137.22 119.28 15.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.026 -1.102 . . . . 3.1899999999999999 108.026 -176.739 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.486 ' N ' HD21 ' A' ' 227' ' ' LEU . 39.3 mt-10 -92.14 104.9 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.017 -0.538 . . . . 4.2699999999999996 111.334 -173.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -87.73 59.74 5.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.064 0.935 . . . . 6.0199999999999996 109.303 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.536 HG21 ' HD3' ' A' ' 231' ' ' PRO . 1.5 m -86.06 -29.53 0.41 Allowed Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.601 -1.181 . . . . 6.8799999999999999 113.589 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.536 ' HD3' HG21 ' A' ' 230' ' ' VAL . 10.0 Cg_endo -90.32 14.13 2.12 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 121.824 1.682 . . . . 8.5800000000000001 112.005 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.197 -0.906 . . . . 10.369999999999999 111.168 -179.191 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.699 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.664 0.269 . . . . 7.3300000000000001 110.628 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.42 96.46 0.24 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.238 2.625 . . . . 5.8700000000000001 111.953 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -122.62 133.61 54.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.011 -0.54 . . . . 5.2400000000000002 110.768 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -124.78 101.18 33.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 121.47 0.653 . . . . 4.8099999999999996 109.546 176.703 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.439 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.2 Cg_endo -87.26 136.31 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.529 2.819 . . . . 2.8599999999999999 111.711 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.44 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.0 pp -142.07 144.55 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.739 0.304 . . . . 2.3500000000000001 110.602 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.429 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.9 t -110.66 119.55 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.851 -0.796 . . . . 2.3599999999999999 108.851 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.573 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 8.0 mtp85 -87.88 104.19 16.37 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.447 0.641 . . . . 4.0300000000000002 111.365 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 222' ' ' LEU . 85.2 t -88.74 138.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 1.3999999999999999 111.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.4 m-85 -96.95 104.84 16.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.532 0.682 . . . . 2.79 109.891 171.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.555 HD12 ' HB ' ' A' ' 167' ' ' THR . 15.3 mt -64.69 160.16 55.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.596 -1.184 . . . . 2.6200000000000001 110.778 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.98 154.11 13.97 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.539 2.16 . . . . 2.27 112.441 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.33 30.51 4.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.659 -0.701 . . . . 3.75 110.43 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 55.56 47.85 19.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.11 -0.95 . . . . 5.0 112.716 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 165' ' ' GLN . 0.9 OUTLIER -109.08 178.17 4.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.643 -0.873 . . . . 3.9199999999999999 108.643 174.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 31.5 ptt180 -148.44 134.82 19.54 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.563 0.697 . . . . 3.75 112.61 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.555 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.7 OUTLIER -134.58 132.62 39.29 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.712 -1.131 . . . . 2.2000000000000002 108.794 173.178 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.573 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -95.08 150.31 4.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.284 -0.635 . . . . 2.6200000000000001 109.284 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.77 126.81 14.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.54 -0.541 . . . . 2.2000000000000002 109.54 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.4 Cg_endo -49.71 134.27 33.82 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.207 2.605 . . . . 2.27 112.211 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.531 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -62.72 95.19 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.2799999999999998 109.748 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.54 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 40.1 mmt180 -76.17 110.73 10.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.986 -1.006 . . . . 4.3799999999999999 110.391 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 2.1 p -81.82 117.77 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.58 . . . . 3.77 110.834 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.39 19.61 41.14 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.755 -0.938 . . . . 3.48 110.755 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.586 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 81.4 t -131.07 148.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.402 . . . . 3.0699999999999998 110.271 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.479 HG21 ' HA ' ' A' ' 211' ' ' ASP . 19.9 p -84.83 157.55 20.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.413 -0.958 . . . . 3.0 108.413 -177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.756 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 14.6 p -59.51 -22.42 23.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.817 -0.809 . . . . 2.46 108.817 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.9 tpt180 -57.51 -51.64 68.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.915 -0.584 . . . . 4.9100000000000001 112.408 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.586 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 11.0 t70 -69.42 -49.93 50.48 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.81 0.814 . . . . 2.8700000000000001 110.412 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -61.1 -53.89 51.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.334 -1.303 . . . . 2.3100000000000001 110.677 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.756 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.1 mm? -69.43 -20.17 63.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.7 -0.682 . . . . 1.75 112.237 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.9 -44.8 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.23 -0.656 . . . . 3.3999999999999999 109.23 173.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.498 ' HE3' ' HE2' ' A' ' 187' ' ' MET . 27.8 tttp -63.07 -49.87 72.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.609 -0.436 . . . . 3.0899999999999999 110.226 174.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.526 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.4 -52.48 45.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.264 -0.88 . . . . 1.4299999999999999 111.373 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.684 HD22 ' SG ' ' A' ' 195' ' ' CYS . 8.5 tp -71.1 -35.94 72.0 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.359 -0.837 . . . . 2.1600000000000001 110.711 -175.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -20.71 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 2.4900000000000002 111.722 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.498 ' HE2' ' HE3' ' A' ' 183' ' ' LYS . 38.9 mtt -64.76 -44.03 91.36 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.697 -0.853 . . . . 2.5 108.697 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.539 ' CD ' HD13 ' A' ' 161' ' ' LEU . 11.1 mmm180 -69.49 -24.72 63.81 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.389 -1.278 . . . . 5.0599999999999996 110.454 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.32 19.13 26.56 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.595 -0.73 . . . . 2.4900000000000002 111.572 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.484 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . 11.3 mp -105.6 171.08 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.191 -0.3 . . . . 2.8399999999999999 110.191 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.53 ' C ' HD23 ' A' ' 185' ' ' LEU . 34.9 pt -123.66 135.24 25.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 2.5499999999999998 111.774 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.71 -3.75 7.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.784 2.989 . . . . 2.0800000000000001 113.518 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.423 ' HB2' HD11 ' A' ' 191' ' ' ILE . 32.3 mt-10 -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.857 0.36 . . . . 3.3199999999999998 110.605 178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 31.6 t -110.02 14.7 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 3.3399999999999999 111.7 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.684 ' SG ' HD22 ' A' ' 185' ' ' LEU . 35.3 m -127.84 169.26 14.11 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.905 -0.497 . . . . 1.9099999999999999 110.358 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.488 ' HB2' HD12 ' A' ' 227' ' ' LEU . . . -139.46 149.46 44.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 111.75 0.278 . . . . 1.8799999999999999 111.75 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.603 HG21 HD13 ' A' ' 208' ' ' ILE . 1.9 m -110.85 134.36 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.423 1.106 . . . . 2.0099999999999998 111.582 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 225' ' ' GLU . 13.1 m-85 -122.63 173.18 7.87 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.671 -1.604 . . . . 3.2200000000000002 109.525 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.432 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.4 ptm180 -151.48 127.86 10.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.735 -0.666 . . . . 3.1200000000000001 109.651 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.632 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -84.53 122.72 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.517 0.675 . . . . 2.75 109.84 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 31.9 tt0 -111.19 -136.5 0.37 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.807 -1.182 . . . . 3.5499999999999998 107.807 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.94 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.616 0.766 . . . . 4.0199999999999996 112.882 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 6.45 7.39 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 116.018 -0.537 . . . . 3.6699999999999999 113.474 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 10.5 pt-20 -137.07 -179.25 5.6 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 117.776 0.788 . . . . 3.48 111.991 -172.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.632 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 43.0 mtpt -112.16 139.83 47.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.304 -0.862 . . . . 2.9700000000000002 111.098 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -122.75 110.57 31.65 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 3.54 109.483 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.51 131.38 18.7 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.035 1.823 . . . . 2.6800000000000002 112.028 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.603 HD13 HG21 ' A' ' 197' ' ' VAL . 17.0 mt -103.12 160.78 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.154 -0.475 . . . . 1.9099999999999999 111.525 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -98.16 144.61 17.36 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.953 -0.859 . . . . 2.4700000000000002 110.953 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 73.2 m95 -66.19 -13.75 60.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.357 0.873 . . . . 2.3999999999999999 113.357 -172.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.479 ' HA ' HG21 ' A' ' 176' ' ' THR . 4.1 p-10 -103.3 11.51 36.66 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.04 -0.412 . . . . 3.79 111.313 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.9 m -73.06 122.0 21.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 2.6099999999999999 109.474 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 175' ' ' VAL . 9.9 t0 -60.99 117.27 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.256 -0.646 . . . . 3.4700000000000002 109.256 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.433 HG23 HD11 ' A' ' 214' ' ' ILE . 4.4 tt -68.82 -15.17 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 2.02 112.41 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.531 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 95.1 p -71.4 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.781 -0.574 . . . . 3.1899999999999999 111.702 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -90.13 -11.68 40.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.313 0.577 . . . . 5.5099999999999998 110.216 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.644 ' N ' HD11 ' A' ' 217' ' ' LEU . 6.3 mp -102.02 11.85 37.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.579 -0.737 . . . . 2.5600000000000001 111.709 -174.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.429 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.7 m -56.7 153.24 10.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.283 0.563 . . . . 2.2000000000000002 111.607 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.03 -19.57 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.511 -0.768 . . . . 2.1400000000000001 113.12 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.26 151.89 19.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.109 0.481 . . . . 2.6099999999999999 111.131 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 53.0 mt-10 -100.0 126.04 46.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.92 -0.77 . . . . 3.0600000000000001 108.92 170.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 35.9 mt -94.46 167.3 11.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.667 -0.697 . . . . 1.9199999999999999 110.206 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -140.18 122.46 15.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.357 -0.608 . . . . 4.0999999999999996 109.357 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.62 135.78 36.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.456 0.646 . . . . 1.5800000000000001 111.407 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 198' ' ' TYR . 2.1 mm-40 -108.85 167.99 9.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.209 -1.404 . . . . 2.7400000000000002 107.209 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 21.7 t -113.56 112.09 38.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.308 -0.557 . . . . 3.0099999999999998 110.211 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 196' ' ' ALA . 9.4 mt -74.41 81.72 1.91 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.103 -0.499 . . . . 3.1899999999999999 110.673 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -96.58 97.11 9.13 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.391 -0.596 . . . . 4.2699999999999996 109.391 175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 55.34 3.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.641 0.734 . . . . 6.0199999999999996 110.466 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.4 m -67.99 152.81 96.13 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 114.709 -1.132 . . . . 6.8799999999999999 110.601 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.09 -60.67 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.631 2.22 . . . . 8.5800000000000001 112.03 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.835 -0.602 . . . . 10.369999999999999 109.768 178.646 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.685 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.576 0.227 . . . . 7.3300000000000001 110.565 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.19 143.79 99.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.52 2.146 . . . . 5.8700000000000001 110.99 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.38 98.96 5.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.939 0.4 . . . . 5.2400000000000002 110.316 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -100.9 110.16 60.12 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.812 -0.631 . . . . 4.8099999999999996 109.888 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.75 128.74 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.499 2.133 . . . . 2.8599999999999999 112.222 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.517 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -137.29 163.13 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.855 0.359 . . . . 2.3500000000000001 111.062 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.408 HG22 ' HA ' ' A' ' 218' ' ' THR . 35.3 t -126.93 122.8 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.337 -0.616 . . . . 2.3599999999999999 109.337 171.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.462 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 91.4 mtt180 -80.6 106.12 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.812 -0.44 . . . . 4.0300000000000002 109.812 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.62 107.78 20.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.836 -0.62 . . . . 1.3999999999999999 110.959 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 m-85 -71.63 103.23 2.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.807 0.813 . . . . 2.79 110.438 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.608 HD12 ' HB ' ' A' ' 167' ' ' THR . 14.4 mt -63.61 159.73 49.68 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.241 -1.345 . . . . 2.6200000000000001 111.051 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.64 148.25 21.67 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.487 2.125 . . . . 2.27 111.825 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.426 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 15.0 m120 69.95 36.06 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.505 0.669 . . . . 3.75 110.755 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' HD3' ' C ' ' A' ' 163' ' ' ASN . 0.0 OUTLIER 58.49 33.27 22.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 5.0 113.281 169.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -98.35 -179.99 4.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.0 -0.741 . . . . 3.9199999999999999 109.0 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.1 ptt180 -149.93 132.96 16.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 3.75 112.011 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.608 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -121.56 136.92 54.92 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.637 -0.875 . . . . 2.2000000000000002 108.637 170.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.517 HG13 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -92.6 141.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.324 -0.621 . . . . 2.6200000000000001 109.324 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.8 p -134.95 123.51 15.95 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.425 -0.583 . . . . 2.2000000000000002 109.425 175.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 10.5 Cg_endo -51.17 138.51 44.78 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.348 2.699 . . . . 2.27 111.675 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -65.3 87.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.507 -0.77 . . . . 2.2799999999999998 110.324 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 37.3 mmt180 -66.82 113.04 4.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.527 -1.215 . . . . 4.3799999999999999 111.542 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.483 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 20.7 p -76.34 131.23 39.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 3.77 110.651 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.27 79.8 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.052 -0.819 . . . . 3.48 111.052 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.613 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 89.0 t -129.06 144.95 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.661 -0.496 . . . . 3.0699999999999998 109.661 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.8 p -93.3 170.81 9.34 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.074 -0.713 . . . . 3.0 109.074 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.731 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.2 m -60.83 -21.31 23.66 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 108.995 -0.743 . . . . 2.46 108.995 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -53.04 -61.22 2.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.013 -0.54 . . . . 4.9100000000000001 111.883 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.613 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 10.3 t70 -66.38 -48.12 71.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.722 0.773 . . . . 2.8700000000000001 110.786 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 p -61.57 -53.13 60.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.908 -1.042 . . . . 2.3100000000000001 110.658 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.731 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -65.94 -24.98 66.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.669 -0.696 . . . . 1.75 112.101 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.47 -40.34 71.52 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.679 -0.489 . . . . 3.3999999999999999 109.679 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 187' ' ' MET . 38.1 tttp -68.7 -46.2 69.61 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.322 -0.551 . . . . 3.0899999999999999 109.945 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.7 -55.9 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 1.4299999999999999 111.945 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -49.08 75.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 2.1600000000000001 111.227 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -23.38 66.11 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.356 0.502 . . . . 2.4900000000000002 112.356 -175.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.467 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 44.1 mtm -76.06 -31.45 58.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 2.5 110.505 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.537 ' CD ' HD13 ' A' ' 161' ' ' LEU . 12.0 mmm180 -72.99 -25.72 61.09 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.187 0.518 . . . . 5.0599999999999996 110.478 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.75 16.56 25.96 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.374 -0.83 . . . . 2.4900000000000002 111.063 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.6 mp -105.33 172.35 6.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.873 0.368 . . . . 2.8399999999999999 110.246 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.46 140.52 28.34 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 2.5499999999999998 110.291 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.12 -4.22 12.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.049 2.5 . . . . 2.0800000000000001 112.7 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -73.99 -47.29 38.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 3.3199999999999998 110.578 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 86.0 m -102.01 37.74 1.79 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.902 -0.59 . . . . 3.3399999999999999 111.113 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 72.7 m -143.31 162.67 35.07 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.379 -0.6 . . . . 1.9099999999999999 109.379 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 224' ' ' VAL . . . -133.73 156.68 47.52 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.444 0.164 . . . . 1.8799999999999999 111.274 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.517 HG11 HD13 ' A' ' 208' ' ' ILE . 35.9 t -113.81 126.66 71.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.769 0.795 . . . . 2.0099999999999998 111.258 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -129.13 161.84 29.14 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.499 -1.228 . . . . 3.2200000000000002 109.547 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -145.84 154.93 42.54 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.645 -0.502 . . . . 3.1200000000000001 109.645 168.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.754 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 40.2 mm -104.54 129.31 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 2.75 110.81 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 32.5 tt0 -113.34 -138.96 0.38 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.089 -1.078 . . . . 3.5499999999999998 108.089 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.413 ' H ' ' HG2' ' A' ' 201' ' ' GLN . 14.3 t70 -56.3 78.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.471 0.708 . . . . 4.0199999999999996 112.248 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.11 11.12 17.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.397 -0.43 . . . . 3.6699999999999999 112.309 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.78 178.63 6.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 3.48 111.296 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.754 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 54.7 mtpt -118.78 139.5 51.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.159 -0.928 . . . . 2.9700000000000002 111.17 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -120.84 108.86 36.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.789 -1.096 . . . . 3.54 108.513 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.32 128.91 15.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.615 1.543 . . . . 2.6800000000000002 110.967 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.517 HD13 HG11 ' A' ' 197' ' ' VAL . 20.5 mt -99.49 153.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.725 -0.671 . . . . 1.9099999999999999 111.381 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.3 147.5 18.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.215 -0.754 . . . . 2.4700000000000002 111.215 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.591 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 85.8 m95 -74.28 -13.75 60.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.016 0.376 . . . . 2.3999999999999999 112.016 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -106.88 20.42 19.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.197 0.523 . . . . 3.79 110.339 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.7 m -83.77 128.49 34.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.489 -0.778 . . . . 2.6099999999999999 109.942 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -65.15 114.43 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 3.4700000000000002 109.531 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.1 tt -71.27 -15.16 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.066 -0.515 . . . . 2.02 111.948 -171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 91.8 p -73.07 -8.96 58.1 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.064 -0.654 . . . . 3.1899999999999999 111.075 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -88.8 -26.15 21.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.341 0.591 . . . . 5.5099999999999998 110.084 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.58 18.43 7.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.395 -0.82 . . . . 2.5600000000000001 112.293 -174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.408 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.4 m -59.47 153.27 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.168 0.508 . . . . 2.2000000000000002 111.353 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.66 5.3 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.718 -0.673 . . . . 2.1400000000000001 112.933 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.4 ' O ' HG11 ' A' ' 157' ' ' VAL . 27.5 mm-40 -81.34 145.9 30.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.937 0.399 . . . . 2.6099999999999999 110.951 -175.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 50.2 mt-10 -101.53 114.16 27.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 3.0600000000000001 108.698 167.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.64 171.73 8.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.32 -0.855 . . . . 1.9199999999999999 109.441 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -148.53 134.15 18.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.898 -0.408 . . . . 4.0999999999999996 109.898 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.97 139.81 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.577 0.703 . . . . 1.5800000000000001 111.103 -174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -107.84 169.27 8.71 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.523 -1.288 . . . . 2.7400000000000002 107.523 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 77.8 t -113.51 112.95 42.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 120.601 -0.44 . . . . 3.0099999999999998 110.817 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 9.4 mt -81.94 90.36 6.46 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.89 -0.782 . . . . 3.1899999999999999 108.89 173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.79 100.32 0.15 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.894 -0.593 . . . . 4.2699999999999996 111.271 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.21 62.89 7.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.762 -0.654 . . . . 6.0199999999999996 110.237 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 6.0 m -67.87 124.23 88.98 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.11 -0.95 . . . . 6.8799999999999999 110.766 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 8.4 Cg_exo -72.82 94.62 0.79 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.65 2.234 . . . . 8.5800000000000001 111.305 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.525 ' H ' HD21 ' A' ' 232' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.806 -0.616 . . . . 10.369999999999999 110.21 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.683 ' H13' ' C11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.766 0.317 . . . . 7.3300000000000001 110.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.14 50.54 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.751 2.968 . . . . 5.8700000000000001 112.271 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.78 139.03 47.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.755 -0.657 . . . . 5.2400000000000002 109.835 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -124.96 96.79 39.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.41 -0.589 . . . . 4.8099999999999996 109.41 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.43 127.94 16.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.158 1.905 . . . . 2.8599999999999999 112.074 -176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.5 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -138.58 165.5 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.989 -0.551 . . . . 2.3500000000000001 110.195 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.512 HG11 ' O ' ' A' ' 220' ' ' GLU . 44.6 t -128.44 120.76 53.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.61 -0.515 . . . . 2.3599999999999999 109.61 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -83.09 104.07 13.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.877 -0.601 . . . . 4.0300000000000002 110.192 178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.411 HG12 ' CD1' ' A' ' 181' ' ' LEU . 60.1 t -95.66 119.7 44.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.169 -0.923 . . . . 1.3999999999999999 111.337 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 5.3 m-85 -79.05 102.8 8.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.656 0.741 . . . . 2.79 109.931 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.531 HD12 ' HB ' ' A' ' 167' ' ' THR . 14.3 mt -64.27 159.2 59.95 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.759 -1.109 . . . . 2.6200000000000001 110.246 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.524 ' HD2' ' CD1' ' A' ' 190' ' ' LEU . 41.5 Cg_exo -56.63 142.24 90.83 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.702 2.268 . . . . 2.27 111.18 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.4 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 64.6 t30 75.87 43.97 0.16 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.126 0.965 . . . . 3.75 110.424 -176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 164' ' ' LYS . 1.3 mppt? 53.01 32.5 12.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.743 -1.571 . . . . 5.0 113.378 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -101.12 173.7 6.34 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.933 -0.766 . . . . 3.9199999999999999 108.933 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -148.47 137.73 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.166 0.508 . . . . 3.75 111.948 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.556 HG22 ' HA ' ' A' ' 184' ' ' ALA . 0.6 OUTLIER -130.54 139.24 50.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.035 -0.984 . . . . 2.2000000000000002 108.958 174.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.5 HG13 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -95.22 142.57 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.265 -0.643 . . . . 2.6200000000000001 109.265 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.19 125.64 13.63 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 109.332 -0.618 . . . . 2.2000000000000002 109.332 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 6.8 Cg_endo -49.79 137.35 34.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.284 2.656 . . . . 2.27 112.252 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -67.72 85.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.338 -0.846 . . . . 2.2799999999999998 109.889 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.545 ' HB3' HG22 ' A' ' 175' ' ' VAL . 23.6 mmm180 -71.13 112.18 7.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.055 -0.975 . . . . 4.3799999999999999 111.694 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 31.6 m -72.29 131.8 43.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.742 -0.663 . . . . 3.77 110.323 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.05 12.15 84.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 3.48 111.351 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 172' ' ' ARG . 67.6 t -118.49 150.0 20.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.115 0.483 . . . . 3.0699999999999998 109.902 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.432 HG21 ' HA ' ' A' ' 211' ' ' ASP . 22.0 p -85.02 151.46 24.15 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.596 -0.89 . . . . 3.0 108.596 -178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.753 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 12.6 p -58.33 -22.65 20.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.484 -0.932 . . . . 2.46 108.484 170.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.564 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -58.1 -50.62 72.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.959 -0.564 . . . . 4.9100000000000001 112.044 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.647 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 7.7 t70 -67.23 -52.13 44.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.12 0.962 . . . . 2.8700000000000001 110.152 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.445 ' OG ' HG23 ' A' ' 214' ' ' ILE . 60.0 m -63.18 -45.63 90.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.446 -1.252 . . . . 2.3100000000000001 111.132 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.0 OUTLIER -75.71 -21.69 57.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.615 0.598 . . . . 1.75 112.615 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.647 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 9.6 pttt -60.3 -37.8 81.66 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.535 -0.866 . . . . 3.3999999999999999 108.96 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 187' ' ' MET . 15.5 tttp -63.15 -52.9 60.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.522 -0.471 . . . . 3.0899999999999999 109.824 170.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.556 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -48.52 -53.92 16.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 1.4299999999999999 111.673 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 79.6 mt -66.98 -51.06 59.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.694 -0.685 . . . . 2.1600000000000001 111.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -23.23 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 2.4900000000000002 112.878 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.45 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 41.8 mtm -64.61 -44.62 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 2.5 110.285 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.555 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -71.18 -26.03 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.553 0.692 . . . . 5.0599999999999996 111.331 171.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.38 21.45 9.33 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 114.744 -1.116 . . . . 2.4900000000000002 111.163 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.555 ' HG ' ' HB3' ' A' ' 188' ' ' ARG . 26.1 mt -94.87 159.06 15.21 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.899 -0.651 . . . . 2.8399999999999999 109.981 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 193' ' ' GLU . 48.8 pt -120.28 135.39 24.43 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.153 0.501 . . . . 2.5499999999999998 111.524 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.2 -4.74 14.94 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.144 2.563 . . . . 2.0800000000000001 112.474 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.486 ' HB3' HD11 ' A' ' 191' ' ' ILE . 26.1 tt0 -61.22 -49.97 74.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.789 -0.641 . . . . 3.3199999999999998 111.548 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.89 -1.22 22.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 3.3399999999999999 111.286 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 49.9 m -109.25 161.15 15.52 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.289 -0.257 . . . . 1.9099999999999999 110.519 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.485 ' HB2' HD12 ' A' ' 227' ' ' LEU . . . -133.06 154.29 50.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 116.478 -0.328 . . . . 1.8799999999999999 110.237 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 208' ' ' ILE . 2.2 m -104.49 135.78 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.24 1.019 . . . . 2.0099999999999998 110.851 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.654 ' CD2' ' HB3' ' A' ' 225' ' ' GLU . 9.2 m-85 -129.48 167.04 18.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.839 -1.528 . . . . 3.2200000000000002 109.795 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -149.92 131.98 15.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.122 -0.49 . . . . 3.1200000000000001 110.226 175.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -92.34 121.27 42.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.522 0.677 . . . . 2.75 110.375 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.2 tt0 -103.76 -137.66 0.35 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.976 -1.12 . . . . 3.5499999999999998 107.976 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.81 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.392 0.515 . . . . 4.0199999999999996 112.392 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.47 6.25 14.83 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.125 -0.489 . . . . 3.6699999999999999 112.764 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.5 pt-20 -127.7 -179.52 4.98 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 117.318 0.559 . . . . 3.48 111.866 -172.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 51.8 mtpt -118.78 140.97 49.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.374 -0.83 . . . . 2.9700000000000002 111.042 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -124.93 113.6 26.71 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.152 -0.931 . . . . 3.54 108.652 174.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.449 ' HB3' ' CZ ' ' A' ' 198' ' ' TYR . 54.6 Cg_endo -76.71 127.94 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.891 1.727 . . . . 2.6800000000000002 111.799 175.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.587 HD13 HG21 ' A' ' 197' ' ' VAL . 8.5 mt -100.79 156.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.932 -0.576 . . . . 1.9099999999999999 110.988 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -94.78 146.85 18.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.139 -0.784 . . . . 2.4700000000000002 111.139 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.429 ' CE3' ' HA ' ' A' ' 178' ' ' ARG . 67.1 m95 -66.09 -20.2 66.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.325 0.861 . . . . 2.3999999999999999 113.325 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.432 ' HA ' HG21 ' A' ' 176' ' ' THR . 4.0 p-10 -103.28 15.59 28.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.281 -0.567 . . . . 3.79 110.809 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 42.0 m -73.68 131.4 41.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.338 -0.846 . . . . 2.6099999999999999 109.756 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.46 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 9.8 t70 -62.81 109.92 1.59 Allowed 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.363 0.414 . . . . 3.4700000000000002 109.948 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.494 ' HA ' HD21 ' A' ' 217' ' ' LEU . 3.4 tt -64.4 -18.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.381 . . . . 2.02 111.689 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.589 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 38.2 t -69.42 -11.64 60.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.924 -0.31 . . . . 3.1899999999999999 111.307 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -90.01 -25.56 20.78 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.106 -0.371 . . . . 5.5099999999999998 110.525 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.497 HD22 ' H ' ' A' ' 217' ' ' LEU . 1.4 mm? -87.6 16.93 5.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 111.928 0.344 . . . . 2.5600000000000001 111.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 m -55.33 149.07 13.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 2.2000000000000002 110.095 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.9 -8.28 37.78 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 121.06 -0.59 . . . . 2.1400000000000001 113.128 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.512 ' O ' HG11 ' A' ' 157' ' ' VAL . 52.3 mm-40 -101.67 137.99 39.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.816 0.308 . . . . 2.6099999999999999 110.557 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.24 118.78 30.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.873 -0.788 . . . . 3.0600000000000001 108.873 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.44 174.3 6.74 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.435 -0.802 . . . . 1.9199999999999999 109.816 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 5.9 p80 -156.11 149.89 25.05 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.671 -1.233 . . . . 4.0999999999999996 107.671 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.44 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 84.1 t -100.65 123.52 53.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 122.032 0.92 . . . . 1.5800000000000001 111.106 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.654 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 0.0 OUTLIER -109.64 120.44 42.51 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.666 -1.606 . . . . 2.7400000000000002 109.276 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.444 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 64.1 t -75.46 126.98 36.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.421 -0.809 . . . . 3.0099999999999998 112.03 -171.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' A' ' 196' ' ' ALA . 10.0 mt -79.09 96.85 5.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.393 -0.821 . . . . 3.1899999999999999 110.347 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -77.95 96.03 4.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.174 0.512 . . . . 4.2699999999999996 110.019 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -158.8 67.78 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.165 -0.925 . . . . 6.0199999999999996 109.197 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.24 127.92 39.32 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.204 -0.907 . . . . 6.8799999999999999 111.507 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.45 119.33 6.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.06 2.506 . . . . 8.5800000000000001 112.825 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.2 tp . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.651 -0.69 . . . . 10.369999999999999 109.54 177.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.702 ' H13' ' C11' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.877 -0.416 . . . . 7.3300000000000001 109.877 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -42.12 70.04 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.183 2.589 . . . . 5.8700000000000001 112.22 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -99.71 99.22 10.03 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.353 -0.61 . . . . 5.2400000000000002 109.353 173.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 154' ' ' LYS . 1.1 tmmt? -125.11 98.31 36.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.448 0.642 . . . . 4.8099999999999996 110.679 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -88.14 135.73 3.33 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.721 2.947 . . . . 2.8599999999999999 111.457 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.525 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -137.84 165.53 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.177 0.513 . . . . 2.3500000000000001 111.017 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 220' ' ' GLU . 1.1 p -139.43 123.1 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.409 -0.814 . . . . 2.3599999999999999 109.559 173.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -81.22 109.37 15.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 4.0300000000000002 110.711 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.8 t -98.7 110.81 26.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.095 -0.957 . . . . 1.3999999999999999 111.485 -176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.5 m-85 -75.48 103.63 5.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.336 0.589 . . . . 2.79 109.986 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.534 HD12 ' HB ' ' A' ' 167' ' ' THR . 16.1 mt -62.54 161.03 29.77 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.973 -1.012 . . . . 2.6200000000000001 111.362 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.457 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.02 148.7 37.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.762 2.308 . . . . 2.27 111.491 175.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.6 m120 72.94 23.64 2.74 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.724 0.64 . . . . 3.75 110.894 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 67.38 34.06 4.98 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.537 0.94 . . . . 5.0 113.537 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -98.08 -179.35 4.36 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.598 -0.89 . . . . 3.9199999999999999 108.598 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.435 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 2.9 ptt180 -149.51 139.58 22.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.585 0.629 . . . . 3.75 111.666 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.534 ' HB ' HD12 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -132.35 138.94 47.94 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.698 -0.852 . . . . 2.2000000000000002 108.698 170.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.525 HG13 ' HB ' ' A' ' 156' ' ' ILE . 3.5 t -93.08 140.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.16 -0.616 . . . . 2.6200000000000001 110.057 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 180' ' ' SER . 20.0 t -119.28 122.51 29.41 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.295 -0.411 . . . . 2.2000000000000002 110.424 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.555 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 9.7 Cg_endo -52.96 123.34 12.9 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.343 2.029 . . . . 2.27 109.971 168.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -60.42 101.13 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 2.2799999999999998 110.49 -173.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 23.9 mmm180 -82.57 119.14 23.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.562 -1.199 . . . . 4.3799999999999999 111.415 -172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 34.7 t -85.03 136.07 33.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 3.77 109.527 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.32 75.51 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.053 -1.219 . . . . 3.48 110.053 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 172' ' ' ARG . 23.3 t -132.79 136.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.651 -0.774 . . . . 3.0699999999999998 110.318 -174.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 23.4 p -89.37 167.03 13.35 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.663 -0.699 . . . . 3.0 109.683 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 24.2 t -53.02 -34.17 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.261 -0.644 . . . . 2.46 109.261 171.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -53.28 -56.53 15.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.848 -1.069 . . . . 4.9100000000000001 112.812 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' HB3' HG11 ' A' ' 175' ' ' VAL . 9.1 t70 -72.52 -43.62 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 2.8700000000000001 110.926 -173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 169' ' ' VAL . 1.3 m -65.21 -50.24 66.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.423 -0.808 . . . . 2.3100000000000001 111.104 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -70.51 -21.12 62.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.625 -0.43 . . . . 1.75 111.968 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.548 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.53 -47.05 73.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.933 -0.765 . . . . 3.3999999999999999 108.933 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.548 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 25.5 ttpt -63.4 -46.61 85.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.984 -0.553 . . . . 3.0899999999999999 110.041 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 167' ' ' THR . . . -51.33 -54.13 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.707 -0.679 . . . . 1.4299999999999999 111.865 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.42 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -65.11 -51.94 58.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 2.1600000000000001 110.752 178.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.437 ' HE1' ' O ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -62.41 -21.55 65.48 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.257 0.836 . . . . 2.4900000000000002 113.257 -172.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 45.6 mtm -71.87 -28.17 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.497 -0.481 . . . . 2.5 110.914 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -96.82 -8.47 30.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 5.0599999999999996 110.896 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.58 35.5 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.502 -0.772 . . . . 2.4900000000000002 112.433 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.437 ' O ' ' HE1' ' A' ' 186' ' ' MET . 7.9 mp -95.19 176.8 6.08 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.933 -0.395 . . . . 2.8399999999999999 109.933 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.9 pt -132.61 143.53 49.13 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.159 0.504 . . . . 2.5499999999999998 111.08 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.17 -3.74 6.62 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 123.7 2.933 . . . . 2.0800000000000001 112.46 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -76.03 -49.89 16.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.49 0.662 . . . . 3.3199999999999998 110.724 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 228' ' ' GLU . 63.5 m -103.66 38.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.938 -1.028 . . . . 3.3399999999999999 112.363 -172.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 98.1 m -145.78 162.62 37.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.258 -0.276 . . . . 1.9099999999999999 110.375 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.582 ' HB2' ' HB3' ' A' ' 227' ' ' LEU . . . -132.13 140.36 48.77 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.496 -0.187 . . . . 1.8799999999999999 110.496 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.6 ' CG2' ' HB ' ' A' ' 208' ' ' ILE . 1.3 m -105.35 130.22 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 122.633 1.206 . . . . 2.0099999999999998 111.541 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.27 165.17 14.6 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.605 -1.634 . . . . 3.2200000000000002 109.622 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.426 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 10.8 ptm180 -144.58 145.28 31.72 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.868 -0.605 . . . . 3.1200000000000001 109.7 172.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.559 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -98.38 121.92 49.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.729 . . . . 2.75 110.52 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.9 tt0 -99.41 -142.11 0.32 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.62 -1.173 . . . . 3.5499999999999998 108.115 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.23 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.193 0.597 . . . . 4.0199999999999996 112.321 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.96 7.65 8.94 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.619 -0.324 . . . . 3.6699999999999999 112.313 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -123.76 -175.74 3.29 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.887 0.375 . . . . 3.48 110.686 -171.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.559 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.8 mtpt -123.21 149.23 44.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.958 -0.565 . . . . 2.9700000000000002 111.162 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -136.22 117.72 11.62 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 114.74 -1.118 . . . . 3.54 108.807 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.33 131.08 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.206 1.937 . . . . 2.6800000000000002 111.494 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.6 ' HB ' ' CG2' ' A' ' 197' ' ' VAL . 19.5 mt -98.02 156.83 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.573 . . . . 1.9099999999999999 111.738 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -98.36 145.8 17.91 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.084 -0.806 . . . . 2.4700000000000002 111.084 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.506 ' O ' ' HB ' ' A' ' 176' ' ' THR . 88.1 m95 -68.48 -13.19 62.14 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.868 0.692 . . . . 2.3999999999999999 112.868 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.471 ' HA ' HG21 ' A' ' 176' ' ' THR . 1.4 p30 -105.66 14.26 28.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.531 . . . . 3.79 111.211 -178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.5 m -75.56 128.49 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.723 -0.671 . . . . 2.6099999999999999 109.352 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.447 ' HB3' ' CE3' ' A' ' 216' ' ' TRP . 15.9 t70 -65.89 114.09 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.282 -0.636 . . . . 3.4700000000000002 109.282 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.447 ' O ' HG12 ' A' ' 214' ' ' ILE . 5.7 tt -69.6 -11.15 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 2.02 112.03 -170.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 34.3 t -70.48 -14.49 62.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.835 -0.541 . . . . 3.1899999999999999 110.634 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.447 ' CE3' ' HB3' ' A' ' 213' ' ' ASP . 13.2 m0 -92.25 -1.77 56.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.932 0.396 . . . . 5.5099999999999998 110.567 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.83 9.33 34.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.402 -0.363 . . . . 2.5600000000000001 110.81 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 153.38 18.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.078 0.466 . . . . 2.2000000000000002 111.189 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 75.13 -7.36 23.12 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.636 -0.711 . . . . 2.1400000000000001 113.697 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.641 ' O ' HG21 ' A' ' 157' ' ' VAL . 12.3 mm-40 -99.62 149.32 23.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.044 0.422 . . . . 2.6099999999999999 110.253 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -95.68 119.8 34.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.475 0.655 . . . . 3.0600000000000001 109.447 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 70.6 mt -98.21 167.33 10.93 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.85 -1.068 . . . . 1.9199999999999999 109.252 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -149.7 144.08 25.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.324 -0.621 . . . . 4.0999999999999996 109.324 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 21.3 t -114.42 141.09 32.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.749 0.785 . . . . 1.5800000000000001 111.507 -171.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.01 179.38 4.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.02 -1.445 . . . . 2.7400000000000002 107.774 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 87.0 t -105.06 108.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.272 0.558 . . . . 3.0099999999999998 110.064 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.589 HD11 ' O ' ' A' ' 227' ' ' LEU . 0.0 OUTLIER -148.42 124.36 10.65 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.961 -1.126 . . . . 3.1899999999999999 107.961 -177.508 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.54 ' N ' HD21 ' A' ' 227' ' ' LEU . 47.4 mt-10 -85.23 97.85 10.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.283 0.563 . . . . 4.2699999999999996 111.288 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.94 56.24 0.95 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.433 -0.803 . . . . 6.0199999999999996 109.086 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.445 ' CG2' ' HD3' ' A' ' 231' ' ' PRO . 15.5 m -80.93 -34.62 0.76 Allowed Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 114.112 1.152 . . . . 6.8799999999999999 114.112 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.445 ' HD3' ' CG2' ' A' ' 230' ' ' VAL . 7.4 Cg_exo -73.86 -73.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.454 1.436 . . . . 8.5800000000000001 112.5 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.504 -0.76 . . . . 10.369999999999999 109.172 -178.506 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.686 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.817 0.341 . . . . 7.3300000000000001 110.396 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.06 -48.82 9.34 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.91 2.407 . . . . 5.8700000000000001 112.026 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -125.74 125.4 42.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.322 -0.622 . . . . 5.2400000000000002 109.322 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -77.83 116.01 54.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 4.8099999999999996 110.219 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -84.13 128.94 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.517 2.144 . . . . 2.8599999999999999 112.23 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.493 ' HB ' HG13 ' A' ' 168' ' ' VAL . 2.7 pp -137.28 162.77 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.272 -0.422 . . . . 2.3500000000000001 110.813 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -135.04 120.63 30.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.315 0.578 . . . . 2.3599999999999999 109.985 170.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 168' ' ' VAL . 99.3 mtt180 -74.71 119.97 19.62 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.312 -0.858 . . . . 4.0300000000000002 110.26 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.6 t -106.08 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.749 -1.114 . . . . 1.3999999999999999 111.277 -176.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.4 m-85 -73.28 103.45 3.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.566 0.698 . . . . 2.79 109.664 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.531 HD12 ' HB ' ' A' ' 167' ' ' THR . 12.7 mt -64.98 161.64 45.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.511 -1.222 . . . . 2.6200000000000001 111.077 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.431 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 78.4 Cg_exo -51.63 150.45 16.53 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.511 2.141 . . . . 2.27 111.272 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 164' ' ' LYS . 21.6 t-20 63.89 36.98 9.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.408 1.099 . . . . 3.75 110.237 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.7 mppt? 57.64 28.7 16.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.407 -1.724 . . . . 5.0 114.167 164.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.578 ' NE2' ' HD2' ' A' ' 188' ' ' ARG . 5.5 mt-30 -93.34 -179.07 4.94 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.028 -0.731 . . . . 3.9199999999999999 109.028 169.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 34.3 ptt180 -147.62 135.05 20.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 3.75 111.511 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.531 ' HB ' HD12 ' A' ' 161' ' ' LEU . 2.8 t -111.38 -177.76 3.28 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.909 -1.145 . . . . 2.2000000000000002 107.909 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.493 HG13 ' HB ' ' A' ' 156' ' ' ILE . 4.6 t -135.75 132.36 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.178 -1.045 . . . . 2.6200000000000001 108.178 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.88 123.51 26.19 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.735 -0.386 . . . . 2.2000000000000002 110.014 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.554 ' O ' ' HG2' ' A' ' 172' ' ' ARG . 6.5 Cg_endo -50.71 134.17 40.2 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.095 2.53 . . . . 2.27 111.786 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 215' ' ' SER . . . -61.27 117.69 5.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.761 . . . . 2.2799999999999998 109.482 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.554 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 3.4 mmp_? -105.37 111.78 24.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.075 -0.966 . . . . 4.3799999999999999 110.823 -173.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.6 p -81.2 122.43 27.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.099 -0.501 . . . . 3.77 110.379 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.99 67.32 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.743 -0.943 . . . . 3.48 110.743 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.537 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 59.2 t -122.33 140.66 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.239 -0.481 . . . . 3.0699999999999998 109.742 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.418 ' OG1' ' HB3' ' A' ' 178' ' ' ARG . 44.3 p -86.78 168.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.054 -0.721 . . . . 3.0 109.054 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.712 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -59.53 -24.93 29.9 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 N-CA-C 108.703 -0.851 . . . . 2.46 108.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.418 ' HB3' ' OG1' ' A' ' 176' ' ' THR . 9.5 tmm_? -56.19 -60.57 3.31 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.516 0.561 . . . . 4.9100000000000001 112.516 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.53 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 1.9 t70 -64.52 -48.51 74.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.152 0.977 . . . . 2.8700000000000001 110.607 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.62 ' OG ' HG23 ' A' ' 214' ' ' ILE . 1.3 m -61.31 -50.82 71.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.268 -1.333 . . . . 2.3100000000000001 110.496 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.712 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.9 mm? -68.82 -24.25 64.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.677 -0.692 . . . . 1.75 111.594 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 186' ' ' MET . 0.0 OUTLIER -54.94 -41.93 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.642 -0.503 . . . . 3.3999999999999999 109.642 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 187' ' ' MET . 19.9 tttt -65.07 -52.21 56.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.648 -0.421 . . . . 3.0899999999999999 110.155 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.43 ' CB ' HG22 ' A' ' 167' ' ' THR . . . -47.52 -52.4 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 1.4299999999999999 111.683 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 91.0 mt -69.33 -54.34 15.07 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.263 -0.881 . . . . 2.1600000000000001 110.919 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.497 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 5.2 mmt -62.54 -21.36 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.683 0.994 . . . . 2.4900000000000002 113.683 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.411 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 47.1 mtm -67.93 -28.85 67.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.5 110.225 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.578 ' HD2' ' NE2' ' A' ' 165' ' ' GLN . 22.9 mtp180 -95.44 -2.69 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.265 0.555 . . . . 5.0599999999999996 111.204 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.13 15.76 64.17 Favored Glycine 0 C--N 1.315 -0.583 0 CA-C-N 115.319 -0.855 . . . . 2.4900000000000002 111.731 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.521 ' HB2' ' HB3' ' A' ' 185' ' ' LEU . 16.6 mt -86.11 159.78 19.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.324 -0.438 . . . . 2.8399999999999999 109.985 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 49.4 pt -121.65 143.15 37.42 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 2.5499999999999998 111.564 -177.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.37 -4.51 15.14 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.113 2.542 . . . . 2.0800000000000001 112.628 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -71.5 -39.71 70.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.999 -0.546 . . . . 3.3199999999999998 111.035 -176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.62 37.5 4.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.285 -0.416 . . . . 3.3399999999999999 111.466 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 86.1 m -136.86 163.51 30.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.512 -0.551 . . . . 1.9099999999999999 109.512 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.9 139.73 41.8 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 111.195 0.072 . . . . 1.8799999999999999 111.195 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.581 HG21 HD13 ' A' ' 208' ' ' ILE . 1.3 m -102.48 129.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.323 1.058 . . . . 2.0099999999999998 111.075 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -120.81 170.53 9.37 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.74 -1.573 . . . . 3.2200000000000002 110.059 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -150.88 131.1 13.58 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.526 -0.761 . . . . 3.1200000000000001 109.295 171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -83.57 124.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.353 0.597 . . . . 2.75 110.167 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.4 tt0 -111.25 -139.45 0.38 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.508 -1.294 . . . . 3.5499999999999998 107.508 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.17 82.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.702 0.63 . . . . 4.0199999999999996 112.702 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 7.99 10.6 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.213 -0.449 . . . . 3.6699999999999999 113.578 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.69 -179.02 5.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 117.463 0.632 . . . . 3.48 111.895 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 36.9 mtpt -111.96 140.13 46.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.181 -0.918 . . . . 2.9700000000000002 111.064 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.83 115.51 33.46 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.372 -0.831 . . . . 3.54 109.417 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.46 123.46 6.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.87 1.714 . . . . 2.6800000000000002 111.739 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.581 HD13 HG21 ' A' ' 197' ' ' VAL . 16.0 mt -94.04 159.33 2.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 1.9099999999999999 111.301 -173.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 208' ' ' ILE . . . -92.39 151.27 20.56 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.985 -0.846 . . . . 2.4700000000000002 110.985 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.519 ' HA ' ' CG2' ' A' ' 177' ' ' VAL . 80.5 m95 -76.98 -12.95 60.01 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.506 0.558 . . . . 2.3999999999999999 112.506 -172.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.74 12.56 36.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.08 0.467 . . . . 3.79 110.574 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.9 m -79.23 131.48 36.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.868 -0.606 . . . . 2.6099999999999999 110.316 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.421 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 17.5 t70 -61.71 117.9 6.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 3.4700000000000002 109.921 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.62 HG23 ' OG ' ' A' ' 180' ' ' SER . 5.8 tt -74.11 -16.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.455 . . . . 2.02 111.889 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 171' ' ' ALA . 20.7 t -67.54 -18.61 65.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.461 0.648 . . . . 3.1899999999999999 109.94 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 20.0 t90 -77.83 -18.21 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.839 -0.618 . . . . 5.5099999999999998 110.385 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.1 mt -102.79 14.04 32.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.091 -0.504 . . . . 2.5600000000000001 111.211 -171.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 m -60.96 153.31 25.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 2.2000000000000002 110.435 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.72 24.63 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.977 -0.556 . . . . 2.1400000000000001 113.576 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.571 ' O ' HG21 ' A' ' 157' ' ' VAL . 16.0 mm-40 -99.44 166.12 11.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.13 -0.322 . . . . 2.6099999999999999 110.13 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.92 126.61 55.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.065 -0.717 . . . . 3.0600000000000001 109.065 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 26.9 mt -95.74 156.4 16.35 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.491 -0.777 . . . . 1.9199999999999999 109.571 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -132.65 117.25 17.66 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.036 -0.728 . . . . 4.0999999999999996 109.036 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 45.9 t -101.31 133.37 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.585 0.707 . . . . 1.5800000000000001 110.895 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.3 174.4 5.89 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.326 -1.306 . . . . 2.7400000000000002 108.033 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 16.4 t -114.3 116.27 52.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 110.276 -0.268 . . . . 3.0099999999999998 110.276 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.421 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -81.15 97.97 7.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.888 0.375 . . . . 3.1899999999999999 110.486 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -117.52 141.79 47.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 4.2699999999999996 110.525 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.25 67.07 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.819 -0.628 . . . . 6.0199999999999996 110.356 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.43 127.48 46.28 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.81 -0.632 . . . . 6.8799999999999999 111.204 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.7 -15.29 12.24 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.762 2.308 . . . . 8.5800000000000001 112.904 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.608 -0.71 . . . . 10.369999999999999 110.561 -176.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' 6FS . . . . . 0.692 ' H11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.455 -0.77 0 CA-C-O 120.504 0.127 . . . . 2.69 112.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.6 pp -139.87 161.16 26.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.908 0.385 . . . . 2.15 110.948 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.6 t -125.32 117.8 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.297 -0.631 . . . . 1.67 109.297 170.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 90.4 mtt180 -82.63 103.69 12.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.438 0.637 . . . . 3.61 110.51 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 181' ' ' LEU . 77.1 t -92.54 116.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.071 -0.968 . . . . 1.4 111.507 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 4.1 m-85 -77.32 103.71 7.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.076 0.941 . . . . 2.54 109.641 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 167' ' ' THR . 3.7 mt -70.53 166.68 33.23 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.067 -1.424 . . . . 2.07 110.677 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 85.3 Cg_exo -50.81 154.25 7.2 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.566 2.177 . . . . 2.27 111.954 172.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 15.1 m120 69.06 23.92 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 3.47 110.905 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 60.81 31.35 20.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.666 -0.697 . . . . 4.66 112.684 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.88 178.85 5.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.396 -0.965 . . . . 3.57 108.396 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -148.95 140.01 23.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 3.54 111.148 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.75 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -130.43 136.45 49.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.309 -0.859 . . . . 1.91 108.724 169.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 156' ' ' ILE . 1.3 m -99.28 140.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.023 -0.671 . . . . 2.31 110.091 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -123.4 123.08 26.58 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.952 -0.567 . . . . 1.67 109.476 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 156' ' ' ILE . 7.5 Cg_endo -50.71 129.59 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.632 2.221 . . . . 2.12 110.954 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.0 107.6 0.65 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.501 0.667 . . . . 2.28 109.595 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.2 mmp_? -90.51 112.24 23.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.048 -0.978 . . . . 3.98 110.512 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.16 122.49 28.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 3.37 110.396 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.51 11.31 60.96 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.228 -1.149 . . . . 3.34 110.228 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 94.8 t -123.62 143.08 38.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.92 -0.64 . . . . 2.87 109.616 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 36.7 p -91.92 168.99 11.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.783 -0.644 . . . . 2.83 109.508 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 17.7 t -56.09 -31.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.185 -0.672 . . . . 1.92 109.185 173.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 15.8 tpt180 -52.67 -53.81 42.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.347 -0.842 . . . . 4.27 112.581 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -74.64 -44.47 50.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.645 0.736 . . . . 2.87 110.966 -174.517 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 p -64.51 -52.39 58.08 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.966 -1.015 . . . . 1.99 110.584 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -68.41 -23.64 64.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.318 -0.856 . . . . 1.34 111.599 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.43 -44.33 72.36 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.381 -0.6 . . . . 3.08 109.381 176.333 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 27.4 ttpt -64.01 -47.8 78.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.313 -0.555 . . . . 2.75 109.991 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.09 -52.25 45.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.431 -0.804 . . . . 1.43 112.026 -175.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.33 -48.75 66.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.71 0.29 . . . . 1.7 110.789 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -29.38 68.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.792 . . . . 2.29 113.14 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 41.6 mtm -70.15 -29.75 66.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 2.5 110.26 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.596 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.5 mmp_? -83.74 -13.97 52.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.682 . . . . 4.43 110.48 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.53 14.48 47.18 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.425 -0.807 . . . . 2.31 111.281 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.17 173.72 6.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.934 0.397 . . . . 2.37 110.424 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.4 140.94 34.97 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.937 -0.574 . . . . 2.42 111.085 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.79 -4.31 14.84 Favored 'Trans proline' 0 CA--C 1.526 0.114 0 C-N-CA 122.892 2.394 . . . . 1.84 112.296 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.38 -52.17 29.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 3.32 110.753 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.2 m -100.37 27.62 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.205 -0.907 . . . . 2.85 111.267 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.624 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.0 m -128.32 151.72 48.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 1.74 109.88 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -121.53 151.91 39.79 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.47 0.176 . . . . 1.73 111.043 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.626 HG12 HD12 ' A' ' 208' ' ' ILE . 44.3 t -110.73 122.99 66.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 1.38 110.859 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.474 ' CD2' ' HG3' ' A' ' 225' ' ' GLU . 11.4 m-85 -126.29 157.45 38.31 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.674 -1.148 . . . . 2.99 109.745 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.602 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -142.56 144.84 33.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 120.542 -0.463 . . . . 2.64 110.203 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.702 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 47.7 mm -86.81 122.89 39.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.609 -0.723 . . . . 2.6 110.175 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.9 tt0 -104.23 -138.92 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.658 -1.238 . . . . 3.22 107.658 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.18 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.02 0.528 . . . . 4.02 112.214 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.33 8.43 9.11 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.184 -0.462 . . . . 3.47 113.24 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -137.17 -179.38 5.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.452 0.626 . . . . 3.48 112.049 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.702 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -106.92 136.98 45.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 2.75 111.515 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 199' ' ' ARG . 34.8 mmtp -125.7 117.8 24.45 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 114.68 -1.146 . . . . 3.25 108.766 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.39 136.37 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.092 1.861 . . . . 2.47 112.171 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.626 HD12 HG12 ' A' ' 197' ' ' VAL . 43.6 mt -102.05 152.65 5.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.637 -0.71 . . . . 1.91 111.543 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 145.41 17.68 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.008 -0.837 . . . . 2.25 111.008 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.662 ' O ' ' HB ' ' A' ' 176' ' ' THR . 98.4 m95 -69.76 -17.53 63.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.059 0.392 . . . . 2.3 112.059 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.1 4.03 54.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.906 0.384 . . . . 3.79 110.956 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.0 m -75.42 128.91 36.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.015 -0.538 . . . . 2.44 110.418 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 215' ' ' SER . 16.0 t70 -62.43 115.47 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 3.47 109.849 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 169' ' ' VAL . 5.0 tt -66.81 -15.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.946 -0.57 . . . . 1.95 112.043 -173.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.528 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 17.0 m -75.84 -9.93 59.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.951 -0.468 . . . . 2.91 111.876 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -81.32 -27.95 34.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 4.8 109.64 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -87.81 5.63 39.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.022 -0.99 . . . . 2.13 111.9 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.478 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.2 m -58.45 151.51 19.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.877 0.37 . . . . 2.03 110.273 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.66 -9.99 57.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.844 -0.693 . . . . 2.12 112.997 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -106.35 155.44 19.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.896 0.379 . . . . 2.61 111.185 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -102.55 124.5 48.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.659 -0.867 . . . . 3.06 108.659 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.441 ' HG ' ' CG1' ' A' ' 157' ' ' VAL . 46.5 mt -96.49 172.18 8.09 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.642 -0.708 . . . . 1.3 109.912 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 16.8 p80 -153.15 136.38 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.499 -0.556 . . . . 3.31 109.499 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 86.6 t -102.39 135.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.362 0.601 . . . . 1.58 111.266 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 5.5 mm-40 -108.18 120.48 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.079 -0.964 . . . . 2.74 109.31 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.316 -0.869 0 C-N-CA 120.375 -0.53 . . . . 2.61 111.593 -178.247 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.462 -0.374 0 CA-C-O 120.884 0.285 . . . . 2.69 112.001 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -136.09 162.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.875 0.369 . . . . 2.15 111.004 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 218' ' ' THR . 26.0 t -126.69 127.59 70.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.017 -0.735 . . . . 1.67 109.017 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.736 ' HG2' HG22 ' A' ' 168' ' ' VAL . 86.0 mtm180 -88.79 107.62 19.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.357 0.599 . . . . 3.61 110.244 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 161' ' ' LEU . 53.6 t -94.85 122.95 46.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.265 -0.879 . . . . 1.4 111.433 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 4.4 m-85 -87.22 102.91 14.93 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.61 -0.436 . . . . 2.54 110.226 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.924 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -63.21 167.79 5.95 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 2.07 110.432 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 75.5 Cg_exo -50.52 158.24 2.84 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.101 1.868 . . . . 2.27 110.919 168.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 t30 70.31 13.08 7.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.392 0.615 . . . . 3.47 110.361 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.69 40.39 16.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.356 -0.838 . . . . 4.66 112.941 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 2.1 mt-30 -98.96 174.2 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.635 -0.876 . . . . 3.57 108.635 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.5 ptt180 -139.44 130.27 26.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.892 0.769 . . . . 3.54 111.916 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.719 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -128.67 136.1 50.18 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.993 -1.003 . . . . 1.91 108.479 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.736 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.9 t -94.46 144.79 9.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.616 -0.434 . . . . 2.31 110.681 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 6.2 p -137.56 124.72 13.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.048 -0.524 . . . . 1.67 110.009 175.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.614 ' HA ' HG22 ' A' ' 156' ' ' ILE . 8.5 Cg_endo -50.88 133.33 39.68 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.097 2.531 . . . . 2.12 112.234 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.45 110.58 1.49 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.28 109.546 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.4 mmp_? -98.98 112.02 24.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.537 -0.756 . . . . 3.98 111.428 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.9 p -76.5 135.93 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.779 -0.646 . . . . 3.37 110.321 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 15.21 78.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.99 -0.844 . . . . 3.34 110.99 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 86.7 t -128.11 143.86 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.228 -0.656 . . . . 2.87 109.228 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 71.1 p -94.78 169.68 9.98 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.919 -0.771 . . . . 2.83 108.919 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -60.65 -22.88 27.16 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.753 -0.832 . . . . 1.92 108.753 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.709 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 38.2 tpt85 -62.31 -41.55 98.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 112.116 0.413 . . . . 4.27 112.116 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.533 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 6.7 t70 -77.48 -51.91 9.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.816 0.817 . . . . 2.87 109.957 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.464 ' OG ' HG21 ' A' ' 214' ' ' ILE . 47.6 m -63.64 -45.54 89.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 1.99 111.101 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.74 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -72.25 -27.12 62.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.071 -0.513 . . . . 1.34 111.718 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.709 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 1.0 OUTLIER -55.32 -43.22 74.69 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.27 -0.572 . . . . 3.08 109.841 178.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -65.57 -46.88 77.73 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.412 -0.515 . . . . 2.75 109.995 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -50.82 -49.62 58.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.446 -0.797 . . . . 1.43 111.569 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.14 -53.4 30.96 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.671 -0.695 . . . . 1.7 110.61 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.06 65.31 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.902 0.704 . . . . 2.29 112.902 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 43.1 mtm -66.22 -35.1 79.54 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.528 -0.469 . . . . 2.5 110.789 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -90.92 -0.23 57.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.251 0.548 . . . . 4.43 111.431 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.19 66.96 Favored Glycine 0 C--N 1.314 -0.654 0 CA-C-N 115.146 -0.934 . . . . 2.31 111.679 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.51 160.58 16.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.199 -0.5 . . . . 2.37 109.661 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 193' ' ' GLU . 44.5 pt -126.44 141.37 39.84 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.507 . . . . 2.42 111.56 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.71 -10.23 24.81 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 123.188 2.592 . . . . 1.84 112.471 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.503 ' HB2' HD12 ' A' ' 191' ' ' ILE . 32.7 mt-10 -64.63 -35.36 80.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.958 -0.564 . . . . 3.32 111.322 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 58.7 m -118.26 16.47 13.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.316 0.487 . . . . 2.85 112.316 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 63.6 m -124.49 164.34 19.95 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.576 -0.45 . . . . 1.74 110.896 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -129.14 154.52 46.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 116.474 -0.33 . . . . 1.73 111.424 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 208' ' ' ILE . 43.4 t -112.8 129.03 69.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.652 0.739 . . . . 1.38 111.329 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -128.92 162.2 28.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.714 -1.13 . . . . 2.99 110.099 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -139.95 134.49 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.669 -0.493 . . . . 2.64 109.669 172.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -92.26 122.86 44.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.393 0.616 . . . . 2.6 110.863 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.9 tt0 -102.04 -141.15 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.436 -0.949 . . . . 3.22 108.436 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.54 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.184 0.594 . . . . 4.02 111.822 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.48 6.03 7.56 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.52 -0.309 . . . . 3.47 112.757 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 16.6 pt-20 -120.16 -178.72 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.074 0.464 . . . . 3.48 111.301 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 200' ' ' ILE . 39.2 mtpt -123.54 141.97 51.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.75 110.635 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.63 120.69 23.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.747 -0.834 . . . . 3.25 108.747 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.21 130.94 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.968 1.779 . . . . 2.47 112.217 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.766 HD12 HG12 ' A' ' 197' ' ' VAL . 65.6 mt -99.76 157.4 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.324 -0.853 . . . . 1.91 111.484 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.11 147.33 18.54 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.146 -1.181 . . . . 2.25 110.146 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.684 ' HA ' HG22 ' A' ' 177' ' ' VAL . 91.5 m95 -69.93 -13.37 62.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.312 0.556 . . . . 2.3 112.064 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.42 8.31 45.03 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 120.952 0.406 . . . . 3.79 110.622 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -76.63 129.26 36.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.07 -0.513 . . . . 2.44 110.328 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.86 110.44 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 3.47 110.377 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -62.29 -17.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.95 111.127 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.524 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 8.0 p -66.29 -16.32 63.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.067 -0.515 . . . . 2.91 112.185 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -86.17 -31.19 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 4.8 110.702 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.1 mm? -86.58 15.02 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.214 -0.448 . . . . 2.13 111.766 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.473 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -56.81 151.64 13.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 2.03 110.451 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.65 -1.5 72.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.067 -0.587 . . . . 2.12 112.96 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -115.27 165.51 12.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.012 0.434 . . . . 2.61 111.069 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.6 mp0 -113.23 124.79 53.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.768 -0.651 . . . . 3.06 109.388 172.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.97 167.91 10.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.568 -0.742 . . . . 1.3 110.439 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.84 129.34 24.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.293 -0.632 . . . . 3.31 109.293 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 196' ' ' ALA . 89.8 t -104.58 136.7 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.329 0.585 . . . . 1.58 110.383 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.56 171.1 7.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.725 -1.213 . . . . 2.74 107.725 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 61.8 t . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 109.409 -0.589 . . . . 2.61 109.409 170.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 82.9 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 N-CA-C 111.595 -0.194 . . . . 2.69 111.595 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.7 pp -142.89 152.57 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.178 0.513 . . . . 2.15 111.79 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.4 t -118.95 123.13 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.303 -0.999 . . . . 1.67 108.303 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 68.4 mtm180 -86.31 101.65 13.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.602 0.715 . . . . 3.61 110.687 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 224' ' ' VAL . 74.8 t -91.91 121.24 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.803 -1.09 . . . . 1.4 111.795 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.8 m-85 -84.63 102.72 13.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.312 0.577 . . . . 2.54 109.813 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.728 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.0 mt -66.2 163.59 37.39 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.933 -1.031 . . . . 2.07 111.366 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 95.2 Cg_exo -45.18 145.6 3.33 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.179 2.586 . . . . 2.27 113.0 173.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.03 43.52 5.12 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.567 -0.742 . . . . 3.47 111.442 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.5 mppt? 57.68 32.56 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.27 -1.332 . . . . 4.66 112.238 168.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.516 ' OE1' ' HD3' ' A' ' 188' ' ' ARG . 33.0 mt-30 -94.31 172.8 7.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.653 -0.703 . . . . 3.57 109.186 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.1 ptt180 -148.99 137.87 21.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.567 0.699 . . . . 3.54 112.122 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.728 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -139.74 133.89 31.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.615 -1.175 . . . . 1.91 108.337 172.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.497 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -97.67 137.11 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.258 -0.645 . . . . 2.31 109.258 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.441 HG13 HD11 ' A' ' 214' ' ' ILE . 6.5 p -123.87 130.6 24.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.836 -0.431 . . . . 1.67 109.836 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.531 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.6 Cg_endo -50.21 129.2 24.8 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.905 2.403 . . . . 2.12 111.738 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.8 77.98 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.36 -0.836 . . . . 2.28 110.303 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.8 mtm180 -59.32 133.56 56.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.402 -1.272 . . . . 3.98 110.664 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 2.8 p -95.54 135.66 36.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.342 -0.39 . . . . 3.37 110.748 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.49 22.31 70.45 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.65 -0.786 . . . . 3.34 111.433 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 172' ' ' ARG . 2.9 p -123.34 171.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.655 -0.498 . . . . 2.87 109.655 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 43.3 p -105.43 160.24 15.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.594 -0.521 . . . . 2.83 109.594 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 7.3 t -53.59 -33.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.962 -0.755 . . . . 1.92 108.962 171.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -55.15 -49.9 70.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.652 -0.704 . . . . 4.27 112.62 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 175' ' ' VAL . 15.3 t70 -71.46 -47.49 55.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.866 0.841 . . . . 2.87 110.514 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 169' ' ' VAL . 4.4 m -65.13 -47.89 75.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.118 -0.946 . . . . 1.99 111.026 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.6 mm? -68.58 -25.22 64.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.486 -0.325 . . . . 1.34 111.565 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.03 -39.09 68.78 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.427 -0.583 . . . . 3.08 109.427 175.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.669 ' HE3' ' SD ' ' A' ' 187' ' ' MET . 33.5 tttp -67.39 -48.36 67.62 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.575 -0.45 . . . . 2.75 110.27 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -49.98 -55.58 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.553 -0.749 . . . . 1.43 112.097 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.432 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 1.1 mm? -63.17 -53.09 58.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 1.7 110.657 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.4 mmt -58.17 -27.83 64.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.543 0.942 . . . . 2.29 113.543 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.669 ' SD ' ' HE3' ' A' ' 183' ' ' LYS . 58.7 mtm -67.86 -22.2 65.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.513 -0.475 . . . . 2.5 111.285 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 45.1 mtt-85 -112.81 16.28 19.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.741 0.781 . . . . 4.43 111.713 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.54 25.34 75.6 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.419 -1.264 . . . . 2.31 111.892 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.432 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.6 mt -96.18 163.51 13.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.629 -0.878 . . . . 2.37 108.629 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.8 138.26 32.51 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.964 0.411 . . . . 2.42 111.058 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.32 -8.49 23.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.036 2.49 . . . . 1.84 112.634 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.154 0.502 . . . . 3.32 110.301 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 61.5 m -101.73 21.52 14.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.598 -0.728 . . . . 2.85 111.184 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.579 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 69.4 m -129.59 149.31 51.41 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.893 -0.323 . . . . 1.74 110.929 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -125.39 155.9 39.63 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.329 -0.396 . . . . 1.73 110.608 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 208' ' ' ILE . 36.2 t -115.15 124.97 72.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.162 -0.615 . . . . 1.38 111.66 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.84 164.52 18.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.014 -0.994 . . . . 2.99 110.095 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.9 ptm180 -141.78 131.82 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.733 -0.469 . . . . 2.64 109.733 171.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -90.63 122.16 41.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.147 -0.479 . . . . 2.6 110.655 -175.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 203' ' ' GLY . 5.6 tt0 -103.0 -137.07 0.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.494 -0.928 . . . . 3.22 108.494 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.45 78.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.435 0.694 . . . . 4.02 112.117 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.57 10.19 16.41 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.421 -0.354 . . . . 3.47 112.255 -177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 17.0 pt-20 -120.56 179.29 4.37 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 121.183 0.516 . . . . 3.48 111.398 -172.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.9 mtpt -124.96 137.42 54.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.317 -0.856 . . . . 2.75 110.488 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -121.17 117.26 30.71 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.408 -0.814 . . . . 3.25 108.983 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.76 133.84 19.17 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 121.931 1.754 . . . . 2.47 111.932 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 197' ' ' VAL . 72.2 mt -105.84 154.34 7.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 1.91 112.097 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 151.43 19.48 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.63 -0.988 . . . . 2.25 110.63 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.66 ' O ' ' HB ' ' A' ' 176' ' ' THR . 95.8 m95 -74.97 -13.04 60.47 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.684 0.624 . . . . 2.3 112.684 -172.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.42 ' HA ' ' CG2' ' A' ' 176' ' ' THR . 3.2 p30 -102.11 9.44 40.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.161 0.505 . . . . 3.79 110.874 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.8 m -69.76 136.76 51.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.702 -0.681 . . . . 2.44 109.292 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.74 107.07 3.32 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.809 -0.441 . . . . 3.47 109.809 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.58 ' HA ' HD23 ' A' ' 217' ' ' LEU . 1.0 OUTLIER -58.66 -17.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 1.95 111.23 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 5.7 p -66.48 -8.74 28.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.101 -0.499 . . . . 2.91 111.989 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -90.21 -34.53 15.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.026 0.441 . . . . 4.8 110.629 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -85.82 13.77 6.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.064 -0.517 . . . . 2.13 112.066 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -51.97 150.08 4.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.502 . . . . 2.03 111.617 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.1 -31.61 2.04 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.485 -0.78 . . . . 2.12 113.208 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.87 163.04 25.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.575 0.702 . . . . 2.61 111.672 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 22.6 mt-10 -105.36 114.96 29.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.958 -1.019 . . . . 3.06 108.703 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.83 155.83 16.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.84 120.08 29.55 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.614 -0.513 . . . . 3.31 109.614 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 75.4 t -100.66 133.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.402 0.62 . . . . 1.58 110.172 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -107.23 159.8 16.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.717 -1.129 . . . . 2.74 108.68 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 122.201 1.0 . . . . 2.61 110.603 -179.152 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 111.583 -0.199 . . . . 2.69 111.583 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.4 pp -138.37 160.23 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.967 0.413 . . . . 2.15 111.152 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -134.51 127.3 49.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.566 0.698 . . . . 1.67 109.122 170.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 168' ' ' VAL . 66.6 mtm180 -88.88 107.84 19.22 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.997 -1.001 . . . . 3.61 111.238 -171.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 161' ' ' LEU . 56.7 t -97.2 122.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.757 -1.11 . . . . 1.4 111.62 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 4.3 m-85 -90.73 102.8 15.55 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 122.027 -0.421 . . . . 2.54 110.396 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -67.95 169.89 8.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 2.07 111.166 -175.472 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 54.4 Cg_exo -52.72 154.97 11.28 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.087 1.858 . . . . 2.27 110.095 165.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 162' ' ' PRO . 9.5 t30 78.2 10.86 1.93 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.676 0.75 . . . . 3.47 109.912 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 62.23 32.95 17.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.277 -0.874 . . . . 4.66 112.8 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 10.1 mt-30 -102.11 -178.73 3.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.462 -0.569 . . . . 3.57 109.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 21.6 ptt180 -139.57 137.59 35.51 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.652 0.739 . . . . 3.54 111.343 175.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.618 HG21 ' HA ' ' A' ' 184' ' ' ALA . 0.4 OUTLIER -129.51 127.54 41.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.963 -1.495 . . . . 1.91 106.963 170.619 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -94.86 135.48 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.883 -0.784 . . . . 2.31 108.883 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.01 128.68 25.82 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.878 -0.416 . . . . 1.67 109.878 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 9.4 Cg_endo -51.81 132.58 42.39 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.832 2.355 . . . . 2.12 110.944 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -64.1 88.4 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.641 -0.708 . . . . 2.28 110.371 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 42.8 mmt180 -68.09 111.28 4.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.993 -1.003 . . . . 3.98 110.939 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 12.8 p -77.88 130.75 37.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.045 -0.525 . . . . 3.37 109.882 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.63 4.54 87.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.607 -0.806 . . . . 3.34 111.228 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 1.6 t -118.66 144.18 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.371 0.605 . . . . 2.87 110.041 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 10.9 p -93.8 173.22 7.79 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.378 -0.828 . . . . 2.83 109.265 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 44.9 t -50.47 -33.81 11.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.512 -0.551 . . . . 1.92 109.512 171.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.613 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 12.1 tpt180 -48.98 -62.68 1.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.404 -0.816 . . . . 4.27 112.934 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.691 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 10.6 t70 -75.78 -36.5 59.78 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.513 0.673 . . . . 2.87 111.493 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 p -65.63 -49.93 66.88 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.669 0.747 . . . . 1.99 110.105 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.6 mm? -68.71 -22.23 64.36 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.303 -0.862 . . . . 1.34 111.601 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.691 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.1 mtpt -48.52 -51.12 28.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.311 -0.625 . . . . 3.08 109.311 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 24.7 tttp -59.88 -51.44 69.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.655 -0.418 . . . . 2.75 110.729 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.75 -49.23 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.741 -0.663 . . . . 1.43 112.132 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -47.4 54.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.106 -0.497 . . . . 1.7 111.076 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -27.72 65.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.391 0.515 . . . . 2.29 112.391 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 42.3 mtm -73.14 -32.91 65.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.71 -0.396 . . . . 2.5 110.352 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.468 ' CG ' ' HG ' ' A' ' 161' ' ' LEU . 14.2 mmm180 -74.77 -22.6 58.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.214 0.531 . . . . 4.43 110.76 171.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.51 12.84 37.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.661 -0.7 . . . . 2.31 111.401 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.4 mp -106.28 176.78 5.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 2.37 110.54 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.493 HD11 ' SG ' ' A' ' 194' ' ' CYS . 46.2 pt -124.97 144.49 47.2 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 121.09 0.472 . . . . 2.42 110.514 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.27 -3.8 12.43 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 123.352 2.701 . . . . 1.84 112.796 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -86.2 -28.12 24.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.094 -0.503 . . . . 3.32 110.773 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.493 ' SG ' HD11 ' A' ' 191' ' ' ILE . 74.6 m -111.66 18.98 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 2.85 111.267 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 68.9 m -131.35 163.8 27.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.547 -0.538 . . . . 1.74 109.547 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -129.65 146.27 51.45 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 111.24 0.089 . . . . 1.73 111.24 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.696 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -111.21 130.67 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.449 1.119 . . . . 1.38 111.421 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -123.69 164.99 18.0 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.489 -1.687 . . . . 2.99 109.82 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 199' ' ' ARG . 2.8 ptm180 -147.2 133.44 19.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.108 -0.701 . . . . 2.64 109.108 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -83.91 118.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.255 0.55 . . . . 2.6 110.524 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.6 tt0 -101.45 -140.86 0.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.585 -1.265 . . . . 3.22 107.585 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.15 81.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.552 0.575 . . . . 4.02 112.552 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.62 7.65 16.38 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.163 -0.471 . . . . 3.47 113.06 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 12.7 pt-20 -131.1 -179.39 5.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 117.346 0.573 . . . . 3.48 111.324 -174.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.624 ' HG2' HD11 ' A' ' 200' ' ' ILE . 27.8 mtpt -114.05 138.08 50.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.502 -0.772 . . . . 2.75 110.611 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.69 111.22 39.64 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.376 -0.829 . . . . 3.25 109.619 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.73 121.71 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.85 1.7 . . . . 2.47 111.462 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 197' ' ' VAL . 13.2 mt -93.75 158.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.494 -0.776 . . . . 1.91 111.361 -171.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.22 144.23 17.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 2.25 110.935 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 177' ' ' VAL . 92.8 m95 -72.77 -14.88 61.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 111.955 0.354 . . . . 2.3 111.955 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -98.72 20.26 13.33 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.423 0.63 . . . . 3.79 110.397 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.416 ' CG2' HD11 ' A' ' 217' ' ' LEU . 27.8 m -85.26 127.07 34.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.367 -0.833 . . . . 2.44 109.874 176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.31 109.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 3.47 109.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.551 ' HA ' HD13 ' A' ' 217' ' ' LEU . 6.7 tt -67.23 -14.35 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.95 112.247 -170.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.489 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 22.7 t -69.27 -13.81 62.6 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.051 -0.406 . . . . 2.91 110.673 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -90.35 -14.07 33.84 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.44 0.638 . . . . 4.8 110.271 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.5 mp -101.74 17.88 21.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 2.13 111.645 -176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 m -60.51 153.51 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 2.03 111.074 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.29 -29.17 1.68 Allowed Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.982 -0.554 . . . . 2.12 113.911 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.3 mm-40 -70.2 164.13 24.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.15 0.5 . . . . 2.61 111.351 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.3 mt-10 -112.85 118.71 35.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.037 -0.727 . . . . 3.06 109.037 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.414 HD12 HG22 ' A' ' 159' ' ' VAL . 32.3 mt -95.91 160.18 14.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.127 -0.942 . . . . 1.3 110.16 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -132.72 117.86 18.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.315 -0.624 . . . . 3.31 109.315 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 64.9 t -101.72 134.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.724 0.774 . . . . 1.58 111.355 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.298 -1.319 . . . . 2.74 107.712 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 97.2 t . . . . . 0 C--N 1.309 -1.171 0 C-N-CA 121.056 -0.258 . . . . 2.61 110.608 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 93.8 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 CA-C-O 120.663 0.193 . . . . 2.69 112.131 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -132.04 161.93 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 2.15 111.596 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 HD23 ' A' ' 217' ' ' LEU . 47.1 t -132.44 125.02 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.923 -0.769 . . . . 1.67 108.923 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 168' ' ' VAL . 77.5 mtm-85 -87.45 104.98 16.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 3.61 110.391 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.9 t -93.3 114.97 31.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.317 -0.856 . . . . 1.4 111.476 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.58 103.62 7.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.534 0.683 . . . . 2.54 109.583 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.86 HD11 ' HB ' ' A' ' 167' ' ' THR . 2.3 mt -72.09 168.25 24.63 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.568 -1.197 . . . . 2.07 110.975 -175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 71.1 Cg_exo -52.68 156.11 9.43 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.393 2.062 . . . . 2.27 111.299 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 18.4 m120 70.29 19.81 6.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.147 0.499 . . . . 3.47 110.479 -175.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 58.75 31.26 21.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.242 -0.89 . . . . 4.66 112.493 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.4 179.21 5.74 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.844 -0.799 . . . . 3.57 108.844 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -148.02 129.84 15.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 118.418 0.554 . . . . 3.54 111.689 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.86 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -121.04 137.62 54.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.572 -0.899 . . . . 1.91 108.572 172.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 158' ' ' ARG . 6.1 t -92.84 144.42 9.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.093 -0.706 . . . . 2.31 109.093 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.89 130.89 14.35 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 108.713 -0.847 . . . . 1.67 108.713 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.7 Cg_endo -50.02 135.8 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.687 2.258 . . . . 2.12 111.757 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.654 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.06 82.37 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 2.28 109.427 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.58 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 41.0 mmt180 -64.47 111.12 2.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.878 -1.056 . . . . 3.98 111.291 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.32 125.17 31.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 3.37 109.95 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.12 71.58 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.496 -1.041 . . . . 3.34 110.496 -174.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 88.5 t -118.71 152.16 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.852 -0.674 . . . . 2.87 109.451 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 33.8 p -97.09 163.76 12.8 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.671 -0.492 . . . . 2.83 109.671 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 18.7 t -52.17 -32.18 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.548 -0.538 . . . . 1.92 109.548 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.4 tpt180 -53.05 -53.56 48.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.371 -0.831 . . . . 4.27 112.454 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 2.0 t70 -74.53 -43.15 57.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.516 0.674 . . . . 2.87 110.669 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 214' ' ' ILE . 41.1 m -67.2 -49.85 63.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.359 -0.837 . . . . 1.99 111.318 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.619 HD21 HG21 ' A' ' 224' ' ' VAL . 0.0 OUTLIER -68.02 -23.67 65.02 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.98 0.363 . . . . 1.34 111.98 173.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.07 -43.21 77.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.057 -0.72 . . . . 3.08 109.057 176.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 187' ' ' MET . 23.1 tttp -63.28 -48.44 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 2.75 110.079 173.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -52.54 -50.31 63.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 1.43 111.82 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -67.87 -52.57 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.391 -0.368 . . . . 1.7 110.633 178.128 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.44 62.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.796 0.665 . . . . 2.29 112.796 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 45.6 mtm -69.42 -40.77 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.646 -0.422 . . . . 2.5 109.877 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.505 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.2 mmp_? -74.83 -20.55 59.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.879 -0.6 . . . . 4.43 111.025 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.55 15.55 22.57 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.041 -0.599 . . . . 2.31 111.752 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.408 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.2 mp -104.53 177.43 4.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.294 . . . . 2.37 110.267 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 193' ' ' GLU . 12.8 pt -133.42 145.74 57.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.209 0.528 . . . . 2.42 110.606 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.71 -9.87 12.66 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 124.015 3.143 . . . . 1.84 113.531 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.443 ' HB2' HD12 ' A' ' 191' ' ' ILE . 27.2 mt-10 -83.41 -25.72 31.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.846 0.355 . . . . 3.32 110.541 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 69.7 m -112.14 36.25 3.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.504 . . . . 2.85 111.412 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.504 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 89.6 m -152.96 162.74 40.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.143 -0.481 . . . . 1.74 109.876 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.484 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -129.8 149.62 51.47 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 110.452 -0.203 . . . . 1.73 110.452 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.659 HG12 HD12 ' A' ' 208' ' ' ILE . 55.6 t -108.1 127.96 63.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.791 -0.764 . . . . 1.38 111.307 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.43 168.94 15.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.425 -1.261 . . . . 2.99 109.946 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.427 ' HG2' HD11 ' A' ' 208' ' ' ILE . 11.7 ptm180 -147.17 132.76 18.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.852 -0.613 . . . . 2.64 109.695 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.659 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -90.46 123.18 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.388 0.613 . . . . 2.6 110.44 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.512 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 21.8 mt-30 -106.08 -146.79 0.39 Allowed 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.294 -0.867 . . . . 3.22 109.094 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 39.0 t70 -49.12 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.579 0.751 . . . . 4.02 112.812 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.85 9.02 11.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.246 -0.434 . . . . 3.47 113.303 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.56 -178.34 4.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.364 0.582 . . . . 3.48 111.923 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.659 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.8 mtpt -122.47 142.11 50.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.251 -0.886 . . . . 2.75 110.692 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 70.8 mmtt -125.31 113.29 25.91 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.56 -0.746 . . . . 3.25 109.334 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.67 131.92 19.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.252 1.968 . . . . 2.47 112.025 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.659 HD12 HG12 ' A' ' 197' ' ' VAL . 42.9 mt -103.46 154.8 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.42 -0.809 . . . . 1.91 111.476 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.62 148.84 19.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.128 -0.789 . . . . 2.25 111.128 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.537 ' O ' ' HB ' ' A' ' 176' ' ' THR . 94.9 m95 -77.78 -15.09 59.35 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.575 -0.368 . . . . 2.3 111.946 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.75 3.75 54.97 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.231 0.538 . . . . 3.79 110.641 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 177' ' ' VAL . 67.8 m -73.83 130.45 39.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.444 -0.798 . . . . 2.44 110.509 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 216' ' ' TRP . 16.6 t70 -60.81 114.17 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.658 ' O ' HG12 ' A' ' 214' ' ' ILE . 2.8 tt -77.35 2.41 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.36 0.6 . . . . 1.95 112.136 -170.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.654 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 35.5 t -76.2 -7.23 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.255 -0.903 . . . . 2.91 109.148 170.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.812 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -65.27 -57.54 8.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.254 -0.885 . . . . 4.8 111.202 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 216' ' ' TRP . 0.0 OUTLIER -88.33 31.07 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.968 0.729 . . . . 2.13 112.968 -172.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.1 m -57.36 146.69 28.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.353 0.597 . . . . 2.03 111.111 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 67.75 6.15 42.1 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.149 -0.932 . . . . 2.12 113.361 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -115.22 165.51 12.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.886 0.343 . . . . 2.61 110.486 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -112.38 126.61 55.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.298 0.571 . . . . 3.06 110.508 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.414 HD21 ' HG ' ' A' ' 217' ' ' LEU . 29.2 mt -96.45 166.8 11.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.3 110.866 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -137.23 123.41 20.47 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.373 -0.603 . . . . 3.31 109.373 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 181' ' ' LEU . 52.2 t -106.05 140.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.283 0.564 . . . . 1.58 110.924 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.33 174.47 5.85 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 4.1 t . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 121.096 0.474 . . . . 2.61 109.851 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.2 Cg_endo . . . . . 0 N--CA 1.451 -1.007 0 CA-C-O 120.646 0.186 . . . . 2.69 111.711 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.0 pp -142.07 144.55 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.739 0.304 . . . . 2.15 110.602 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.9 t -110.66 119.55 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.851 -0.796 . . . . 1.67 108.851 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.579 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 8.0 mtp85 -87.88 104.19 16.37 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.447 0.641 . . . . 3.61 111.365 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 222' ' ' LEU . 85.2 t -88.74 138.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 1.4 111.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.4 m-85 -96.95 104.84 16.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.532 0.682 . . . . 2.54 109.891 171.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.65 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.3 mt -64.69 160.16 55.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.596 -1.184 . . . . 2.07 110.778 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.98 154.11 13.97 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.539 2.16 . . . . 2.27 112.441 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.33 30.51 4.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.659 -0.701 . . . . 3.47 110.43 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 55.56 47.85 19.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.11 -0.95 . . . . 4.66 112.716 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -109.08 178.17 4.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.643 -0.873 . . . . 3.57 108.643 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 31.5 ptt180 -148.44 134.82 19.54 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.563 0.697 . . . . 3.54 112.61 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.65 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.7 OUTLIER -134.58 132.62 39.29 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.712 -1.131 . . . . 1.91 108.794 173.178 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.579 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -95.08 150.31 4.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.284 -0.635 . . . . 2.31 109.284 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.77 126.81 14.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.54 -0.541 . . . . 1.67 109.54 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 156' ' ' ILE . 5.4 Cg_endo -49.71 134.27 33.82 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.207 2.605 . . . . 2.12 112.211 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -62.72 95.19 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.28 109.748 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.524 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 40.1 mmt180 -76.17 110.73 10.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.986 -1.006 . . . . 3.98 110.391 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 2.1 p -81.82 117.77 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.58 . . . . 3.37 110.834 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.39 19.61 41.14 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.755 -0.938 . . . . 3.34 110.755 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.615 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 81.4 t -131.07 148.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.402 . . . . 2.87 110.271 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.9 p -84.83 157.55 20.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.413 -0.958 . . . . 2.83 108.413 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 14.6 p -59.51 -22.42 23.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.817 -0.809 . . . . 1.92 108.817 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.9 tpt180 -57.51 -51.64 68.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.915 -0.584 . . . . 4.27 112.408 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.615 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 11.0 t70 -69.42 -49.93 50.48 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.81 0.814 . . . . 2.87 110.412 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -61.1 -53.89 51.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.334 -1.303 . . . . 1.99 110.677 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.752 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.1 mm? -69.43 -20.17 63.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.7 -0.682 . . . . 1.34 112.237 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.9 -44.8 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.23 -0.656 . . . . 3.08 109.23 173.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -63.07 -49.87 72.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.609 -0.436 . . . . 2.75 110.226 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.4 -52.48 45.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.264 -0.88 . . . . 1.43 111.373 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.703 HD21 ' SG ' ' A' ' 195' ' ' CYS . 8.5 tp -71.1 -35.94 72.0 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.359 -0.837 . . . . 1.7 110.711 -175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -20.71 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 2.29 111.722 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 38.9 mtt -64.76 -44.03 91.36 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.697 -0.853 . . . . 2.5 108.697 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.503 ' HG2' HD13 ' A' ' 161' ' ' LEU . 11.1 mmm180 -69.49 -24.72 63.81 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.389 -1.278 . . . . 4.43 110.454 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.32 19.13 26.56 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.595 -0.73 . . . . 2.31 111.572 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.521 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . 11.3 mp -105.6 171.08 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.191 -0.3 . . . . 2.37 110.191 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.497 ' C ' HD23 ' A' ' 185' ' ' LEU . 34.9 pt -123.66 135.24 25.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 2.42 111.774 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.71 -3.75 7.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.784 2.989 . . . . 1.84 113.518 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.857 0.36 . . . . 3.32 110.605 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 31.6 t -110.02 14.7 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 2.85 111.7 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.703 ' SG ' HD21 ' A' ' 185' ' ' LEU . 35.3 m -127.84 169.26 14.11 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.905 -0.497 . . . . 1.74 110.358 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -139.46 149.46 44.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 111.75 0.278 . . . . 1.73 111.75 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.628 HG23 ' HB ' ' A' ' 208' ' ' ILE . 1.9 m -110.85 134.36 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.423 1.106 . . . . 1.38 111.582 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 225' ' ' GLU . 13.1 m-85 -122.63 173.18 7.87 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.671 -1.604 . . . . 2.99 109.525 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.448 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.4 ptm180 -151.48 127.86 10.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.735 -0.666 . . . . 2.64 109.651 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.728 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -84.53 122.72 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.517 0.675 . . . . 2.6 109.84 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 31.9 tt0 -111.19 -136.5 0.37 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.807 -1.182 . . . . 3.22 107.807 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.94 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.616 0.766 . . . . 4.02 112.882 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 6.45 7.39 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 116.018 -0.537 . . . . 3.47 113.474 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 10.5 pt-20 -137.07 -179.25 5.6 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 117.776 0.788 . . . . 3.48 111.991 -172.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.728 ' HG2' HD11 ' A' ' 200' ' ' ILE . 43.0 mtpt -112.16 139.83 47.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.304 -0.862 . . . . 2.75 111.098 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -122.75 110.57 31.65 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 3.25 109.483 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.51 131.38 18.7 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.035 1.823 . . . . 2.47 112.028 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.628 ' HB ' HG23 ' A' ' 197' ' ' VAL . 17.0 mt -103.12 160.78 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.154 -0.475 . . . . 1.91 111.525 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.16 144.61 17.36 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.953 -0.859 . . . . 2.25 110.953 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.415 ' HA ' ' CG1' ' A' ' 177' ' ' VAL . 73.2 m95 -66.19 -13.75 60.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.357 0.873 . . . . 2.3 113.357 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -103.3 11.51 36.66 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.04 -0.412 . . . . 3.79 111.313 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.9 m -73.06 122.0 21.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.474 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 175' ' ' VAL . 9.9 t0 -60.99 117.27 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.256 -0.646 . . . . 3.47 109.256 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' A' ' 217' ' ' LEU . 4.4 tt -68.82 -15.17 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 1.95 112.41 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.567 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 95.1 p -71.4 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.781 -0.574 . . . . 2.91 111.702 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -90.13 -11.68 40.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.313 0.577 . . . . 4.8 110.216 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.3 mp -102.02 11.85 37.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.579 -0.737 . . . . 2.13 111.709 -174.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.7 m -56.7 153.24 10.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.283 0.563 . . . . 2.03 111.607 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.03 -19.57 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.511 -0.768 . . . . 2.12 113.12 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.26 151.89 19.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.109 0.481 . . . . 2.61 111.131 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 53.0 mt-10 -100.0 126.04 46.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.92 -0.77 . . . . 3.06 108.92 170.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 35.9 mt -94.46 167.3 11.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.667 -0.697 . . . . 1.3 110.206 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.408 ' CD2' HD13 ' A' ' 200' ' ' ILE . 83.8 m-70 -140.18 122.46 15.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.357 -0.608 . . . . 3.31 109.357 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.62 135.78 36.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.456 0.646 . . . . 1.58 111.407 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 198' ' ' TYR . 2.1 mm-40 -108.85 167.99 9.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.209 -1.404 . . . . 2.74 107.209 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 21.7 t . . . . . 0 C--N 1.307 -1.253 0 C-N-CA 120.308 -0.557 . . . . 2.61 110.211 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 120.895 0.289 . . . . 2.69 112.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.29 163.13 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.855 0.359 . . . . 2.15 111.062 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 218' ' ' THR . 35.3 t -126.93 122.8 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.337 -0.616 . . . . 1.67 109.337 171.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.473 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 91.4 mtt180 -80.6 106.12 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.812 -0.44 . . . . 3.61 109.812 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.62 107.78 20.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.836 -0.62 . . . . 1.4 110.959 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 m-85 -71.63 103.23 2.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.807 0.813 . . . . 2.54 110.438 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.4 mt -63.61 159.73 49.68 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.241 -1.345 . . . . 2.07 111.051 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.64 148.25 21.67 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.487 2.125 . . . . 2.27 111.825 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.4 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 91.2 m-20 69.95 36.06 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.505 0.669 . . . . 3.47 110.755 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.486 ' HB2' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.49 33.27 22.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 4.66 113.281 169.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -98.35 -179.99 4.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.0 -0.741 . . . . 3.57 109.0 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.1 ptt180 -149.93 132.96 16.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 3.54 112.011 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.63 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -121.56 136.92 54.92 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.637 -0.875 . . . . 1.91 108.637 170.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.49 HG12 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -92.6 141.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.324 -0.621 . . . . 2.31 109.324 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 14.8 p -134.95 123.51 15.95 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.425 -0.583 . . . . 1.67 109.425 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.599 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.5 Cg_endo -51.17 138.51 44.78 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.348 2.699 . . . . 2.12 111.675 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.3 87.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.507 -0.77 . . . . 2.28 110.324 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.513 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 37.3 mmt180 -66.82 113.04 4.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.527 -1.215 . . . . 3.98 111.542 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 20.7 p -76.34 131.23 39.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 3.37 110.651 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.27 79.8 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.052 -0.819 . . . . 3.34 111.052 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 89.0 t -129.06 144.95 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.661 -0.496 . . . . 2.87 109.661 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.8 p -93.3 170.81 9.34 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.074 -0.713 . . . . 2.83 109.074 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.737 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.2 m -60.83 -21.31 23.66 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 108.995 -0.743 . . . . 1.92 108.995 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 23.9 tpp180 -53.04 -61.22 2.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.013 -0.54 . . . . 4.27 111.883 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.641 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 10.3 t70 -66.38 -48.12 71.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.722 0.773 . . . . 2.87 110.786 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.49 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 p -61.57 -53.13 60.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.908 -1.042 . . . . 1.99 110.658 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.737 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -65.94 -24.98 66.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.669 -0.696 . . . . 1.34 112.101 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.47 -40.34 71.52 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.679 -0.489 . . . . 3.08 109.679 178.596 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 187' ' ' MET . 38.1 tttp -68.7 -46.2 69.61 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.322 -0.551 . . . . 2.75 109.945 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.7 -55.9 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 1.43 111.945 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -49.08 75.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 1.7 111.227 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -23.38 66.11 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.356 0.502 . . . . 2.29 112.356 -175.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 44.1 mtm -76.06 -31.45 58.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 2.5 110.505 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.594 ' CD ' HD13 ' A' ' 161' ' ' LEU . 12.0 mmm180 -72.99 -25.72 61.09 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.187 0.518 . . . . 4.43 110.478 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.75 16.56 25.96 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.374 -0.83 . . . . 2.31 111.063 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.423 HD13 ' HB3' ' A' ' 188' ' ' ARG . 10.6 mp -105.33 172.35 6.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.873 0.368 . . . . 2.37 110.246 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.46 140.52 28.34 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 2.42 110.291 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.12 -4.22 12.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.049 2.5 . . . . 1.84 112.7 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -73.99 -47.29 38.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 3.32 110.578 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 86.0 m -102.01 37.74 1.79 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.902 -0.59 . . . . 2.85 111.113 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 72.7 m -143.31 162.67 35.07 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.379 -0.6 . . . . 1.74 109.379 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.486 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -133.73 156.68 47.52 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.444 0.164 . . . . 1.73 111.274 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 208' ' ' ILE . 35.9 t -113.81 126.66 71.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.769 0.795 . . . . 1.38 111.258 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -129.13 161.84 29.14 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.499 -1.228 . . . . 2.99 109.547 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -145.84 154.93 42.54 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.645 -0.502 . . . . 2.64 109.645 168.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.779 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 40.2 mm -104.54 129.31 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 2.6 110.81 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 32.5 tt0 -113.34 -138.96 0.38 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.089 -1.078 . . . . 3.22 108.089 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 201' ' ' GLN . 14.3 t70 -56.3 78.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.471 0.708 . . . . 4.02 112.248 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.11 11.12 17.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.397 -0.43 . . . . 3.47 112.309 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.78 178.63 6.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 3.48 111.296 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.779 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 54.7 mtpt -118.78 139.5 51.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.159 -0.928 . . . . 2.75 111.17 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -120.84 108.86 36.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.789 -1.096 . . . . 3.25 108.513 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.32 128.91 15.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.615 1.543 . . . . 2.47 110.967 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 197' ' ' VAL . 20.5 mt -99.49 153.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.725 -0.671 . . . . 1.91 111.381 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.3 147.5 18.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.215 -0.754 . . . . 2.25 111.215 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.704 ' HA ' HG22 ' A' ' 177' ' ' VAL . 85.8 m95 -74.28 -13.75 60.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.016 0.376 . . . . 2.3 112.016 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -106.88 20.42 19.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.197 0.523 . . . . 3.79 110.339 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.7 m -83.77 128.49 34.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.489 -0.778 . . . . 2.44 109.942 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -65.15 114.43 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 3.47 109.531 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 214' ' ' ILE . 6.1 tt -71.27 -15.16 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.066 -0.515 . . . . 1.95 111.948 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.578 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 91.8 p -73.07 -8.96 58.1 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.064 -0.654 . . . . 2.91 111.075 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -88.8 -26.15 21.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.341 0.591 . . . . 4.8 110.084 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -91.58 18.43 7.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.395 -0.82 . . . . 2.13 112.293 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.4 m -59.47 153.27 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.168 0.508 . . . . 2.03 111.353 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.66 5.3 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.718 -0.673 . . . . 2.12 112.933 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -81.34 145.9 30.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.937 0.399 . . . . 2.61 110.951 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 50.2 mt-10 -101.53 114.16 27.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 3.06 108.698 167.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.64 171.73 8.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.32 -0.855 . . . . 1.3 109.441 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -148.53 134.15 18.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.898 -0.408 . . . . 3.31 109.898 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.97 139.81 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.577 0.703 . . . . 1.58 111.103 -174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -107.84 169.27 8.71 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.523 -1.288 . . . . 2.74 107.523 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 77.8 t . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 120.601 -0.44 . . . . 2.61 110.817 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.4 Cg_endo . . . . . 0 N--CA 1.462 -0.324 0 CA-C-O 120.987 0.328 . . . . 2.69 112.074 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -138.58 165.5 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.989 -0.551 . . . . 2.15 110.195 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 220' ' ' GLU . 44.6 t -128.44 120.76 53.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.61 -0.515 . . . . 1.67 109.61 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 168' ' ' VAL . 89.3 mtm180 -83.09 104.07 13.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.877 -0.601 . . . . 3.61 110.192 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 181' ' ' LEU . 60.1 t -95.66 119.7 44.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.169 -0.923 . . . . 1.4 111.337 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 5.3 m-85 -79.05 102.8 8.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.656 0.741 . . . . 2.54 109.931 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.658 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.3 mt -64.27 159.2 59.95 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.759 -1.109 . . . . 2.07 110.246 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 190' ' ' LEU . 41.5 Cg_exo -56.63 142.24 90.83 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.702 2.268 . . . . 2.27 111.18 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.6 t30 75.87 43.97 0.16 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.126 0.965 . . . . 3.47 110.424 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 164' ' ' LYS . 1.3 mppt? 53.01 32.5 12.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.743 -1.571 . . . . 4.66 113.378 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -101.12 173.7 6.34 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.933 -0.766 . . . . 3.57 108.933 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -148.47 137.73 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.166 0.508 . . . . 3.54 111.948 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.658 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -130.54 139.24 50.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.035 -0.984 . . . . 1.91 108.958 174.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -95.22 142.57 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.265 -0.643 . . . . 2.31 109.265 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.425 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.1 p -138.19 125.64 13.63 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 109.332 -0.618 . . . . 1.67 109.332 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.8 Cg_endo -49.79 137.35 34.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.284 2.656 . . . . 2.12 112.252 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.753 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -67.72 85.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.338 -0.846 . . . . 2.28 109.889 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 23.6 mmm180 -71.13 112.18 7.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.055 -0.975 . . . . 3.98 111.694 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 31.6 m -72.29 131.8 43.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.742 -0.663 . . . . 3.37 110.323 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.05 12.15 84.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 3.34 111.351 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 67.6 t -118.49 150.0 20.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.115 0.483 . . . . 2.87 109.902 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.0 p -85.02 151.46 24.15 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.596 -0.89 . . . . 2.83 108.596 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 12.6 p -58.33 -22.65 20.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.484 -0.932 . . . . 1.92 108.484 170.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -58.1 -50.62 72.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.959 -0.564 . . . . 4.27 112.044 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 7.7 t70 -67.23 -52.13 44.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.12 0.962 . . . . 2.87 110.152 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 214' ' ' ILE . 60.0 m -63.18 -45.63 90.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.446 -1.252 . . . . 1.99 111.132 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.0 OUTLIER -75.71 -21.69 57.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.615 0.598 . . . . 1.34 112.615 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 9.6 pttt -60.3 -37.8 81.66 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.535 -0.866 . . . . 3.08 108.96 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 187' ' ' MET . 15.5 tttp -63.15 -52.9 60.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.522 -0.471 . . . . 2.75 109.824 170.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -48.52 -53.92 16.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 1.43 111.673 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 79.6 mt -66.98 -51.06 59.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.694 -0.685 . . . . 1.7 111.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -23.23 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 2.29 112.878 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 41.8 mtm -64.61 -44.62 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 2.5 110.285 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.58 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -71.18 -26.03 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.553 0.692 . . . . 4.43 111.331 171.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.38 21.45 9.33 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 114.744 -1.116 . . . . 2.31 111.163 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 188' ' ' ARG . 26.1 mt -94.87 159.06 15.21 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.899 -0.651 . . . . 2.37 109.981 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 193' ' ' GLU . 48.8 pt -120.28 135.39 24.43 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.153 0.501 . . . . 2.42 111.524 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.2 -4.74 14.94 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.144 2.563 . . . . 1.84 112.474 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 191' ' ' ILE . 26.1 tt0 -61.22 -49.97 74.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.789 -0.641 . . . . 3.32 111.548 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.89 -1.22 22.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 2.85 111.286 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 49.9 m -109.25 161.15 15.52 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.289 -0.257 . . . . 1.74 110.519 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -133.06 154.29 50.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 116.478 -0.328 . . . . 1.73 110.237 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 208' ' ' ILE . 2.2 m -104.49 135.78 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.24 1.019 . . . . 1.38 110.851 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 225' ' ' GLU . 9.2 m-85 -129.48 167.04 18.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.839 -1.528 . . . . 2.99 109.795 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 206' ' ' LYS . 3.2 ptm180 -149.92 131.98 15.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.122 -0.49 . . . . 2.64 110.226 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.777 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -92.34 121.27 42.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.522 0.677 . . . . 2.6 110.375 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.2 tt0 -103.76 -137.66 0.35 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.976 -1.12 . . . . 3.22 107.976 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.81 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.392 0.515 . . . . 4.02 112.392 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.47 6.25 14.83 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.125 -0.489 . . . . 3.47 112.764 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.5 pt-20 -127.7 -179.52 4.98 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 117.318 0.559 . . . . 3.48 111.866 -172.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HG2' HD11 ' A' ' 200' ' ' ILE . 51.8 mtpt -118.78 140.97 49.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.374 -0.83 . . . . 2.75 111.042 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' A' ' 199' ' ' ARG . 70.6 mmtt -124.93 113.6 26.71 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.152 -0.931 . . . . 3.25 108.652 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 198' ' ' TYR . 54.6 Cg_endo -76.71 127.94 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.891 1.727 . . . . 2.47 111.799 175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 197' ' ' VAL . 8.5 mt -100.79 156.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.932 -0.576 . . . . 1.91 110.988 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.78 146.85 18.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.139 -0.784 . . . . 2.25 111.139 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 178' ' ' ARG . 67.1 m95 -66.09 -20.2 66.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.325 0.861 . . . . 2.3 113.325 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.28 15.59 28.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.281 -0.567 . . . . 3.79 110.809 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 42.0 m -73.68 131.4 41.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.338 -0.846 . . . . 2.44 109.756 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 9.8 t70 -62.81 109.92 1.59 Allowed 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.363 0.414 . . . . 3.47 109.948 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.594 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -64.4 -18.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.381 . . . . 1.95 111.689 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.753 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 38.2 t -69.42 -11.64 60.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.924 -0.31 . . . . 2.91 111.307 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -90.01 -25.56 20.78 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.106 -0.371 . . . . 4.8 110.525 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -87.6 16.93 5.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 111.928 0.344 . . . . 2.13 111.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 m -55.33 149.07 13.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 2.03 110.095 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.9 -8.28 37.78 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 121.06 -0.59 . . . . 2.12 113.128 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 157' ' ' VAL . 52.3 mm-40 -101.67 137.99 39.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.816 0.308 . . . . 2.61 110.557 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.24 118.78 30.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.873 -0.788 . . . . 3.06 108.873 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.44 174.3 6.74 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.435 -0.802 . . . . 1.3 109.816 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 5.9 p80 -156.11 149.89 25.05 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.671 -1.233 . . . . 3.31 107.671 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 196' ' ' ALA . 84.1 t -100.65 123.52 53.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 122.032 0.92 . . . . 1.58 111.106 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.66 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 0.0 OUTLIER -109.64 120.44 42.51 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.666 -1.606 . . . . 2.74 109.276 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 64.1 t . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 115.421 -0.809 . . . . 2.61 112.03 -171.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 111.457 -0.247 . . . . 2.69 111.457 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.84 165.53 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.177 0.513 . . . . 2.15 111.017 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.1 p -139.43 123.1 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.409 -0.814 . . . . 1.67 109.559 173.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 168' ' ' VAL . 53.4 mtt85 -81.22 109.37 15.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 3.61 110.711 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.495 HG22 HD12 ' A' ' 222' ' ' LEU . 53.8 t -98.7 110.81 26.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.095 -0.957 . . . . 1.4 111.485 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.5 m-85 -75.48 103.63 5.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.336 0.589 . . . . 2.54 109.986 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.596 HD11 ' HB ' ' A' ' 167' ' ' THR . 16.1 mt -62.54 161.03 29.77 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.973 -1.012 . . . . 2.07 111.362 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.02 148.7 37.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.762 2.308 . . . . 2.27 111.491 175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 72.94 23.64 2.74 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.724 0.64 . . . . 3.47 110.894 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 67.38 34.06 4.98 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.537 0.94 . . . . 4.66 113.537 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -98.08 -179.35 4.36 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.598 -0.89 . . . . 3.57 108.598 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 2.9 ptt180 -149.51 139.58 22.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.585 0.629 . . . . 3.54 111.666 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.596 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -132.35 138.94 47.94 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.698 -0.852 . . . . 1.91 108.698 170.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 156' ' ' ILE . 3.5 t -93.08 140.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.16 -0.616 . . . . 2.31 110.057 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 180' ' ' SER . 20.0 t -119.28 122.51 29.41 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.295 -0.411 . . . . 1.67 110.424 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 156' ' ' ILE . 9.7 Cg_endo -52.96 123.34 12.9 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.343 2.029 . . . . 2.12 109.971 168.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.42 101.13 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 2.28 110.49 -173.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.597 ' HB3' HG21 ' A' ' 175' ' ' VAL . 23.9 mmm180 -82.57 119.14 23.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.562 -1.199 . . . . 3.98 111.415 -172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 34.7 t -85.03 136.07 33.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 3.37 109.527 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.32 75.51 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.053 -1.219 . . . . 3.34 110.053 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 172' ' ' ARG . 23.3 t -132.79 136.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.651 -0.774 . . . . 2.87 110.318 -174.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 23.4 p -89.37 167.03 13.35 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.663 -0.699 . . . . 2.83 109.683 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 24.2 t -53.02 -34.17 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.261 -0.644 . . . . 1.92 109.261 171.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -53.28 -56.53 15.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.848 -1.069 . . . . 4.27 112.812 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.491 ' HB3' HG13 ' A' ' 175' ' ' VAL . 9.1 t70 -72.52 -43.62 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 2.87 110.926 -173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 169' ' ' VAL . 1.3 m -65.21 -50.24 66.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.423 -0.808 . . . . 1.99 111.104 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -70.51 -21.12 62.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.625 -0.43 . . . . 1.34 111.968 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.53 -47.05 73.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.933 -0.765 . . . . 3.08 108.933 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.544 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 25.5 ttpt -63.4 -46.61 85.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.984 -0.553 . . . . 2.75 110.041 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.33 -54.13 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.707 -0.679 . . . . 1.43 111.865 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.438 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -65.11 -51.94 58.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 1.7 110.752 178.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.419 ' HE3' ' O ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -62.41 -21.55 65.48 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.257 0.836 . . . . 2.29 113.257 -172.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 45.6 mtm -71.87 -28.17 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.497 -0.481 . . . . 2.5 110.914 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -96.82 -8.47 30.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 4.43 110.896 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.58 35.5 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.502 -0.772 . . . . 2.31 112.433 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 7.9 mp -95.19 176.8 6.08 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.933 -0.395 . . . . 2.37 109.933 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.9 pt -132.61 143.53 49.13 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.159 0.504 . . . . 2.42 111.08 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.17 -3.74 6.62 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 123.7 2.933 . . . . 1.84 112.46 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -76.03 -49.89 16.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.49 0.662 . . . . 3.32 110.724 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.421 ' O ' HG13 ' A' ' 226' ' ' VAL . 63.5 m -103.66 38.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.938 -1.028 . . . . 2.85 112.363 -172.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 98.1 m -145.78 162.62 37.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.258 -0.276 . . . . 1.74 110.375 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -132.13 140.36 48.77 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.496 -0.187 . . . . 1.73 110.496 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.693 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -105.35 130.22 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 122.633 1.206 . . . . 1.38 111.541 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.27 165.17 14.6 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.605 -1.634 . . . . 2.99 109.622 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 10.8 ptm180 -144.58 145.28 31.72 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.868 -0.605 . . . . 2.64 109.7 172.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.615 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -98.38 121.92 49.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.729 . . . . 2.6 110.52 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.9 tt0 -99.41 -142.11 0.32 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.62 -1.173 . . . . 3.22 108.115 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.23 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.193 0.597 . . . . 4.02 112.321 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.96 7.65 8.94 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.619 -0.324 . . . . 3.47 112.313 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.6 pt-20 -123.76 -175.74 3.29 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.887 0.375 . . . . 3.48 110.686 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.8 mtpt -123.21 149.23 44.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.958 -0.565 . . . . 2.75 111.162 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -136.22 117.72 11.62 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 114.74 -1.118 . . . . 3.25 108.807 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.33 131.08 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.206 1.937 . . . . 2.47 111.494 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.693 HD12 HG23 ' A' ' 197' ' ' VAL . 19.5 mt -98.02 156.83 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.573 . . . . 1.91 111.738 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.36 145.8 17.91 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.084 -0.806 . . . . 2.25 111.084 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 176' ' ' THR . 88.1 m95 -68.48 -13.19 62.14 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.868 0.692 . . . . 2.3 112.868 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.66 14.26 28.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.531 . . . . 3.79 111.211 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.5 m -75.56 128.49 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.723 -0.671 . . . . 2.44 109.352 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.463 ' HB3' ' CE3' ' A' ' 216' ' ' TRP . 15.9 t70 -65.89 114.09 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.282 -0.636 . . . . 3.47 109.282 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 214' ' ' ILE . 5.7 tt -69.6 -11.15 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 1.95 112.03 -170.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.3 t -70.48 -14.49 62.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.835 -0.541 . . . . 2.91 110.634 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 213' ' ' ASP . 13.2 m0 -92.25 -1.77 56.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.932 0.396 . . . . 4.8 110.567 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.83 9.33 34.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.402 -0.363 . . . . 2.13 110.81 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 153.38 18.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.078 0.466 . . . . 2.03 111.189 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 75.13 -7.36 23.12 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.636 -0.711 . . . . 2.12 113.697 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 157' ' ' VAL . 12.3 mm-40 -99.62 149.32 23.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.044 0.422 . . . . 2.61 110.253 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -95.68 119.8 34.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.475 0.655 . . . . 3.06 109.447 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 159' ' ' VAL . 70.6 mt -98.21 167.33 10.93 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.85 -1.068 . . . . 1.3 109.252 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -149.7 144.08 25.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.324 -0.621 . . . . 3.31 109.324 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 21.3 t -114.42 141.09 32.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.749 0.785 . . . . 1.58 111.507 -171.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.01 179.38 4.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.02 -1.445 . . . . 2.74 107.774 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 87.0 t . . . . . 0 C--N 1.314 -0.958 0 CA-C-O 121.272 0.558 . . . . 2.61 110.064 172.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.457 -0.667 0 CA-C-O 120.974 0.322 . . . . 2.69 112.23 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.28 162.77 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.272 -0.422 . . . . 2.15 110.813 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -135.04 120.63 30.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.315 0.578 . . . . 1.67 109.985 170.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.624 ' HG2' HG22 ' A' ' 168' ' ' VAL . 99.3 mtt180 -74.71 119.97 19.62 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.312 -0.858 . . . . 3.61 110.26 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.44 HG11 ' CD1' ' A' ' 181' ' ' LEU . 45.6 t -106.08 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.749 -1.114 . . . . 1.4 111.277 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.4 m-85 -73.28 103.45 3.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.566 0.698 . . . . 2.54 109.664 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.565 HD11 ' HB ' ' A' ' 167' ' ' THR . 12.7 mt -64.98 161.64 45.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.511 -1.222 . . . . 2.07 111.077 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 78.4 Cg_exo -51.63 150.45 16.53 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.511 2.141 . . . . 2.27 111.272 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 164' ' ' LYS . 21.6 t-20 63.89 36.98 9.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.408 1.099 . . . . 3.47 110.237 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.7 mppt? 57.64 28.7 16.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.407 -1.724 . . . . 4.66 114.167 164.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.442 ' OE1' ' HD2' ' A' ' 188' ' ' ARG . 17.4 mt-30 -93.34 -179.07 4.94 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.028 -0.731 . . . . 3.57 109.028 169.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 34.3 ptt180 -147.62 135.05 20.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 3.54 111.511 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 161' ' ' LEU . 2.8 t -111.38 -177.76 3.28 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.909 -1.145 . . . . 1.91 107.909 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' A' ' 158' ' ' ARG . 4.6 t -135.75 132.36 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.178 -1.045 . . . . 2.31 108.178 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.88 123.51 26.19 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.735 -0.386 . . . . 1.67 110.014 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.62 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.5 Cg_endo -50.71 134.17 40.2 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.095 2.53 . . . . 2.12 111.786 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.27 117.69 5.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.761 . . . . 2.28 109.482 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 3.4 mmp_? -105.37 111.78 24.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.075 -0.966 . . . . 3.98 110.823 -173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.6 p -81.2 122.43 27.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.099 -0.501 . . . . 3.37 110.379 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.99 67.32 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.743 -0.943 . . . . 3.34 110.743 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 59.2 t -122.33 140.66 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.239 -0.481 . . . . 2.87 109.742 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 178' ' ' ARG . 44.3 p -86.78 168.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.054 -0.721 . . . . 2.83 109.054 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -59.53 -24.93 29.9 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 N-CA-C 108.703 -0.851 . . . . 1.92 108.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.431 ' HB3' ' OG1' ' A' ' 176' ' ' THR . 9.5 tmm_? -56.19 -60.57 3.31 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.516 0.561 . . . . 4.27 112.516 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 1.9 t70 -64.52 -48.51 74.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.152 0.977 . . . . 2.87 110.607 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.522 ' OG ' HG21 ' A' ' 214' ' ' ILE . 1.3 m -61.31 -50.82 71.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.268 -1.333 . . . . 1.99 110.496 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.9 mm? -68.82 -24.25 64.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.677 -0.692 . . . . 1.34 111.594 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 186' ' ' MET . 0.0 OUTLIER -54.94 -41.93 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.642 -0.503 . . . . 3.08 109.642 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 187' ' ' MET . 19.9 tttt -65.07 -52.21 56.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.648 -0.421 . . . . 2.75 110.155 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 167' ' ' THR . . . -47.52 -52.4 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 1.43 111.683 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 91.0 mt -69.33 -54.34 15.07 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.263 -0.881 . . . . 1.7 110.919 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 5.2 mmt -62.54 -21.36 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.683 0.994 . . . . 2.29 113.683 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 47.1 mtm -67.93 -28.85 67.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.5 110.225 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 165' ' ' GLN . 22.9 mtp180 -95.44 -2.69 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.265 0.555 . . . . 4.43 111.204 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.13 15.76 64.17 Favored Glycine 0 C--N 1.315 -0.583 0 CA-C-N 115.319 -0.855 . . . . 2.31 111.731 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 185' ' ' LEU . 16.6 mt -86.11 159.78 19.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.324 -0.438 . . . . 2.37 109.985 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 193' ' ' GLU . 49.4 pt -121.65 143.15 37.42 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 2.42 111.564 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.37 -4.51 15.14 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.113 2.542 . . . . 1.84 112.628 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.401 ' HB2' HD12 ' A' ' 191' ' ' ILE . 25.9 mt-10 -71.5 -39.71 70.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.999 -0.546 . . . . 3.32 111.035 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.62 37.5 4.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.285 -0.416 . . . . 2.85 111.466 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 86.1 m -136.86 163.51 30.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.512 -0.551 . . . . 1.74 109.512 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.9 139.73 41.8 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 111.195 0.072 . . . . 1.73 111.195 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.646 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -102.48 129.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.323 1.058 . . . . 1.38 111.075 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -120.81 170.53 9.37 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.74 -1.573 . . . . 2.99 110.059 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 199' ' ' ARG . 3.0 ptm180 -150.88 131.1 13.58 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.526 -0.761 . . . . 2.64 109.295 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.696 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -83.57 124.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.353 0.597 . . . . 2.6 110.167 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.4 tt0 -111.25 -139.45 0.38 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.508 -1.294 . . . . 3.22 107.508 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.17 82.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.702 0.63 . . . . 4.02 112.702 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 7.99 10.6 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.213 -0.449 . . . . 3.47 113.578 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.69 -179.02 5.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 117.463 0.632 . . . . 3.48 111.895 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.696 ' HG2' HD11 ' A' ' 200' ' ' ILE . 36.9 mtpt -111.96 140.13 46.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.181 -0.918 . . . . 2.75 111.064 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.83 115.51 33.46 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.372 -0.831 . . . . 3.25 109.417 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.46 123.46 6.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.87 1.714 . . . . 2.47 111.739 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 197' ' ' VAL . 16.0 mt -94.04 159.33 2.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 1.91 111.301 -173.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.39 151.27 20.56 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.985 -0.846 . . . . 2.25 110.985 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HA ' HG22 ' A' ' 177' ' ' VAL . 80.5 m95 -76.98 -12.95 60.01 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.506 0.558 . . . . 2.3 112.506 -172.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.74 12.56 36.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.08 0.467 . . . . 3.79 110.574 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.9 m -79.23 131.48 36.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.868 -0.606 . . . . 2.44 110.316 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 17.5 t70 -61.71 117.9 6.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 3.47 109.921 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.522 HG21 ' OG ' ' A' ' 180' ' ' SER . 5.8 tt -74.11 -16.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.455 . . . . 1.95 111.889 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.496 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 20.7 t -67.54 -18.61 65.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.461 0.648 . . . . 2.91 109.94 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 20.0 t90 -77.83 -18.21 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.839 -0.618 . . . . 4.8 110.385 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.1 mt -102.79 14.04 32.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.091 -0.504 . . . . 2.13 111.211 -171.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 m -60.96 153.31 25.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 2.03 110.435 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.72 24.63 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.977 -0.556 . . . . 2.12 113.576 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.0 mm-40 -99.44 166.12 11.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.13 -0.322 . . . . 2.61 110.13 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.92 126.61 55.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.065 -0.717 . . . . 3.06 109.065 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.402 HD12 HG22 ' A' ' 159' ' ' VAL . 26.9 mt -95.74 156.4 16.35 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.571 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -132.65 117.25 17.66 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.036 -0.728 . . . . 3.31 109.036 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 45.9 t -101.31 133.37 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.585 0.707 . . . . 1.58 110.895 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.3 174.4 5.89 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.326 -1.306 . . . . 2.74 108.033 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 16.4 t . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 110.276 -0.268 . . . . 2.61 110.276 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.895 -0.409 . . . . 7.11 109.895 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.84 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.671 2.248 . . . . 5.39 111.748 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -65.76 131.84 47.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.798 -0.637 . . . . 4.84 110.493 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' HD3' HG23 ' A' ' 156' ' ' ILE . 0.8 OUTLIER -120.16 105.58 42.07 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 4.47 110.108 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -88.18 134.28 3.0 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.691 2.927 . . . . 2.69 112.034 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.6 pp -139.87 161.16 26.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.908 0.385 . . . . 2.15 110.948 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.6 t -125.32 117.8 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.297 -0.631 . . . . 1.67 109.297 170.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 90.4 mtt180 -82.63 103.69 12.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.438 0.637 . . . . 3.61 110.51 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 181' ' ' LEU . 77.1 t -92.54 116.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.071 -0.968 . . . . 1.4 111.507 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 4.1 m-85 -77.32 103.71 7.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.076 0.941 . . . . 2.54 109.641 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 167' ' ' THR . 3.7 mt -70.53 166.68 33.23 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.067 -1.424 . . . . 2.07 110.677 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 85.3 Cg_exo -50.81 154.25 7.2 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.566 2.177 . . . . 2.27 111.954 172.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 15.1 m120 69.06 23.92 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 3.47 110.905 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 60.81 31.35 20.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.666 -0.697 . . . . 4.66 112.684 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.88 178.85 5.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.396 -0.965 . . . . 3.57 108.396 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -148.95 140.01 23.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 3.54 111.148 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.75 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -130.43 136.45 49.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.309 -0.859 . . . . 1.91 108.724 169.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 156' ' ' ILE . 1.3 m -99.28 140.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.023 -0.671 . . . . 2.31 110.091 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -123.4 123.08 26.58 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.952 -0.567 . . . . 1.67 109.476 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 156' ' ' ILE . 7.5 Cg_endo -50.71 129.59 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.632 2.221 . . . . 2.12 110.954 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.0 107.6 0.65 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.501 0.667 . . . . 2.28 109.595 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.2 mmp_? -90.51 112.24 23.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.048 -0.978 . . . . 3.98 110.512 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.16 122.49 28.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 3.37 110.396 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.51 11.31 60.96 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.228 -1.149 . . . . 3.34 110.228 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 94.8 t -123.62 143.08 38.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.92 -0.64 . . . . 2.87 109.616 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 36.7 p -91.92 168.99 11.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.783 -0.644 . . . . 2.83 109.508 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 17.7 t -56.09 -31.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.185 -0.672 . . . . 1.92 109.185 173.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 15.8 tpt180 -52.67 -53.81 42.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.347 -0.842 . . . . 4.27 112.581 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -74.64 -44.47 50.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.645 0.736 . . . . 2.87 110.966 -174.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 p -64.51 -52.39 58.08 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.966 -1.015 . . . . 1.99 110.584 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -68.41 -23.64 64.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.318 -0.856 . . . . 1.34 111.599 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.43 -44.33 72.36 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.381 -0.6 . . . . 3.08 109.381 176.333 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 27.4 ttpt -64.01 -47.8 78.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.313 -0.555 . . . . 2.75 109.991 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.09 -52.25 45.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.431 -0.804 . . . . 1.43 112.026 -175.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.33 -48.75 66.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.71 0.29 . . . . 1.7 110.789 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -29.38 68.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.792 . . . . 2.29 113.14 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 41.6 mtm -70.15 -29.75 66.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 2.5 110.26 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.596 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.5 mmp_? -83.74 -13.97 52.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.682 . . . . 4.43 110.48 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.53 14.48 47.18 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.425 -0.807 . . . . 2.31 111.281 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.17 173.72 6.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.934 0.397 . . . . 2.37 110.424 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.4 140.94 34.97 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.937 -0.574 . . . . 2.42 111.085 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.79 -4.31 14.84 Favored 'Trans proline' 0 CA--C 1.526 0.114 0 C-N-CA 122.892 2.394 . . . . 1.84 112.296 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.38 -52.17 29.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 3.32 110.753 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.2 m -100.37 27.62 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.205 -0.907 . . . . 2.85 111.267 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.624 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.0 m -128.32 151.72 48.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 1.74 109.88 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -121.53 151.91 39.79 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.47 0.176 . . . . 1.73 111.043 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.626 HG12 HD12 ' A' ' 208' ' ' ILE . 44.3 t -110.73 122.99 66.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 1.38 110.859 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.474 ' CD2' ' HG3' ' A' ' 225' ' ' GLU . 11.4 m-85 -126.29 157.45 38.31 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.674 -1.148 . . . . 2.99 109.745 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.602 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -142.56 144.84 33.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 120.542 -0.463 . . . . 2.64 110.203 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.702 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 47.7 mm -86.81 122.89 39.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.609 -0.723 . . . . 2.6 110.175 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.9 tt0 -104.23 -138.92 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.658 -1.238 . . . . 3.22 107.658 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.18 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.02 0.528 . . . . 4.02 112.214 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.33 8.43 9.11 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.184 -0.462 . . . . 3.47 113.24 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -137.17 -179.38 5.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.452 0.626 . . . . 3.48 112.049 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.702 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -106.92 136.98 45.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 2.75 111.515 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 199' ' ' ARG . 34.8 mmtp -125.7 117.8 24.45 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 114.68 -1.146 . . . . 3.25 108.766 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.39 136.37 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.092 1.861 . . . . 2.47 112.171 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.626 HD12 HG12 ' A' ' 197' ' ' VAL . 43.6 mt -102.05 152.65 5.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.637 -0.71 . . . . 1.91 111.543 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 145.41 17.68 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.008 -0.837 . . . . 2.25 111.008 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.662 ' O ' ' HB ' ' A' ' 176' ' ' THR . 98.4 m95 -69.76 -17.53 63.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.059 0.392 . . . . 2.3 112.059 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.1 4.03 54.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.906 0.384 . . . . 3.79 110.956 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.0 m -75.42 128.91 36.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.015 -0.538 . . . . 2.44 110.418 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 215' ' ' SER . 16.0 t70 -62.43 115.47 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 3.47 109.849 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 169' ' ' VAL . 5.0 tt -66.81 -15.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.946 -0.57 . . . . 1.95 112.043 -173.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.528 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 17.0 m -75.84 -9.93 59.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.951 -0.468 . . . . 2.91 111.876 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -81.32 -27.95 34.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 4.8 109.64 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -87.81 5.63 39.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.022 -0.99 . . . . 2.13 111.9 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.478 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.2 m -58.45 151.51 19.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.877 0.37 . . . . 2.03 110.273 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.66 -9.99 57.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.844 -0.693 . . . . 2.12 112.997 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -106.35 155.44 19.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.896 0.379 . . . . 2.61 111.185 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -102.55 124.5 48.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.659 -0.867 . . . . 3.06 108.659 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.441 ' HG ' ' CG1' ' A' ' 157' ' ' VAL . 46.5 mt -96.49 172.18 8.09 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.642 -0.708 . . . . 1.3 109.912 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 16.8 p80 -153.15 136.38 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.499 -0.556 . . . . 3.31 109.499 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 86.6 t -102.39 135.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.362 0.601 . . . . 1.58 111.266 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 5.5 mm-40 -108.18 120.48 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.079 -0.964 . . . . 2.74 109.31 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.7 m -70.35 113.31 6.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.375 -0.53 . . . . 2.61 111.593 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' A' ' 196' ' ' ALA . 6.8 mt -83.96 93.61 8.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.86 109.251 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.17 94.96 7.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.135 0.493 . . . . 4.27 110.749 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -135.93 43.59 2.54 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.278 -0.873 . . . . 6.02 109.201 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.8 m -70.23 146.03 94.14 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.474 -1.239 . . . . 6.23 111.017 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 69.39 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.938 2.425 . . . . 8.56 111.752 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 tt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.361 -0.828 . . . . 10.1 108.898 -177.767 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.5 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.214 -0.291 . . . . 7.11 110.214 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.02 -40.09 74.26 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.134 2.556 . . . . 5.39 112.54 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -104.64 103.51 13.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.384 -0.371 . . . . 4.84 110.049 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -98.39 110.88 58.33 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.199 -0.455 . . . . 4.47 110.429 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.22 129.14 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.382 2.055 . . . . 2.69 112.001 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -136.09 162.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.875 0.369 . . . . 2.15 111.004 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 218' ' ' THR . 26.0 t -126.69 127.59 70.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.017 -0.735 . . . . 1.67 109.017 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.736 ' HG2' HG22 ' A' ' 168' ' ' VAL . 86.0 mtm180 -88.79 107.62 19.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.357 0.599 . . . . 3.61 110.244 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 161' ' ' LEU . 53.6 t -94.85 122.95 46.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.265 -0.879 . . . . 1.4 111.433 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 4.4 m-85 -87.22 102.91 14.93 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.61 -0.436 . . . . 2.54 110.226 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.924 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -63.21 167.79 5.95 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 2.07 110.432 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 75.5 Cg_exo -50.52 158.24 2.84 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.101 1.868 . . . . 2.27 110.919 168.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 t30 70.31 13.08 7.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.392 0.615 . . . . 3.47 110.361 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.69 40.39 16.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.356 -0.838 . . . . 4.66 112.941 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 3.4 mt-30 -98.96 174.2 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.635 -0.876 . . . . 3.57 108.635 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.5 ptt180 -139.44 130.27 26.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.892 0.769 . . . . 3.54 111.916 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.719 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -128.67 136.1 50.18 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.993 -1.003 . . . . 1.91 108.479 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.736 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.9 t -94.46 144.79 9.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.616 -0.434 . . . . 2.31 110.681 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 6.2 p -137.56 124.72 13.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.048 -0.524 . . . . 1.67 110.009 175.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.614 ' HA ' HG22 ' A' ' 156' ' ' ILE . 8.5 Cg_endo -50.88 133.33 39.68 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.097 2.531 . . . . 2.12 112.234 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.45 110.58 1.49 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.28 109.546 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.4 mmp_? -98.98 112.02 24.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.537 -0.756 . . . . 3.98 111.428 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.9 p -76.5 135.93 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.779 -0.646 . . . . 3.37 110.321 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 15.21 78.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.99 -0.844 . . . . 3.34 110.99 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 86.7 t -128.11 143.86 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.228 -0.656 . . . . 2.87 109.228 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 71.1 p -94.78 169.68 9.98 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.919 -0.771 . . . . 2.83 108.919 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -60.65 -22.88 27.16 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.753 -0.832 . . . . 1.92 108.753 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.709 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 38.2 tpt85 -62.31 -41.55 98.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 112.116 0.413 . . . . 4.27 112.116 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.533 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 6.7 t70 -77.48 -51.91 9.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.816 0.817 . . . . 2.87 109.957 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.464 ' OG ' HG21 ' A' ' 214' ' ' ILE . 47.6 m -63.64 -45.54 89.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 1.99 111.101 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.74 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -72.25 -27.12 62.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.071 -0.513 . . . . 1.34 111.718 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.709 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 1.0 OUTLIER -55.32 -43.22 74.69 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.27 -0.572 . . . . 3.08 109.841 178.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -65.57 -46.88 77.73 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.412 -0.515 . . . . 2.75 109.995 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -50.82 -49.62 58.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.446 -0.797 . . . . 1.43 111.569 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.14 -53.4 30.96 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.671 -0.695 . . . . 1.7 110.61 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.06 65.31 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.902 0.704 . . . . 2.29 112.902 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 43.1 mtm -66.22 -35.1 79.54 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.528 -0.469 . . . . 2.5 110.789 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -90.92 -0.23 57.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.251 0.548 . . . . 4.43 111.431 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.19 66.96 Favored Glycine 0 C--N 1.314 -0.654 0 CA-C-N 115.146 -0.934 . . . . 2.31 111.679 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.51 160.58 16.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.199 -0.5 . . . . 2.37 109.661 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 193' ' ' GLU . 44.5 pt -126.44 141.37 39.84 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.507 . . . . 2.42 111.56 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.71 -10.23 24.81 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 123.188 2.592 . . . . 1.84 112.471 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.503 ' HB2' HD12 ' A' ' 191' ' ' ILE . 32.7 mt-10 -64.63 -35.36 80.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.958 -0.564 . . . . 3.32 111.322 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 58.7 m -118.26 16.47 13.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.316 0.487 . . . . 2.85 112.316 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 63.6 m -124.49 164.34 19.95 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.576 -0.45 . . . . 1.74 110.896 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -129.14 154.52 46.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 116.474 -0.33 . . . . 1.73 111.424 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 208' ' ' ILE . 43.4 t -112.8 129.03 69.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.652 0.739 . . . . 1.38 111.329 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -128.92 162.2 28.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.714 -1.13 . . . . 2.99 110.099 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -139.95 134.49 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.669 -0.493 . . . . 2.64 109.669 172.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -92.26 122.86 44.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.393 0.616 . . . . 2.6 110.863 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.9 tt0 -102.04 -141.15 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.436 -0.949 . . . . 3.22 108.436 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.54 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.184 0.594 . . . . 4.02 111.822 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.48 6.03 7.56 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.52 -0.309 . . . . 3.47 112.757 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 16.6 pt-20 -120.16 -178.72 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.074 0.464 . . . . 3.48 111.301 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 200' ' ' ILE . 39.2 mtpt -123.54 141.97 51.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.75 110.635 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.63 120.69 23.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.747 -0.834 . . . . 3.25 108.747 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.21 130.94 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.968 1.779 . . . . 2.47 112.217 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.766 HD12 HG12 ' A' ' 197' ' ' VAL . 65.6 mt -99.76 157.4 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.324 -0.853 . . . . 1.91 111.484 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.11 147.33 18.54 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.146 -1.181 . . . . 2.25 110.146 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.684 ' HA ' HG22 ' A' ' 177' ' ' VAL . 91.5 m95 -69.93 -13.37 62.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.312 0.556 . . . . 2.3 112.064 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.42 8.31 45.03 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 120.952 0.406 . . . . 3.79 110.622 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -76.63 129.26 36.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.07 -0.513 . . . . 2.44 110.328 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.86 110.44 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 3.47 110.377 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -62.29 -17.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.95 111.127 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.524 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 8.0 p -66.29 -16.32 63.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.067 -0.515 . . . . 2.91 112.185 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -86.17 -31.19 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 4.8 110.702 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.1 mm? -86.58 15.02 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.214 -0.448 . . . . 2.13 111.766 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.473 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -56.81 151.64 13.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 2.03 110.451 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.65 -1.5 72.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.067 -0.587 . . . . 2.12 112.96 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -115.27 165.51 12.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.012 0.434 . . . . 2.61 111.069 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.6 mp0 -113.23 124.79 53.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.768 -0.651 . . . . 3.06 109.388 172.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.97 167.91 10.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.568 -0.742 . . . . 1.3 110.439 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.84 129.34 24.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.293 -0.632 . . . . 3.31 109.293 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 196' ' ' ALA . 89.8 t -104.58 136.7 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.329 0.585 . . . . 1.58 110.383 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.56 171.1 7.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.725 -1.213 . . . . 2.74 107.725 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 61.8 t -115.01 129.79 70.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.409 -0.589 . . . . 2.61 109.409 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.17 81.12 3.68 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.169 0.509 . . . . 2.86 110.183 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -99.29 115.73 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.667 -0.697 . . . . 4.27 111.06 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 56.58 53.54 8.4 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.517 0.675 . . . . 6.02 111.454 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 230' ' ' VAL . 6.2 m -87.57 154.34 53.52 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.022 -0.99 . . . . 6.23 109.729 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 12.6 Cg_exo -71.08 65.88 2.58 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.06 2.506 . . . . 8.56 112.058 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.531 -0.747 . . . . 10.1 109.412 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.503 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.164 -0.31 . . . . 7.11 110.164 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.08 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.774 2.316 . . . . 5.39 111.305 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -65.98 123.5 19.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.393 -0.367 . . . . 4.84 111.077 -174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 118.81 70.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 4.47 110.912 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 82.9 Cg_endo -76.88 147.95 27.73 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.813 2.342 . . . . 2.69 111.595 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.7 pp -142.89 152.57 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.178 0.513 . . . . 2.15 111.79 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.4 t -118.95 123.13 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.303 -0.999 . . . . 1.67 108.303 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 68.4 mtm180 -86.31 101.65 13.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.602 0.715 . . . . 3.61 110.687 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 224' ' ' VAL . 74.8 t -91.91 121.24 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.803 -1.09 . . . . 1.4 111.795 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.8 m-85 -84.63 102.72 13.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.312 0.577 . . . . 2.54 109.813 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.728 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.0 mt -66.2 163.59 37.39 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.933 -1.031 . . . . 2.07 111.366 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 95.2 Cg_exo -45.18 145.6 3.33 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.179 2.586 . . . . 2.27 113.0 173.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.03 43.52 5.12 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.567 -0.742 . . . . 3.47 111.442 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.5 mppt? 57.68 32.56 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.27 -1.332 . . . . 4.66 112.238 168.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.516 ' OE1' ' HD3' ' A' ' 188' ' ' ARG . 33.0 mt-30 -94.31 172.8 7.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.653 -0.703 . . . . 3.57 109.186 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.1 ptt180 -148.99 137.87 21.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.567 0.699 . . . . 3.54 112.122 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.728 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -139.74 133.89 31.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.615 -1.175 . . . . 1.91 108.337 172.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.497 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -97.67 137.11 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.258 -0.645 . . . . 2.31 109.258 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.441 HG13 HD11 ' A' ' 214' ' ' ILE . 6.5 p -123.87 130.6 24.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.836 -0.431 . . . . 1.67 109.836 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.531 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.6 Cg_endo -50.21 129.2 24.8 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.905 2.403 . . . . 2.12 111.738 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.8 77.98 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.36 -0.836 . . . . 2.28 110.303 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.8 mtm180 -59.32 133.56 56.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.402 -1.272 . . . . 3.98 110.664 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 2.8 p -95.54 135.66 36.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.342 -0.39 . . . . 3.37 110.748 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.49 22.31 70.45 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.65 -0.786 . . . . 3.34 111.433 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 172' ' ' ARG . 2.9 p -123.34 171.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.655 -0.498 . . . . 2.87 109.655 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 43.3 p -105.43 160.24 15.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.594 -0.521 . . . . 2.83 109.594 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 7.3 t -53.59 -33.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.962 -0.755 . . . . 1.92 108.962 171.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -55.15 -49.9 70.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.652 -0.704 . . . . 4.27 112.62 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 175' ' ' VAL . 15.3 t70 -71.46 -47.49 55.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.866 0.841 . . . . 2.87 110.514 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 169' ' ' VAL . 4.4 m -65.13 -47.89 75.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.118 -0.946 . . . . 1.99 111.026 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.6 mm? -68.58 -25.22 64.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.486 -0.325 . . . . 1.34 111.565 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.03 -39.09 68.78 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.427 -0.583 . . . . 3.08 109.427 175.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.669 ' HE3' ' SD ' ' A' ' 187' ' ' MET . 33.5 tttp -67.39 -48.36 67.62 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.575 -0.45 . . . . 2.75 110.27 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -49.98 -55.58 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.553 -0.749 . . . . 1.43 112.097 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.432 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 1.1 mm? -63.17 -53.09 58.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 1.7 110.657 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.4 mmt -58.17 -27.83 64.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.543 0.942 . . . . 2.29 113.543 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.669 ' SD ' ' HE3' ' A' ' 183' ' ' LYS . 58.7 mtm -67.86 -22.2 65.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.513 -0.475 . . . . 2.5 111.285 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 45.1 mtt-85 -112.81 16.28 19.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.741 0.781 . . . . 4.43 111.713 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.54 25.34 75.6 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.419 -1.264 . . . . 2.31 111.892 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.432 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.6 mt -96.18 163.51 13.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.629 -0.878 . . . . 2.37 108.629 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.8 138.26 32.51 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.964 0.411 . . . . 2.42 111.058 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.32 -8.49 23.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.036 2.49 . . . . 1.84 112.634 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.154 0.502 . . . . 3.32 110.301 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 61.5 m -101.73 21.52 14.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.598 -0.728 . . . . 2.85 111.184 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.579 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 69.4 m -129.59 149.31 51.41 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.893 -0.323 . . . . 1.74 110.929 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -125.39 155.9 39.63 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.329 -0.396 . . . . 1.73 110.608 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 208' ' ' ILE . 36.2 t -115.15 124.97 72.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.162 -0.615 . . . . 1.38 111.66 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.84 164.52 18.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.014 -0.994 . . . . 2.99 110.095 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.9 ptm180 -141.78 131.82 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.733 -0.469 . . . . 2.64 109.733 171.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -90.63 122.16 41.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.147 -0.479 . . . . 2.6 110.655 -175.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 203' ' ' GLY . 5.6 tt0 -103.0 -137.07 0.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.494 -0.928 . . . . 3.22 108.494 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.45 78.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.435 0.694 . . . . 4.02 112.117 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.57 10.19 16.41 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.421 -0.354 . . . . 3.47 112.255 -177.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 17.0 pt-20 -120.56 179.29 4.37 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 121.183 0.516 . . . . 3.48 111.398 -172.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.9 mtpt -124.96 137.42 54.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.317 -0.856 . . . . 2.75 110.488 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -121.17 117.26 30.71 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.408 -0.814 . . . . 3.25 108.983 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.76 133.84 19.17 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 121.931 1.754 . . . . 2.47 111.932 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 197' ' ' VAL . 72.2 mt -105.84 154.34 7.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 1.91 112.097 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 151.43 19.48 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.63 -0.988 . . . . 2.25 110.63 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.66 ' O ' ' HB ' ' A' ' 176' ' ' THR . 95.8 m95 -74.97 -13.04 60.47 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.684 0.624 . . . . 2.3 112.684 -172.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.42 ' HA ' ' CG2' ' A' ' 176' ' ' THR . 3.2 p30 -102.11 9.44 40.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.161 0.505 . . . . 3.79 110.874 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.8 m -69.76 136.76 51.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.702 -0.681 . . . . 2.44 109.292 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.74 107.07 3.32 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.809 -0.441 . . . . 3.47 109.809 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.58 ' HA ' HD23 ' A' ' 217' ' ' LEU . 1.0 OUTLIER -58.66 -17.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 1.95 111.23 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 5.7 p -66.48 -8.74 28.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.101 -0.499 . . . . 2.91 111.989 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -90.21 -34.53 15.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.026 0.441 . . . . 4.8 110.629 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -85.82 13.77 6.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.064 -0.517 . . . . 2.13 112.066 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -51.97 150.08 4.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.502 . . . . 2.03 111.617 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.1 -31.61 2.04 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.485 -0.78 . . . . 2.12 113.208 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.87 163.04 25.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.575 0.702 . . . . 2.61 111.672 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 22.6 mt-10 -105.36 114.96 29.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.958 -1.019 . . . . 3.06 108.703 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.83 155.83 16.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.84 120.08 29.55 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.614 -0.513 . . . . 3.31 109.614 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 75.4 t -100.66 133.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.402 0.62 . . . . 1.58 110.172 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -107.23 159.8 16.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.717 -1.129 . . . . 2.74 108.68 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.52 109.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.201 1.0 . . . . 2.61 110.603 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 196' ' ' ALA . 15.7 mt -78.54 81.07 4.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.344 -1.298 . . . . 2.86 111.012 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -82.15 96.86 7.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.905 -0.589 . . . . 4.27 109.52 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -113.63 61.28 0.65 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.547 . . . . 6.02 110.535 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.4 m 38.35 70.28 1.32 Allowed Pre-proline 0 N--CA 1.468 0.437 0 O-C-N 124.716 1.26 . . . . 6.23 112.937 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.18 148.8 92.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.554 2.169 . . . . 8.56 111.692 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.571 -0.728 . . . . 10.1 110.118 -179.238 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.519 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.984 -0.376 . . . . 7.11 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.58 104.81 0.23 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.834 2.356 . . . . 5.39 111.848 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -104.48 99.58 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 4.84 109.612 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -90.55 120.19 68.97 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 116.232 -0.44 . . . . 4.47 110.278 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.83 140.38 12.82 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.468 2.112 . . . . 2.69 111.583 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.4 pp -138.37 160.23 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.967 0.413 . . . . 2.15 111.152 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -134.51 127.3 49.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.566 0.698 . . . . 1.67 109.122 170.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 168' ' ' VAL . 66.6 mtm180 -88.88 107.84 19.22 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.997 -1.001 . . . . 3.61 111.238 -171.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 161' ' ' LEU . 56.7 t -97.2 122.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.757 -1.11 . . . . 1.4 111.62 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 4.3 m-85 -90.73 102.8 15.55 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 122.027 -0.421 . . . . 2.54 110.396 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -67.95 169.89 8.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 2.07 111.166 -175.472 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 54.4 Cg_exo -52.72 154.97 11.28 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.087 1.858 . . . . 2.27 110.095 165.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 162' ' ' PRO . 9.5 t30 78.2 10.86 1.93 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.676 0.75 . . . . 3.47 109.912 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 62.23 32.95 17.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.277 -0.874 . . . . 4.66 112.8 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 10.1 mt-30 -102.11 -178.73 3.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.462 -0.569 . . . . 3.57 109.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 21.6 ptt180 -139.57 137.59 35.51 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.652 0.739 . . . . 3.54 111.343 175.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.618 HG21 ' HA ' ' A' ' 184' ' ' ALA . 0.4 OUTLIER -129.51 127.54 41.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.963 -1.495 . . . . 1.91 106.963 170.619 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -94.86 135.48 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.883 -0.784 . . . . 2.31 108.883 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.01 128.68 25.82 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.878 -0.416 . . . . 1.67 109.878 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 9.4 Cg_endo -51.81 132.58 42.39 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.832 2.355 . . . . 2.12 110.944 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -64.1 88.4 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.641 -0.708 . . . . 2.28 110.371 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 42.8 mmt180 -68.09 111.28 4.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.993 -1.003 . . . . 3.98 110.939 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 12.8 p -77.88 130.75 37.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.045 -0.525 . . . . 3.37 109.882 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.63 4.54 87.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.607 -0.806 . . . . 3.34 111.228 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 1.6 t -118.66 144.18 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.371 0.605 . . . . 2.87 110.041 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 10.9 p -93.8 173.22 7.79 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.378 -0.828 . . . . 2.83 109.265 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 44.9 t -50.47 -33.81 11.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.512 -0.551 . . . . 1.92 109.512 171.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.613 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 12.1 tpt180 -48.98 -62.68 1.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.404 -0.816 . . . . 4.27 112.934 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.691 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 10.6 t70 -75.78 -36.5 59.78 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.513 0.673 . . . . 2.87 111.493 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 p -65.63 -49.93 66.88 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.669 0.747 . . . . 1.99 110.105 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.6 mm? -68.71 -22.23 64.36 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.303 -0.862 . . . . 1.34 111.601 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.691 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.1 mtpt -48.52 -51.12 28.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.311 -0.625 . . . . 3.08 109.311 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 24.7 tttp -59.88 -51.44 69.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.655 -0.418 . . . . 2.75 110.729 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.75 -49.23 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.741 -0.663 . . . . 1.43 112.132 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -47.4 54.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.106 -0.497 . . . . 1.7 111.076 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -27.72 65.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.391 0.515 . . . . 2.29 112.391 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 42.3 mtm -73.14 -32.91 65.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.71 -0.396 . . . . 2.5 110.352 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.468 ' CG ' ' HG ' ' A' ' 161' ' ' LEU . 14.2 mmm180 -74.77 -22.6 58.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.214 0.531 . . . . 4.43 110.76 171.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.51 12.84 37.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.661 -0.7 . . . . 2.31 111.401 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.4 mp -106.28 176.78 5.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 2.37 110.54 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.493 HD11 ' SG ' ' A' ' 194' ' ' CYS . 46.2 pt -124.97 144.49 47.2 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 121.09 0.472 . . . . 2.42 110.514 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.27 -3.8 12.43 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 123.352 2.701 . . . . 1.84 112.796 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -86.2 -28.12 24.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.094 -0.503 . . . . 3.32 110.773 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.493 ' SG ' HD11 ' A' ' 191' ' ' ILE . 74.6 m -111.66 18.98 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 2.85 111.267 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 68.9 m -131.35 163.8 27.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.547 -0.538 . . . . 1.74 109.547 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 227' ' ' LEU . . . -129.65 146.27 51.45 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 111.24 0.089 . . . . 1.73 111.24 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.696 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -111.21 130.67 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.449 1.119 . . . . 1.38 111.421 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -123.69 164.99 18.0 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.489 -1.687 . . . . 2.99 109.82 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 199' ' ' ARG . 2.8 ptm180 -147.2 133.44 19.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.108 -0.701 . . . . 2.64 109.108 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -83.91 118.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.255 0.55 . . . . 2.6 110.524 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.6 tt0 -101.45 -140.86 0.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.585 -1.265 . . . . 3.22 107.585 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.15 81.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.552 0.575 . . . . 4.02 112.552 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.62 7.65 16.38 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.163 -0.471 . . . . 3.47 113.06 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 12.7 pt-20 -131.1 -179.39 5.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 117.346 0.573 . . . . 3.48 111.324 -174.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.624 ' HG2' HD11 ' A' ' 200' ' ' ILE . 27.8 mtpt -114.05 138.08 50.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.502 -0.772 . . . . 2.75 110.611 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.69 111.22 39.64 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.376 -0.829 . . . . 3.25 109.619 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.73 121.71 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.85 1.7 . . . . 2.47 111.462 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 197' ' ' VAL . 13.2 mt -93.75 158.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.494 -0.776 . . . . 1.91 111.361 -171.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.22 144.23 17.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 2.25 110.935 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 177' ' ' VAL . 92.8 m95 -72.77 -14.88 61.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 111.955 0.354 . . . . 2.3 111.955 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -98.72 20.26 13.33 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.423 0.63 . . . . 3.79 110.397 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.416 ' CG2' HD11 ' A' ' 217' ' ' LEU . 27.8 m -85.26 127.07 34.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.367 -0.833 . . . . 2.44 109.874 176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.31 109.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 3.47 109.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.551 ' HA ' HD13 ' A' ' 217' ' ' LEU . 6.7 tt -67.23 -14.35 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.95 112.247 -170.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.489 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 22.7 t -69.27 -13.81 62.6 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.051 -0.406 . . . . 2.91 110.673 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -90.35 -14.07 33.84 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.44 0.638 . . . . 4.8 110.271 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.5 mp -101.74 17.88 21.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 2.13 111.645 -176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 m -60.51 153.51 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 2.03 111.074 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.29 -29.17 1.68 Allowed Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.982 -0.554 . . . . 2.12 113.911 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.3 mm-40 -70.2 164.13 24.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.15 0.5 . . . . 2.61 111.351 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.3 mt-10 -112.85 118.71 35.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.037 -0.727 . . . . 3.06 109.037 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.414 HD12 HG22 ' A' ' 159' ' ' VAL . 32.3 mt -95.91 160.18 14.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.127 -0.942 . . . . 1.3 110.16 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -132.72 117.86 18.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.315 -0.624 . . . . 3.31 109.315 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 64.9 t -101.72 134.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.724 0.774 . . . . 1.58 111.355 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.298 -1.319 . . . . 2.74 107.712 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 97.2 t -114.05 133.39 60.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 121.056 -0.258 . . . . 2.61 110.608 173.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.595 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 4.0 mm? -77.05 81.98 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.467 -0.568 . . . . 2.86 109.467 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.77 97.2 2.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.073 0.463 . . . . 4.27 109.794 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -83.34 64.3 7.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.527 0.68 . . . . 6.02 110.25 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 4.7 m -59.52 135.25 88.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.84 -1.073 . . . . 6.23 110.446 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 10.5 Cg_exo -70.52 86.79 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.67 2.247 . . . . 8.56 112.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.558 -0.734 . . . . 10.1 109.662 178.194 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.511 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.072 -0.344 . . . . 7.11 110.072 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.12 131.67 31.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.236 2.624 . . . . 5.39 112.955 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 153' ' ' GLN . 14.9 mm-40 -103.1 99.61 9.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 4.84 110.828 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -103.9 106.75 54.31 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.634 -0.712 . . . . 4.47 109.526 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 93.8 Cg_endo -77.04 129.36 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.578 2.185 . . . . 2.69 112.131 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -132.04 161.93 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 2.15 111.596 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 HD23 ' A' ' 217' ' ' LEU . 47.1 t -132.44 125.02 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.923 -0.769 . . . . 1.67 108.923 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 168' ' ' VAL . 77.5 mtm-85 -87.45 104.98 16.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 3.61 110.391 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.9 t -93.3 114.97 31.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.317 -0.856 . . . . 1.4 111.476 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.58 103.62 7.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.534 0.683 . . . . 2.54 109.583 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.86 HD11 ' HB ' ' A' ' 167' ' ' THR . 2.3 mt -72.09 168.25 24.63 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.568 -1.197 . . . . 2.07 110.975 -175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 71.1 Cg_exo -52.68 156.11 9.43 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.393 2.062 . . . . 2.27 111.299 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 18.4 m120 70.29 19.81 6.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.147 0.499 . . . . 3.47 110.479 -175.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 58.75 31.26 21.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.242 -0.89 . . . . 4.66 112.493 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.4 179.21 5.74 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.844 -0.799 . . . . 3.57 108.844 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -148.02 129.84 15.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 118.418 0.554 . . . . 3.54 111.689 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.86 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -121.04 137.62 54.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.572 -0.899 . . . . 1.91 108.572 172.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 158' ' ' ARG . 6.1 t -92.84 144.42 9.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.093 -0.706 . . . . 2.31 109.093 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.89 130.89 14.35 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 108.713 -0.847 . . . . 1.67 108.713 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.7 Cg_endo -50.02 135.8 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.687 2.258 . . . . 2.12 111.757 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.654 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.06 82.37 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 2.28 109.427 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.58 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 41.0 mmt180 -64.47 111.12 2.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.878 -1.056 . . . . 3.98 111.291 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.32 125.17 31.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 3.37 109.95 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.12 71.58 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.496 -1.041 . . . . 3.34 110.496 -174.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 88.5 t -118.71 152.16 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.852 -0.674 . . . . 2.87 109.451 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 33.8 p -97.09 163.76 12.8 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.671 -0.492 . . . . 2.83 109.671 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 18.7 t -52.17 -32.18 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.548 -0.538 . . . . 1.92 109.548 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.4 tpt180 -53.05 -53.56 48.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.371 -0.831 . . . . 4.27 112.454 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 2.0 t70 -74.53 -43.15 57.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.516 0.674 . . . . 2.87 110.669 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 214' ' ' ILE . 41.1 m -67.2 -49.85 63.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.359 -0.837 . . . . 1.99 111.318 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.619 HD21 HG21 ' A' ' 224' ' ' VAL . 0.0 OUTLIER -68.02 -23.67 65.02 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.98 0.363 . . . . 1.34 111.98 173.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.07 -43.21 77.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.057 -0.72 . . . . 3.08 109.057 176.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 187' ' ' MET . 23.1 tttp -63.28 -48.44 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 2.75 110.079 173.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -52.54 -50.31 63.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 1.43 111.82 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -67.87 -52.57 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.391 -0.368 . . . . 1.7 110.633 178.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.44 62.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.796 0.665 . . . . 2.29 112.796 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 45.6 mtm -69.42 -40.77 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.646 -0.422 . . . . 2.5 109.877 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.505 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.2 mmp_? -74.83 -20.55 59.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.879 -0.6 . . . . 4.43 111.025 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.55 15.55 22.57 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.041 -0.599 . . . . 2.31 111.752 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.408 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.2 mp -104.53 177.43 4.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.294 . . . . 2.37 110.267 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 193' ' ' GLU . 12.8 pt -133.42 145.74 57.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.209 0.528 . . . . 2.42 110.606 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.71 -9.87 12.66 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 124.015 3.143 . . . . 1.84 113.531 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.443 ' HB2' HD12 ' A' ' 191' ' ' ILE . 27.2 mt-10 -83.41 -25.72 31.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.846 0.355 . . . . 3.32 110.541 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 69.7 m -112.14 36.25 3.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.504 . . . . 2.85 111.412 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.504 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 89.6 m -152.96 162.74 40.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.143 -0.481 . . . . 1.74 109.876 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 227' ' ' LEU . . . -129.8 149.62 51.47 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 110.452 -0.203 . . . . 1.73 110.452 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.659 HG12 HD12 ' A' ' 208' ' ' ILE . 55.6 t -108.1 127.96 63.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.791 -0.764 . . . . 1.38 111.307 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.43 168.94 15.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.425 -1.261 . . . . 2.99 109.946 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.427 ' HG2' HD11 ' A' ' 208' ' ' ILE . 11.7 ptm180 -147.17 132.76 18.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.852 -0.613 . . . . 2.64 109.695 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.659 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -90.46 123.18 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.388 0.613 . . . . 2.6 110.44 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.512 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 21.8 mt-30 -106.08 -146.79 0.39 Allowed 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.294 -0.867 . . . . 3.22 109.094 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 39.0 t70 -49.12 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.579 0.751 . . . . 4.02 112.812 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.85 9.02 11.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.246 -0.434 . . . . 3.47 113.303 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.56 -178.34 4.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.364 0.582 . . . . 3.48 111.923 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.659 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.8 mtpt -122.47 142.11 50.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.251 -0.886 . . . . 2.75 110.692 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 70.8 mmtt -125.31 113.29 25.91 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.56 -0.746 . . . . 3.25 109.334 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.67 131.92 19.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.252 1.968 . . . . 2.47 112.025 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.659 HD12 HG12 ' A' ' 197' ' ' VAL . 42.9 mt -103.46 154.8 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.42 -0.809 . . . . 1.91 111.476 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.62 148.84 19.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.128 -0.789 . . . . 2.25 111.128 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.537 ' O ' ' HB ' ' A' ' 176' ' ' THR . 94.9 m95 -77.78 -15.09 59.35 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.575 -0.368 . . . . 2.3 111.946 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.75 3.75 54.97 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.231 0.538 . . . . 3.79 110.641 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 177' ' ' VAL . 67.8 m -73.83 130.45 39.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.444 -0.798 . . . . 2.44 110.509 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 216' ' ' TRP . 16.6 t70 -60.81 114.17 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.658 ' O ' HG12 ' A' ' 214' ' ' ILE . 2.8 tt -77.35 2.41 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.36 0.6 . . . . 1.95 112.136 -170.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.654 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 35.5 t -76.2 -7.23 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.255 -0.903 . . . . 2.91 109.148 170.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.812 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -65.27 -57.54 8.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.254 -0.885 . . . . 4.8 111.202 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 216' ' ' TRP . 0.0 OUTLIER -88.33 31.07 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.968 0.729 . . . . 2.13 112.968 -172.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.1 m -57.36 146.69 28.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.353 0.597 . . . . 2.03 111.111 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 67.75 6.15 42.1 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.149 -0.932 . . . . 2.12 113.361 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -115.22 165.51 12.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.886 0.343 . . . . 2.61 110.486 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -112.38 126.61 55.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.298 0.571 . . . . 3.06 110.508 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.414 HD21 ' HG ' ' A' ' 217' ' ' LEU . 29.2 mt -96.45 166.8 11.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.3 110.866 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -137.23 123.41 20.47 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.373 -0.603 . . . . 3.31 109.373 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 181' ' ' LEU . 52.2 t -106.05 140.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.283 0.564 . . . . 1.58 110.924 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.33 174.47 5.85 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 4.1 t -100.0 110.03 26.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.096 0.474 . . . . 2.61 109.851 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -137.22 119.28 15.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.026 -1.102 . . . . 2.86 108.026 -176.739 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.47 ' N ' HD22 ' A' ' 227' ' ' LEU . 39.3 mt-10 -92.14 104.9 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.017 -0.538 . . . . 4.27 111.334 -173.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -87.73 59.74 5.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.064 0.935 . . . . 6.02 109.303 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 1.5 m -86.06 -29.53 0.41 Allowed Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.601 -1.181 . . . . 6.23 113.589 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 10.0 Cg_endo -90.32 14.13 2.12 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 121.824 1.682 . . . . 8.56 112.005 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.197 -0.906 . . . . 10.1 111.168 -179.191 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.524 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.664 0.269 . . . . 7.11 110.628 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.42 96.46 0.24 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.238 2.625 . . . . 5.39 111.953 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -122.62 133.61 54.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.011 -0.54 . . . . 4.84 110.768 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -124.78 101.18 33.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 121.47 0.653 . . . . 4.47 109.546 176.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.2 Cg_endo -87.26 136.31 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.529 2.819 . . . . 2.69 111.711 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.0 pp -142.07 144.55 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.739 0.304 . . . . 2.15 110.602 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.9 t -110.66 119.55 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.851 -0.796 . . . . 1.67 108.851 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.579 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 8.0 mtp85 -87.88 104.19 16.37 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.447 0.641 . . . . 3.61 111.365 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 222' ' ' LEU . 85.2 t -88.74 138.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 1.4 111.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.4 m-85 -96.95 104.84 16.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.532 0.682 . . . . 2.54 109.891 171.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.65 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.3 mt -64.69 160.16 55.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.596 -1.184 . . . . 2.07 110.778 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.98 154.11 13.97 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.539 2.16 . . . . 2.27 112.441 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.33 30.51 4.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.659 -0.701 . . . . 3.47 110.43 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 55.56 47.85 19.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.11 -0.95 . . . . 4.66 112.716 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -109.08 178.17 4.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.643 -0.873 . . . . 3.57 108.643 174.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 31.5 ptt180 -148.44 134.82 19.54 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.563 0.697 . . . . 3.54 112.61 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.65 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.7 OUTLIER -134.58 132.62 39.29 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.712 -1.131 . . . . 1.91 108.794 173.178 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.579 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -95.08 150.31 4.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.284 -0.635 . . . . 2.31 109.284 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.77 126.81 14.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.54 -0.541 . . . . 1.67 109.54 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 156' ' ' ILE . 5.4 Cg_endo -49.71 134.27 33.82 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.207 2.605 . . . . 2.12 112.211 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -62.72 95.19 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.28 109.748 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.524 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 40.1 mmt180 -76.17 110.73 10.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.986 -1.006 . . . . 3.98 110.391 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 2.1 p -81.82 117.77 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.58 . . . . 3.37 110.834 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.39 19.61 41.14 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.755 -0.938 . . . . 3.34 110.755 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.615 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 81.4 t -131.07 148.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.402 . . . . 2.87 110.271 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.9 p -84.83 157.55 20.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.413 -0.958 . . . . 2.83 108.413 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 14.6 p -59.51 -22.42 23.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.817 -0.809 . . . . 1.92 108.817 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.9 tpt180 -57.51 -51.64 68.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.915 -0.584 . . . . 4.27 112.408 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.615 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 11.0 t70 -69.42 -49.93 50.48 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.81 0.814 . . . . 2.87 110.412 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -61.1 -53.89 51.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.334 -1.303 . . . . 1.99 110.677 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.752 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.1 mm? -69.43 -20.17 63.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.7 -0.682 . . . . 1.34 112.237 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.9 -44.8 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.23 -0.656 . . . . 3.08 109.23 173.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -63.07 -49.87 72.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.609 -0.436 . . . . 2.75 110.226 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.4 -52.48 45.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.264 -0.88 . . . . 1.43 111.373 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.703 HD21 ' SG ' ' A' ' 195' ' ' CYS . 8.5 tp -71.1 -35.94 72.0 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.359 -0.837 . . . . 1.7 110.711 -175.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -20.71 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 2.29 111.722 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.4 ' SD ' ' C17' ' A' ' 301' ' ' 6FS . 38.9 mtt -64.76 -44.03 91.36 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.697 -0.853 . . . . 2.5 108.697 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.503 ' HG2' HD13 ' A' ' 161' ' ' LEU . 11.1 mmm180 -69.49 -24.72 63.81 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.389 -1.278 . . . . 4.43 110.454 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.32 19.13 26.56 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.595 -0.73 . . . . 2.31 111.572 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.521 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . 11.3 mp -105.6 171.08 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.191 -0.3 . . . . 2.37 110.191 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.497 ' C ' HD23 ' A' ' 185' ' ' LEU . 34.9 pt -123.66 135.24 25.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 2.42 111.774 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.71 -3.75 7.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.784 2.989 . . . . 1.84 113.518 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.857 0.36 . . . . 3.32 110.605 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 31.6 t -110.02 14.7 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 2.85 111.7 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.703 ' SG ' HD21 ' A' ' 185' ' ' LEU . 35.3 m -127.84 169.26 14.11 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.905 -0.497 . . . . 1.74 110.358 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.702 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -139.46 149.46 44.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 111.75 0.278 . . . . 1.73 111.75 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.628 HG23 ' HB ' ' A' ' 208' ' ' ILE . 1.9 m -110.85 134.36 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.423 1.106 . . . . 1.38 111.582 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 225' ' ' GLU . 13.1 m-85 -122.63 173.18 7.87 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.671 -1.604 . . . . 2.99 109.525 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.448 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.4 ptm180 -151.48 127.86 10.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.735 -0.666 . . . . 2.64 109.651 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.728 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -84.53 122.72 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.517 0.675 . . . . 2.6 109.84 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 31.9 tt0 -111.19 -136.5 0.37 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.807 -1.182 . . . . 3.22 107.807 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.94 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.616 0.766 . . . . 4.02 112.882 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 6.45 7.39 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 116.018 -0.537 . . . . 3.47 113.474 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 10.5 pt-20 -137.07 -179.25 5.6 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 117.776 0.788 . . . . 3.48 111.991 -172.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.728 ' HG2' HD11 ' A' ' 200' ' ' ILE . 43.0 mtpt -112.16 139.83 47.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.304 -0.862 . . . . 2.75 111.098 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -122.75 110.57 31.65 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 3.25 109.483 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.51 131.38 18.7 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.035 1.823 . . . . 2.47 112.028 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.628 ' HB ' HG23 ' A' ' 197' ' ' VAL . 17.0 mt -103.12 160.78 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.154 -0.475 . . . . 1.91 111.525 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.16 144.61 17.36 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.953 -0.859 . . . . 2.25 110.953 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.415 ' HA ' ' CG1' ' A' ' 177' ' ' VAL . 73.2 m95 -66.19 -13.75 60.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.357 0.873 . . . . 2.3 113.357 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -103.3 11.51 36.66 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.04 -0.412 . . . . 3.79 111.313 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.9 m -73.06 122.0 21.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.474 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 175' ' ' VAL . 9.9 t0 -60.99 117.27 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.256 -0.646 . . . . 3.47 109.256 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' A' ' 217' ' ' LEU . 4.4 tt -68.82 -15.17 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 1.95 112.41 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.567 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 95.1 p -71.4 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.781 -0.574 . . . . 2.91 111.702 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -90.13 -11.68 40.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.313 0.577 . . . . 4.8 110.216 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.3 mp -102.02 11.85 37.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.579 -0.737 . . . . 2.13 111.709 -174.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.7 m -56.7 153.24 10.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.283 0.563 . . . . 2.03 111.607 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.03 -19.57 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.511 -0.768 . . . . 2.12 113.12 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.26 151.89 19.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.109 0.481 . . . . 2.61 111.131 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 53.0 mt-10 -100.0 126.04 46.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.92 -0.77 . . . . 3.06 108.92 170.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 35.9 mt -94.46 167.3 11.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.667 -0.697 . . . . 1.3 110.206 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.408 ' CD2' HD13 ' A' ' 200' ' ' ILE . 83.8 m-70 -140.18 122.46 15.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.357 -0.608 . . . . 3.31 109.357 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.62 135.78 36.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.456 0.646 . . . . 1.58 111.407 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 198' ' ' TYR . 2.1 mm-40 -108.85 167.99 9.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.209 -1.404 . . . . 2.74 107.209 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 21.7 t -113.56 112.09 38.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.308 -0.557 . . . . 2.61 110.211 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.702 HD11 ' HB2' ' A' ' 196' ' ' ALA . 9.4 mt -74.41 81.72 1.91 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.103 -0.499 . . . . 2.86 110.673 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.421 ' HG3' HG12 ' A' ' 226' ' ' VAL . 43.6 mt-10 -96.58 97.11 9.13 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.391 -0.596 . . . . 4.27 109.391 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -87.64 55.34 3.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.641 0.734 . . . . 6.02 110.466 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.4 m -67.99 152.81 96.13 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 114.709 -1.132 . . . . 6.23 110.601 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.09 -60.67 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.631 2.22 . . . . 8.56 112.03 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.835 -0.602 . . . . 10.1 109.768 178.646 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.523 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.576 0.227 . . . . 7.11 110.565 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.19 143.79 99.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.52 2.146 . . . . 5.39 110.99 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.38 98.96 5.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.939 0.4 . . . . 4.84 110.316 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -100.9 110.16 60.12 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.812 -0.631 . . . . 4.47 109.888 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.75 128.74 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.499 2.133 . . . . 2.69 112.222 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.29 163.13 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.855 0.359 . . . . 2.15 111.062 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 218' ' ' THR . 35.3 t -126.93 122.8 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.337 -0.616 . . . . 1.67 109.337 171.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.473 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 91.4 mtt180 -80.6 106.12 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.812 -0.44 . . . . 3.61 109.812 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.62 107.78 20.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.836 -0.62 . . . . 1.4 110.959 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 m-85 -71.63 103.23 2.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.807 0.813 . . . . 2.54 110.438 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.4 mt -63.61 159.73 49.68 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.241 -1.345 . . . . 2.07 111.051 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.64 148.25 21.67 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.487 2.125 . . . . 2.27 111.825 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.4 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 91.2 m-20 69.95 36.06 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.505 0.669 . . . . 3.47 110.755 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.486 ' HB2' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.49 33.27 22.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 4.66 113.281 169.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -98.35 -179.99 4.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.0 -0.741 . . . . 3.57 109.0 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.1 ptt180 -149.93 132.96 16.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 3.54 112.011 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.63 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -121.56 136.92 54.92 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.637 -0.875 . . . . 1.91 108.637 170.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.49 HG12 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -92.6 141.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.324 -0.621 . . . . 2.31 109.324 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 14.8 p -134.95 123.51 15.95 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.425 -0.583 . . . . 1.67 109.425 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.599 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.5 Cg_endo -51.17 138.51 44.78 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.348 2.699 . . . . 2.12 111.675 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.3 87.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.507 -0.77 . . . . 2.28 110.324 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 37.3 mmt180 -66.82 113.04 4.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.527 -1.215 . . . . 3.98 111.542 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 20.7 p -76.34 131.23 39.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 3.37 110.651 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.27 79.8 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.052 -0.819 . . . . 3.34 111.052 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 89.0 t -129.06 144.95 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.661 -0.496 . . . . 2.87 109.661 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.8 p -93.3 170.81 9.34 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.074 -0.713 . . . . 2.83 109.074 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.737 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.2 m -60.83 -21.31 23.66 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 108.995 -0.743 . . . . 1.92 108.995 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 23.9 tpp180 -53.04 -61.22 2.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.013 -0.54 . . . . 4.27 111.883 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.641 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 10.3 t70 -66.38 -48.12 71.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.722 0.773 . . . . 2.87 110.786 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.49 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 p -61.57 -53.13 60.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.908 -1.042 . . . . 1.99 110.658 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.737 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -65.94 -24.98 66.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.669 -0.696 . . . . 1.34 112.101 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.47 -40.34 71.52 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.679 -0.489 . . . . 3.08 109.679 178.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 187' ' ' MET . 38.1 tttp -68.7 -46.2 69.61 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.322 -0.551 . . . . 2.75 109.945 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.7 -55.9 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 1.43 111.945 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -49.08 75.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 1.7 111.227 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -23.38 66.11 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.356 0.502 . . . . 2.29 112.356 -175.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 44.1 mtm -76.06 -31.45 58.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 2.5 110.505 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.594 ' CD ' HD13 ' A' ' 161' ' ' LEU . 12.0 mmm180 -72.99 -25.72 61.09 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.187 0.518 . . . . 4.43 110.478 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.75 16.56 25.96 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.374 -0.83 . . . . 2.31 111.063 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.423 HD13 ' HB3' ' A' ' 188' ' ' ARG . 10.6 mp -105.33 172.35 6.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.873 0.368 . . . . 2.37 110.246 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.46 140.52 28.34 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 2.42 110.291 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.12 -4.22 12.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.049 2.5 . . . . 1.84 112.7 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -73.99 -47.29 38.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 3.32 110.578 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 86.0 m -102.01 37.74 1.79 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.902 -0.59 . . . . 2.85 111.113 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 72.7 m -143.31 162.67 35.07 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.379 -0.6 . . . . 1.74 109.379 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.551 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -133.73 156.68 47.52 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.444 0.164 . . . . 1.73 111.274 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 208' ' ' ILE . 35.9 t -113.81 126.66 71.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.769 0.795 . . . . 1.38 111.258 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -129.13 161.84 29.14 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.499 -1.228 . . . . 2.99 109.547 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -145.84 154.93 42.54 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.645 -0.502 . . . . 2.64 109.645 168.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.779 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 40.2 mm -104.54 129.31 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 2.6 110.81 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 32.5 tt0 -113.34 -138.96 0.38 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.089 -1.078 . . . . 3.22 108.089 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 201' ' ' GLN . 14.3 t70 -56.3 78.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.471 0.708 . . . . 4.02 112.248 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.11 11.12 17.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.397 -0.43 . . . . 3.47 112.309 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.78 178.63 6.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 3.48 111.296 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.779 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 54.7 mtpt -118.78 139.5 51.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.159 -0.928 . . . . 2.75 111.17 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -120.84 108.86 36.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.789 -1.096 . . . . 3.25 108.513 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.32 128.91 15.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.615 1.543 . . . . 2.47 110.967 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 197' ' ' VAL . 20.5 mt -99.49 153.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.725 -0.671 . . . . 1.91 111.381 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.3 147.5 18.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.215 -0.754 . . . . 2.25 111.215 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.704 ' HA ' HG22 ' A' ' 177' ' ' VAL . 85.8 m95 -74.28 -13.75 60.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.016 0.376 . . . . 2.3 112.016 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -106.88 20.42 19.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.197 0.523 . . . . 3.79 110.339 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.7 m -83.77 128.49 34.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.489 -0.778 . . . . 2.44 109.942 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -65.15 114.43 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 3.47 109.531 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 214' ' ' ILE . 6.1 tt -71.27 -15.16 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.066 -0.515 . . . . 1.95 111.948 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.578 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 91.8 p -73.07 -8.96 58.1 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.064 -0.654 . . . . 2.91 111.075 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -88.8 -26.15 21.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.341 0.591 . . . . 4.8 110.084 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -91.58 18.43 7.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.395 -0.82 . . . . 2.13 112.293 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.4 m -59.47 153.27 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.168 0.508 . . . . 2.03 111.353 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.66 5.3 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.718 -0.673 . . . . 2.12 112.933 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -81.34 145.9 30.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.937 0.399 . . . . 2.61 110.951 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 50.2 mt-10 -101.53 114.16 27.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 3.06 108.698 167.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.64 171.73 8.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.32 -0.855 . . . . 1.3 109.441 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -148.53 134.15 18.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.898 -0.408 . . . . 3.31 109.898 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.97 139.81 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.577 0.703 . . . . 1.58 111.103 -174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -107.84 169.27 8.71 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.523 -1.288 . . . . 2.74 107.523 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 77.8 t -113.51 112.95 42.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 120.601 -0.44 . . . . 2.61 110.817 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 196' ' ' ALA . 9.4 mt -81.94 90.36 6.46 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.89 -0.782 . . . . 2.86 108.89 173.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.79 100.32 0.15 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.894 -0.593 . . . . 4.27 111.271 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -86.21 62.89 7.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.762 -0.654 . . . . 6.02 110.237 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 6.0 m -67.87 124.23 88.98 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.11 -0.95 . . . . 6.23 110.766 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 8.4 Cg_exo -72.82 94.62 0.79 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.65 2.234 . . . . 8.56 111.305 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.806 -0.616 . . . . 10.1 110.21 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.648 ' O6 ' ' C21' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.766 0.317 . . . . 7.11 110.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.14 50.54 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.751 2.968 . . . . 5.39 112.271 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.78 139.03 47.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.755 -0.657 . . . . 4.84 109.835 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -124.96 96.79 39.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.41 -0.589 . . . . 4.47 109.41 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.4 Cg_endo -68.43 127.94 16.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.158 1.905 . . . . 2.69 112.074 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -138.58 165.5 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.989 -0.551 . . . . 2.15 110.195 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 220' ' ' GLU . 44.6 t -128.44 120.76 53.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.61 -0.515 . . . . 1.67 109.61 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 168' ' ' VAL . 89.3 mtm180 -83.09 104.07 13.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.877 -0.601 . . . . 3.61 110.192 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 181' ' ' LEU . 60.1 t -95.66 119.7 44.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.169 -0.923 . . . . 1.4 111.337 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 5.3 m-85 -79.05 102.8 8.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.656 0.741 . . . . 2.54 109.931 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.658 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.3 mt -64.27 159.2 59.95 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.759 -1.109 . . . . 2.07 110.246 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 190' ' ' LEU . 41.5 Cg_exo -56.63 142.24 90.83 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.702 2.268 . . . . 2.27 111.18 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.6 t30 75.87 43.97 0.16 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.126 0.965 . . . . 3.47 110.424 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 164' ' ' LYS . 1.3 mppt? 53.01 32.5 12.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.743 -1.571 . . . . 4.66 113.378 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -101.12 173.7 6.34 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.933 -0.766 . . . . 3.57 108.933 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -148.47 137.73 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.166 0.508 . . . . 3.54 111.948 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.658 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -130.54 139.24 50.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.035 -0.984 . . . . 1.91 108.958 174.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -95.22 142.57 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.265 -0.643 . . . . 2.31 109.265 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.425 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.1 p -138.19 125.64 13.63 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 109.332 -0.618 . . . . 1.67 109.332 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.8 Cg_endo -49.79 137.35 34.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.284 2.656 . . . . 2.12 112.252 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.753 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -67.72 85.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.338 -0.846 . . . . 2.28 109.889 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 23.6 mmm180 -71.13 112.18 7.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.055 -0.975 . . . . 3.98 111.694 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 31.6 m -72.29 131.8 43.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.742 -0.663 . . . . 3.37 110.323 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.05 12.15 84.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 3.34 111.351 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 67.6 t -118.49 150.0 20.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.115 0.483 . . . . 2.87 109.902 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.0 p -85.02 151.46 24.15 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.596 -0.89 . . . . 2.83 108.596 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 12.6 p -58.33 -22.65 20.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.484 -0.932 . . . . 1.92 108.484 170.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -58.1 -50.62 72.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.959 -0.564 . . . . 4.27 112.044 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 7.7 t70 -67.23 -52.13 44.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.12 0.962 . . . . 2.87 110.152 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 214' ' ' ILE . 60.0 m -63.18 -45.63 90.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.446 -1.252 . . . . 1.99 111.132 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.0 OUTLIER -75.71 -21.69 57.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.615 0.598 . . . . 1.34 112.615 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 9.6 pttt -60.3 -37.8 81.66 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.535 -0.866 . . . . 3.08 108.96 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 187' ' ' MET . 15.5 tttp -63.15 -52.9 60.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.522 -0.471 . . . . 2.75 109.824 170.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -48.52 -53.92 16.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 1.43 111.673 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 79.6 mt -66.98 -51.06 59.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.694 -0.685 . . . . 1.7 111.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -23.23 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 2.29 112.878 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 41.8 mtm -64.61 -44.62 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 2.5 110.285 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.58 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -71.18 -26.03 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.553 0.692 . . . . 4.43 111.331 171.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.38 21.45 9.33 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 114.744 -1.116 . . . . 2.31 111.163 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 188' ' ' ARG . 26.1 mt -94.87 159.06 15.21 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.899 -0.651 . . . . 2.37 109.981 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 193' ' ' GLU . 48.8 pt -120.28 135.39 24.43 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.153 0.501 . . . . 2.42 111.524 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.2 -4.74 14.94 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.144 2.563 . . . . 1.84 112.474 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 191' ' ' ILE . 26.1 tt0 -61.22 -49.97 74.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.789 -0.641 . . . . 3.32 111.548 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.89 -1.22 22.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 2.85 111.286 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 49.9 m -109.25 161.15 15.52 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.289 -0.257 . . . . 1.74 110.519 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -133.06 154.29 50.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 116.478 -0.328 . . . . 1.73 110.237 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 208' ' ' ILE . 2.2 m -104.49 135.78 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.24 1.019 . . . . 1.38 110.851 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 225' ' ' GLU . 9.2 m-85 -129.48 167.04 18.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.839 -1.528 . . . . 2.99 109.795 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 206' ' ' LYS . 3.2 ptm180 -149.92 131.98 15.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.122 -0.49 . . . . 2.64 110.226 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.777 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -92.34 121.27 42.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.522 0.677 . . . . 2.6 110.375 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.2 tt0 -103.76 -137.66 0.35 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.976 -1.12 . . . . 3.22 107.976 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.81 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.392 0.515 . . . . 4.02 112.392 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.47 6.25 14.83 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.125 -0.489 . . . . 3.47 112.764 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.5 pt-20 -127.7 -179.52 4.98 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 117.318 0.559 . . . . 3.48 111.866 -172.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HG2' HD11 ' A' ' 200' ' ' ILE . 51.8 mtpt -118.78 140.97 49.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.374 -0.83 . . . . 2.75 111.042 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' A' ' 199' ' ' ARG . 70.6 mmtt -124.93 113.6 26.71 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.152 -0.931 . . . . 3.25 108.652 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 198' ' ' TYR . 54.6 Cg_endo -76.71 127.94 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.891 1.727 . . . . 2.47 111.799 175.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 197' ' ' VAL . 8.5 mt -100.79 156.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.932 -0.576 . . . . 1.91 110.988 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.78 146.85 18.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.139 -0.784 . . . . 2.25 111.139 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 178' ' ' ARG . 67.1 m95 -66.09 -20.2 66.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.325 0.861 . . . . 2.3 113.325 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.28 15.59 28.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.281 -0.567 . . . . 3.79 110.809 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 42.0 m -73.68 131.4 41.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.338 -0.846 . . . . 2.44 109.756 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 9.8 t70 -62.81 109.92 1.59 Allowed 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.363 0.414 . . . . 3.47 109.948 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.594 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -64.4 -18.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.381 . . . . 1.95 111.689 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.753 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 38.2 t -69.42 -11.64 60.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.924 -0.31 . . . . 2.91 111.307 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -90.01 -25.56 20.78 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.106 -0.371 . . . . 4.8 110.525 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -87.6 16.93 5.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 111.928 0.344 . . . . 2.13 111.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 m -55.33 149.07 13.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 2.03 110.095 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.9 -8.28 37.78 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 121.06 -0.59 . . . . 2.12 113.128 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 157' ' ' VAL . 52.3 mm-40 -101.67 137.99 39.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.816 0.308 . . . . 2.61 110.557 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.24 118.78 30.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.873 -0.788 . . . . 3.06 108.873 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.44 174.3 6.74 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.435 -0.802 . . . . 1.3 109.816 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 5.9 p80 -156.11 149.89 25.05 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.671 -1.233 . . . . 3.31 107.671 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 196' ' ' ALA . 84.1 t -100.65 123.52 53.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 122.032 0.92 . . . . 1.58 111.106 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.66 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 0.0 OUTLIER -109.64 120.44 42.51 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.666 -1.606 . . . . 2.74 109.276 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 64.1 t -75.46 126.98 36.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.421 -0.809 . . . . 2.61 112.03 -171.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 196' ' ' ALA . 10.0 mt -79.09 96.85 5.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.393 -0.821 . . . . 2.86 110.347 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -77.95 96.03 4.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.174 0.512 . . . . 4.27 110.019 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -158.8 67.78 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.165 -0.925 . . . . 6.02 109.197 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.24 127.92 39.32 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.204 -0.907 . . . . 6.23 111.507 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.45 119.33 6.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.06 2.506 . . . . 8.56 112.825 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.2 tp . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.651 -0.69 . . . . 10.1 109.54 177.696 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.527 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.877 -0.416 . . . . 7.11 109.877 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -42.12 70.04 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.183 2.589 . . . . 5.39 112.22 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -99.71 99.22 10.03 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.353 -0.61 . . . . 4.84 109.353 173.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 154' ' ' LYS . 1.1 tmmt? -125.11 98.31 36.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.448 0.642 . . . . 4.47 110.679 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -88.14 135.73 3.33 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.721 2.947 . . . . 2.69 111.457 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.84 165.53 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.177 0.513 . . . . 2.15 111.017 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.1 p -139.43 123.1 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.409 -0.814 . . . . 1.67 109.559 173.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 168' ' ' VAL . 53.4 mtt85 -81.22 109.37 15.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 3.61 110.711 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.495 HG22 HD12 ' A' ' 222' ' ' LEU . 53.8 t -98.7 110.81 26.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.095 -0.957 . . . . 1.4 111.485 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.5 m-85 -75.48 103.63 5.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.336 0.589 . . . . 2.54 109.986 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.596 HD11 ' HB ' ' A' ' 167' ' ' THR . 16.1 mt -62.54 161.03 29.77 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.973 -1.012 . . . . 2.07 111.362 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.02 148.7 37.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.762 2.308 . . . . 2.27 111.491 175.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 72.94 23.64 2.74 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.724 0.64 . . . . 3.47 110.894 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 67.38 34.06 4.98 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.537 0.94 . . . . 4.66 113.537 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -98.08 -179.35 4.36 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.598 -0.89 . . . . 3.57 108.598 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 2.9 ptt180 -149.51 139.58 22.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.585 0.629 . . . . 3.54 111.666 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.596 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -132.35 138.94 47.94 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.698 -0.852 . . . . 1.91 108.698 170.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 156' ' ' ILE . 3.5 t -93.08 140.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.16 -0.616 . . . . 2.31 110.057 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 180' ' ' SER . 20.0 t -119.28 122.51 29.41 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.295 -0.411 . . . . 1.67 110.424 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 156' ' ' ILE . 9.7 Cg_endo -52.96 123.34 12.9 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.343 2.029 . . . . 2.12 109.971 168.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.42 101.13 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 2.28 110.49 -173.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.597 ' HB3' HG21 ' A' ' 175' ' ' VAL . 23.9 mmm180 -82.57 119.14 23.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.562 -1.199 . . . . 3.98 111.415 -172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 34.7 t -85.03 136.07 33.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 3.37 109.527 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.32 75.51 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.053 -1.219 . . . . 3.34 110.053 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 172' ' ' ARG . 23.3 t -132.79 136.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.651 -0.774 . . . . 2.87 110.318 -174.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 23.4 p -89.37 167.03 13.35 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.663 -0.699 . . . . 2.83 109.683 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 24.2 t -53.02 -34.17 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.261 -0.644 . . . . 1.92 109.261 171.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -53.28 -56.53 15.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.848 -1.069 . . . . 4.27 112.812 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.491 ' HB3' HG13 ' A' ' 175' ' ' VAL . 9.1 t70 -72.52 -43.62 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 2.87 110.926 -173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 169' ' ' VAL . 1.3 m -65.21 -50.24 66.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.423 -0.808 . . . . 1.99 111.104 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -70.51 -21.12 62.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.625 -0.43 . . . . 1.34 111.968 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.53 -47.05 73.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.933 -0.765 . . . . 3.08 108.933 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.544 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 25.5 ttpt -63.4 -46.61 85.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.984 -0.553 . . . . 2.75 110.041 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.33 -54.13 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.707 -0.679 . . . . 1.43 111.865 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.438 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -65.11 -51.94 58.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 1.7 110.752 178.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.419 ' HE3' ' O ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -62.41 -21.55 65.48 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.257 0.836 . . . . 2.29 113.257 -172.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 45.6 mtm -71.87 -28.17 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.497 -0.481 . . . . 2.5 110.914 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -96.82 -8.47 30.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 4.43 110.896 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.58 35.5 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.502 -0.772 . . . . 2.31 112.433 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 7.9 mp -95.19 176.8 6.08 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.933 -0.395 . . . . 2.37 109.933 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.9 pt -132.61 143.53 49.13 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.159 0.504 . . . . 2.42 111.08 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.17 -3.74 6.62 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 123.7 2.933 . . . . 1.84 112.46 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -76.03 -49.89 16.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.49 0.662 . . . . 3.32 110.724 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 228' ' ' GLU . 63.5 m -103.66 38.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.938 -1.028 . . . . 2.85 112.363 -172.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 98.1 m -145.78 162.62 37.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.258 -0.276 . . . . 1.74 110.375 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.774 ' HB2' HD12 ' A' ' 227' ' ' LEU . . . -132.13 140.36 48.77 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.496 -0.187 . . . . 1.73 110.496 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.693 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -105.35 130.22 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 122.633 1.206 . . . . 1.38 111.541 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.27 165.17 14.6 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.605 -1.634 . . . . 2.99 109.622 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 10.8 ptm180 -144.58 145.28 31.72 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.868 -0.605 . . . . 2.64 109.7 172.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.615 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -98.38 121.92 49.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.729 . . . . 2.6 110.52 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.9 tt0 -99.41 -142.11 0.32 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.62 -1.173 . . . . 3.22 108.115 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.23 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.193 0.597 . . . . 4.02 112.321 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.96 7.65 8.94 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.619 -0.324 . . . . 3.47 112.313 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.6 pt-20 -123.76 -175.74 3.29 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.887 0.375 . . . . 3.48 110.686 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.8 mtpt -123.21 149.23 44.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.958 -0.565 . . . . 2.75 111.162 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -136.22 117.72 11.62 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 114.74 -1.118 . . . . 3.25 108.807 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.33 131.08 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.206 1.937 . . . . 2.47 111.494 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.693 HD12 HG23 ' A' ' 197' ' ' VAL . 19.5 mt -98.02 156.83 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.573 . . . . 1.91 111.738 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.36 145.8 17.91 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.084 -0.806 . . . . 2.25 111.084 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 176' ' ' THR . 88.1 m95 -68.48 -13.19 62.14 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.868 0.692 . . . . 2.3 112.868 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.66 14.26 28.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.531 . . . . 3.79 111.211 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.5 m -75.56 128.49 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.723 -0.671 . . . . 2.44 109.352 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.463 ' HB3' ' CE3' ' A' ' 216' ' ' TRP . 15.9 t70 -65.89 114.09 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.282 -0.636 . . . . 3.47 109.282 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 214' ' ' ILE . 5.7 tt -69.6 -11.15 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 1.95 112.03 -170.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.3 t -70.48 -14.49 62.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.835 -0.541 . . . . 2.91 110.634 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 213' ' ' ASP . 13.2 m0 -92.25 -1.77 56.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.932 0.396 . . . . 4.8 110.567 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.83 9.33 34.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.402 -0.363 . . . . 2.13 110.81 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 153.38 18.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.078 0.466 . . . . 2.03 111.189 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 75.13 -7.36 23.12 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.636 -0.711 . . . . 2.12 113.697 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 157' ' ' VAL . 12.3 mm-40 -99.62 149.32 23.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.044 0.422 . . . . 2.61 110.253 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -95.68 119.8 34.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.475 0.655 . . . . 3.06 109.447 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 159' ' ' VAL . 70.6 mt -98.21 167.33 10.93 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.85 -1.068 . . . . 1.3 109.252 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -149.7 144.08 25.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.324 -0.621 . . . . 3.31 109.324 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 21.3 t -114.42 141.09 32.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.749 0.785 . . . . 1.58 111.507 -171.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.01 179.38 4.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.02 -1.445 . . . . 2.74 107.774 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 87.0 t -105.06 108.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.272 0.558 . . . . 2.61 110.064 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -148.42 124.36 10.65 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.961 -1.126 . . . . 2.86 107.961 -177.508 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.531 ' N ' HD22 ' A' ' 227' ' ' LEU . 47.4 mt-10 -85.23 97.85 10.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.283 0.563 . . . . 4.27 111.288 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -99.94 56.24 0.95 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.433 -0.803 . . . . 6.02 109.086 177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.437 ' CG2' ' HD3' ' A' ' 231' ' ' PRO . 15.5 m -80.93 -34.62 0.76 Allowed Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 114.112 1.152 . . . . 6.23 114.112 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.437 ' HD3' ' CG2' ' A' ' 230' ' ' VAL . 7.4 Cg_exo -73.86 -73.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.454 1.436 . . . . 8.56 112.5 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.504 -0.76 . . . . 10.1 109.172 -178.506 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.512 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.817 0.341 . . . . 7.11 110.396 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.06 -48.82 9.34 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.91 2.407 . . . . 5.39 112.026 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -125.74 125.4 42.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.322 -0.622 . . . . 4.84 109.322 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -77.83 116.01 54.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 4.47 110.219 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -84.13 128.94 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.517 2.144 . . . . 2.69 112.23 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.28 162.77 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.272 -0.422 . . . . 2.15 110.813 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -135.04 120.63 30.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.315 0.578 . . . . 1.67 109.985 170.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.624 ' HG2' HG22 ' A' ' 168' ' ' VAL . 99.3 mtt180 -74.71 119.97 19.62 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.312 -0.858 . . . . 3.61 110.26 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.44 HG11 ' CD1' ' A' ' 181' ' ' LEU . 45.6 t -106.08 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.749 -1.114 . . . . 1.4 111.277 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.4 m-85 -73.28 103.45 3.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.566 0.698 . . . . 2.54 109.664 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.565 HD11 ' HB ' ' A' ' 167' ' ' THR . 12.7 mt -64.98 161.64 45.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.511 -1.222 . . . . 2.07 111.077 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 78.4 Cg_exo -51.63 150.45 16.53 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.511 2.141 . . . . 2.27 111.272 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 164' ' ' LYS . 21.6 t-20 63.89 36.98 9.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.408 1.099 . . . . 3.47 110.237 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.7 mppt? 57.64 28.7 16.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.407 -1.724 . . . . 4.66 114.167 164.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.442 ' OE1' ' HD2' ' A' ' 188' ' ' ARG . 17.4 mt-30 -93.34 -179.07 4.94 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.028 -0.731 . . . . 3.57 109.028 169.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 34.3 ptt180 -147.62 135.05 20.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 3.54 111.511 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 161' ' ' LEU . 2.8 t -111.38 -177.76 3.28 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.909 -1.145 . . . . 1.91 107.909 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' A' ' 158' ' ' ARG . 4.6 t -135.75 132.36 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.178 -1.045 . . . . 2.31 108.178 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.88 123.51 26.19 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.735 -0.386 . . . . 1.67 110.014 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.62 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.5 Cg_endo -50.71 134.17 40.2 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.095 2.53 . . . . 2.12 111.786 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.27 117.69 5.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.761 . . . . 2.28 109.482 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 3.4 mmp_? -105.37 111.78 24.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.075 -0.966 . . . . 3.98 110.823 -173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.6 p -81.2 122.43 27.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.099 -0.501 . . . . 3.37 110.379 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.99 67.32 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.743 -0.943 . . . . 3.34 110.743 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 59.2 t -122.33 140.66 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.239 -0.481 . . . . 2.87 109.742 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 178' ' ' ARG . 44.3 p -86.78 168.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.054 -0.721 . . . . 2.83 109.054 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -59.53 -24.93 29.9 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 N-CA-C 108.703 -0.851 . . . . 1.92 108.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.431 ' HB3' ' OG1' ' A' ' 176' ' ' THR . 9.5 tmm_? -56.19 -60.57 3.31 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.516 0.561 . . . . 4.27 112.516 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 1.9 t70 -64.52 -48.51 74.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.152 0.977 . . . . 2.87 110.607 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.522 ' OG ' HG21 ' A' ' 214' ' ' ILE . 1.3 m -61.31 -50.82 71.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.268 -1.333 . . . . 1.99 110.496 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.9 mm? -68.82 -24.25 64.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.677 -0.692 . . . . 1.34 111.594 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 186' ' ' MET . 0.0 OUTLIER -54.94 -41.93 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.642 -0.503 . . . . 3.08 109.642 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 187' ' ' MET . 19.9 tttt -65.07 -52.21 56.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.648 -0.421 . . . . 2.75 110.155 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 167' ' ' THR . . . -47.52 -52.4 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 1.43 111.683 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 91.0 mt -69.33 -54.34 15.07 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.263 -0.881 . . . . 1.7 110.919 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 5.2 mmt -62.54 -21.36 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.683 0.994 . . . . 2.29 113.683 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 47.1 mtm -67.93 -28.85 67.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.5 110.225 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.442 ' HD2' ' OE1' ' A' ' 165' ' ' GLN . 22.9 mtp180 -95.44 -2.69 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.265 0.555 . . . . 4.43 111.204 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.13 15.76 64.17 Favored Glycine 0 C--N 1.315 -0.583 0 CA-C-N 115.319 -0.855 . . . . 2.31 111.731 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 185' ' ' LEU . 16.6 mt -86.11 159.78 19.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.324 -0.438 . . . . 2.37 109.985 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 193' ' ' GLU . 49.4 pt -121.65 143.15 37.42 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 2.42 111.564 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.37 -4.51 15.14 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.113 2.542 . . . . 1.84 112.628 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.401 ' HB2' HD12 ' A' ' 191' ' ' ILE . 25.9 mt-10 -71.5 -39.71 70.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.999 -0.546 . . . . 3.32 111.035 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.62 37.5 4.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.285 -0.416 . . . . 2.85 111.466 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 86.1 m -136.86 163.51 30.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.512 -0.551 . . . . 1.74 109.512 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.9 139.73 41.8 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 111.195 0.072 . . . . 1.73 111.195 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.646 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -102.48 129.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.323 1.058 . . . . 1.38 111.075 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -120.81 170.53 9.37 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.74 -1.573 . . . . 2.99 110.059 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 199' ' ' ARG . 3.0 ptm180 -150.88 131.1 13.58 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.526 -0.761 . . . . 2.64 109.295 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.696 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -83.57 124.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.353 0.597 . . . . 2.6 110.167 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.4 tt0 -111.25 -139.45 0.38 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.508 -1.294 . . . . 3.22 107.508 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.17 82.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.702 0.63 . . . . 4.02 112.702 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 7.99 10.6 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.213 -0.449 . . . . 3.47 113.578 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.69 -179.02 5.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 117.463 0.632 . . . . 3.48 111.895 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.696 ' HG2' HD11 ' A' ' 200' ' ' ILE . 36.9 mtpt -111.96 140.13 46.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.181 -0.918 . . . . 2.75 111.064 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.83 115.51 33.46 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.372 -0.831 . . . . 3.25 109.417 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.46 123.46 6.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.87 1.714 . . . . 2.47 111.739 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 197' ' ' VAL . 16.0 mt -94.04 159.33 2.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 1.91 111.301 -173.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.39 151.27 20.56 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.985 -0.846 . . . . 2.25 110.985 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HA ' HG22 ' A' ' 177' ' ' VAL . 80.5 m95 -76.98 -12.95 60.01 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.506 0.558 . . . . 2.3 112.506 -172.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.74 12.56 36.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.08 0.467 . . . . 3.79 110.574 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.9 m -79.23 131.48 36.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.868 -0.606 . . . . 2.44 110.316 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 17.5 t70 -61.71 117.9 6.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 3.47 109.921 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.522 HG21 ' OG ' ' A' ' 180' ' ' SER . 5.8 tt -74.11 -16.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.455 . . . . 1.95 111.889 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.496 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 20.7 t -67.54 -18.61 65.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.461 0.648 . . . . 2.91 109.94 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 20.0 t90 -77.83 -18.21 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.839 -0.618 . . . . 4.8 110.385 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.1 mt -102.79 14.04 32.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.091 -0.504 . . . . 2.13 111.211 -171.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 m -60.96 153.31 25.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 2.03 110.435 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.72 24.63 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.977 -0.556 . . . . 2.12 113.576 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.0 mm-40 -99.44 166.12 11.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.13 -0.322 . . . . 2.61 110.13 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.92 126.61 55.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.065 -0.717 . . . . 3.06 109.065 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.402 HD12 HG22 ' A' ' 159' ' ' VAL . 26.9 mt -95.74 156.4 16.35 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.571 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -132.65 117.25 17.66 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.036 -0.728 . . . . 3.31 109.036 177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 45.9 t -101.31 133.37 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.585 0.707 . . . . 1.58 110.895 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.3 174.4 5.89 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.326 -1.306 . . . . 2.74 108.033 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.485 HG12 ' HG3' ' A' ' 228' ' ' GLU . 16.4 t -114.3 116.27 52.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 110.276 -0.268 . . . . 2.61 110.276 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -81.15 97.97 7.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.888 0.375 . . . . 2.86 110.486 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.485 ' HG3' HG12 ' A' ' 226' ' ' VAL . 49.6 mt-10 -117.52 141.79 47.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 4.27 110.525 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 55.25 67.07 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.819 -0.628 . . . . 6.02 110.356 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.43 127.48 46.28 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.81 -0.632 . . . . 6.23 111.204 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.7 -15.29 12.24 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.762 2.308 . . . . 8.56 112.904 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.608 -0.71 . . . . 10.1 110.561 -176.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' 6FS . . . . . 0.548 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo . . . . . 0 N--CA 1.455 -0.77 0 CA-C-O 120.504 0.127 . . . . 2.69 112.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.6 pp -139.87 161.16 26.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.908 0.385 . . . . 2.15 110.948 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.6 t -125.32 117.8 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.297 -0.631 . . . . 1.67 109.297 170.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 90.4 mtt180 -82.63 103.69 12.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.438 0.637 . . . . 3.61 110.51 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 181' ' ' LEU . 77.1 t -92.54 116.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.071 -0.968 . . . . 1.4 111.507 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 4.1 m-85 -77.32 103.71 7.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.076 0.941 . . . . 2.54 109.641 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 167' ' ' THR . 3.7 mt -70.53 166.68 33.23 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.067 -1.424 . . . . 2.07 110.677 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 85.3 Cg_exo -50.81 154.25 7.2 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.566 2.177 . . . . 2.27 111.954 172.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 15.1 m120 69.06 23.92 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 3.47 110.905 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 60.81 31.35 20.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.666 -0.697 . . . . 4.66 112.684 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.88 178.85 5.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.396 -0.965 . . . . 3.57 108.396 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -148.95 140.01 23.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 3.54 111.148 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.75 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -130.43 136.45 49.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.309 -0.859 . . . . 1.91 108.724 169.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 156' ' ' ILE . 1.3 m -99.28 140.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.023 -0.671 . . . . 2.31 110.091 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -123.4 123.08 26.58 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.952 -0.567 . . . . 1.67 109.476 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 156' ' ' ILE . 7.5 Cg_endo -50.71 129.59 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.632 2.221 . . . . 2.12 110.954 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.0 107.6 0.65 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.501 0.667 . . . . 2.28 109.595 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.2 mmp_? -90.51 112.24 23.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.048 -0.978 . . . . 3.98 110.512 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.16 122.49 28.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 3.37 110.396 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.51 11.31 60.96 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.228 -1.149 . . . . 3.34 110.228 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 94.8 t -123.62 143.08 38.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.92 -0.64 . . . . 2.87 109.616 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 36.7 p -91.92 168.99 11.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.783 -0.644 . . . . 2.83 109.508 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 17.7 t -56.09 -31.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.185 -0.672 . . . . 1.92 109.185 173.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 15.8 tpt180 -52.67 -53.81 42.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.347 -0.842 . . . . 4.27 112.581 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -74.64 -44.47 50.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.645 0.736 . . . . 2.87 110.966 -174.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 p -64.51 -52.39 58.08 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.966 -1.015 . . . . 1.99 110.584 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -68.41 -23.64 64.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.318 -0.856 . . . . 1.34 111.599 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.43 -44.33 72.36 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.381 -0.6 . . . . 3.08 109.381 176.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 27.4 ttpt -64.01 -47.8 78.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.313 -0.555 . . . . 2.75 109.991 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.09 -52.25 45.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.431 -0.804 . . . . 1.43 112.026 -175.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.33 -48.75 66.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.71 0.29 . . . . 1.7 110.789 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -29.38 68.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.792 . . . . 2.29 113.14 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 41.6 mtm -70.15 -29.75 66.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 2.5 110.26 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.596 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.5 mmp_? -83.74 -13.97 52.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.682 . . . . 4.43 110.48 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.53 14.48 47.18 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.425 -0.807 . . . . 2.31 111.281 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.17 173.72 6.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.934 0.397 . . . . 2.37 110.424 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.4 140.94 34.97 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.937 -0.574 . . . . 2.42 111.085 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.79 -4.31 14.84 Favored 'Trans proline' 0 CA--C 1.526 0.114 0 C-N-CA 122.892 2.394 . . . . 1.84 112.296 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.38 -52.17 29.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 3.32 110.753 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.2 m -100.37 27.62 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.205 -0.907 . . . . 2.85 111.267 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.624 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.0 m -128.32 151.72 48.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 1.74 109.88 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.527 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -121.53 151.91 39.79 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.47 0.176 . . . . 1.73 111.043 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.626 HG12 HD12 ' A' ' 208' ' ' ILE . 44.3 t -110.73 122.99 66.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 1.38 110.859 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.474 ' CD2' ' HG3' ' A' ' 225' ' ' GLU . 11.4 m-85 -126.29 157.45 38.31 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.674 -1.148 . . . . 2.99 109.745 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.602 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -142.56 144.84 33.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 120.542 -0.463 . . . . 2.64 110.203 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.702 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 47.7 mm -86.81 122.89 39.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.609 -0.723 . . . . 2.6 110.175 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.9 tt0 -104.23 -138.92 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.658 -1.238 . . . . 3.22 107.658 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.18 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.02 0.528 . . . . 4.02 112.214 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.33 8.43 9.11 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.184 -0.462 . . . . 3.47 113.24 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -137.17 -179.38 5.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.452 0.626 . . . . 3.48 112.049 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.702 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -106.92 136.98 45.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 2.75 111.515 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 199' ' ' ARG . 34.8 mmtp -125.7 117.8 24.45 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 114.68 -1.146 . . . . 3.25 108.766 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.39 136.37 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.092 1.861 . . . . 2.47 112.171 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.626 HD12 HG12 ' A' ' 197' ' ' VAL . 43.6 mt -102.05 152.65 5.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.637 -0.71 . . . . 1.91 111.543 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 145.41 17.68 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.008 -0.837 . . . . 2.25 111.008 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.662 ' O ' ' HB ' ' A' ' 176' ' ' THR . 98.4 m95 -69.76 -17.53 63.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.059 0.392 . . . . 2.3 112.059 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.1 4.03 54.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.906 0.384 . . . . 3.79 110.956 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.0 m -75.42 128.91 36.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.015 -0.538 . . . . 2.44 110.418 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 215' ' ' SER . 16.0 t70 -62.43 115.47 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 3.47 109.849 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 169' ' ' VAL . 5.0 tt -66.81 -15.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.946 -0.57 . . . . 1.95 112.043 -173.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.528 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 17.0 m -75.84 -9.93 59.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.951 -0.468 . . . . 2.91 111.876 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -81.32 -27.95 34.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 4.8 109.64 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -87.81 5.63 39.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.022 -0.99 . . . . 2.13 111.9 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.478 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.2 m -58.45 151.51 19.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.877 0.37 . . . . 2.03 110.273 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.66 -9.99 57.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.844 -0.693 . . . . 2.12 112.997 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -106.35 155.44 19.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.896 0.379 . . . . 2.61 111.185 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -102.55 124.5 48.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.659 -0.867 . . . . 3.06 108.659 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.441 ' HG ' ' CG1' ' A' ' 157' ' ' VAL . 46.5 mt -96.49 172.18 8.09 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.642 -0.708 . . . . 1.3 109.912 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 16.8 p80 -153.15 136.38 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.499 -0.556 . . . . 3.31 109.499 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 86.6 t -102.39 135.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.362 0.601 . . . . 1.58 111.266 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 5.5 mm-40 -108.18 120.48 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.079 -0.964 . . . . 2.74 109.31 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 C--N 1.316 -0.869 0 C-N-CA 120.375 -0.53 . . . . 2.61 111.593 -178.247 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.462 -0.374 0 CA-C-O 120.884 0.285 . . . . 2.69 112.001 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -136.09 162.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.875 0.369 . . . . 2.15 111.004 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 218' ' ' THR . 26.0 t -126.69 127.59 70.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.017 -0.735 . . . . 1.67 109.017 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.736 ' HG2' HG22 ' A' ' 168' ' ' VAL . 86.0 mtm180 -88.79 107.62 19.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.357 0.599 . . . . 3.61 110.244 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 161' ' ' LEU . 53.6 t -94.85 122.95 46.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.265 -0.879 . . . . 1.4 111.433 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 4.4 m-85 -87.22 102.91 14.93 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.61 -0.436 . . . . 2.54 110.226 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.924 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -63.21 167.79 5.95 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 2.07 110.432 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 75.5 Cg_exo -50.52 158.24 2.84 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.101 1.868 . . . . 2.27 110.919 168.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 t30 70.31 13.08 7.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.392 0.615 . . . . 3.47 110.361 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.69 40.39 16.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.356 -0.838 . . . . 4.66 112.941 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 3.4 mt-30 -98.96 174.2 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.635 -0.876 . . . . 3.57 108.635 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.5 ptt180 -139.44 130.27 26.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.892 0.769 . . . . 3.54 111.916 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.719 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -128.67 136.1 50.18 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.993 -1.003 . . . . 1.91 108.479 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.736 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.9 t -94.46 144.79 9.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.616 -0.434 . . . . 2.31 110.681 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 6.2 p -137.56 124.72 13.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.048 -0.524 . . . . 1.67 110.009 175.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.614 ' HA ' HG22 ' A' ' 156' ' ' ILE . 8.5 Cg_endo -50.88 133.33 39.68 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.097 2.531 . . . . 2.12 112.234 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.45 110.58 1.49 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.28 109.546 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.4 mmp_? -98.98 112.02 24.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.537 -0.756 . . . . 3.98 111.428 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.9 p -76.5 135.93 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.779 -0.646 . . . . 3.37 110.321 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 15.21 78.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.99 -0.844 . . . . 3.34 110.99 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 86.7 t -128.11 143.86 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.228 -0.656 . . . . 2.87 109.228 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 71.1 p -94.78 169.68 9.98 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.919 -0.771 . . . . 2.83 108.919 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -60.65 -22.88 27.16 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.753 -0.832 . . . . 1.92 108.753 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.709 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 38.2 tpt85 -62.31 -41.55 98.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 112.116 0.413 . . . . 4.27 112.116 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.533 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 6.7 t70 -77.48 -51.91 9.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.816 0.817 . . . . 2.87 109.957 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.464 ' OG ' HG21 ' A' ' 214' ' ' ILE . 47.6 m -63.64 -45.54 89.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 1.99 111.101 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.74 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -72.25 -27.12 62.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.071 -0.513 . . . . 1.34 111.718 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.709 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 1.0 OUTLIER -55.32 -43.22 74.69 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.27 -0.572 . . . . 3.08 109.841 178.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -65.57 -46.88 77.73 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.412 -0.515 . . . . 2.75 109.995 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -50.82 -49.62 58.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.446 -0.797 . . . . 1.43 111.569 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.14 -53.4 30.96 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.671 -0.695 . . . . 1.7 110.61 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.06 65.31 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.902 0.704 . . . . 2.29 112.902 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 43.1 mtm -66.22 -35.1 79.54 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.528 -0.469 . . . . 2.5 110.789 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -90.92 -0.23 57.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.251 0.548 . . . . 4.43 111.431 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.19 66.96 Favored Glycine 0 C--N 1.314 -0.654 0 CA-C-N 115.146 -0.934 . . . . 2.31 111.679 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.51 160.58 16.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.199 -0.5 . . . . 2.37 109.661 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 193' ' ' GLU . 44.5 pt -126.44 141.37 39.84 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.507 . . . . 2.42 111.56 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.71 -10.23 24.81 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 123.188 2.592 . . . . 1.84 112.471 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.503 ' HB2' HD12 ' A' ' 191' ' ' ILE . 32.7 mt-10 -64.63 -35.36 80.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.958 -0.564 . . . . 3.32 111.322 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 58.7 m -118.26 16.47 13.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.316 0.487 . . . . 2.85 112.316 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 63.6 m -124.49 164.34 19.95 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.576 -0.45 . . . . 1.74 110.896 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -129.14 154.52 46.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 116.474 -0.33 . . . . 1.73 111.424 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 208' ' ' ILE . 43.4 t -112.8 129.03 69.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.652 0.739 . . . . 1.38 111.329 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -128.92 162.2 28.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.714 -1.13 . . . . 2.99 110.099 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -139.95 134.49 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.669 -0.493 . . . . 2.64 109.669 172.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -92.26 122.86 44.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.393 0.616 . . . . 2.6 110.863 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.9 tt0 -102.04 -141.15 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.436 -0.949 . . . . 3.22 108.436 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.54 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.184 0.594 . . . . 4.02 111.822 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.48 6.03 7.56 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.52 -0.309 . . . . 3.47 112.757 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 16.6 pt-20 -120.16 -178.72 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.074 0.464 . . . . 3.48 111.301 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 200' ' ' ILE . 39.2 mtpt -123.54 141.97 51.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.75 110.635 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.63 120.69 23.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.747 -0.834 . . . . 3.25 108.747 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.21 130.94 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.968 1.779 . . . . 2.47 112.217 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.766 HD12 HG12 ' A' ' 197' ' ' VAL . 65.6 mt -99.76 157.4 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.324 -0.853 . . . . 1.91 111.484 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.11 147.33 18.54 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.146 -1.181 . . . . 2.25 110.146 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.684 ' HA ' HG22 ' A' ' 177' ' ' VAL . 91.5 m95 -69.93 -13.37 62.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.312 0.556 . . . . 2.3 112.064 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.42 8.31 45.03 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 120.952 0.406 . . . . 3.79 110.622 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -76.63 129.26 36.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.07 -0.513 . . . . 2.44 110.328 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.86 110.44 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 3.47 110.377 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -62.29 -17.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.95 111.127 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.524 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 8.0 p -66.29 -16.32 63.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.067 -0.515 . . . . 2.91 112.185 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -86.17 -31.19 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 4.8 110.702 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.1 mm? -86.58 15.02 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.214 -0.448 . . . . 2.13 111.766 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.473 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -56.81 151.64 13.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 2.03 110.451 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.65 -1.5 72.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.067 -0.587 . . . . 2.12 112.96 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -115.27 165.51 12.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.012 0.434 . . . . 2.61 111.069 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.6 mp0 -113.23 124.79 53.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.768 -0.651 . . . . 3.06 109.388 172.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.97 167.91 10.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.568 -0.742 . . . . 1.3 110.439 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.84 129.34 24.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.293 -0.632 . . . . 3.31 109.293 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 196' ' ' ALA . 89.8 t -104.58 136.7 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.329 0.585 . . . . 1.58 110.383 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.56 171.1 7.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.725 -1.213 . . . . 2.74 107.725 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 61.8 t . . . . . 0 C--N 1.305 -1.344 0 N-CA-C 109.409 -0.589 . . . . 2.61 109.409 170.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 82.9 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 N-CA-C 111.595 -0.194 . . . . 2.69 111.595 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.7 pp -142.89 152.57 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.178 0.513 . . . . 2.15 111.79 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.4 t -118.95 123.13 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.303 -0.999 . . . . 1.67 108.303 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 68.4 mtm180 -86.31 101.65 13.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.602 0.715 . . . . 3.61 110.687 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 224' ' ' VAL . 74.8 t -91.91 121.24 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.803 -1.09 . . . . 1.4 111.795 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.8 m-85 -84.63 102.72 13.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.312 0.577 . . . . 2.54 109.813 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.728 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.0 mt -66.2 163.59 37.39 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.933 -1.031 . . . . 2.07 111.366 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 95.2 Cg_exo -45.18 145.6 3.33 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.179 2.586 . . . . 2.27 113.0 173.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.03 43.52 5.12 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.567 -0.742 . . . . 3.47 111.442 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.5 mppt? 57.68 32.56 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.27 -1.332 . . . . 4.66 112.238 168.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.516 ' OE1' ' HD3' ' A' ' 188' ' ' ARG . 33.0 mt-30 -94.31 172.8 7.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.653 -0.703 . . . . 3.57 109.186 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.1 ptt180 -148.99 137.87 21.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.567 0.699 . . . . 3.54 112.122 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.728 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -139.74 133.89 31.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.615 -1.175 . . . . 1.91 108.337 172.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.497 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -97.67 137.11 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.258 -0.645 . . . . 2.31 109.258 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.441 HG13 HD11 ' A' ' 214' ' ' ILE . 6.5 p -123.87 130.6 24.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.836 -0.431 . . . . 1.67 109.836 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.531 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.6 Cg_endo -50.21 129.2 24.8 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.905 2.403 . . . . 2.12 111.738 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.8 77.98 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.36 -0.836 . . . . 2.28 110.303 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.8 mtm180 -59.32 133.56 56.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.402 -1.272 . . . . 3.98 110.664 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 2.8 p -95.54 135.66 36.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.342 -0.39 . . . . 3.37 110.748 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.49 22.31 70.45 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.65 -0.786 . . . . 3.34 111.433 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 172' ' ' ARG . 2.9 p -123.34 171.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.655 -0.498 . . . . 2.87 109.655 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 43.3 p -105.43 160.24 15.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.594 -0.521 . . . . 2.83 109.594 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 7.3 t -53.59 -33.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.962 -0.755 . . . . 1.92 108.962 171.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -55.15 -49.9 70.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.652 -0.704 . . . . 4.27 112.62 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 175' ' ' VAL . 15.3 t70 -71.46 -47.49 55.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.866 0.841 . . . . 2.87 110.514 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 169' ' ' VAL . 4.4 m -65.13 -47.89 75.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.118 -0.946 . . . . 1.99 111.026 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.6 mm? -68.58 -25.22 64.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.486 -0.325 . . . . 1.34 111.565 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.03 -39.09 68.78 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.427 -0.583 . . . . 3.08 109.427 175.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.669 ' HE3' ' SD ' ' A' ' 187' ' ' MET . 33.5 tttp -67.39 -48.36 67.62 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.575 -0.45 . . . . 2.75 110.27 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -49.98 -55.58 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.553 -0.749 . . . . 1.43 112.097 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.432 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 1.1 mm? -63.17 -53.09 58.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 1.7 110.657 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.4 mmt -58.17 -27.83 64.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.543 0.942 . . . . 2.29 113.543 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.669 ' SD ' ' HE3' ' A' ' 183' ' ' LYS . 58.7 mtm -67.86 -22.2 65.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.513 -0.475 . . . . 2.5 111.285 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 45.1 mtt-85 -112.81 16.28 19.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.741 0.781 . . . . 4.43 111.713 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.54 25.34 75.6 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.419 -1.264 . . . . 2.31 111.892 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.432 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.6 mt -96.18 163.51 13.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.629 -0.878 . . . . 2.37 108.629 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.8 138.26 32.51 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.964 0.411 . . . . 2.42 111.058 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.32 -8.49 23.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.036 2.49 . . . . 1.84 112.634 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.154 0.502 . . . . 3.32 110.301 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 61.5 m -101.73 21.52 14.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.598 -0.728 . . . . 2.85 111.184 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.579 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 69.4 m -129.59 149.31 51.41 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.893 -0.323 . . . . 1.74 110.929 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -125.39 155.9 39.63 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.329 -0.396 . . . . 1.73 110.608 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 208' ' ' ILE . 36.2 t -115.15 124.97 72.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.162 -0.615 . . . . 1.38 111.66 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.84 164.52 18.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.014 -0.994 . . . . 2.99 110.095 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.9 ptm180 -141.78 131.82 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.733 -0.469 . . . . 2.64 109.733 171.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -90.63 122.16 41.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.147 -0.479 . . . . 2.6 110.655 -175.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 203' ' ' GLY . 5.6 tt0 -103.0 -137.07 0.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.494 -0.928 . . . . 3.22 108.494 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.45 78.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.435 0.694 . . . . 4.02 112.117 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.57 10.19 16.41 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.421 -0.354 . . . . 3.47 112.255 -177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 17.0 pt-20 -120.56 179.29 4.37 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 121.183 0.516 . . . . 3.48 111.398 -172.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.9 mtpt -124.96 137.42 54.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.317 -0.856 . . . . 2.75 110.488 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -121.17 117.26 30.71 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.408 -0.814 . . . . 3.25 108.983 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.76 133.84 19.17 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 121.931 1.754 . . . . 2.47 111.932 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 197' ' ' VAL . 72.2 mt -105.84 154.34 7.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 1.91 112.097 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 151.43 19.48 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.63 -0.988 . . . . 2.25 110.63 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.66 ' O ' ' HB ' ' A' ' 176' ' ' THR . 95.8 m95 -74.97 -13.04 60.47 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.684 0.624 . . . . 2.3 112.684 -172.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.42 ' HA ' ' CG2' ' A' ' 176' ' ' THR . 3.2 p30 -102.11 9.44 40.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.161 0.505 . . . . 3.79 110.874 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.8 m -69.76 136.76 51.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.702 -0.681 . . . . 2.44 109.292 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.74 107.07 3.32 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.809 -0.441 . . . . 3.47 109.809 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.58 ' HA ' HD23 ' A' ' 217' ' ' LEU . 1.0 OUTLIER -58.66 -17.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 1.95 111.23 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 5.7 p -66.48 -8.74 28.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.101 -0.499 . . . . 2.91 111.989 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -90.21 -34.53 15.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.026 0.441 . . . . 4.8 110.629 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -85.82 13.77 6.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.064 -0.517 . . . . 2.13 112.066 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -51.97 150.08 4.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.502 . . . . 2.03 111.617 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.1 -31.61 2.04 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.485 -0.78 . . . . 2.12 113.208 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.87 163.04 25.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.575 0.702 . . . . 2.61 111.672 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 22.6 mt-10 -105.36 114.96 29.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.958 -1.019 . . . . 3.06 108.703 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.83 155.83 16.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.84 120.08 29.55 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.614 -0.513 . . . . 3.31 109.614 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 75.4 t -100.66 133.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.402 0.62 . . . . 1.58 110.172 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -107.23 159.8 16.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.717 -1.129 . . . . 2.74 108.68 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.303 -1.453 0 CA-C-O 122.201 1.0 . . . . 2.61 110.603 -179.152 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo . . . . . 0 N--CA 1.455 -0.788 0 N-CA-C 111.583 -0.199 . . . . 2.69 111.583 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.4 pp -138.37 160.23 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.967 0.413 . . . . 2.15 111.152 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -134.51 127.3 49.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.566 0.698 . . . . 1.67 109.122 170.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 168' ' ' VAL . 66.6 mtm180 -88.88 107.84 19.22 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.997 -1.001 . . . . 3.61 111.238 -171.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 161' ' ' LEU . 56.7 t -97.2 122.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.757 -1.11 . . . . 1.4 111.62 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 4.3 m-85 -90.73 102.8 15.55 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 122.027 -0.421 . . . . 2.54 110.396 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -67.95 169.89 8.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 2.07 111.166 -175.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 54.4 Cg_exo -52.72 154.97 11.28 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.087 1.858 . . . . 2.27 110.095 165.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 162' ' ' PRO . 9.5 t30 78.2 10.86 1.93 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.676 0.75 . . . . 3.47 109.912 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 62.23 32.95 17.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.277 -0.874 . . . . 4.66 112.8 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 10.1 mt-30 -102.11 -178.73 3.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.462 -0.569 . . . . 3.57 109.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 21.6 ptt180 -139.57 137.59 35.51 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.652 0.739 . . . . 3.54 111.343 175.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.618 HG21 ' HA ' ' A' ' 184' ' ' ALA . 0.4 OUTLIER -129.51 127.54 41.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.963 -1.495 . . . . 1.91 106.963 170.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -94.86 135.48 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.883 -0.784 . . . . 2.31 108.883 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.01 128.68 25.82 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.878 -0.416 . . . . 1.67 109.878 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 9.4 Cg_endo -51.81 132.58 42.39 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.832 2.355 . . . . 2.12 110.944 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -64.1 88.4 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.641 -0.708 . . . . 2.28 110.371 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 42.8 mmt180 -68.09 111.28 4.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.993 -1.003 . . . . 3.98 110.939 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 12.8 p -77.88 130.75 37.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.045 -0.525 . . . . 3.37 109.882 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.63 4.54 87.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.607 -0.806 . . . . 3.34 111.228 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 1.6 t -118.66 144.18 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.371 0.605 . . . . 2.87 110.041 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 10.9 p -93.8 173.22 7.79 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.378 -0.828 . . . . 2.83 109.265 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 44.9 t -50.47 -33.81 11.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.512 -0.551 . . . . 1.92 109.512 171.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.613 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 12.1 tpt180 -48.98 -62.68 1.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.404 -0.816 . . . . 4.27 112.934 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.691 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 10.6 t70 -75.78 -36.5 59.78 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.513 0.673 . . . . 2.87 111.493 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 p -65.63 -49.93 66.88 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.669 0.747 . . . . 1.99 110.105 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.6 mm? -68.71 -22.23 64.36 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.303 -0.862 . . . . 1.34 111.601 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.691 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.1 mtpt -48.52 -51.12 28.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.311 -0.625 . . . . 3.08 109.311 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 24.7 tttp -59.88 -51.44 69.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.655 -0.418 . . . . 2.75 110.729 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.75 -49.23 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.741 -0.663 . . . . 1.43 112.132 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -47.4 54.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.106 -0.497 . . . . 1.7 111.076 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -27.72 65.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.391 0.515 . . . . 2.29 112.391 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 42.3 mtm -73.14 -32.91 65.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.71 -0.396 . . . . 2.5 110.352 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.468 ' CG ' ' HG ' ' A' ' 161' ' ' LEU . 14.2 mmm180 -74.77 -22.6 58.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.214 0.531 . . . . 4.43 110.76 171.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.51 12.84 37.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.661 -0.7 . . . . 2.31 111.401 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.4 mp -106.28 176.78 5.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 2.37 110.54 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.493 HD11 ' SG ' ' A' ' 194' ' ' CYS . 46.2 pt -124.97 144.49 47.2 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 121.09 0.472 . . . . 2.42 110.514 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.27 -3.8 12.43 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 123.352 2.701 . . . . 1.84 112.796 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -86.2 -28.12 24.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.094 -0.503 . . . . 3.32 110.773 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.493 ' SG ' HD11 ' A' ' 191' ' ' ILE . 74.6 m -111.66 18.98 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 2.85 111.267 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 68.9 m -131.35 163.8 27.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.547 -0.538 . . . . 1.74 109.547 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -129.65 146.27 51.45 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 111.24 0.089 . . . . 1.73 111.24 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.696 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -111.21 130.67 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.449 1.119 . . . . 1.38 111.421 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -123.69 164.99 18.0 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.489 -1.687 . . . . 2.99 109.82 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 199' ' ' ARG . 2.8 ptm180 -147.2 133.44 19.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.108 -0.701 . . . . 2.64 109.108 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -83.91 118.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.255 0.55 . . . . 2.6 110.524 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.6 tt0 -101.45 -140.86 0.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.585 -1.265 . . . . 3.22 107.585 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.15 81.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.552 0.575 . . . . 4.02 112.552 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.62 7.65 16.38 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.163 -0.471 . . . . 3.47 113.06 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 12.7 pt-20 -131.1 -179.39 5.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 117.346 0.573 . . . . 3.48 111.324 -174.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.624 ' HG2' HD11 ' A' ' 200' ' ' ILE . 27.8 mtpt -114.05 138.08 50.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.502 -0.772 . . . . 2.75 110.611 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.69 111.22 39.64 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.376 -0.829 . . . . 3.25 109.619 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.73 121.71 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.85 1.7 . . . . 2.47 111.462 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 197' ' ' VAL . 13.2 mt -93.75 158.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.494 -0.776 . . . . 1.91 111.361 -171.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.22 144.23 17.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 2.25 110.935 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 177' ' ' VAL . 92.8 m95 -72.77 -14.88 61.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 111.955 0.354 . . . . 2.3 111.955 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -98.72 20.26 13.33 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.423 0.63 . . . . 3.79 110.397 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.416 ' CG2' HD11 ' A' ' 217' ' ' LEU . 27.8 m -85.26 127.07 34.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.367 -0.833 . . . . 2.44 109.874 176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.31 109.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 3.47 109.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.551 ' HA ' HD13 ' A' ' 217' ' ' LEU . 6.7 tt -67.23 -14.35 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.95 112.247 -170.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.489 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 22.7 t -69.27 -13.81 62.6 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.051 -0.406 . . . . 2.91 110.673 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -90.35 -14.07 33.84 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.44 0.638 . . . . 4.8 110.271 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.5 mp -101.74 17.88 21.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 2.13 111.645 -176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 m -60.51 153.51 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 2.03 111.074 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.29 -29.17 1.68 Allowed Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.982 -0.554 . . . . 2.12 113.911 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.3 mm-40 -70.2 164.13 24.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.15 0.5 . . . . 2.61 111.351 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.3 mt-10 -112.85 118.71 35.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.037 -0.727 . . . . 3.06 109.037 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.414 HD12 HG22 ' A' ' 159' ' ' VAL . 32.3 mt -95.91 160.18 14.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.127 -0.942 . . . . 1.3 110.16 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.72 117.86 18.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.315 -0.624 . . . . 3.31 109.315 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 64.9 t -101.72 134.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.724 0.774 . . . . 1.58 111.355 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.298 -1.319 . . . . 2.74 107.712 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 97.2 t . . . . . 0 C--N 1.309 -1.171 0 C-N-CA 121.056 -0.258 . . . . 2.61 110.608 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 93.8 Cg_endo . . . . . 0 N--CA 1.462 -0.347 0 CA-C-O 120.663 0.193 . . . . 2.69 112.131 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -132.04 161.93 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 2.15 111.596 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 HD23 ' A' ' 217' ' ' LEU . 47.1 t -132.44 125.02 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.923 -0.769 . . . . 1.67 108.923 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 168' ' ' VAL . 77.5 mtm-85 -87.45 104.98 16.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 3.61 110.391 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.9 t -93.3 114.97 31.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.317 -0.856 . . . . 1.4 111.476 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.58 103.62 7.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.534 0.683 . . . . 2.54 109.583 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.86 HD11 ' HB ' ' A' ' 167' ' ' THR . 2.3 mt -72.09 168.25 24.63 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.568 -1.197 . . . . 2.07 110.975 -175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 71.1 Cg_exo -52.68 156.11 9.43 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.393 2.062 . . . . 2.27 111.299 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 18.4 m120 70.29 19.81 6.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.147 0.499 . . . . 3.47 110.479 -175.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 58.75 31.26 21.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.242 -0.89 . . . . 4.66 112.493 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.4 179.21 5.74 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.844 -0.799 . . . . 3.57 108.844 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -148.02 129.84 15.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 118.418 0.554 . . . . 3.54 111.689 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.86 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -121.04 137.62 54.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.572 -0.899 . . . . 1.91 108.572 172.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 158' ' ' ARG . 6.1 t -92.84 144.42 9.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.093 -0.706 . . . . 2.31 109.093 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.89 130.89 14.35 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 108.713 -0.847 . . . . 1.67 108.713 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.7 Cg_endo -50.02 135.8 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.687 2.258 . . . . 2.12 111.757 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.654 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.06 82.37 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 2.28 109.427 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.58 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 41.0 mmt180 -64.47 111.12 2.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.878 -1.056 . . . . 3.98 111.291 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.32 125.17 31.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 3.37 109.95 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.12 71.58 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.496 -1.041 . . . . 3.34 110.496 -174.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 88.5 t -118.71 152.16 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.852 -0.674 . . . . 2.87 109.451 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 33.8 p -97.09 163.76 12.8 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.671 -0.492 . . . . 2.83 109.671 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 18.7 t -52.17 -32.18 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.548 -0.538 . . . . 1.92 109.548 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.4 tpt180 -53.05 -53.56 48.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.371 -0.831 . . . . 4.27 112.454 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 2.0 t70 -74.53 -43.15 57.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.516 0.674 . . . . 2.87 110.669 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 214' ' ' ILE . 41.1 m -67.2 -49.85 63.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.359 -0.837 . . . . 1.99 111.318 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.619 HD21 HG21 ' A' ' 224' ' ' VAL . 0.0 OUTLIER -68.02 -23.67 65.02 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.98 0.363 . . . . 1.34 111.98 173.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.07 -43.21 77.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.057 -0.72 . . . . 3.08 109.057 176.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 187' ' ' MET . 23.1 tttp -63.28 -48.44 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 2.75 110.079 173.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -52.54 -50.31 63.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 1.43 111.82 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -67.87 -52.57 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.391 -0.368 . . . . 1.7 110.633 178.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.44 62.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.796 0.665 . . . . 2.29 112.796 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 45.6 mtm -69.42 -40.77 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.646 -0.422 . . . . 2.5 109.877 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.505 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.2 mmp_? -74.83 -20.55 59.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.879 -0.6 . . . . 4.43 111.025 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.55 15.55 22.57 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.041 -0.599 . . . . 2.31 111.752 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.408 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.2 mp -104.53 177.43 4.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.294 . . . . 2.37 110.267 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 193' ' ' GLU . 12.8 pt -133.42 145.74 57.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.209 0.528 . . . . 2.42 110.606 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.71 -9.87 12.66 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 124.015 3.143 . . . . 1.84 113.531 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.443 ' HB2' HD12 ' A' ' 191' ' ' ILE . 27.2 mt-10 -83.41 -25.72 31.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.846 0.355 . . . . 3.32 110.541 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 69.7 m -112.14 36.25 3.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.504 . . . . 2.85 111.412 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.504 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 89.6 m -152.96 162.74 40.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.143 -0.481 . . . . 1.74 109.876 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.484 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -129.8 149.62 51.47 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 110.452 -0.203 . . . . 1.73 110.452 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.659 HG12 HD12 ' A' ' 208' ' ' ILE . 55.6 t -108.1 127.96 63.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.791 -0.764 . . . . 1.38 111.307 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.43 168.94 15.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.425 -1.261 . . . . 2.99 109.946 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.427 ' HG2' HD11 ' A' ' 208' ' ' ILE . 11.7 ptm180 -147.17 132.76 18.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.852 -0.613 . . . . 2.64 109.695 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.659 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -90.46 123.18 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.388 0.613 . . . . 2.6 110.44 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.512 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 21.8 mt-30 -106.08 -146.79 0.39 Allowed 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.294 -0.867 . . . . 3.22 109.094 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 39.0 t70 -49.12 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.579 0.751 . . . . 4.02 112.812 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.85 9.02 11.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.246 -0.434 . . . . 3.47 113.303 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.56 -178.34 4.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.364 0.582 . . . . 3.48 111.923 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.659 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.8 mtpt -122.47 142.11 50.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.251 -0.886 . . . . 2.75 110.692 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 70.8 mmtt -125.31 113.29 25.91 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.56 -0.746 . . . . 3.25 109.334 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.67 131.92 19.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.252 1.968 . . . . 2.47 112.025 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.659 HD12 HG12 ' A' ' 197' ' ' VAL . 42.9 mt -103.46 154.8 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.42 -0.809 . . . . 1.91 111.476 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.62 148.84 19.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.128 -0.789 . . . . 2.25 111.128 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.537 ' O ' ' HB ' ' A' ' 176' ' ' THR . 94.9 m95 -77.78 -15.09 59.35 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.575 -0.368 . . . . 2.3 111.946 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.75 3.75 54.97 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.231 0.538 . . . . 3.79 110.641 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 177' ' ' VAL . 67.8 m -73.83 130.45 39.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.444 -0.798 . . . . 2.44 110.509 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 216' ' ' TRP . 16.6 t70 -60.81 114.17 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.658 ' O ' HG12 ' A' ' 214' ' ' ILE . 2.8 tt -77.35 2.41 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.36 0.6 . . . . 1.95 112.136 -170.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.654 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 35.5 t -76.2 -7.23 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.255 -0.903 . . . . 2.91 109.148 170.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.812 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -65.27 -57.54 8.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.254 -0.885 . . . . 4.8 111.202 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 216' ' ' TRP . 0.0 OUTLIER -88.33 31.07 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.968 0.729 . . . . 2.13 112.968 -172.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.1 m -57.36 146.69 28.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.353 0.597 . . . . 2.03 111.111 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 67.75 6.15 42.1 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.149 -0.932 . . . . 2.12 113.361 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -115.22 165.51 12.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.886 0.343 . . . . 2.61 110.486 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -112.38 126.61 55.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.298 0.571 . . . . 3.06 110.508 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.414 HD21 ' HG ' ' A' ' 217' ' ' LEU . 29.2 mt -96.45 166.8 11.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.3 110.866 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -137.23 123.41 20.47 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.373 -0.603 . . . . 3.31 109.373 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 181' ' ' LEU . 52.2 t -106.05 140.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.283 0.564 . . . . 1.58 110.924 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.33 174.47 5.85 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 4.1 t . . . . . 0 C--N 1.311 -1.095 0 CA-C-O 121.096 0.474 . . . . 2.61 109.851 172.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.2 Cg_endo . . . . . 0 N--CA 1.451 -1.007 0 CA-C-O 120.646 0.186 . . . . 2.69 111.711 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.0 pp -142.07 144.55 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.739 0.304 . . . . 2.15 110.602 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.9 t -110.66 119.55 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.851 -0.796 . . . . 1.67 108.851 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.579 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 8.0 mtp85 -87.88 104.19 16.37 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.447 0.641 . . . . 3.61 111.365 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 222' ' ' LEU . 85.2 t -88.74 138.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 1.4 111.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.4 m-85 -96.95 104.84 16.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.532 0.682 . . . . 2.54 109.891 171.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.65 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.3 mt -64.69 160.16 55.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.596 -1.184 . . . . 2.07 110.778 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.98 154.11 13.97 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.539 2.16 . . . . 2.27 112.441 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.33 30.51 4.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.659 -0.701 . . . . 3.47 110.43 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 55.56 47.85 19.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.11 -0.95 . . . . 4.66 112.716 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 165' ' ' GLN . 0.9 OUTLIER -109.08 178.17 4.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.643 -0.873 . . . . 3.57 108.643 174.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 31.5 ptt180 -148.44 134.82 19.54 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.563 0.697 . . . . 3.54 112.61 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.65 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.7 OUTLIER -134.58 132.62 39.29 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.712 -1.131 . . . . 1.91 108.794 173.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.579 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -95.08 150.31 4.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.284 -0.635 . . . . 2.31 109.284 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.77 126.81 14.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.54 -0.541 . . . . 1.67 109.54 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 156' ' ' ILE . 5.4 Cg_endo -49.71 134.27 33.82 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.207 2.605 . . . . 2.12 112.211 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -62.72 95.19 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.28 109.748 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.524 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 40.1 mmt180 -76.17 110.73 10.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.986 -1.006 . . . . 3.98 110.391 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 2.1 p -81.82 117.77 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.58 . . . . 3.37 110.834 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.39 19.61 41.14 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.755 -0.938 . . . . 3.34 110.755 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.615 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 81.4 t -131.07 148.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.402 . . . . 2.87 110.271 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.9 p -84.83 157.55 20.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.413 -0.958 . . . . 2.83 108.413 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 14.6 p -59.51 -22.42 23.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.817 -0.809 . . . . 1.92 108.817 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.9 tpt180 -57.51 -51.64 68.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.915 -0.584 . . . . 4.27 112.408 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.615 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 11.0 t70 -69.42 -49.93 50.48 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.81 0.814 . . . . 2.87 110.412 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -61.1 -53.89 51.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.334 -1.303 . . . . 1.99 110.677 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.752 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.1 mm? -69.43 -20.17 63.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.7 -0.682 . . . . 1.34 112.237 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.9 -44.8 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.23 -0.656 . . . . 3.08 109.23 173.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -63.07 -49.87 72.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.609 -0.436 . . . . 2.75 110.226 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.4 -52.48 45.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.264 -0.88 . . . . 1.43 111.373 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.703 HD21 ' SG ' ' A' ' 195' ' ' CYS . 8.5 tp -71.1 -35.94 72.0 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.359 -0.837 . . . . 1.7 110.711 -175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -20.71 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 2.29 111.722 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 38.9 mtt -64.76 -44.03 91.36 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.697 -0.853 . . . . 2.5 108.697 175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.503 ' HG2' HD13 ' A' ' 161' ' ' LEU . 11.1 mmm180 -69.49 -24.72 63.81 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.389 -1.278 . . . . 4.43 110.454 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.32 19.13 26.56 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.595 -0.73 . . . . 2.31 111.572 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.521 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . 11.3 mp -105.6 171.08 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.191 -0.3 . . . . 2.37 110.191 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.497 ' C ' HD23 ' A' ' 185' ' ' LEU . 34.9 pt -123.66 135.24 25.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 2.42 111.774 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.71 -3.75 7.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.784 2.989 . . . . 1.84 113.518 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.857 0.36 . . . . 3.32 110.605 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 31.6 t -110.02 14.7 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 2.85 111.7 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.703 ' SG ' HD21 ' A' ' 185' ' ' LEU . 35.3 m -127.84 169.26 14.11 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.905 -0.497 . . . . 1.74 110.358 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.448 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -139.46 149.46 44.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 111.75 0.278 . . . . 1.73 111.75 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.628 HG23 ' HB ' ' A' ' 208' ' ' ILE . 1.9 m -110.85 134.36 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.423 1.106 . . . . 1.38 111.582 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 225' ' ' GLU . 13.1 m-85 -122.63 173.18 7.87 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.671 -1.604 . . . . 2.99 109.525 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.448 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.4 ptm180 -151.48 127.86 10.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.735 -0.666 . . . . 2.64 109.651 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.728 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -84.53 122.72 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.517 0.675 . . . . 2.6 109.84 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 31.9 tt0 -111.19 -136.5 0.37 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.807 -1.182 . . . . 3.22 107.807 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.94 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.616 0.766 . . . . 4.02 112.882 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 6.45 7.39 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 116.018 -0.537 . . . . 3.47 113.474 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 10.5 pt-20 -137.07 -179.25 5.6 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 117.776 0.788 . . . . 3.48 111.991 -172.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.728 ' HG2' HD11 ' A' ' 200' ' ' ILE . 43.0 mtpt -112.16 139.83 47.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.304 -0.862 . . . . 2.75 111.098 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -122.75 110.57 31.65 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 3.25 109.483 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.51 131.38 18.7 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.035 1.823 . . . . 2.47 112.028 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.628 ' HB ' HG23 ' A' ' 197' ' ' VAL . 17.0 mt -103.12 160.78 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.154 -0.475 . . . . 1.91 111.525 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.16 144.61 17.36 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.953 -0.859 . . . . 2.25 110.953 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.415 ' HA ' ' CG1' ' A' ' 177' ' ' VAL . 73.2 m95 -66.19 -13.75 60.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.357 0.873 . . . . 2.3 113.357 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -103.3 11.51 36.66 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.04 -0.412 . . . . 3.79 111.313 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.9 m -73.06 122.0 21.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.474 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 175' ' ' VAL . 9.9 t0 -60.99 117.27 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.256 -0.646 . . . . 3.47 109.256 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' A' ' 217' ' ' LEU . 4.4 tt -68.82 -15.17 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 1.95 112.41 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.567 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 95.1 p -71.4 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.781 -0.574 . . . . 2.91 111.702 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -90.13 -11.68 40.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.313 0.577 . . . . 4.8 110.216 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.3 mp -102.02 11.85 37.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.579 -0.737 . . . . 2.13 111.709 -174.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.7 m -56.7 153.24 10.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.283 0.563 . . . . 2.03 111.607 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.03 -19.57 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.511 -0.768 . . . . 2.12 113.12 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.26 151.89 19.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.109 0.481 . . . . 2.61 111.131 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 53.0 mt-10 -100.0 126.04 46.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.92 -0.77 . . . . 3.06 108.92 170.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 35.9 mt -94.46 167.3 11.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.667 -0.697 . . . . 1.3 110.206 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.408 ' CD2' HD13 ' A' ' 200' ' ' ILE . 83.8 m-70 -140.18 122.46 15.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.357 -0.608 . . . . 3.31 109.357 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.62 135.78 36.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.456 0.646 . . . . 1.58 111.407 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 198' ' ' TYR . 2.1 mm-40 -108.85 167.99 9.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.209 -1.404 . . . . 2.74 107.209 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 21.7 t . . . . . 0 C--N 1.307 -1.253 0 C-N-CA 120.308 -0.557 . . . . 2.61 110.211 172.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.461 -0.414 0 CA-C-O 120.895 0.289 . . . . 2.69 112.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.29 163.13 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.855 0.359 . . . . 2.15 111.062 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 218' ' ' THR . 35.3 t -126.93 122.8 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.337 -0.616 . . . . 1.67 109.337 171.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.473 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 91.4 mtt180 -80.6 106.12 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.812 -0.44 . . . . 3.61 109.812 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.62 107.78 20.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.836 -0.62 . . . . 1.4 110.959 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 m-85 -71.63 103.23 2.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.807 0.813 . . . . 2.54 110.438 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.4 mt -63.61 159.73 49.68 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.241 -1.345 . . . . 2.07 111.051 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.64 148.25 21.67 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.487 2.125 . . . . 2.27 111.825 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.4 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 15.0 m120 69.95 36.06 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.505 0.669 . . . . 3.47 110.755 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.486 ' HB2' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.49 33.27 22.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 4.66 113.281 169.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -98.35 -179.99 4.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.0 -0.741 . . . . 3.57 109.0 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.1 ptt180 -149.93 132.96 16.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 3.54 112.011 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.63 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -121.56 136.92 54.92 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.637 -0.875 . . . . 1.91 108.637 170.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.49 HG12 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -92.6 141.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.324 -0.621 . . . . 2.31 109.324 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 14.8 p -134.95 123.51 15.95 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.425 -0.583 . . . . 1.67 109.425 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.599 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.5 Cg_endo -51.17 138.51 44.78 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.348 2.699 . . . . 2.12 111.675 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.3 87.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.507 -0.77 . . . . 2.28 110.324 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.513 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 37.3 mmt180 -66.82 113.04 4.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.527 -1.215 . . . . 3.98 111.542 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 20.7 p -76.34 131.23 39.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 3.37 110.651 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.27 79.8 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.052 -0.819 . . . . 3.34 111.052 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 89.0 t -129.06 144.95 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.661 -0.496 . . . . 2.87 109.661 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.8 p -93.3 170.81 9.34 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.074 -0.713 . . . . 2.83 109.074 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.737 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.2 m -60.83 -21.31 23.66 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 108.995 -0.743 . . . . 1.92 108.995 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 23.9 tpp180 -53.04 -61.22 2.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.013 -0.54 . . . . 4.27 111.883 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.641 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 10.3 t70 -66.38 -48.12 71.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.722 0.773 . . . . 2.87 110.786 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.49 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 p -61.57 -53.13 60.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.908 -1.042 . . . . 1.99 110.658 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.737 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -65.94 -24.98 66.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.669 -0.696 . . . . 1.34 112.101 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.47 -40.34 71.52 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.679 -0.489 . . . . 3.08 109.679 178.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 187' ' ' MET . 38.1 tttp -68.7 -46.2 69.61 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.322 -0.551 . . . . 2.75 109.945 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.7 -55.9 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 1.43 111.945 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -49.08 75.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 1.7 111.227 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -23.38 66.11 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.356 0.502 . . . . 2.29 112.356 -175.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 44.1 mtm -76.06 -31.45 58.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 2.5 110.505 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.594 ' CD ' HD13 ' A' ' 161' ' ' LEU . 12.0 mmm180 -72.99 -25.72 61.09 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.187 0.518 . . . . 4.43 110.478 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.75 16.56 25.96 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.374 -0.83 . . . . 2.31 111.063 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.423 HD13 ' HB3' ' A' ' 188' ' ' ARG . 10.6 mp -105.33 172.35 6.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.873 0.368 . . . . 2.37 110.246 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.46 140.52 28.34 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 2.42 110.291 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.12 -4.22 12.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.049 2.5 . . . . 1.84 112.7 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -73.99 -47.29 38.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 3.32 110.578 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 86.0 m -102.01 37.74 1.79 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.902 -0.59 . . . . 2.85 111.113 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 72.7 m -143.31 162.67 35.07 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.379 -0.6 . . . . 1.74 109.379 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.486 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -133.73 156.68 47.52 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.444 0.164 . . . . 1.73 111.274 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 208' ' ' ILE . 35.9 t -113.81 126.66 71.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.769 0.795 . . . . 1.38 111.258 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -129.13 161.84 29.14 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.499 -1.228 . . . . 2.99 109.547 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -145.84 154.93 42.54 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.645 -0.502 . . . . 2.64 109.645 168.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.779 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 40.2 mm -104.54 129.31 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 2.6 110.81 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 32.5 tt0 -113.34 -138.96 0.38 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.089 -1.078 . . . . 3.22 108.089 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 201' ' ' GLN . 14.3 t70 -56.3 78.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.471 0.708 . . . . 4.02 112.248 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.11 11.12 17.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.397 -0.43 . . . . 3.47 112.309 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.78 178.63 6.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 3.48 111.296 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.779 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 54.7 mtpt -118.78 139.5 51.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.159 -0.928 . . . . 2.75 111.17 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -120.84 108.86 36.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.789 -1.096 . . . . 3.25 108.513 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.32 128.91 15.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.615 1.543 . . . . 2.47 110.967 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 197' ' ' VAL . 20.5 mt -99.49 153.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.725 -0.671 . . . . 1.91 111.381 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.3 147.5 18.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.215 -0.754 . . . . 2.25 111.215 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.704 ' HA ' HG22 ' A' ' 177' ' ' VAL . 85.8 m95 -74.28 -13.75 60.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.016 0.376 . . . . 2.3 112.016 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -106.88 20.42 19.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.197 0.523 . . . . 3.79 110.339 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.7 m -83.77 128.49 34.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.489 -0.778 . . . . 2.44 109.942 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -65.15 114.43 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 3.47 109.531 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 214' ' ' ILE . 6.1 tt -71.27 -15.16 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.066 -0.515 . . . . 1.95 111.948 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.578 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 91.8 p -73.07 -8.96 58.1 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.064 -0.654 . . . . 2.91 111.075 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -88.8 -26.15 21.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.341 0.591 . . . . 4.8 110.084 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -91.58 18.43 7.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.395 -0.82 . . . . 2.13 112.293 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.4 m -59.47 153.27 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.168 0.508 . . . . 2.03 111.353 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.66 5.3 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.718 -0.673 . . . . 2.12 112.933 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -81.34 145.9 30.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.937 0.399 . . . . 2.61 110.951 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 50.2 mt-10 -101.53 114.16 27.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 3.06 108.698 167.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.64 171.73 8.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.32 -0.855 . . . . 1.3 109.441 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -148.53 134.15 18.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.898 -0.408 . . . . 3.31 109.898 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.97 139.81 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.577 0.703 . . . . 1.58 111.103 -174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -107.84 169.27 8.71 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.523 -1.288 . . . . 2.74 107.523 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 77.8 t . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 120.601 -0.44 . . . . 2.61 110.817 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.4 Cg_endo . . . . . 0 N--CA 1.462 -0.324 0 CA-C-O 120.987 0.328 . . . . 2.69 112.074 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -138.58 165.5 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.989 -0.551 . . . . 2.15 110.195 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 220' ' ' GLU . 44.6 t -128.44 120.76 53.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.61 -0.515 . . . . 1.67 109.61 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 168' ' ' VAL . 89.3 mtm180 -83.09 104.07 13.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.877 -0.601 . . . . 3.61 110.192 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 181' ' ' LEU . 60.1 t -95.66 119.7 44.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.169 -0.923 . . . . 1.4 111.337 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 5.3 m-85 -79.05 102.8 8.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.656 0.741 . . . . 2.54 109.931 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.658 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.3 mt -64.27 159.2 59.95 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.759 -1.109 . . . . 2.07 110.246 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 190' ' ' LEU . 41.5 Cg_exo -56.63 142.24 90.83 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.702 2.268 . . . . 2.27 111.18 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.6 t30 75.87 43.97 0.16 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.126 0.965 . . . . 3.47 110.424 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 164' ' ' LYS . 1.3 mppt? 53.01 32.5 12.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.743 -1.571 . . . . 4.66 113.378 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -101.12 173.7 6.34 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.933 -0.766 . . . . 3.57 108.933 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -148.47 137.73 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.166 0.508 . . . . 3.54 111.948 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.658 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -130.54 139.24 50.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.035 -0.984 . . . . 1.91 108.958 174.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -95.22 142.57 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.265 -0.643 . . . . 2.31 109.265 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.425 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.1 p -138.19 125.64 13.63 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 109.332 -0.618 . . . . 1.67 109.332 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.8 Cg_endo -49.79 137.35 34.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.284 2.656 . . . . 2.12 112.252 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.753 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -67.72 85.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.338 -0.846 . . . . 2.28 109.889 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 23.6 mmm180 -71.13 112.18 7.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.055 -0.975 . . . . 3.98 111.694 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 31.6 m -72.29 131.8 43.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.742 -0.663 . . . . 3.37 110.323 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.05 12.15 84.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 3.34 111.351 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 67.6 t -118.49 150.0 20.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.115 0.483 . . . . 2.87 109.902 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.0 p -85.02 151.46 24.15 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.596 -0.89 . . . . 2.83 108.596 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 12.6 p -58.33 -22.65 20.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.484 -0.932 . . . . 1.92 108.484 170.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -58.1 -50.62 72.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.959 -0.564 . . . . 4.27 112.044 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 7.7 t70 -67.23 -52.13 44.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.12 0.962 . . . . 2.87 110.152 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 214' ' ' ILE . 60.0 m -63.18 -45.63 90.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.446 -1.252 . . . . 1.99 111.132 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.0 OUTLIER -75.71 -21.69 57.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.615 0.598 . . . . 1.34 112.615 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 9.6 pttt -60.3 -37.8 81.66 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.535 -0.866 . . . . 3.08 108.96 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 187' ' ' MET . 15.5 tttp -63.15 -52.9 60.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.522 -0.471 . . . . 2.75 109.824 170.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -48.52 -53.92 16.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 1.43 111.673 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 79.6 mt -66.98 -51.06 59.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.694 -0.685 . . . . 1.7 111.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -23.23 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 2.29 112.878 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 41.8 mtm -64.61 -44.62 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 2.5 110.285 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.58 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -71.18 -26.03 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.553 0.692 . . . . 4.43 111.331 171.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.38 21.45 9.33 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 114.744 -1.116 . . . . 2.31 111.163 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 188' ' ' ARG . 26.1 mt -94.87 159.06 15.21 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.899 -0.651 . . . . 2.37 109.981 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 193' ' ' GLU . 48.8 pt -120.28 135.39 24.43 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.153 0.501 . . . . 2.42 111.524 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.2 -4.74 14.94 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.144 2.563 . . . . 1.84 112.474 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 191' ' ' ILE . 26.1 tt0 -61.22 -49.97 74.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.789 -0.641 . . . . 3.32 111.548 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.89 -1.22 22.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 2.85 111.286 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 49.9 m -109.25 161.15 15.52 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.289 -0.257 . . . . 1.74 110.519 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.488 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -133.06 154.29 50.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 116.478 -0.328 . . . . 1.73 110.237 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 208' ' ' ILE . 2.2 m -104.49 135.78 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.24 1.019 . . . . 1.38 110.851 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 225' ' ' GLU . 9.2 m-85 -129.48 167.04 18.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.839 -1.528 . . . . 2.99 109.795 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 206' ' ' LYS . 3.2 ptm180 -149.92 131.98 15.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.122 -0.49 . . . . 2.64 110.226 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.777 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -92.34 121.27 42.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.522 0.677 . . . . 2.6 110.375 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.2 tt0 -103.76 -137.66 0.35 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.976 -1.12 . . . . 3.22 107.976 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.81 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.392 0.515 . . . . 4.02 112.392 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.47 6.25 14.83 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.125 -0.489 . . . . 3.47 112.764 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.5 pt-20 -127.7 -179.52 4.98 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 117.318 0.559 . . . . 3.48 111.866 -172.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HG2' HD11 ' A' ' 200' ' ' ILE . 51.8 mtpt -118.78 140.97 49.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.374 -0.83 . . . . 2.75 111.042 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' A' ' 199' ' ' ARG . 70.6 mmtt -124.93 113.6 26.71 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.152 -0.931 . . . . 3.25 108.652 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 198' ' ' TYR . 54.6 Cg_endo -76.71 127.94 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.891 1.727 . . . . 2.47 111.799 175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 197' ' ' VAL . 8.5 mt -100.79 156.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.932 -0.576 . . . . 1.91 110.988 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.78 146.85 18.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.139 -0.784 . . . . 2.25 111.139 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 178' ' ' ARG . 67.1 m95 -66.09 -20.2 66.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.325 0.861 . . . . 2.3 113.325 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.28 15.59 28.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.281 -0.567 . . . . 3.79 110.809 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 42.0 m -73.68 131.4 41.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.338 -0.846 . . . . 2.44 109.756 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 9.8 t70 -62.81 109.92 1.59 Allowed 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.363 0.414 . . . . 3.47 109.948 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.594 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -64.4 -18.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.381 . . . . 1.95 111.689 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.753 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 38.2 t -69.42 -11.64 60.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.924 -0.31 . . . . 2.91 111.307 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -90.01 -25.56 20.78 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.106 -0.371 . . . . 4.8 110.525 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -87.6 16.93 5.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 111.928 0.344 . . . . 2.13 111.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 m -55.33 149.07 13.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 2.03 110.095 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.9 -8.28 37.78 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 121.06 -0.59 . . . . 2.12 113.128 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 157' ' ' VAL . 52.3 mm-40 -101.67 137.99 39.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.816 0.308 . . . . 2.61 110.557 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.24 118.78 30.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.873 -0.788 . . . . 3.06 108.873 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.44 174.3 6.74 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.435 -0.802 . . . . 1.3 109.816 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 5.9 p80 -156.11 149.89 25.05 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.671 -1.233 . . . . 3.31 107.671 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 196' ' ' ALA . 84.1 t -100.65 123.52 53.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 122.032 0.92 . . . . 1.58 111.106 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.66 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 0.0 OUTLIER -109.64 120.44 42.51 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.666 -1.606 . . . . 2.74 109.276 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 64.1 t . . . . . 0 C--N 1.304 -1.381 0 CA-C-N 115.421 -0.809 . . . . 2.61 112.03 -171.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 111.457 -0.247 . . . . 2.69 111.457 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.84 165.53 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.177 0.513 . . . . 2.15 111.017 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.1 p -139.43 123.1 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.409 -0.814 . . . . 1.67 109.559 173.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 168' ' ' VAL . 53.4 mtt85 -81.22 109.37 15.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 3.61 110.711 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.495 HG22 HD12 ' A' ' 222' ' ' LEU . 53.8 t -98.7 110.81 26.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.095 -0.957 . . . . 1.4 111.485 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.5 m-85 -75.48 103.63 5.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.336 0.589 . . . . 2.54 109.986 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.596 HD11 ' HB ' ' A' ' 167' ' ' THR . 16.1 mt -62.54 161.03 29.77 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.973 -1.012 . . . . 2.07 111.362 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.02 148.7 37.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.762 2.308 . . . . 2.27 111.491 175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.6 m120 72.94 23.64 2.74 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.724 0.64 . . . . 3.47 110.894 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 67.38 34.06 4.98 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.537 0.94 . . . . 4.66 113.537 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -98.08 -179.35 4.36 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.598 -0.89 . . . . 3.57 108.598 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 2.9 ptt180 -149.51 139.58 22.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.585 0.629 . . . . 3.54 111.666 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.596 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -132.35 138.94 47.94 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.698 -0.852 . . . . 1.91 108.698 170.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 156' ' ' ILE . 3.5 t -93.08 140.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.16 -0.616 . . . . 2.31 110.057 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 180' ' ' SER . 20.0 t -119.28 122.51 29.41 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.295 -0.411 . . . . 1.67 110.424 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 156' ' ' ILE . 9.7 Cg_endo -52.96 123.34 12.9 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.343 2.029 . . . . 2.12 109.971 168.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.42 101.13 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 2.28 110.49 -173.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.597 ' HB3' HG21 ' A' ' 175' ' ' VAL . 23.9 mmm180 -82.57 119.14 23.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.562 -1.199 . . . . 3.98 111.415 -172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 34.7 t -85.03 136.07 33.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 3.37 109.527 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.32 75.51 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.053 -1.219 . . . . 3.34 110.053 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 172' ' ' ARG . 23.3 t -132.79 136.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.651 -0.774 . . . . 2.87 110.318 -174.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 23.4 p -89.37 167.03 13.35 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.663 -0.699 . . . . 2.83 109.683 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 24.2 t -53.02 -34.17 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.261 -0.644 . . . . 1.92 109.261 171.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -53.28 -56.53 15.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.848 -1.069 . . . . 4.27 112.812 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.491 ' HB3' HG13 ' A' ' 175' ' ' VAL . 9.1 t70 -72.52 -43.62 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 2.87 110.926 -173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 169' ' ' VAL . 1.3 m -65.21 -50.24 66.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.423 -0.808 . . . . 1.99 111.104 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -70.51 -21.12 62.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.625 -0.43 . . . . 1.34 111.968 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.53 -47.05 73.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.933 -0.765 . . . . 3.08 108.933 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.544 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 25.5 ttpt -63.4 -46.61 85.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.984 -0.553 . . . . 2.75 110.041 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.33 -54.13 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.707 -0.679 . . . . 1.43 111.865 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.438 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -65.11 -51.94 58.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 1.7 110.752 178.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.419 ' HE3' ' O ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -62.41 -21.55 65.48 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.257 0.836 . . . . 2.29 113.257 -172.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 45.6 mtm -71.87 -28.17 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.497 -0.481 . . . . 2.5 110.914 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -96.82 -8.47 30.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 4.43 110.896 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.58 35.5 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.502 -0.772 . . . . 2.31 112.433 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 7.9 mp -95.19 176.8 6.08 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.933 -0.395 . . . . 2.37 109.933 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.9 pt -132.61 143.53 49.13 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.159 0.504 . . . . 2.42 111.08 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.17 -3.74 6.62 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 123.7 2.933 . . . . 1.84 112.46 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -76.03 -49.89 16.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.49 0.662 . . . . 3.32 110.724 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.421 ' O ' HG13 ' A' ' 226' ' ' VAL . 63.5 m -103.66 38.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.938 -1.028 . . . . 2.85 112.363 -172.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 98.1 m -145.78 162.62 37.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.258 -0.276 . . . . 1.74 110.375 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -132.13 140.36 48.77 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.496 -0.187 . . . . 1.73 110.496 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.693 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -105.35 130.22 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 122.633 1.206 . . . . 1.38 111.541 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.27 165.17 14.6 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.605 -1.634 . . . . 2.99 109.622 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 10.8 ptm180 -144.58 145.28 31.72 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.868 -0.605 . . . . 2.64 109.7 172.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.615 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -98.38 121.92 49.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.729 . . . . 2.6 110.52 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.9 tt0 -99.41 -142.11 0.32 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.62 -1.173 . . . . 3.22 108.115 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.23 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.193 0.597 . . . . 4.02 112.321 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.96 7.65 8.94 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.619 -0.324 . . . . 3.47 112.313 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.6 pt-20 -123.76 -175.74 3.29 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.887 0.375 . . . . 3.48 110.686 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.8 mtpt -123.21 149.23 44.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.958 -0.565 . . . . 2.75 111.162 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -136.22 117.72 11.62 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 114.74 -1.118 . . . . 3.25 108.807 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.33 131.08 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.206 1.937 . . . . 2.47 111.494 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.693 HD12 HG23 ' A' ' 197' ' ' VAL . 19.5 mt -98.02 156.83 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.573 . . . . 1.91 111.738 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.36 145.8 17.91 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.084 -0.806 . . . . 2.25 111.084 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 176' ' ' THR . 88.1 m95 -68.48 -13.19 62.14 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.868 0.692 . . . . 2.3 112.868 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.66 14.26 28.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.531 . . . . 3.79 111.211 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.5 m -75.56 128.49 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.723 -0.671 . . . . 2.44 109.352 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.463 ' HB3' ' CE3' ' A' ' 216' ' ' TRP . 15.9 t70 -65.89 114.09 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.282 -0.636 . . . . 3.47 109.282 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 214' ' ' ILE . 5.7 tt -69.6 -11.15 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 1.95 112.03 -170.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.3 t -70.48 -14.49 62.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.835 -0.541 . . . . 2.91 110.634 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 213' ' ' ASP . 13.2 m0 -92.25 -1.77 56.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.932 0.396 . . . . 4.8 110.567 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.83 9.33 34.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.402 -0.363 . . . . 2.13 110.81 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 153.38 18.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.078 0.466 . . . . 2.03 111.189 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 75.13 -7.36 23.12 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.636 -0.711 . . . . 2.12 113.697 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 157' ' ' VAL . 12.3 mm-40 -99.62 149.32 23.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.044 0.422 . . . . 2.61 110.253 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -95.68 119.8 34.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.475 0.655 . . . . 3.06 109.447 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 159' ' ' VAL . 70.6 mt -98.21 167.33 10.93 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.85 -1.068 . . . . 1.3 109.252 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -149.7 144.08 25.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.324 -0.621 . . . . 3.31 109.324 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 21.3 t -114.42 141.09 32.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.749 0.785 . . . . 1.58 111.507 -171.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.01 179.38 4.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.02 -1.445 . . . . 2.74 107.774 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 87.0 t . . . . . 0 C--N 1.314 -0.958 0 CA-C-O 121.272 0.558 . . . . 2.61 110.064 172.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo . . . . . 0 N--CA 1.457 -0.667 0 CA-C-O 120.974 0.322 . . . . 2.69 112.23 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.28 162.77 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.272 -0.422 . . . . 2.15 110.813 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -135.04 120.63 30.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.315 0.578 . . . . 1.67 109.985 170.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.624 ' HG2' HG22 ' A' ' 168' ' ' VAL . 99.3 mtt180 -74.71 119.97 19.62 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.312 -0.858 . . . . 3.61 110.26 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.44 HG11 ' CD1' ' A' ' 181' ' ' LEU . 45.6 t -106.08 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.749 -1.114 . . . . 1.4 111.277 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.4 m-85 -73.28 103.45 3.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.566 0.698 . . . . 2.54 109.664 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.565 HD11 ' HB ' ' A' ' 167' ' ' THR . 12.7 mt -64.98 161.64 45.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.511 -1.222 . . . . 2.07 111.077 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 78.4 Cg_exo -51.63 150.45 16.53 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.511 2.141 . . . . 2.27 111.272 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 164' ' ' LYS . 21.6 t-20 63.89 36.98 9.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.408 1.099 . . . . 3.47 110.237 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.7 mppt? 57.64 28.7 16.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.407 -1.724 . . . . 4.66 114.167 164.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.591 ' NE2' ' HD2' ' A' ' 188' ' ' ARG . 5.5 mt-30 -93.34 -179.07 4.94 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.028 -0.731 . . . . 3.57 109.028 169.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 34.3 ptt180 -147.62 135.05 20.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 3.54 111.511 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 161' ' ' LEU . 2.8 t -111.38 -177.76 3.28 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.909 -1.145 . . . . 1.91 107.909 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' A' ' 158' ' ' ARG . 4.6 t -135.75 132.36 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.178 -1.045 . . . . 2.31 108.178 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.88 123.51 26.19 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.735 -0.386 . . . . 1.67 110.014 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.62 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.5 Cg_endo -50.71 134.17 40.2 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.095 2.53 . . . . 2.12 111.786 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.27 117.69 5.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.761 . . . . 2.28 109.482 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 3.4 mmp_? -105.37 111.78 24.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.075 -0.966 . . . . 3.98 110.823 -173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.6 p -81.2 122.43 27.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.099 -0.501 . . . . 3.37 110.379 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.99 67.32 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.743 -0.943 . . . . 3.34 110.743 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 59.2 t -122.33 140.66 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.239 -0.481 . . . . 2.87 109.742 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 178' ' ' ARG . 44.3 p -86.78 168.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.054 -0.721 . . . . 2.83 109.054 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -59.53 -24.93 29.9 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 N-CA-C 108.703 -0.851 . . . . 1.92 108.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.431 ' HB3' ' OG1' ' A' ' 176' ' ' THR . 9.5 tmm_? -56.19 -60.57 3.31 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.516 0.561 . . . . 4.27 112.516 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 1.9 t70 -64.52 -48.51 74.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.152 0.977 . . . . 2.87 110.607 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.522 ' OG ' HG21 ' A' ' 214' ' ' ILE . 1.3 m -61.31 -50.82 71.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.268 -1.333 . . . . 1.99 110.496 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.9 mm? -68.82 -24.25 64.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.677 -0.692 . . . . 1.34 111.594 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 186' ' ' MET . 0.0 OUTLIER -54.94 -41.93 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.642 -0.503 . . . . 3.08 109.642 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 187' ' ' MET . 19.9 tttt -65.07 -52.21 56.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.648 -0.421 . . . . 2.75 110.155 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 167' ' ' THR . . . -47.52 -52.4 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 1.43 111.683 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 91.0 mt -69.33 -54.34 15.07 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.263 -0.881 . . . . 1.7 110.919 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 5.2 mmt -62.54 -21.36 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.683 0.994 . . . . 2.29 113.683 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 47.1 mtm -67.93 -28.85 67.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.5 110.225 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.591 ' HD2' ' NE2' ' A' ' 165' ' ' GLN . 22.9 mtp180 -95.44 -2.69 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.265 0.555 . . . . 4.43 111.204 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.13 15.76 64.17 Favored Glycine 0 C--N 1.315 -0.583 0 CA-C-N 115.319 -0.855 . . . . 2.31 111.731 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 185' ' ' LEU . 16.6 mt -86.11 159.78 19.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.324 -0.438 . . . . 2.37 109.985 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 193' ' ' GLU . 49.4 pt -121.65 143.15 37.42 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 2.42 111.564 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.37 -4.51 15.14 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.113 2.542 . . . . 1.84 112.628 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.401 ' HB2' HD12 ' A' ' 191' ' ' ILE . 25.9 mt-10 -71.5 -39.71 70.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.999 -0.546 . . . . 3.32 111.035 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.62 37.5 4.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.285 -0.416 . . . . 2.85 111.466 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 86.1 m -136.86 163.51 30.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.512 -0.551 . . . . 1.74 109.512 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.9 139.73 41.8 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 111.195 0.072 . . . . 1.73 111.195 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.646 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -102.48 129.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.323 1.058 . . . . 1.38 111.075 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -120.81 170.53 9.37 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.74 -1.573 . . . . 2.99 110.059 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 199' ' ' ARG . 3.0 ptm180 -150.88 131.1 13.58 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.526 -0.761 . . . . 2.64 109.295 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.696 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -83.57 124.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.353 0.597 . . . . 2.6 110.167 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.4 tt0 -111.25 -139.45 0.38 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.508 -1.294 . . . . 3.22 107.508 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.17 82.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.702 0.63 . . . . 4.02 112.702 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 7.99 10.6 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.213 -0.449 . . . . 3.47 113.578 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.69 -179.02 5.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 117.463 0.632 . . . . 3.48 111.895 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.696 ' HG2' HD11 ' A' ' 200' ' ' ILE . 36.9 mtpt -111.96 140.13 46.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.181 -0.918 . . . . 2.75 111.064 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.83 115.51 33.46 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.372 -0.831 . . . . 3.25 109.417 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.46 123.46 6.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.87 1.714 . . . . 2.47 111.739 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 197' ' ' VAL . 16.0 mt -94.04 159.33 2.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 1.91 111.301 -173.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.39 151.27 20.56 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.985 -0.846 . . . . 2.25 110.985 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HA ' HG22 ' A' ' 177' ' ' VAL . 80.5 m95 -76.98 -12.95 60.01 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.506 0.558 . . . . 2.3 112.506 -172.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.74 12.56 36.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.08 0.467 . . . . 3.79 110.574 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.9 m -79.23 131.48 36.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.868 -0.606 . . . . 2.44 110.316 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 17.5 t70 -61.71 117.9 6.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 3.47 109.921 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.522 HG21 ' OG ' ' A' ' 180' ' ' SER . 5.8 tt -74.11 -16.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.455 . . . . 1.95 111.889 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.496 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 20.7 t -67.54 -18.61 65.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.461 0.648 . . . . 2.91 109.94 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 20.0 t90 -77.83 -18.21 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.839 -0.618 . . . . 4.8 110.385 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.1 mt -102.79 14.04 32.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.091 -0.504 . . . . 2.13 111.211 -171.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 m -60.96 153.31 25.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 2.03 110.435 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.72 24.63 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.977 -0.556 . . . . 2.12 113.576 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.0 mm-40 -99.44 166.12 11.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.13 -0.322 . . . . 2.61 110.13 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.92 126.61 55.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.065 -0.717 . . . . 3.06 109.065 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.402 HD12 HG22 ' A' ' 159' ' ' VAL . 26.9 mt -95.74 156.4 16.35 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.571 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.432 ' CD2' HD13 ' A' ' 200' ' ' ILE . 80.5 m-70 -132.65 117.25 17.66 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.036 -0.728 . . . . 3.31 109.036 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 45.9 t -101.31 133.37 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.585 0.707 . . . . 1.58 110.895 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.3 174.4 5.89 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.326 -1.306 . . . . 2.74 108.033 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 16.4 t . . . . . 0 C--N 1.311 -1.079 0 N-CA-C 110.276 -0.268 . . . . 2.61 110.276 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 109.895 -0.409 . . . . 7.11 109.895 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.84 109.88 0.48 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.671 2.248 . . . . 5.39 111.748 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -65.76 131.84 47.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.798 -0.637 . . . . 4.84 110.493 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.463 ' HD3' HG23 ' A' ' 156' ' ' ILE . 0.8 OUTLIER -120.16 105.58 42.07 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.809 -0.632 . . . . 4.47 110.108 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -88.18 134.28 3.0 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.691 2.927 . . . . 2.69 112.034 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.627 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.6 pp -139.87 161.16 26.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.908 0.385 . . . . 2.15 110.948 177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.6 t -125.32 117.8 50.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.297 -0.631 . . . . 1.67 109.297 170.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.408 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 90.4 mtt180 -82.63 103.69 12.34 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.438 0.637 . . . . 3.61 110.51 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.426 HG11 ' CD1' ' A' ' 181' ' ' LEU . 77.1 t -92.54 116.37 33.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.071 -0.968 . . . . 1.4 111.507 -176.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 4.1 m-85 -77.32 103.71 7.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 122.076 0.941 . . . . 2.54 109.641 174.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.75 HD11 ' HB ' ' A' ' 167' ' ' THR . 3.7 mt -70.53 166.68 33.23 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 114.067 -1.424 . . . . 2.07 110.677 -176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 85.3 Cg_exo -50.81 154.25 7.2 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.566 2.177 . . . . 2.27 111.954 172.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 15.1 m120 69.06 23.92 6.36 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.04 -0.527 . . . . 3.47 110.905 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt 60.81 31.35 20.05 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.666 -0.697 . . . . 4.66 112.684 174.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -94.88 178.85 5.44 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.396 -0.965 . . . . 3.57 108.396 171.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -148.95 140.01 23.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 121.199 0.523 . . . . 3.54 111.148 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.75 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -130.43 136.45 49.05 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.309 -0.859 . . . . 1.91 108.724 169.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.451 HG23 ' HB ' ' A' ' 156' ' ' ILE . 1.3 m -99.28 140.82 17.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.023 -0.671 . . . . 2.31 110.091 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 214' ' ' ILE . 3.3 p -123.4 123.08 26.58 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.952 -0.567 . . . . 1.67 109.476 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.627 ' HA ' HG22 ' A' ' 156' ' ' ILE . 7.5 Cg_endo -50.71 129.59 27.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.632 2.221 . . . . 2.12 110.954 176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.528 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.0 107.6 0.65 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.501 0.667 . . . . 2.28 109.595 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.2 mmp_? -90.51 112.24 23.82 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.048 -0.978 . . . . 3.98 110.512 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 8.0 p -83.16 122.49 28.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.037 0.446 . . . . 3.37 110.396 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.51 11.31 60.96 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.228 -1.149 . . . . 3.34 110.228 -172.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 94.8 t -123.62 143.08 38.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.92 -0.64 . . . . 2.87 109.616 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.662 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 36.7 p -91.92 168.99 11.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.783 -0.644 . . . . 2.83 109.508 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 17.7 t -56.09 -31.92 32.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.185 -0.672 . . . . 1.92 109.185 173.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 15.8 tpt180 -52.67 -53.81 42.14 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.347 -0.842 . . . . 4.27 112.581 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 0.7 OUTLIER -74.64 -44.47 50.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.645 0.736 . . . . 2.87 110.966 -174.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.5 p -64.51 -52.39 58.08 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.966 -1.015 . . . . 1.99 110.584 -175.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -68.41 -23.64 64.66 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.318 -0.856 . . . . 1.34 111.599 176.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.43 -44.33 72.36 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.381 -0.6 . . . . 3.08 109.381 176.333 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.504 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 27.4 ttpt -64.01 -47.8 78.85 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.313 -0.555 . . . . 2.75 109.991 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.09 -52.25 45.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.431 -0.804 . . . . 1.43 112.026 -175.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -67.33 -48.75 66.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.71 0.29 . . . . 1.7 110.789 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -59.96 -29.38 68.39 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.14 0.792 . . . . 2.29 113.14 -174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.429 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 41.6 mtm -70.15 -29.75 66.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.098 0.475 . . . . 2.5 110.26 -178.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.596 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.5 mmp_? -83.74 -13.97 52.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.701 -0.682 . . . . 4.43 110.48 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 95.53 14.48 47.18 Favored Glycine 0 N--CA 1.448 -0.567 0 CA-C-N 115.425 -0.807 . . . . 2.31 111.281 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.17 173.72 6.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.934 0.397 . . . . 2.37 110.424 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 38.6 pt -123.4 140.94 34.97 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.937 -0.574 . . . . 2.42 111.085 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.79 -4.31 14.84 Favored 'Trans proline' 0 CA--C 1.526 0.114 0 C-N-CA 122.892 2.394 . . . . 1.84 112.296 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.38 -52.17 29.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.389 0.614 . . . . 3.32 110.753 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 64.2 m -100.37 27.62 5.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.205 -0.907 . . . . 2.85 111.267 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.624 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 71.0 m -128.32 151.72 48.99 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 1.74 109.88 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.607 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -121.53 151.91 39.79 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 120.47 0.176 . . . . 1.73 111.043 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.626 HG12 HD12 ' A' ' 208' ' ' ILE . 44.3 t -110.73 122.99 66.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-O 121.684 0.754 . . . . 1.38 110.859 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.474 ' CD2' ' HG3' ' A' ' 225' ' ' GLU . 11.4 m-85 -126.29 157.45 38.31 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.674 -1.148 . . . . 2.99 109.745 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.602 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.0 OUTLIER -142.56 144.84 33.08 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 120.542 -0.463 . . . . 2.64 110.203 167.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.702 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 47.7 mm -86.81 122.89 39.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.609 -0.723 . . . . 2.6 110.175 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.9 tt0 -104.23 -138.92 0.36 Allowed 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.658 -1.238 . . . . 3.22 107.658 176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -55.18 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.02 0.528 . . . . 4.02 112.214 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.33 8.43 9.11 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 116.184 -0.462 . . . . 3.47 113.24 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -137.17 -179.38 5.69 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 117.452 0.626 . . . . 3.48 112.049 -172.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.702 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 42.6 mtpt -106.92 136.98 45.84 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 2.75 111.515 -177.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 199' ' ' ARG . 34.8 mmtp -125.7 117.8 24.45 Favored Pre-proline 0 C--N 1.308 -1.213 0 CA-C-N 114.68 -1.146 . . . . 3.25 108.766 173.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -75.39 136.37 19.54 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.092 1.861 . . . . 2.47 112.171 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.626 HD12 HG12 ' A' ' 197' ' ' VAL . 43.6 mt -102.05 152.65 5.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.637 -0.71 . . . . 1.91 111.543 -174.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 145.41 17.68 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.008 -0.837 . . . . 2.25 111.008 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.662 ' O ' ' HB ' ' A' ' 176' ' ' THR . 98.4 m95 -69.76 -17.53 63.44 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.059 0.392 . . . . 2.3 112.059 -174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -94.1 4.03 54.46 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.906 0.384 . . . . 3.79 110.956 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 27.0 m -75.42 128.91 36.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.015 -0.538 . . . . 2.44 110.418 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.526 ' OD2' ' HB2' ' A' ' 215' ' ' SER . 16.0 t70 -62.43 115.47 4.24 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.849 -0.426 . . . . 3.47 109.849 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.415 HD11 HG13 ' A' ' 169' ' ' VAL . 5.0 tt -66.81 -15.85 20.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.946 -0.57 . . . . 1.95 112.043 -173.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.528 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 17.0 m -75.84 -9.93 59.01 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 121.951 -0.468 . . . . 2.91 111.876 -178.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -81.32 -27.95 34.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.572 0.701 . . . . 4.8 109.64 170.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -87.81 5.63 39.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.022 -0.99 . . . . 2.13 111.9 -174.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.478 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.2 m -58.45 151.51 19.96 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.877 0.37 . . . . 2.03 110.273 174.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.66 -9.99 57.53 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.844 -0.693 . . . . 2.12 112.997 -179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -106.35 155.44 19.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.896 0.379 . . . . 2.61 111.185 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -102.55 124.5 48.21 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.659 -0.867 . . . . 3.06 108.659 168.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.441 ' HG ' ' CG1' ' A' ' 157' ' ' VAL . 46.5 mt -96.49 172.18 8.09 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.642 -0.708 . . . . 1.3 109.912 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 16.8 p80 -153.15 136.38 15.7 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.499 -0.556 . . . . 3.31 109.499 172.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.624 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 86.6 t -102.39 135.62 38.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.362 0.601 . . . . 1.58 111.266 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.474 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 5.5 mm-40 -108.18 120.48 42.47 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.079 -0.964 . . . . 2.74 109.31 -175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 15.7 m -70.35 113.31 6.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 C-N-CA 120.375 -0.53 . . . . 2.61 111.593 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' A' ' 196' ' ' ALA . 6.8 mt -83.96 93.61 8.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 109.251 -0.648 . . . . 2.86 109.251 174.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -83.17 94.96 7.97 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.135 0.493 . . . . 4.27 110.749 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -135.93 43.59 2.54 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.278 -0.873 . . . . 6.02 109.201 176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.8 m -70.23 146.03 94.14 Favored Pre-proline 0 C--N 1.313 -0.999 0 CA-C-N 114.474 -1.239 . . . . 6.23 111.017 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.0 69.39 1.78 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.938 2.425 . . . . 8.56 111.752 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 tt . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.361 -0.828 . . . . 10.1 108.898 -177.767 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.5 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.8 t . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 110.214 -0.291 . . . . 7.11 110.214 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -59.02 -40.09 74.26 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.134 2.556 . . . . 5.39 112.54 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -104.64 103.51 13.17 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.384 -0.371 . . . . 4.84 110.049 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.6 tptm -98.39 110.88 58.33 Favored Pre-proline 0 C--N 1.318 -0.766 0 CA-C-N 116.199 -0.455 . . . . 4.47 110.429 -177.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.22 129.14 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.382 2.055 . . . . 2.69 112.001 -179.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.614 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -136.09 162.17 36.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.875 0.369 . . . . 2.15 111.004 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.473 HG22 ' HA ' ' A' ' 218' ' ' THR . 26.0 t -126.69 127.59 70.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.017 -0.735 . . . . 1.67 109.017 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.736 ' HG2' HG22 ' A' ' 168' ' ' VAL . 86.0 mtm180 -88.79 107.62 19.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.357 0.599 . . . . 3.61 110.244 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.452 HG12 HD13 ' A' ' 161' ' ' LEU . 53.6 t -94.85 122.95 46.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.265 -0.879 . . . . 1.4 111.433 -176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.525 ' HA ' ' O ' ' A' ' 165' ' ' GLN . 4.4 m-85 -87.22 102.91 14.93 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 120.61 -0.436 . . . . 2.54 110.226 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.924 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -63.21 167.79 5.95 Favored Pre-proline 0 N--CA 1.447 -0.615 0 CA-C-N 115.841 -0.618 . . . . 2.07 110.432 179.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.503 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 75.5 Cg_exo -50.52 158.24 2.84 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.101 1.868 . . . . 2.27 110.919 168.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 67.2 t30 70.31 13.08 7.61 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.392 0.615 . . . . 3.47 110.361 -175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm 60.69 40.39 16.41 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.356 -0.838 . . . . 4.66 112.941 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 3.4 mt-30 -98.96 174.2 6.47 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.635 -0.876 . . . . 3.57 108.635 173.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.5 ptt180 -139.44 130.27 26.14 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.892 0.769 . . . . 3.54 111.916 178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.719 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.5 OUTLIER -128.67 136.1 50.18 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 114.993 -1.003 . . . . 1.91 108.479 176.106 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.736 HG22 ' HG2' ' A' ' 158' ' ' ARG . 3.9 t -94.46 144.79 9.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 120.616 -0.434 . . . . 2.31 110.681 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.428 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 6.2 p -137.56 124.72 13.77 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 116.048 -0.524 . . . . 1.67 110.009 175.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.614 ' HA ' HG22 ' A' ' 156' ' ' ILE . 8.5 Cg_endo -50.88 133.33 39.68 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 123.097 2.531 . . . . 2.12 112.234 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.524 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.45 110.58 1.49 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.454 -0.794 . . . . 2.28 109.546 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.622 ' NE ' ' HA ' ' A' ' 172' ' ' ARG . 4.4 mmp_? -98.98 112.02 24.26 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.537 -0.756 . . . . 3.98 111.428 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.9 p -76.5 135.93 39.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.779 -0.646 . . . . 3.37 110.321 178.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.3 15.21 78.91 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.99 -0.844 . . . . 3.34 110.99 -175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 86.7 t -128.11 143.86 39.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.228 -0.656 . . . . 2.87 109.228 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 71.1 p -94.78 169.68 9.98 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.919 -0.771 . . . . 2.83 108.919 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.74 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -60.65 -22.88 27.16 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.997 0 N-CA-C 108.753 -0.832 . . . . 1.92 108.753 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.709 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 38.2 tpt85 -62.31 -41.55 98.63 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 112.116 0.413 . . . . 4.27 112.116 -177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.533 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 6.7 t70 -77.48 -51.91 9.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.816 0.817 . . . . 2.87 109.957 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.464 ' OG ' HG21 ' A' ' 214' ' ' ILE . 47.6 m -63.64 -45.54 89.75 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.781 -1.1 . . . . 1.99 111.101 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.74 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.8 mm? -72.25 -27.12 62.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 116.071 -0.513 . . . . 1.34 111.718 177.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.709 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 1.0 OUTLIER -55.32 -43.22 74.69 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 120.27 -0.572 . . . . 3.08 109.841 178.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -65.57 -46.88 77.73 Favored 'General case' 0 C--O 1.233 0.193 0 C-N-CA 120.412 -0.515 . . . . 2.75 109.995 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.552 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -50.82 -49.62 58.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.446 -0.797 . . . . 1.43 111.569 -177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.0 mt -67.14 -53.4 30.96 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.671 -0.695 . . . . 1.7 110.61 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -59.16 -27.06 65.31 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.902 0.704 . . . . 2.29 112.902 -173.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 43.1 mtm -66.22 -35.1 79.54 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.528 -0.469 . . . . 2.5 110.789 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -90.92 -0.23 57.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.251 0.548 . . . . 4.43 111.431 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.19 66.96 Favored Glycine 0 C--N 1.314 -0.654 0 CA-C-N 115.146 -0.934 . . . . 2.31 111.679 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.4 mt -89.51 160.58 16.66 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.199 -0.5 . . . . 2.37 109.661 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 193' ' ' GLU . 44.5 pt -126.44 141.37 39.84 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.507 . . . . 2.42 111.56 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.71 -10.23 24.81 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 123.188 2.592 . . . . 1.84 112.471 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.503 ' HB2' HD12 ' A' ' 191' ' ' ILE . 32.7 mt-10 -64.63 -35.36 80.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.958 -0.564 . . . . 3.32 111.322 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 58.7 m -118.26 16.47 13.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.316 0.487 . . . . 2.85 112.316 -175.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 63.6 m -124.49 164.34 19.95 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.576 -0.45 . . . . 1.74 110.896 -176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.525 ' O ' HG13 ' A' ' 224' ' ' VAL . . . -129.14 154.52 46.64 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 116.474 -0.33 . . . . 1.73 111.424 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.766 HG12 HD12 ' A' ' 208' ' ' ILE . 43.4 t -112.8 129.03 69.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 121.652 0.739 . . . . 1.38 111.329 -177.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -128.92 162.2 28.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.714 -1.13 . . . . 2.99 110.099 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.404 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.8 OUTLIER -139.95 134.49 31.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.669 -0.493 . . . . 2.64 109.669 172.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.673 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -92.26 122.86 44.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-O 121.393 0.616 . . . . 2.6 110.863 -174.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 203' ' ' GLY . 4.9 tt0 -102.04 -141.15 0.35 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.436 -0.949 . . . . 3.22 108.436 177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -56.54 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.184 0.594 . . . . 4.02 111.822 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.48 6.03 7.56 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.52 -0.309 . . . . 3.47 112.757 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 16.6 pt-20 -120.16 -178.72 3.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.074 0.464 . . . . 3.48 111.301 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.673 ' HG2' HD11 ' A' ' 200' ' ' ILE . 39.2 mtpt -123.54 141.97 51.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.319 -0.855 . . . . 2.75 110.635 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -126.63 120.69 23.16 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.747 -0.834 . . . . 3.25 108.747 174.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.21 130.94 12.47 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.968 1.779 . . . . 2.47 112.217 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.766 HD12 HG12 ' A' ' 197' ' ' VAL . 65.6 mt -99.76 157.4 3.89 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-N 115.324 -0.853 . . . . 1.91 111.484 -173.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -98.11 147.33 18.54 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 110.146 -1.181 . . . . 2.25 110.146 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.684 ' HA ' HG22 ' A' ' 177' ' ' VAL . 91.5 m95 -69.93 -13.37 62.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 117.312 0.556 . . . . 2.3 112.064 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -98.42 8.31 45.03 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 120.952 0.406 . . . . 3.79 110.622 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.8 m -76.63 129.26 36.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.07 -0.513 . . . . 2.44 110.328 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.86 110.44 2.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.102 -0.499 . . . . 3.47 110.377 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -62.29 -17.56 18.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.927 -0.579 . . . . 1.95 111.127 -178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.524 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 8.0 p -66.29 -16.32 63.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.067 -0.515 . . . . 2.91 112.185 -178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 30.8 m0 -86.17 -31.19 21.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.839 0.352 . . . . 4.8 110.702 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.1 mm? -86.58 15.02 5.96 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.214 -0.448 . . . . 2.13 111.766 -175.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.473 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -56.81 151.64 13.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 2.03 110.451 172.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.65 -1.5 72.33 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.067 -0.587 . . . . 2.12 112.96 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 64.4 mt-10 -115.27 165.51 12.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.012 0.434 . . . . 2.61 111.069 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.6 mp0 -113.23 124.79 53.34 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.768 -0.651 . . . . 3.06 109.388 172.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.3 mp -95.97 167.91 10.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.568 -0.742 . . . . 1.3 110.439 -176.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.1 m-70 -139.84 129.34 24.23 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.293 -0.632 . . . . 3.31 109.293 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 196' ' ' ALA . 89.8 t -104.58 136.7 36.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.329 0.585 . . . . 1.58 110.383 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -107.56 171.1 7.58 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.725 -1.213 . . . . 2.74 107.725 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 61.8 t -115.01 129.79 70.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 N-CA-C 109.409 -0.589 . . . . 2.61 109.409 170.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.17 81.12 3.68 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.169 0.509 . . . . 2.86 110.183 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -99.29 115.73 29.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.667 -0.697 . . . . 4.27 111.06 -178.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 13.3 m120 56.58 53.54 8.4 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.517 0.675 . . . . 6.02 111.454 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 230' ' ' VAL . 6.2 m -87.57 154.34 53.52 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.022 -0.99 . . . . 6.23 109.729 175.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 12.6 Cg_exo -71.08 65.88 2.58 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.06 2.506 . . . . 8.56 112.058 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 56.3 tp . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.531 -0.747 . . . . 10.1 109.412 179.853 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.503 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 13.4 m . . . . . 0 N--CA 1.474 0.772 0 N-CA-C 110.164 -0.31 . . . . 7.11 110.164 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.08 109.78 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.774 2.316 . . . . 5.39 111.305 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -65.98 123.5 19.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.393 -0.367 . . . . 4.84 111.077 -174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.14 118.81 70.51 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.987 -0.551 . . . . 4.47 110.912 -178.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.481 ' O ' ' HA ' ' A' ' 170' ' ' PRO . 82.9 Cg_endo -76.88 147.95 27.73 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.813 2.342 . . . . 2.69 111.595 177.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.531 HG22 ' HA ' ' A' ' 170' ' ' PRO . 1.7 pp -142.89 152.57 17.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 121.178 0.513 . . . . 2.15 111.79 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.56 HG22 ' HA ' ' A' ' 218' ' ' THR . 34.4 t -118.95 123.13 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.303 -0.999 . . . . 1.67 108.303 172.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.497 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 68.4 mtm180 -86.31 101.65 13.27 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.602 0.715 . . . . 3.61 110.687 -176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 224' ' ' VAL . 74.8 t -91.91 121.24 42.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.803 -1.09 . . . . 1.4 111.795 -173.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.8 m-85 -84.63 102.72 13.15 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.312 0.577 . . . . 2.54 109.813 174.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.728 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.0 mt -66.2 163.59 37.39 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 114.933 -1.031 . . . . 2.07 111.366 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 95.2 Cg_exo -45.18 145.6 3.33 Favored 'Trans proline' 0 CA--C 1.532 0.407 0 C-N-CA 123.179 2.586 . . . . 2.27 113.0 173.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 64.03 43.52 5.12 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.567 -0.742 . . . . 3.47 111.442 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.5 mppt? 57.68 32.56 22.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.27 -1.332 . . . . 4.66 112.238 168.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.516 ' OE1' ' HD3' ' A' ' 188' ' ' ARG . 33.0 mt-30 -94.31 172.8 7.98 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 115.653 -0.703 . . . . 3.57 109.186 175.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 39.1 ptt180 -148.99 137.87 21.32 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.567 0.699 . . . . 3.54 112.122 173.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.728 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -139.74 133.89 31.1 Favored 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.615 -1.175 . . . . 1.91 108.337 172.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.497 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -97.67 137.11 26.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 109.258 -0.645 . . . . 2.31 109.258 -179.57 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.441 HG13 HD11 ' A' ' 214' ' ' ILE . 6.5 p -123.87 130.6 24.37 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 109.836 -0.431 . . . . 1.67 109.836 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.531 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.6 Cg_endo -50.21 129.2 24.8 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.905 2.403 . . . . 2.12 111.738 176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.607 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.8 77.98 0.62 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.36 -0.836 . . . . 2.28 110.303 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 175' ' ' VAL . 6.8 mtm180 -59.32 133.56 56.21 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.402 -1.272 . . . . 3.98 110.664 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 2.8 p -95.54 135.66 36.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.342 -0.39 . . . . 3.37 110.748 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.49 22.31 70.45 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.65 -0.786 . . . . 3.34 111.433 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 172' ' ' ARG . 2.9 p -123.34 171.12 12.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.655 -0.498 . . . . 2.87 109.655 -177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.66 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 43.3 p -105.43 160.24 15.29 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 109.594 -0.521 . . . . 2.83 109.594 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.593 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 7.3 t -53.59 -33.2 21.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.962 -0.755 . . . . 1.92 108.962 171.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -55.15 -49.9 70.64 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.652 -0.704 . . . . 4.27 112.62 -178.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 175' ' ' VAL . 15.3 t70 -71.46 -47.49 55.38 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.866 0.841 . . . . 2.87 110.514 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.44 ' O ' HG21 ' A' ' 169' ' ' VAL . 4.4 m -65.13 -47.89 75.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.118 -0.946 . . . . 1.99 111.026 -177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.6 mm? -68.58 -25.22 64.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.486 -0.325 . . . . 1.34 111.565 176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.03 -39.09 68.78 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.427 -0.583 . . . . 3.08 109.427 175.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.669 ' HE3' ' SD ' ' A' ' 187' ' ' MET . 33.5 tttp -67.39 -48.36 67.62 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 120.575 -0.45 . . . . 2.75 110.27 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.576 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -49.98 -55.58 14.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.553 -0.749 . . . . 1.43 112.097 -175.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.432 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 1.1 mm? -63.17 -53.09 58.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.257 -0.429 . . . . 1.7 110.657 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 12.4 mmt -58.17 -27.83 64.19 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 113.543 0.942 . . . . 2.29 113.543 -173.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.669 ' SD ' ' HE3' ' A' ' 183' ' ' LYS . 58.7 mtm -67.86 -22.2 65.13 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.513 -0.475 . . . . 2.5 111.285 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.655 ' HD2' ' CD1' ' A' ' 161' ' ' LEU . 45.1 mtt-85 -112.81 16.28 19.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 121.741 0.781 . . . . 4.43 111.713 176.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 69.54 25.34 75.6 Favored Glycine 0 C--N 1.309 -0.927 0 CA-C-N 114.419 -1.264 . . . . 2.31 111.892 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.432 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.6 mt -96.18 163.51 13.07 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.629 -0.878 . . . . 2.37 108.629 178.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 44.5 pt -127.8 138.26 32.51 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-O 120.964 0.411 . . . . 2.42 111.058 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.32 -8.49 23.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.036 2.49 . . . . 1.84 112.634 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -64.51 -46.73 81.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.154 0.502 . . . . 3.32 110.301 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 61.5 m -101.73 21.52 14.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.598 -0.728 . . . . 2.85 111.184 -174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.579 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 69.4 m -129.59 149.31 51.41 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.893 -0.323 . . . . 1.74 110.929 -177.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.58 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -125.39 155.9 39.63 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 116.329 -0.396 . . . . 1.73 110.608 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.665 HG12 HD12 ' A' ' 208' ' ' ILE . 36.2 t -115.15 124.97 72.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 C-N-CA 120.162 -0.615 . . . . 1.38 111.66 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -122.84 164.52 18.26 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.014 -0.994 . . . . 2.99 110.095 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.9 ptm180 -141.78 131.82 24.65 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.733 -0.469 . . . . 2.64 109.733 171.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.711 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -90.63 122.16 41.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.147 -0.479 . . . . 2.6 110.655 -175.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 203' ' ' GLY . 5.6 tt0 -103.0 -137.07 0.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.494 -0.928 . . . . 3.22 108.494 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -57.45 78.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.435 0.694 . . . . 4.02 112.117 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.57 10.19 16.41 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.421 -0.354 . . . . 3.47 112.255 -177.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 17.0 pt-20 -120.56 179.29 4.37 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-O 121.183 0.516 . . . . 3.48 111.398 -172.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.711 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.9 mtpt -124.96 137.42 54.26 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.317 -0.856 . . . . 2.75 110.488 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -121.17 117.26 30.71 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.408 -0.814 . . . . 3.25 108.983 175.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.76 133.84 19.17 Favored 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 121.931 1.754 . . . . 2.47 111.932 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.665 HD12 HG12 ' A' ' 197' ' ' VAL . 72.2 mt -105.84 154.34 7.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.873 -0.603 . . . . 1.91 112.097 -172.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -99.02 151.43 19.48 Favored Glycine 0 N--CA 1.443 -0.899 0 N-CA-C 110.63 -0.988 . . . . 2.25 110.63 176.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.66 ' O ' ' HB ' ' A' ' 176' ' ' THR . 95.8 m95 -74.97 -13.04 60.47 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.684 0.624 . . . . 2.3 112.684 -172.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.42 ' HA ' ' CG2' ' A' ' 176' ' ' THR . 3.2 p30 -102.11 9.44 40.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.161 0.505 . . . . 3.79 110.874 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.8 m -69.76 136.76 51.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.702 -0.681 . . . . 2.44 109.292 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -69.74 107.07 3.32 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.809 -0.441 . . . . 3.47 109.809 177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.58 ' HA ' HD23 ' A' ' 217' ' ' LEU . 1.0 OUTLIER -58.66 -17.97 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 1.95 111.23 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.607 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 5.7 p -66.48 -8.74 28.33 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.101 -0.499 . . . . 2.91 111.989 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 18.7 m0 -90.21 -34.53 15.77 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.026 0.441 . . . . 4.8 110.629 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.58 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -85.82 13.77 6.88 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 116.064 -0.517 . . . . 2.13 112.066 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.56 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.8 m -51.97 150.08 4.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.153 0.502 . . . . 2.03 111.617 176.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.1 -31.61 2.04 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.485 -0.78 . . . . 2.12 113.208 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.87 163.04 25.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.575 0.702 . . . . 2.61 111.672 -174.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 22.6 mt-10 -105.36 114.96 29.46 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 114.958 -1.019 . . . . 3.06 108.703 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.83 155.83 16.98 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -125.84 120.08 29.55 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.614 -0.513 . . . . 3.31 109.614 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 75.4 t -100.66 133.89 42.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.402 0.62 . . . . 1.58 110.172 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -107.23 159.8 16.07 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.717 -1.129 . . . . 2.74 108.68 -173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 14.8 p -104.52 109.18 26.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 122.201 1.0 . . . . 2.61 110.603 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' A' ' 196' ' ' ALA . 15.7 mt -78.54 81.07 4.89 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.344 -1.298 . . . . 2.86 111.012 -176.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -82.15 96.86 7.95 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.905 -0.589 . . . . 4.27 109.52 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -113.63 61.28 0.65 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.998 -0.547 . . . . 6.02 110.535 -176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 6.4 m 38.35 70.28 1.32 Allowed Pre-proline 0 N--CA 1.468 0.437 0 O-C-N 124.716 1.26 . . . . 6.23 112.937 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.18 148.8 92.54 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.554 2.169 . . . . 8.56 111.692 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.571 -0.728 . . . . 10.1 110.118 -179.238 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.519 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 109.984 -0.376 . . . . 7.11 109.984 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -59.58 104.81 0.23 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.834 2.356 . . . . 5.39 111.848 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.8 tp60 -104.48 99.58 9.26 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.612 -0.514 . . . . 4.84 109.612 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 50.1 tptt -90.55 120.19 68.97 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 116.232 -0.44 . . . . 4.47 110.278 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -80.83 140.38 12.82 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.468 2.112 . . . . 2.69 111.583 177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.4 pp -138.37 160.23 31.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.967 0.413 . . . . 2.15 111.152 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -134.51 127.3 49.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-O 121.566 0.698 . . . . 1.67 109.122 170.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 168' ' ' VAL . 66.6 mtm180 -88.88 107.84 19.22 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.997 -1.001 . . . . 3.61 111.238 -171.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 161' ' ' LEU . 56.7 t -97.2 122.73 49.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.757 -1.11 . . . . 1.4 111.62 -173.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 4.3 m-85 -90.73 102.8 15.55 Favored 'General case' 0 C--N 1.317 -0.848 0 O-C-N 122.027 -0.421 . . . . 2.54 110.396 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -67.95 169.89 8.68 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.669 -0.696 . . . . 2.07 111.166 -175.472 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 54.4 Cg_exo -52.72 154.97 11.28 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.087 1.858 . . . . 2.27 110.095 165.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 162' ' ' PRO . 9.5 t30 78.2 10.86 1.93 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 121.676 0.75 . . . . 3.47 109.912 -174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm 62.23 32.95 17.0 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.277 -0.874 . . . . 4.66 112.8 172.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 160' ' ' PHE . 10.1 mt-30 -102.11 -178.73 3.79 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.462 -0.569 . . . . 3.57 109.462 175.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 21.6 ptt180 -139.57 137.59 35.51 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.652 0.739 . . . . 3.54 111.343 175.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.618 HG21 ' HA ' ' A' ' 184' ' ' ALA . 0.4 OUTLIER -129.51 127.54 41.01 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 106.963 -1.495 . . . . 1.91 106.963 170.619 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 158' ' ' ARG . 0.7 OUTLIER -94.86 135.48 28.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.883 -0.784 . . . . 2.31 108.883 -178.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.01 128.68 25.82 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.878 -0.416 . . . . 1.67 109.878 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.532 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 9.4 Cg_endo -51.81 132.58 42.39 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.832 2.355 . . . . 2.12 110.944 175.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.489 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -64.1 88.4 0.05 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.641 -0.708 . . . . 2.28 110.371 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.5 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 42.8 mmt180 -68.09 111.28 4.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.993 -1.003 . . . . 3.98 110.939 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 12.8 p -77.88 130.75 37.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.045 -0.525 . . . . 3.37 109.882 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 84.63 4.54 87.47 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.607 -0.806 . . . . 3.34 111.228 -173.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 1.6 t -118.66 144.18 27.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.371 0.605 . . . . 2.87 110.041 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 10.9 p -93.8 173.22 7.79 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.378 -0.828 . . . . 2.83 109.265 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 44.9 t -50.47 -33.81 11.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 109.512 -0.551 . . . . 1.92 109.512 171.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.613 ' O ' ' HG3' ' A' ' 182' ' ' LYS . 12.1 tpt180 -48.98 -62.68 1.39 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.404 -0.816 . . . . 4.27 112.934 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.691 ' O ' ' HB2' ' A' ' 182' ' ' LYS . 10.6 t70 -75.78 -36.5 59.78 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.513 0.673 . . . . 2.87 111.493 -172.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.4 p -65.63 -49.93 66.88 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.669 0.747 . . . . 1.99 110.105 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.6 mm? -68.71 -22.23 64.36 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.303 -0.862 . . . . 1.34 111.601 175.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.691 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 23.1 mtpt -48.52 -51.12 28.98 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.311 -0.625 . . . . 3.08 109.311 171.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' A' ' 187' ' ' MET . 24.7 tttp -59.88 -51.44 69.68 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.655 -0.418 . . . . 2.75 110.729 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.618 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.75 -49.23 63.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.741 -0.663 . . . . 1.43 112.132 -174.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.72 -47.4 54.17 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.106 -0.497 . . . . 1.7 111.076 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -59.19 -27.72 65.97 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.391 0.515 . . . . 2.29 112.391 -177.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.498 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 42.3 mtm -73.14 -32.91 65.19 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.71 -0.396 . . . . 2.5 110.352 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.468 ' CG ' ' HG ' ' A' ' 161' ' ' LEU . 14.2 mmm180 -74.77 -22.6 58.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.214 0.531 . . . . 4.43 110.76 171.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.51 12.84 37.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.661 -0.7 . . . . 2.31 111.401 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.4 mp -106.28 176.78 5.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.798 0.332 . . . . 2.37 110.54 -176.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.493 HD11 ' SG ' ' A' ' 194' ' ' CYS . 46.2 pt -124.97 144.49 47.2 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 121.09 0.472 . . . . 2.42 110.514 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.27 -3.8 12.43 Favored 'Trans proline' 0 CA--C 1.527 0.151 0 C-N-CA 123.352 2.701 . . . . 1.84 112.796 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -86.2 -28.12 24.08 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.094 -0.503 . . . . 3.32 110.773 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.493 ' SG ' HD11 ' A' ' 191' ' ' ILE . 74.6 m -111.66 18.98 18.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.249 -0.432 . . . . 2.85 111.267 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 68.9 m -131.35 163.8 27.06 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.547 -0.538 . . . . 1.74 109.547 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.595 ' HB2' ' CD2' ' A' ' 227' ' ' LEU . . . -129.65 146.27 51.45 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 111.24 0.089 . . . . 1.73 111.24 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.696 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -111.21 130.67 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.449 1.119 . . . . 1.38 111.421 178.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -123.69 164.99 18.0 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.489 -1.687 . . . . 2.99 109.82 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 199' ' ' ARG . 2.8 ptm180 -147.2 133.44 19.46 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 109.108 -0.701 . . . . 2.64 109.108 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -83.91 118.57 31.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.255 0.55 . . . . 2.6 110.524 -174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.428 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.6 tt0 -101.45 -140.86 0.34 Allowed 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.585 -1.265 . . . . 3.22 107.585 177.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -56.15 81.43 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.552 0.575 . . . . 4.02 112.552 -176.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 62.62 7.65 16.38 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 116.163 -0.471 . . . . 3.47 113.06 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 12.7 pt-20 -131.1 -179.39 5.31 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 117.346 0.573 . . . . 3.48 111.324 -174.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.624 ' HG2' HD11 ' A' ' 200' ' ' ILE . 27.8 mtpt -114.05 138.08 50.87 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.502 -0.772 . . . . 2.75 110.611 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -117.69 111.22 39.64 Favored Pre-proline 0 C--N 1.315 -0.923 0 CA-C-N 115.376 -0.829 . . . . 3.25 109.619 176.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.73 121.71 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.85 1.7 . . . . 2.47 111.462 175.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.696 HD12 HG23 ' A' ' 197' ' ' VAL . 13.2 mt -93.75 158.94 2.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 115.494 -0.776 . . . . 1.91 111.361 -171.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.417 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.22 144.23 17.0 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 2.25 110.935 176.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 177' ' ' VAL . 92.8 m95 -72.77 -14.88 61.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 111.955 0.354 . . . . 2.3 111.955 -174.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -98.72 20.26 13.33 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.423 0.63 . . . . 3.79 110.397 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.416 ' CG2' HD11 ' A' ' 217' ' ' LEU . 27.8 m -85.26 127.07 34.18 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.367 -0.833 . . . . 2.44 109.874 176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -63.31 109.18 1.49 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.267 -0.424 . . . . 3.47 109.857 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.551 ' HA ' HD13 ' A' ' 217' ' ' LEU . 6.7 tt -67.23 -14.35 18.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.092 -0.504 . . . . 1.95 112.247 -170.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.489 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 22.7 t -69.27 -13.81 62.6 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.051 -0.406 . . . . 2.91 110.673 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 31.7 t90 -90.35 -14.07 33.84 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 121.44 0.638 . . . . 4.8 110.271 176.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.551 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.5 mp -101.74 17.88 21.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.908 -0.587 . . . . 2.13 111.645 -176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.8 m -60.51 153.51 23.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.906 0.384 . . . . 2.03 111.074 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.29 -29.17 1.68 Allowed Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.982 -0.554 . . . . 2.12 113.911 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.3 mm-40 -70.2 164.13 24.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.15 0.5 . . . . 2.61 111.351 -174.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 36.3 mt-10 -112.85 118.71 35.68 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.037 -0.727 . . . . 3.06 109.037 170.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.414 HD12 HG22 ' A' ' 159' ' ' VAL . 32.3 mt -95.91 160.18 14.6 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.127 -0.942 . . . . 1.3 110.16 -176.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -132.72 117.86 18.36 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.315 -0.624 . . . . 3.31 109.315 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.538 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 64.9 t -101.72 134.25 42.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.724 0.774 . . . . 1.58 111.355 -176.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 114.298 -1.319 . . . . 2.74 107.712 178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.527 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 97.2 t -114.05 133.39 60.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 C-N-CA 121.056 -0.258 . . . . 2.61 110.608 173.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.595 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 4.0 mm? -77.05 81.98 3.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.467 -0.568 . . . . 2.86 109.467 174.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -72.77 97.2 2.17 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.073 0.463 . . . . 4.27 109.794 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -83.34 64.3 7.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.527 0.68 . . . . 6.02 110.25 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 4.7 m -59.52 135.25 88.98 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 114.84 -1.073 . . . . 6.23 110.446 175.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 10.5 Cg_exo -70.52 86.79 0.67 Allowed 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.67 2.247 . . . . 8.56 112.156 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.3 mt . . . . . 0 C--O 1.245 0.851 0 CA-C-O 118.558 -0.734 . . . . 10.1 109.662 178.194 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.511 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 110.072 -0.344 . . . . 7.11 110.072 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -50.12 131.67 31.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.236 2.624 . . . . 5.39 112.955 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 153' ' ' GLN . 14.9 mm-40 -103.1 99.61 9.49 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.991 -0.549 . . . . 4.84 110.828 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -103.9 106.75 54.31 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.634 -0.712 . . . . 4.47 109.526 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.5 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 93.8 Cg_endo -77.04 129.36 10.5 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.578 2.185 . . . . 2.69 112.131 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -132.04 161.93 40.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.889 0.376 . . . . 2.15 111.596 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.557 HG21 HD23 ' A' ' 217' ' ' LEU . 47.1 t -132.44 125.02 52.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.923 -0.769 . . . . 1.67 108.923 173.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 168' ' ' VAL . 77.5 mtm-85 -87.45 104.98 16.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.307 0.575 . . . . 3.61 110.391 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.9 t -93.3 114.97 31.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.317 -0.856 . . . . 1.4 111.476 -175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -77.58 103.62 7.62 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.534 0.683 . . . . 2.54 109.583 175.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.86 HD11 ' HB ' ' A' ' 167' ' ' THR . 2.3 mt -72.09 168.25 24.63 Favored Pre-proline 0 C--N 1.313 -0.998 0 CA-C-N 114.568 -1.197 . . . . 2.07 110.975 -175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.42 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 71.1 Cg_exo -52.68 156.11 9.43 Favored 'Trans proline' 0 C--O 1.237 0.425 0 C-N-CA 122.393 2.062 . . . . 2.27 111.299 169.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.42 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 18.4 m120 70.29 19.81 6.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.147 0.499 . . . . 3.47 110.479 -175.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt 58.75 31.26 21.01 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.242 -0.89 . . . . 4.66 112.493 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -91.4 179.21 5.74 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.844 -0.799 . . . . 3.57 108.844 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -148.02 129.84 15.2 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 118.418 0.554 . . . . 3.54 111.689 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.86 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -121.04 137.62 54.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.572 -0.899 . . . . 1.91 108.572 172.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 158' ' ' ARG . 6.1 t -92.84 144.42 9.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 109.093 -0.706 . . . . 2.31 109.093 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 13.4 p -139.89 130.89 14.35 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 108.713 -0.847 . . . . 1.67 108.713 174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 5.7 Cg_endo -50.02 135.8 36.93 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.687 2.258 . . . . 2.12 111.757 177.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.654 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -68.06 82.37 0.22 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.764 -0.653 . . . . 2.28 109.427 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.58 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 41.0 mmt180 -64.47 111.12 2.54 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.878 -1.056 . . . . 3.98 111.291 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.1 p -83.32 125.17 31.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.803 -0.635 . . . . 3.37 109.95 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.14 2.12 71.58 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.496 -1.041 . . . . 3.34 110.496 -174.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.58 ' HB ' ' CB ' ' A' ' 172' ' ' ARG . 88.5 t -118.71 152.16 20.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 114.852 -0.674 . . . . 2.87 109.451 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 33.8 p -97.09 163.76 12.8 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.671 -0.492 . . . . 2.83 109.671 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 18.7 t -52.17 -32.18 15.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.548 -0.538 . . . . 1.92 109.548 172.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.4 tpt180 -53.05 -53.56 48.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.371 -0.831 . . . . 4.27 112.454 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 2.0 t70 -74.53 -43.15 57.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.516 0.674 . . . . 2.87 110.669 -174.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 214' ' ' ILE . 41.1 m -67.2 -49.85 63.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.359 -0.837 . . . . 1.99 111.318 -176.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.619 HD21 HG21 ' A' ' 224' ' ' VAL . 0.0 OUTLIER -68.02 -23.67 65.02 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 111.98 0.363 . . . . 1.34 111.98 173.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.07 -43.21 77.77 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 109.057 -0.72 . . . . 3.08 109.057 176.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.525 ' O ' ' HG3' ' A' ' 187' ' ' MET . 23.1 tttp -63.28 -48.44 78.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.701 -0.681 . . . . 2.75 110.079 173.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -52.54 -50.31 63.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.501 -0.772 . . . . 1.43 111.82 -177.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 181' ' ' LEU . 0.5 OUTLIER -67.87 -52.57 35.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.391 -0.368 . . . . 1.7 110.633 178.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -29.44 62.94 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.796 0.665 . . . . 2.29 112.796 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.525 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 45.6 mtm -69.42 -40.77 77.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.646 -0.422 . . . . 2.5 109.877 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.505 ' CG ' HD13 ' A' ' 161' ' ' LEU . 2.2 mmp_? -74.83 -20.55 59.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.879 -0.6 . . . . 4.43 111.025 177.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 103.55 15.55 22.57 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 121.041 -0.599 . . . . 2.31 111.752 -176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.408 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 9.2 mp -104.53 177.43 4.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.611 -0.294 . . . . 2.37 110.267 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.443 HD12 ' HB2' ' A' ' 193' ' ' GLU . 12.8 pt -133.42 145.74 57.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 121.209 0.528 . . . . 2.42 110.606 176.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.71 -9.87 12.66 Favored 'Trans proline' 0 N--CA 1.472 0.256 0 C-N-CA 124.015 3.143 . . . . 1.84 113.531 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.443 ' HB2' HD12 ' A' ' 191' ' ' ILE . 27.2 mt-10 -83.41 -25.72 31.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.846 0.355 . . . . 3.32 110.541 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 69.7 m -112.14 36.25 3.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.504 . . . . 2.85 111.412 -177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.504 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 89.6 m -152.96 162.74 40.95 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.143 -0.481 . . . . 1.74 109.876 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 227' ' ' LEU . . . -129.8 149.62 51.47 Favored 'General case' 0 C--O 1.215 -0.751 0 N-CA-C 110.452 -0.203 . . . . 1.73 110.452 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.659 HG12 HD12 ' A' ' 208' ' ' ILE . 55.6 t -108.1 127.96 63.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.791 -0.764 . . . . 1.38 111.307 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -129.43 168.94 15.58 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.425 -1.261 . . . . 2.99 109.946 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.427 ' HG2' HD11 ' A' ' 208' ' ' ILE . 11.7 ptm180 -147.17 132.76 18.77 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.852 -0.613 . . . . 2.64 109.695 170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.659 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.1 mp -90.46 123.18 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.388 0.613 . . . . 2.6 110.44 -175.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.512 ' HB3' ' H ' ' A' ' 202' ' ' ASP . 21.8 mt-30 -106.08 -146.79 0.39 Allowed 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.294 -0.867 . . . . 3.22 109.094 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.512 ' H ' ' HB3' ' A' ' 201' ' ' GLN . 39.0 t70 -49.12 82.03 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.579 0.751 . . . . 4.02 112.812 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.85 9.02 11.64 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 116.246 -0.434 . . . . 3.47 113.303 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -128.56 -178.34 4.54 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 117.364 0.582 . . . . 3.48 111.923 -174.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.659 ' HG2' HD11 ' A' ' 200' ' ' ILE . 40.8 mtpt -122.47 142.11 50.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.251 -0.886 . . . . 2.75 110.692 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.442 ' HG3' ' OE1' ' A' ' 201' ' ' GLN . 70.8 mmtt -125.31 113.29 25.91 Favored Pre-proline 0 C--N 1.314 -0.977 0 CA-C-N 115.56 -0.746 . . . . 3.25 109.334 175.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.67 131.92 19.42 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.252 1.968 . . . . 2.47 112.025 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.659 HD12 HG12 ' A' ' 197' ' ' VAL . 42.9 mt -103.46 154.8 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.42 -0.809 . . . . 1.91 111.476 -173.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.62 148.84 19.15 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 111.128 -0.789 . . . . 2.25 111.128 178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.537 ' O ' ' HB ' ' A' ' 176' ' ' THR . 94.9 m95 -77.78 -15.09 59.35 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 122.575 -0.368 . . . . 2.3 111.946 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -93.75 3.75 54.97 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.231 0.538 . . . . 3.79 110.641 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.41 ' O ' HG23 ' A' ' 177' ' ' VAL . 67.8 m -73.83 130.45 39.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.444 -0.798 . . . . 2.44 110.509 -177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 216' ' ' TRP . 16.6 t70 -60.81 114.17 2.9 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.37 -0.604 . . . . 3.47 109.37 175.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.658 ' O ' HG12 ' A' ' 214' ' ' ILE . 2.8 tt -77.35 2.41 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 121.36 0.6 . . . . 1.95 112.136 -170.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.654 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 35.5 t -76.2 -7.23 54.37 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.255 -0.903 . . . . 2.91 109.148 170.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.812 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.9 OUTLIER -65.27 -57.54 8.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.254 -0.885 . . . . 4.8 111.202 178.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.812 HD13 ' HB3' ' A' ' 216' ' ' TRP . 0.0 OUTLIER -88.33 31.07 0.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.968 0.729 . . . . 2.13 112.968 -172.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.1 m -57.36 146.69 28.2 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.353 0.597 . . . . 2.03 111.111 174.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 67.75 6.15 42.1 Favored Glycine 0 C--N 1.318 -0.458 0 CA-C-N 115.149 -0.932 . . . . 2.12 113.361 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -115.22 165.51 12.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.886 0.343 . . . . 2.61 110.486 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.412 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -112.38 126.61 55.46 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.298 0.571 . . . . 3.06 110.508 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.414 HD21 ' HG ' ' A' ' 217' ' ' LEU . 29.2 mt -96.45 166.8 11.52 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.409 -0.814 . . . . 1.3 110.866 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -137.23 123.41 20.47 Favored 'General case' 0 C--O 1.221 -0.424 0 N-CA-C 109.373 -0.603 . . . . 3.31 109.373 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.619 HG21 HD21 ' A' ' 181' ' ' LEU . 52.2 t -106.05 140.04 25.42 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-O 121.283 0.564 . . . . 1.58 110.924 -177.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -109.33 174.47 5.85 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 107.797 -1.186 . . . . 2.74 107.797 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 4.1 t -100.0 110.03 26.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.096 0.474 . . . . 2.61 109.851 172.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.627 ' HB3' ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -137.22 119.28 15.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 108.026 -1.102 . . . . 2.86 108.026 -176.739 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.47 ' N ' HD22 ' A' ' 227' ' ' LEU . 39.3 mt-10 -92.14 104.9 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.017 -0.538 . . . . 4.27 111.334 -173.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -87.73 59.74 5.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.064 0.935 . . . . 6.02 109.303 174.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.489 ' N ' ' HD3' ' A' ' 231' ' ' PRO . 1.5 m -86.06 -29.53 0.41 Allowed Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 114.601 -1.181 . . . . 6.23 113.589 178.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 230' ' ' VAL . 10.0 Cg_endo -90.32 14.13 2.12 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 121.824 1.682 . . . . 8.56 112.005 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 84.6 mt . . . . . 0 C--O 1.246 0.894 0 CA-C-O 118.197 -0.906 . . . . 10.1 111.168 -179.191 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.524 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.476 0.852 0 CA-C-O 120.664 0.269 . . . . 7.11 110.628 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -64.42 96.46 0.24 Allowed 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 123.238 2.625 . . . . 5.39 111.953 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -122.62 133.61 54.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.011 -0.54 . . . . 4.84 110.768 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -124.78 101.18 33.26 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-O 121.47 0.653 . . . . 4.47 109.546 176.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.2 Cg_endo -87.26 136.31 4.0 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 123.529 2.819 . . . . 2.69 111.711 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.6 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.0 pp -142.07 144.55 25.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.739 0.304 . . . . 2.15 110.602 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.9 t -110.66 119.55 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.851 -0.796 . . . . 1.67 108.851 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.579 ' HG2' ' CG1' ' A' ' 168' ' ' VAL . 8.0 mtp85 -87.88 104.19 16.37 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.447 0.641 . . . . 3.61 111.365 -175.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.44 HG22 ' HB2' ' A' ' 222' ' ' LEU . 85.2 t -88.74 138.94 18.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-N 115.199 -0.91 . . . . 1.4 111.133 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 5.4 m-85 -96.95 104.84 16.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.532 0.682 . . . . 2.54 109.891 171.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.65 HD11 ' HB ' ' A' ' 167' ' ' THR . 15.3 mt -64.69 160.16 55.7 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 114.596 -1.184 . . . . 2.07 110.778 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.98 154.11 13.97 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.539 2.16 . . . . 2.27 112.441 175.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.2 t30 69.33 30.51 4.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.659 -0.701 . . . . 3.47 110.43 -176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm 55.56 47.85 19.97 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.11 -0.95 . . . . 4.66 112.716 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.425 HE21 ' HB2' ' A' ' 165' ' ' GLN . 0.9 OUTLIER -109.08 178.17 4.54 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.643 -0.873 . . . . 3.57 108.643 174.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 31.5 ptt180 -148.44 134.82 19.54 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.563 0.697 . . . . 3.54 112.61 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.65 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.7 OUTLIER -134.58 132.62 39.29 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.712 -1.131 . . . . 1.91 108.794 173.178 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.579 ' CG1' ' HG2' ' A' ' 158' ' ' ARG . 0.8 OUTLIER -95.08 150.31 4.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.284 -0.635 . . . . 2.31 109.284 179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.77 126.81 14.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.54 -0.541 . . . . 1.67 109.54 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.6 ' HA ' HG22 ' A' ' 156' ' ' ILE . 5.4 Cg_endo -49.71 134.27 33.82 Favored 'Trans proline' 0 CA--C 1.515 -0.462 0 C-N-CA 123.207 2.605 . . . . 2.12 112.211 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.567 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -62.72 95.19 0.07 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.326 -0.852 . . . . 2.28 109.748 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.524 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 40.1 mmt180 -76.17 110.73 10.9 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.986 -1.006 . . . . 3.98 110.391 -176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 2.1 p -81.82 117.77 22.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.925 -0.58 . . . . 3.37 110.834 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 91.39 19.61 41.14 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.755 -0.938 . . . . 3.34 110.755 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.615 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 81.4 t -131.07 148.19 33.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.396 -0.402 . . . . 2.87 110.271 -176.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.9 p -84.83 157.55 20.91 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.413 -0.958 . . . . 2.83 108.413 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.752 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 14.6 p -59.51 -22.42 23.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 108.817 -0.809 . . . . 1.92 108.817 171.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 7.9 tpt180 -57.51 -51.64 68.65 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.915 -0.584 . . . . 4.27 112.408 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.615 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 11.0 t70 -69.42 -49.93 50.48 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.81 0.814 . . . . 2.87 110.412 -176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.1 p -61.1 -53.89 51.47 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.334 -1.303 . . . . 1.99 110.677 -176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.752 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.1 mm? -69.43 -20.17 63.78 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 115.7 -0.682 . . . . 1.34 112.237 178.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -56.9 -44.8 82.71 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.23 -0.656 . . . . 3.08 109.23 173.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -63.07 -49.87 72.82 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 120.609 -0.436 . . . . 2.75 110.226 174.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.541 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.4 -52.48 45.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.264 -0.88 . . . . 1.43 111.373 -177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.703 HD21 ' SG ' ' A' ' 195' ' ' CYS . 8.5 tp -71.1 -35.94 72.0 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.359 -0.837 . . . . 1.7 110.711 -175.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -67.07 -20.71 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 2.29 111.722 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.4 ' SD ' ' C17' ' A' ' 301' ' ' 6FS . 38.9 mtt -64.76 -44.03 91.36 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 108.697 -0.853 . . . . 2.5 108.697 175.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.503 ' HG2' HD13 ' A' ' 161' ' ' LEU . 11.1 mmm180 -69.49 -24.72 63.81 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.389 -1.278 . . . . 4.43 110.454 174.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.32 19.13 26.56 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.595 -0.73 . . . . 2.31 111.572 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.521 ' HB2' ' HG ' ' A' ' 185' ' ' LEU . 11.3 mp -105.6 171.08 7.52 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.191 -0.3 . . . . 2.37 110.191 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.497 ' C ' HD23 ' A' ' 185' ' ' LEU . 34.9 pt -123.66 135.24 25.95 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-O 121.237 0.541 . . . . 2.42 111.774 -175.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.71 -3.75 7.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.784 2.989 . . . . 1.84 113.518 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -74.59 -38.12 62.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.857 0.36 . . . . 3.32 110.605 178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 31.6 t -110.02 14.7 22.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.302 -0.408 . . . . 2.85 111.7 -175.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.703 ' SG ' HD21 ' A' ' 185' ' ' LEU . 35.3 m -127.84 169.26 14.11 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 121.905 -0.497 . . . . 1.74 110.358 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.702 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -139.46 149.46 44.04 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 111.75 0.278 . . . . 1.73 111.75 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.628 HG23 ' HB ' ' A' ' 208' ' ' ILE . 1.9 m -110.85 134.36 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 CA-C-O 122.423 1.106 . . . . 1.38 111.582 178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CE2' ' HG3' ' A' ' 225' ' ' GLU . 13.1 m-85 -122.63 173.18 7.87 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.671 -1.604 . . . . 2.99 109.525 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.448 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 12.4 ptm180 -151.48 127.86 10.65 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.735 -0.666 . . . . 2.64 109.651 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.728 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -84.53 122.72 38.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.517 0.675 . . . . 2.6 109.84 -177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 203' ' ' GLY . 31.9 tt0 -111.19 -136.5 0.37 Allowed 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 107.807 -1.182 . . . . 3.22 107.807 177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -52.94 80.65 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.616 0.766 . . . . 4.02 112.882 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 6.45 7.39 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 116.018 -0.537 . . . . 3.47 113.474 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 10.5 pt-20 -137.07 -179.25 5.6 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 117.776 0.788 . . . . 3.48 111.991 -172.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.728 ' HG2' HD11 ' A' ' 200' ' ' ILE . 43.0 mtpt -112.16 139.83 47.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.304 -0.862 . . . . 2.75 111.098 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -122.75 110.57 31.65 Favored Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.259 -0.882 . . . . 3.25 109.483 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.51 131.38 18.7 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.035 1.823 . . . . 2.47 112.028 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.628 ' HB ' HG23 ' A' ' 197' ' ' VAL . 17.0 mt -103.12 160.78 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.154 -0.475 . . . . 1.91 111.525 -174.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.16 144.61 17.36 Favored Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 110.953 -0.859 . . . . 2.25 110.953 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.415 ' HA ' ' CG1' ' A' ' 177' ' ' VAL . 73.2 m95 -66.19 -13.75 60.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.357 0.873 . . . . 2.3 113.357 -172.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -103.3 11.51 36.66 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 122.04 -0.412 . . . . 3.79 111.313 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 32.9 m -73.06 122.0 21.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.829 -0.623 . . . . 2.44 109.474 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 175' ' ' VAL . 9.9 t0 -60.99 117.27 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.256 -0.646 . . . . 3.47 109.256 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.531 ' HA ' HD13 ' A' ' 217' ' ' LEU . 4.4 tt -68.82 -15.17 19.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.823 -0.626 . . . . 1.95 112.41 -170.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.567 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 95.1 p -71.4 -10.73 60.24 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 121.781 -0.574 . . . . 2.91 111.702 -176.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -90.13 -11.68 40.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.313 0.577 . . . . 4.8 110.216 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.531 HD13 ' HA ' ' A' ' 214' ' ' ILE . 6.3 mp -102.02 11.85 37.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.579 -0.737 . . . . 2.13 111.709 -174.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.447 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.7 m -56.7 153.24 10.86 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.283 0.563 . . . . 2.03 111.607 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.03 -19.57 5.25 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.511 -0.768 . . . . 2.12 113.12 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.26 151.89 19.53 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.109 0.481 . . . . 2.61 111.131 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 53.0 mt-10 -100.0 126.04 46.12 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.92 -0.77 . . . . 3.06 108.92 170.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 199' ' ' ARG . 35.9 mt -94.46 167.3 11.59 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.667 -0.697 . . . . 1.3 110.206 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.408 ' CD2' HD13 ' A' ' 200' ' ' ILE . 83.8 m-70 -140.18 122.46 15.92 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.357 -0.608 . . . . 3.31 109.357 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.62 135.78 36.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.456 0.646 . . . . 1.58 111.407 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.44 ' HG3' ' CE2' ' A' ' 198' ' ' TYR . 2.1 mm-40 -108.85 167.99 9.68 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 107.209 -1.404 . . . . 2.74 107.209 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 21.7 t -113.56 112.09 38.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 C-N-CA 120.308 -0.557 . . . . 2.61 110.211 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.702 HD11 ' HB2' ' A' ' 196' ' ' ALA . 9.4 mt -74.41 81.72 1.91 Allowed 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.103 -0.499 . . . . 2.86 110.673 -179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.421 ' HG3' HG12 ' A' ' 226' ' ' VAL . 43.6 mt-10 -96.58 97.11 9.13 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.391 -0.596 . . . . 4.27 109.391 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -87.64 55.34 3.46 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.641 0.734 . . . . 6.02 110.466 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 18.4 m -67.99 152.81 96.13 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 114.709 -1.132 . . . . 6.23 110.601 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -51.09 -60.67 0.73 Allowed 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.631 2.22 . . . . 8.56 112.03 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 54.0 tp . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.835 -0.602 . . . . 10.1 109.768 178.646 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.523 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.9 p . . . . . 0 N--CA 1.476 0.867 0 CA-C-O 120.576 0.227 . . . . 7.11 110.565 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.19 143.79 99.51 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.52 2.146 . . . . 5.39 110.99 174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -77.38 98.96 5.41 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.939 0.4 . . . . 4.84 110.316 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 24.8 tptm -100.9 110.16 60.12 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.812 -0.631 . . . . 4.47 109.888 -177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.75 128.74 12.79 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.499 2.133 . . . . 2.69 112.222 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.599 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.29 163.13 32.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.855 0.359 . . . . 2.15 111.062 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 218' ' ' THR . 35.3 t -126.93 122.8 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 109.337 -0.616 . . . . 1.67 109.337 171.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.473 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 91.4 mtt180 -80.6 106.12 12.37 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.812 -0.44 . . . . 3.61 109.812 177.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 53.1 t -95.62 107.78 20.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-N 115.836 -0.62 . . . . 1.4 110.959 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.548 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 3.8 m-85 -71.63 103.23 2.97 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.807 0.813 . . . . 2.54 110.438 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.4 mt -63.61 159.73 49.68 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 114.241 -1.345 . . . . 2.07 111.051 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.64 148.25 21.67 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.487 2.125 . . . . 2.27 111.825 174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.4 ' C ' ' HD3' ' A' ' 164' ' ' LYS . 15.0 m120 69.95 36.06 2.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.505 0.669 . . . . 3.47 110.755 -176.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.486 ' HB2' ' HE3' ' A' ' 164' ' ' LYS . 0.0 OUTLIER 58.49 33.27 22.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.397 -1.274 . . . . 4.66 113.281 169.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -98.35 -179.99 4.54 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.0 -0.741 . . . . 3.57 109.0 173.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 40.1 ptt180 -149.93 132.96 16.2 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.961 0.41 . . . . 3.54 112.011 174.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.63 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -121.56 136.92 54.92 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 108.637 -0.875 . . . . 1.91 108.637 170.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.49 HG12 ' HB ' ' A' ' 156' ' ' ILE . 2.9 t -92.6 141.18 15.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 109.324 -0.621 . . . . 2.31 109.324 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 14.8 p -134.95 123.51 15.95 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.425 -0.583 . . . . 1.67 109.425 175.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.599 ' HA ' HG22 ' A' ' 156' ' ' ILE . 10.5 Cg_endo -51.17 138.51 44.78 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 123.348 2.699 . . . . 2.12 111.675 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.578 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -65.3 87.98 0.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.507 -0.77 . . . . 2.28 110.324 -177.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.513 ' CB ' ' HB ' ' A' ' 175' ' ' VAL . 37.3 mmt180 -66.82 113.04 4.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.527 -1.215 . . . . 3.98 111.542 -175.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 215' ' ' SER . 20.7 p -76.34 131.23 39.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.121 -0.491 . . . . 3.37 110.651 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.61 20.27 79.8 Favored Glycine 0 N--CA 1.449 -0.463 0 N-CA-C 111.052 -0.819 . . . . 3.34 111.052 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 89.0 t -129.06 144.95 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 109.661 -0.496 . . . . 2.87 109.661 -176.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.8 p -93.3 170.81 9.34 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.074 -0.713 . . . . 2.83 109.074 -176.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.737 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.2 m -60.83 -21.31 23.66 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.785 0 N-CA-C 108.995 -0.743 . . . . 1.92 108.995 174.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.413 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 23.9 tpp180 -53.04 -61.22 2.43 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.013 -0.54 . . . . 4.27 111.883 177.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.641 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 10.3 t70 -66.38 -48.12 71.17 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.722 0.773 . . . . 2.87 110.786 -177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.49 ' OG ' ' HA ' ' A' ' 177' ' ' VAL . 3.5 p -61.57 -53.13 60.32 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.908 -1.042 . . . . 1.99 110.658 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.737 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.3 OUTLIER -65.94 -24.98 66.93 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.669 -0.696 . . . . 1.34 112.101 175.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -55.47 -40.34 71.52 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.679 -0.489 . . . . 3.08 109.679 178.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 187' ' ' MET . 38.1 tttp -68.7 -46.2 69.61 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.322 -0.551 . . . . 2.75 109.945 173.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.593 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.7 -55.9 16.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.653 -0.703 . . . . 1.43 111.945 -177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -49.08 75.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 1.7 111.227 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -23.38 66.11 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.356 0.502 . . . . 2.29 112.356 -175.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 44.1 mtm -76.06 -31.45 58.8 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.613 -0.435 . . . . 2.5 110.505 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.594 ' CD ' HD13 ' A' ' 161' ' ' LEU . 12.0 mmm180 -72.99 -25.72 61.09 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.187 0.518 . . . . 4.43 110.478 168.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 100.75 16.56 25.96 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.374 -0.83 . . . . 2.31 111.063 -173.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.423 HD13 ' HB3' ' A' ' 188' ' ' ARG . 10.6 mp -105.33 172.35 6.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.873 0.368 . . . . 2.37 110.246 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 47.7 pt -118.46 140.52 28.34 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 2.42 110.291 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.12 -4.22 12.19 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.049 2.5 . . . . 1.84 112.7 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -73.99 -47.29 38.26 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.112 0.482 . . . . 3.32 110.578 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 86.0 m -102.01 37.74 1.79 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.902 -0.59 . . . . 2.85 111.113 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 72.7 m -143.31 162.67 35.07 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.379 -0.6 . . . . 1.74 109.379 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.551 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -133.73 156.68 47.52 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 120.444 0.164 . . . . 1.73 111.274 -177.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.564 HG12 HD12 ' A' ' 208' ' ' ILE . 35.9 t -113.81 126.66 71.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.769 0.795 . . . . 1.38 111.258 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -129.13 161.84 29.14 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.499 -1.228 . . . . 2.99 109.547 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -145.84 154.93 42.54 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.645 -0.502 . . . . 2.64 109.645 168.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.779 ' CD1' ' HG2' ' A' ' 205' ' ' LYS . 40.2 mm -104.54 129.31 57.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.104 0.478 . . . . 2.6 110.81 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 32.5 tt0 -113.34 -138.96 0.38 Allowed 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.089 -1.078 . . . . 3.22 108.089 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' H ' ' HG2' ' A' ' 201' ' ' GLN . 14.3 t70 -56.3 78.76 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.471 0.708 . . . . 4.02 112.248 -176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.11 11.12 17.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.397 -0.43 . . . . 3.47 112.309 -178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.78 178.63 6.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.281 0.562 . . . . 3.48 111.296 -171.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.779 ' HG2' ' CD1' ' A' ' 200' ' ' ILE . 54.7 mtpt -118.78 139.5 51.48 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.159 -0.928 . . . . 2.75 111.17 -176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -120.84 108.86 36.42 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 114.789 -1.096 . . . . 3.25 108.513 174.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.32 128.91 15.2 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.615 1.543 . . . . 2.47 110.967 175.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.564 HD12 HG12 ' A' ' 197' ' ' VAL . 20.5 mt -99.49 153.66 4.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.725 -0.671 . . . . 1.91 111.381 -172.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -96.3 147.5 18.67 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.215 -0.754 . . . . 2.25 111.215 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.704 ' HA ' HG22 ' A' ' 177' ' ' VAL . 85.8 m95 -74.28 -13.75 60.81 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.016 0.376 . . . . 2.3 112.016 -174.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -106.88 20.42 19.05 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 121.197 0.523 . . . . 3.79 110.339 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 54.7 m -83.77 128.49 34.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.489 -0.778 . . . . 2.44 109.942 176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -65.15 114.43 4.65 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.531 -0.544 . . . . 3.47 109.531 177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.418 ' O ' HG12 ' A' ' 214' ' ' ILE . 6.1 tt -71.27 -15.16 18.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.066 -0.515 . . . . 1.95 111.948 -171.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.578 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 91.8 p -73.07 -8.96 58.1 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.064 -0.654 . . . . 2.91 111.075 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -88.8 -26.15 21.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.341 0.591 . . . . 4.8 110.084 175.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.44 ' N ' HD12 ' A' ' 217' ' ' LEU . 7.0 mp -91.58 18.43 7.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.395 -0.82 . . . . 2.13 112.293 -174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 1.4 m -59.47 153.27 19.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.168 0.508 . . . . 2.03 111.353 175.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.31 -23.66 5.3 Favored Glycine 0 N--CA 1.452 -0.297 0 CA-C-N 115.718 -0.673 . . . . 2.12 112.933 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -81.34 145.9 30.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.937 0.399 . . . . 2.61 110.951 -175.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 50.2 mt-10 -101.53 114.16 27.93 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.698 -0.853 . . . . 3.06 108.698 167.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 6.6 mp -95.64 171.73 8.49 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.32 -0.855 . . . . 1.3 109.441 -177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -148.53 134.15 18.78 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.898 -0.408 . . . . 3.31 109.898 174.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 196' ' ' ALA . 48.3 t -101.97 139.81 22.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.577 0.703 . . . . 1.58 111.103 -174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -107.84 169.27 8.71 Favored 'General case' 0 C--N 1.309 -1.196 0 N-CA-C 107.523 -1.288 . . . . 2.74 107.523 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 77.8 t -113.51 112.95 42.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 C-N-CA 120.601 -0.44 . . . . 2.61 110.817 176.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.551 HD11 ' HB2' ' A' ' 196' ' ' ALA . 9.4 mt -81.94 90.36 6.46 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.89 -0.782 . . . . 2.86 108.89 173.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -61.79 100.32 0.15 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.894 -0.593 . . . . 4.27 111.271 -175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -86.21 62.89 7.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.762 -0.654 . . . . 6.02 110.237 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 6.0 m -67.87 124.23 88.98 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.11 -0.95 . . . . 6.23 110.766 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 8.4 Cg_exo -72.82 94.62 0.79 Allowed 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.65 2.234 . . . . 8.56 111.305 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.601 HD23 ' H ' ' A' ' 232' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.806 -0.616 . . . . 10.1 110.21 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.648 ' O6 ' ' C21' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 120.766 0.317 . . . . 7.11 110.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -70.14 50.54 0.92 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.751 2.968 . . . . 5.39 112.271 176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -111.78 139.03 47.58 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.755 -0.657 . . . . 4.84 109.835 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -124.96 96.79 39.46 Favored Pre-proline 0 C--N 1.317 -0.811 0 N-CA-C 109.41 -0.589 . . . . 4.47 109.41 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.448 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 56.4 Cg_endo -68.43 127.94 16.48 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.158 1.905 . . . . 2.69 112.074 -176.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.635 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -138.58 165.5 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.989 -0.551 . . . . 2.15 110.195 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.487 HG13 ' O ' ' A' ' 220' ' ' GLU . 44.6 t -128.44 120.76 53.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.61 -0.515 . . . . 1.67 109.61 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.582 ' HG2' HG22 ' A' ' 168' ' ' VAL . 89.3 mtm180 -83.09 104.07 13.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.877 -0.601 . . . . 3.61 110.192 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 181' ' ' LEU . 60.1 t -95.66 119.7 44.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 115.169 -0.923 . . . . 1.4 111.337 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.475 ' O ' ' HA ' ' A' ' 223' ' ' HIS . 5.3 m-85 -79.05 102.8 8.58 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.656 0.741 . . . . 2.54 109.931 174.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.658 HD11 ' HB ' ' A' ' 167' ' ' THR . 14.3 mt -64.27 159.2 59.95 Favored Pre-proline 0 C--N 1.315 -0.892 0 CA-C-N 114.759 -1.109 . . . . 2.07 110.246 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 190' ' ' LEU . 41.5 Cg_exo -56.63 142.24 90.83 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.702 2.268 . . . . 2.27 111.18 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 64.6 t30 75.87 43.97 0.16 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 122.126 0.965 . . . . 3.47 110.424 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 164' ' ' LYS . 1.3 mppt? 53.01 32.5 12.94 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.743 -1.571 . . . . 4.66 113.378 169.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -101.12 173.7 6.34 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.933 -0.766 . . . . 3.57 108.933 174.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -148.47 137.73 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.166 0.508 . . . . 3.54 111.948 176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.658 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -130.54 139.24 50.47 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.035 -0.984 . . . . 1.91 108.958 174.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.582 HG22 ' HG2' ' A' ' 158' ' ' ARG . 2.9 t -95.22 142.57 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.265 -0.643 . . . . 2.31 109.265 177.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.425 ' HA ' ' HD2' ' A' ' 170' ' ' PRO . 7.1 p -138.19 125.64 13.63 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 109.332 -0.618 . . . . 1.67 109.332 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.635 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.8 Cg_endo -49.79 137.35 34.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 123.284 2.656 . . . . 2.12 112.252 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.753 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -67.72 85.3 0.2 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.338 -0.846 . . . . 2.28 109.889 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.452 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 23.6 mmm180 -71.13 112.18 7.07 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.055 -0.975 . . . . 3.98 111.694 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.445 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 31.6 m -72.29 131.8 43.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.742 -0.663 . . . . 3.37 110.323 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.05 12.15 84.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.814 -0.708 . . . . 3.34 111.351 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.52 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 67.6 t -118.49 150.0 20.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.115 0.483 . . . . 2.87 109.902 -178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.0 p -85.02 151.46 24.15 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 108.596 -0.89 . . . . 2.83 108.596 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.749 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 12.6 p -58.33 -22.65 20.37 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.484 -0.932 . . . . 1.92 108.484 170.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 182' ' ' LYS . 8.0 tpt180 -58.1 -50.62 72.83 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.959 -0.564 . . . . 4.27 112.044 174.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.646 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 7.7 t70 -67.23 -52.13 44.76 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 122.12 0.962 . . . . 2.87 110.152 -177.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.46 ' OG ' HG21 ' A' ' 214' ' ' ILE . 60.0 m -63.18 -45.63 90.89 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.446 -1.252 . . . . 1.99 111.132 -176.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.749 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 1.0 OUTLIER -75.71 -21.69 57.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 112.615 0.598 . . . . 1.34 112.615 178.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.646 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 9.6 pttt -60.3 -37.8 81.66 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 119.535 -0.866 . . . . 3.08 108.96 175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 187' ' ' MET . 15.5 tttp -63.15 -52.9 60.62 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 120.522 -0.471 . . . . 2.75 109.824 170.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.581 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -48.52 -53.92 16.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.572 -0.74 . . . . 1.43 111.673 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.555 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 79.6 mt -66.98 -51.06 59.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.694 -0.685 . . . . 1.7 111.151 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -23.23 67.26 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.878 0.696 . . . . 2.29 112.878 -174.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 41.8 mtm -64.61 -44.62 90.0 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 2.5 110.285 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.58 ' HB3' ' HG ' ' A' ' 190' ' ' LEU . 0.0 OUTLIER -71.18 -26.03 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 121.553 0.692 . . . . 4.43 111.331 171.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 104.38 21.45 9.33 Favored Glycine 0 C--N 1.314 -0.675 0 CA-C-N 114.744 -1.116 . . . . 2.31 111.163 -177.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 188' ' ' ARG . 26.1 mt -94.87 159.06 15.21 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.899 -0.651 . . . . 2.37 109.981 -176.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 193' ' ' GLU . 48.8 pt -120.28 135.39 24.43 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.153 0.501 . . . . 2.42 111.524 179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.2 -4.74 14.94 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.144 2.563 . . . . 1.84 112.474 177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.486 ' HB3' HD12 ' A' ' 191' ' ' ILE . 26.1 tt0 -61.22 -49.97 74.99 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 115.789 -0.641 . . . . 3.32 111.548 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.89 -1.22 22.59 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.066 -0.515 . . . . 2.85 111.286 -173.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 49.9 m -109.25 161.15 15.52 Favored 'General case' 0 C--N 1.32 -0.704 0 O-C-N 122.289 -0.257 . . . . 1.74 110.519 -177.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 227' ' ' LEU . . . -133.06 154.29 50.7 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 116.478 -0.328 . . . . 1.73 110.237 177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.635 HG23 ' HB ' ' A' ' 208' ' ' ILE . 2.2 m -104.49 135.78 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.24 1.019 . . . . 1.38 110.851 177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.66 ' CD2' ' HB3' ' A' ' 225' ' ' GLU . 9.2 m-85 -129.48 167.04 18.45 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 113.839 -1.528 . . . . 2.99 109.795 -176.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 206' ' ' LYS . 3.2 ptm180 -149.92 131.98 15.31 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.122 -0.49 . . . . 2.64 110.226 175.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.777 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -92.34 121.27 42.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.522 0.677 . . . . 2.6 110.375 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 203' ' ' GLY . 15.2 tt0 -103.76 -137.66 0.35 Allowed 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 107.976 -1.12 . . . . 3.22 107.976 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.81 80.17 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.392 0.515 . . . . 4.02 112.392 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 63.47 6.25 14.83 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 116.125 -0.489 . . . . 3.47 112.764 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.5 pt-20 -127.7 -179.52 4.98 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 117.318 0.559 . . . . 3.48 111.866 -172.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.777 ' HG2' HD11 ' A' ' 200' ' ' ILE . 51.8 mtpt -118.78 140.97 49.07 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.374 -0.83 . . . . 2.75 111.042 -176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.411 ' HB2' ' HG3' ' A' ' 199' ' ' ARG . 70.6 mmtt -124.93 113.6 26.71 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-N 115.152 -0.931 . . . . 3.25 108.652 174.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.457 ' HB3' ' CZ ' ' A' ' 198' ' ' TYR . 54.6 Cg_endo -76.71 127.94 9.85 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.891 1.727 . . . . 2.47 111.799 175.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 197' ' ' VAL . 8.5 mt -100.79 156.9 4.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.932 -0.576 . . . . 1.91 110.988 -174.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -94.78 146.85 18.36 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 111.139 -0.784 . . . . 2.25 111.139 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.432 ' CE3' ' HA ' ' A' ' 178' ' ' ARG . 67.1 m95 -66.09 -20.2 66.09 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.325 0.861 . . . . 2.3 113.325 -172.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -103.28 15.59 28.78 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.281 -0.567 . . . . 3.79 110.809 -178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 42.0 m -73.68 131.4 41.59 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.338 -0.846 . . . . 2.44 109.756 175.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 9.8 t70 -62.81 109.92 1.59 Allowed 'General case' 0 C--N 1.327 -0.398 0 O-C-N 123.363 0.414 . . . . 3.47 109.948 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.594 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.4 tt -64.4 -18.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.363 -0.381 . . . . 1.95 111.689 -174.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.753 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 38.2 t -69.42 -11.64 60.99 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.924 -0.31 . . . . 2.91 111.307 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -90.01 -25.56 20.78 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 122.106 -0.371 . . . . 4.8 110.525 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.594 HD23 ' HA ' ' A' ' 214' ' ' ILE . 1.4 mm? -87.6 16.93 5.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 111.928 0.344 . . . . 2.13 111.928 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 m -55.33 149.07 13.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.948 0.404 . . . . 2.03 110.095 171.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.9 -8.28 37.78 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 121.06 -0.59 . . . . 2.12 113.128 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 157' ' ' VAL . 52.3 mm-40 -101.67 137.99 39.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.816 0.308 . . . . 2.61 110.557 -177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 8.7 mp0 -90.24 118.78 30.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.873 -0.788 . . . . 3.06 108.873 170.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 4.9 mp -97.44 174.3 6.74 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 115.435 -0.802 . . . . 1.3 109.816 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' PHE . 5.9 p80 -156.11 149.89 25.05 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 107.671 -1.233 . . . . 3.31 107.671 172.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.488 HG13 ' O ' ' A' ' 196' ' ' ALA . 84.1 t -100.65 123.52 53.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 122.032 0.92 . . . . 1.58 111.106 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.66 ' HB3' ' CD2' ' A' ' 198' ' ' TYR . 0.0 OUTLIER -109.64 120.44 42.51 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 113.666 -1.606 . . . . 2.74 109.276 -178.536 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 64.1 t -75.46 126.98 36.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 115.421 -0.809 . . . . 2.61 112.03 -171.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 196' ' ' ALA . 10.0 mt -79.09 96.85 5.93 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.393 -0.821 . . . . 2.86 110.347 178.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -77.95 96.03 4.94 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.174 0.512 . . . . 4.27 110.019 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -158.8 67.78 0.45 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.165 -0.925 . . . . 6.02 109.197 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.24 127.92 39.32 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.204 -0.907 . . . . 6.23 111.507 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.45 119.33 6.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.06 2.506 . . . . 8.56 112.825 -175.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 53.2 tp . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.651 -0.69 . . . . 10.1 109.54 177.696 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.527 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.877 -0.416 . . . . 7.11 109.877 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.18 -42.12 70.04 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.183 2.589 . . . . 5.39 112.22 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -99.71 99.22 10.03 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.353 -0.61 . . . . 4.84 109.353 173.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.442 ' HE3' ' HB3' ' A' ' 154' ' ' LYS . 1.1 tmmt? -125.11 98.31 36.2 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-O 121.448 0.642 . . . . 4.47 110.679 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -88.14 135.73 3.33 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.721 2.947 . . . . 2.69 111.457 172.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.612 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.84 165.53 26.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.177 0.513 . . . . 2.15 111.017 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.1 p -139.43 123.1 18.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.409 -0.814 . . . . 1.67 109.559 173.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.415 ' HG2' HG22 ' A' ' 168' ' ' VAL . 53.4 mtt85 -81.22 109.37 15.69 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 3.61 110.711 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.495 HG22 HD12 ' A' ' 222' ' ' LEU . 53.8 t -98.7 110.81 26.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-N 115.095 -0.957 . . . . 1.4 111.485 -176.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.5 m-85 -75.48 103.63 5.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.336 0.589 . . . . 2.54 109.986 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.596 HD11 ' HB ' ' A' ' 167' ' ' THR . 16.1 mt -62.54 161.03 29.77 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-N 114.973 -1.012 . . . . 2.07 111.362 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.442 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 77.5 Cg_exo -54.02 148.7 37.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.762 2.308 . . . . 2.27 111.491 175.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 14.6 m120 72.94 23.64 2.74 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.724 0.64 . . . . 3.47 110.894 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt 67.38 34.06 4.98 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 113.537 0.94 . . . . 4.66 113.537 171.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -98.08 -179.35 4.36 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.598 -0.89 . . . . 3.57 108.598 170.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.441 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 2.9 ptt180 -149.51 139.58 22.08 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 118.585 0.629 . . . . 3.54 111.666 174.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.596 ' HB ' HD11 ' A' ' 161' ' ' LEU . 0.3 OUTLIER -132.35 138.94 47.94 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.698 -0.852 . . . . 1.91 108.698 170.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 156' ' ' ILE . 3.5 t -93.08 140.46 16.28 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 C-N-CA 120.16 -0.616 . . . . 2.31 110.057 179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 180' ' ' SER . 20.0 t -119.28 122.51 29.41 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 116.295 -0.411 . . . . 1.67 110.424 174.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.612 ' HA ' HG22 ' A' ' 156' ' ' ILE . 9.7 Cg_endo -52.96 123.34 12.9 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.343 2.029 . . . . 2.12 109.971 168.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.621 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -60.42 101.13 0.12 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.654 0.74 . . . . 2.28 110.49 -173.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.597 ' HB3' HG21 ' A' ' 175' ' ' VAL . 23.9 mmm180 -82.57 119.14 23.87 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.562 -1.199 . . . . 3.98 111.415 -172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 215' ' ' SER . 34.7 t -85.03 136.07 33.74 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.979 -0.555 . . . . 3.37 109.527 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.56 22.32 75.51 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.053 -1.219 . . . . 3.34 110.053 -173.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 172' ' ' ARG . 23.3 t -132.79 136.54 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.651 -0.774 . . . . 2.87 110.318 -174.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.507 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 23.4 p -89.37 167.03 13.35 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 115.663 -0.699 . . . . 2.83 109.683 -178.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 24.2 t -53.02 -34.17 20.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.261 -0.644 . . . . 1.92 109.261 171.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -53.28 -56.53 15.82 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 114.848 -1.069 . . . . 4.27 112.812 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.491 ' HB3' HG13 ' A' ' 175' ' ' VAL . 9.1 t70 -72.52 -43.62 63.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.527 0.679 . . . . 2.87 110.926 -173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 169' ' ' VAL . 1.3 m -65.21 -50.24 66.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.423 -0.808 . . . . 1.99 111.104 -177.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 0.0 OUTLIER -70.51 -21.12 62.78 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 120.625 -0.43 . . . . 1.34 111.968 175.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.544 ' HG2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -54.53 -47.05 73.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 108.933 -0.765 . . . . 3.08 108.933 176.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.544 ' N ' ' HG2' ' A' ' 182' ' ' LYS . 25.5 ttpt -63.4 -46.61 85.63 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.984 -0.553 . . . . 2.75 110.041 174.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' HA ' HG21 ' A' ' 167' ' ' THR . . . -51.33 -54.13 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.707 -0.679 . . . . 1.43 111.865 -176.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.438 ' HB3' ' C ' ' A' ' 190' ' ' LEU . 0.9 OUTLIER -65.11 -51.94 58.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.852 0.358 . . . . 1.7 110.752 178.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.419 ' HE3' ' O ' ' A' ' 190' ' ' LEU . 0.1 OUTLIER -62.41 -21.55 65.48 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.257 0.836 . . . . 2.29 113.257 -172.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 183' ' ' LYS . 45.6 mtm -71.87 -28.17 63.35 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.497 -0.481 . . . . 2.5 110.914 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 39.2 mtp85 -96.82 -8.47 30.98 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.231 0.539 . . . . 4.43 110.896 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 101.36 12.58 35.5 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.502 -0.772 . . . . 2.31 112.433 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.438 ' C ' ' HB3' ' A' ' 185' ' ' LEU . 7.9 mp -95.19 176.8 6.08 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.933 -0.395 . . . . 2.37 109.933 176.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.9 pt -132.61 143.53 49.13 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.159 0.504 . . . . 2.42 111.08 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -64.17 -3.74 6.62 Favored 'Trans proline' 0 N--CA 1.472 0.262 0 C-N-CA 123.7 2.933 . . . . 1.84 112.46 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -76.03 -49.89 16.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.49 0.662 . . . . 3.32 110.724 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 228' ' ' GLU . 63.5 m -103.66 38.74 1.74 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.938 -1.028 . . . . 2.85 112.363 -172.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 98.1 m -145.78 162.62 37.22 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.258 -0.276 . . . . 1.74 110.375 177.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.774 ' HB2' HD12 ' A' ' 227' ' ' LEU . . . -132.13 140.36 48.77 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 110.496 -0.187 . . . . 1.73 110.496 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.693 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -105.35 130.22 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.328 0 CA-C-O 122.633 1.206 . . . . 1.38 111.541 178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -119.27 165.17 14.6 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.605 -1.634 . . . . 2.99 109.622 178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.444 ' HB3' ' CD2' ' A' ' 222' ' ' LEU . 10.8 ptm180 -144.58 145.28 31.72 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.868 -0.605 . . . . 2.64 109.7 172.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.615 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -98.38 121.92 49.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.63 0.729 . . . . 2.6 110.52 -177.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.438 ' O ' ' N ' ' A' ' 203' ' ' GLY . 6.9 tt0 -99.41 -142.11 0.32 Allowed 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.62 -1.173 . . . . 3.22 108.115 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.23 78.84 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.193 0.597 . . . . 4.02 112.321 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 60.96 7.65 8.94 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.619 -0.324 . . . . 3.47 112.313 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 200' ' ' ILE . 13.6 pt-20 -123.76 -175.74 3.29 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.887 0.375 . . . . 3.48 110.686 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.615 ' HG2' HD11 ' A' ' 200' ' ' ILE . 44.8 mtpt -123.21 149.23 44.94 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.958 -0.565 . . . . 2.75 111.162 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -136.22 117.72 11.62 Favored Pre-proline 0 C--N 1.313 -0.988 0 CA-C-N 114.74 -1.118 . . . . 3.25 108.807 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.33 131.08 13.53 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.206 1.937 . . . . 2.47 111.494 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.693 HD12 HG23 ' A' ' 197' ' ' VAL . 19.5 mt -98.02 156.83 3.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-O 121.302 0.573 . . . . 1.91 111.738 -173.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.4 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -98.36 145.8 17.91 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.084 -0.806 . . . . 2.25 111.084 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.507 ' O ' ' HB ' ' A' ' 176' ' ' THR . 88.1 m95 -68.48 -13.19 62.14 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.868 0.692 . . . . 2.3 112.868 -172.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.66 14.26 28.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.216 0.531 . . . . 3.79 111.211 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.5 m -75.56 128.49 35.39 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.723 -0.671 . . . . 2.44 109.352 174.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.463 ' HB3' ' CE3' ' A' ' 216' ' ' TRP . 15.9 t70 -65.89 114.09 4.86 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.282 -0.636 . . . . 3.47 109.282 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.471 ' O ' HG12 ' A' ' 214' ' ' ILE . 5.7 tt -69.6 -11.15 14.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.756 -0.656 . . . . 1.95 112.03 -170.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.621 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 34.3 t -70.48 -14.49 62.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 121.835 -0.541 . . . . 2.91 110.634 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.463 ' CE3' ' HB3' ' A' ' 213' ' ' ASP . 13.2 m0 -92.25 -1.77 56.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.932 0.396 . . . . 4.8 110.567 175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 26.5 mt -104.83 9.33 34.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.402 -0.363 . . . . 2.13 110.81 -175.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.27 153.38 18.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.078 0.466 . . . . 2.03 111.189 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 75.13 -7.36 23.12 Favored Glycine 0 CA--C 1.518 0.277 0 CA-C-N 115.636 -0.711 . . . . 2.12 113.697 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' ' 157' ' ' VAL . 12.3 mm-40 -99.62 149.32 23.4 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.044 0.422 . . . . 2.61 110.253 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -95.68 119.8 34.82 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.475 0.655 . . . . 3.06 109.447 166.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.495 HD12 HG22 ' A' ' 159' ' ' VAL . 70.6 mt -98.21 167.33 10.93 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.85 -1.068 . . . . 1.3 109.252 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -149.7 144.08 25.87 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.324 -0.621 . . . . 3.31 109.324 174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 195' ' ' CYS . 21.3 t -114.42 141.09 32.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-O 121.749 0.785 . . . . 1.58 111.507 -171.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -110.01 179.38 4.13 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 114.02 -1.445 . . . . 2.74 107.774 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 195' ' ' CYS . 87.0 t -105.06 108.86 25.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 121.272 0.558 . . . . 2.61 110.064 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.774 HD12 ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -148.42 124.36 10.65 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 107.961 -1.126 . . . . 2.86 107.961 -177.508 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.531 ' N ' HD22 ' A' ' 227' ' ' LEU . 47.4 mt-10 -85.23 97.85 10.16 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.283 0.563 . . . . 4.27 111.288 -175.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.94 56.24 0.95 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.433 -0.803 . . . . 6.02 109.086 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.437 ' CG2' ' HD3' ' A' ' 231' ' ' PRO . 15.5 m -80.93 -34.62 0.76 Allowed Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 114.112 1.152 . . . . 6.23 114.112 -176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.437 ' HD3' ' CG2' ' A' ' 230' ' ' VAL . 7.4 Cg_exo -73.86 -73.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 121.454 1.436 . . . . 8.56 112.5 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.504 -0.76 . . . . 10.1 109.172 -178.506 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.512 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 120.817 0.341 . . . . 7.11 110.396 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -61.06 -48.82 9.34 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.91 2.407 . . . . 5.39 112.026 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -125.74 125.4 42.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.322 -0.622 . . . . 4.84 109.322 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -77.83 116.01 54.88 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.252 -0.431 . . . . 4.47 110.219 -177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -84.13 128.94 4.43 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.517 2.144 . . . . 2.69 112.23 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.62 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.7 pp -137.28 162.77 32.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.272 -0.422 . . . . 2.15 110.813 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 220' ' ' GLU . 1.2 p -135.04 120.63 30.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-O 121.315 0.578 . . . . 1.67 109.985 170.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.624 ' HG2' HG22 ' A' ' 168' ' ' VAL . 99.3 mtt180 -74.71 119.97 19.62 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.312 -0.858 . . . . 3.61 110.26 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.44 HG11 ' CD1' ' A' ' 181' ' ' LEU . 45.6 t -106.08 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 114.749 -1.114 . . . . 1.4 111.277 -176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 2.4 m-85 -73.28 103.45 3.98 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.566 0.698 . . . . 2.54 109.664 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.565 HD11 ' HB ' ' A' ' 167' ' ' THR . 12.7 mt -64.98 161.64 45.58 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.511 -1.222 . . . . 2.07 111.077 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 78.4 Cg_exo -51.63 150.45 16.53 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.511 2.141 . . . . 2.27 111.272 171.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 164' ' ' LYS . 21.6 t-20 63.89 36.98 9.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 122.408 1.099 . . . . 3.47 110.237 -176.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' A' ' 164' ' ' LYS . 1.7 mppt? 57.64 28.7 16.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.407 -1.724 . . . . 4.66 114.167 164.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.591 ' NE2' ' HD2' ' A' ' 188' ' ' ARG . 5.5 mt-30 -93.34 -179.07 4.94 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.028 -0.731 . . . . 3.57 109.028 169.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 34.3 ptt180 -147.62 135.05 20.75 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 121.434 0.635 . . . . 3.54 111.511 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.565 ' HB ' HD11 ' A' ' 161' ' ' LEU . 2.8 t -111.38 -177.76 3.28 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.909 -1.145 . . . . 1.91 107.909 170.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.624 HG22 ' HG2' ' A' ' 158' ' ' ARG . 4.6 t -135.75 132.36 51.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 N-CA-C 108.178 -1.045 . . . . 2.31 108.178 170.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 15.0 p -123.88 123.51 26.19 Favored Pre-proline 0 C--N 1.309 -1.16 0 C-N-CA 120.735 -0.386 . . . . 1.67 110.014 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.62 ' HA ' HG22 ' A' ' 156' ' ' ILE . 6.5 Cg_endo -50.71 134.17 40.2 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 C-N-CA 123.095 2.53 . . . . 2.12 111.786 176.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.496 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -61.27 117.69 5.93 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.527 -0.761 . . . . 2.28 109.482 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 170' ' ' PRO . 3.4 mmp_? -105.37 111.78 24.63 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.075 -0.966 . . . . 3.98 110.823 -173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 5.6 p -81.2 122.43 27.39 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.099 -0.501 . . . . 3.37 110.379 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 88.91 9.99 67.32 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.743 -0.943 . . . . 3.34 110.743 -175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 179' ' ' ASP . 59.2 t -122.33 140.66 45.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.239 -0.481 . . . . 2.87 109.742 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 178' ' ' ARG . 44.3 p -86.78 168.77 13.2 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.054 -0.721 . . . . 2.83 109.054 -177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.701 ' O ' ' HB2' ' A' ' 181' ' ' LEU . 1.3 m -59.53 -24.93 29.9 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.98 0 N-CA-C 108.703 -0.851 . . . . 1.92 108.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.431 ' HB3' ' OG1' ' A' ' 176' ' ' THR . 9.5 tmm_? -56.19 -60.57 3.31 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 112.516 0.561 . . . . 4.27 112.516 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.563 ' HB3' ' CG1' ' A' ' 175' ' ' VAL . 1.9 t70 -64.52 -48.51 74.83 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.152 0.977 . . . . 2.87 110.607 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.522 ' OG ' HG21 ' A' ' 214' ' ' ILE . 1.3 m -61.31 -50.82 71.41 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 114.268 -1.333 . . . . 1.99 110.496 -175.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.701 ' HB2' ' O ' ' A' ' 177' ' ' VAL . 2.9 mm? -68.82 -24.25 64.36 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.677 -0.692 . . . . 1.34 111.594 176.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 186' ' ' MET . 0.0 OUTLIER -54.94 -41.93 71.66 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.642 -0.503 . . . . 3.08 109.642 177.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.422 ' O ' ' HG3' ' A' ' 187' ' ' MET . 19.9 tttt -65.07 -52.21 56.99 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.648 -0.421 . . . . 2.75 110.155 172.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.46 ' CB ' HG21 ' A' ' 167' ' ' THR . . . -47.52 -52.4 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.481 -0.781 . . . . 1.43 111.683 -177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.538 ' HB3' ' HB2' ' A' ' 190' ' ' LEU . 91.0 mt -69.33 -54.34 15.07 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.263 -0.881 . . . . 1.7 110.919 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 5.2 mmt -62.54 -21.36 65.5 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.683 0.994 . . . . 2.29 113.683 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' A' ' 183' ' ' LYS . 47.1 mtm -67.93 -28.85 67.83 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 119.724 -0.79 . . . . 2.5 110.225 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.591 ' HD2' ' NE2' ' A' ' 165' ' ' GLN . 22.9 mtp180 -95.44 -2.69 48.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.265 0.555 . . . . 4.43 111.204 170.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.13 15.76 64.17 Favored Glycine 0 C--N 1.315 -0.583 0 CA-C-N 115.319 -0.855 . . . . 2.31 111.731 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 185' ' ' LEU . 16.6 mt -86.11 159.78 19.44 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.324 -0.438 . . . . 2.37 109.985 -176.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.401 HD12 ' HB2' ' A' ' 193' ' ' GLU . 49.4 pt -121.65 143.15 37.42 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-O 121.14 0.495 . . . . 2.42 111.564 -177.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.37 -4.51 15.14 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.113 2.542 . . . . 1.84 112.628 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.401 ' HB2' HD12 ' A' ' 191' ' ' ILE . 25.9 mt-10 -71.5 -39.71 70.64 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.999 -0.546 . . . . 3.32 111.035 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 68.3 m -120.62 37.5 4.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.285 -0.416 . . . . 2.85 111.466 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 226' ' ' VAL . 86.1 m -136.86 163.51 30.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.512 -0.551 . . . . 1.74 109.512 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -136.9 139.73 41.8 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 111.195 0.072 . . . . 1.73 111.195 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.646 HG23 HD12 ' A' ' 208' ' ' ILE . 1.3 m -102.48 129.73 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.29 0 CA-C-O 122.323 1.058 . . . . 1.38 111.075 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -120.81 170.53 9.37 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 113.74 -1.573 . . . . 2.99 110.059 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 199' ' ' ARG . 3.0 ptm180 -150.88 131.1 13.58 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.526 -0.761 . . . . 2.64 109.295 171.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.696 HD11 ' HG2' ' A' ' 205' ' ' LYS . 1.2 mp -83.57 124.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.353 0.597 . . . . 2.6 110.167 -176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' N ' ' A' ' 203' ' ' GLY . 26.4 tt0 -111.25 -139.45 0.38 Allowed 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 107.508 -1.294 . . . . 3.22 107.508 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.17 82.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.702 0.63 . . . . 4.02 112.702 -176.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 201' ' ' GLN . . . 61.17 7.99 10.6 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 116.213 -0.449 . . . . 3.47 113.578 178.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -138.69 -179.02 5.58 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 117.463 0.632 . . . . 3.48 111.895 -174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.696 ' HG2' HD11 ' A' ' 200' ' ' ILE . 36.9 mtpt -111.96 140.13 46.88 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.181 -0.918 . . . . 2.75 111.064 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -119.83 115.51 33.46 Favored Pre-proline 0 C--N 1.312 -1.046 0 CA-C-N 115.372 -0.831 . . . . 3.25 109.417 175.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -77.46 123.46 6.52 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 121.87 1.714 . . . . 2.47 111.739 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.646 HD12 HG23 ' A' ' 197' ' ' VAL . 16.0 mt -94.04 159.33 2.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.352 -0.84 . . . . 1.91 111.301 -173.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 208' ' ' ILE . . . -92.39 151.27 20.56 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.985 -0.846 . . . . 2.25 110.985 176.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HA ' HG22 ' A' ' 177' ' ' VAL . 80.5 m95 -76.98 -12.95 60.01 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.506 0.558 . . . . 2.3 112.506 -172.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -101.74 12.56 36.9 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.08 0.467 . . . . 3.79 110.574 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 84.9 m -79.23 131.48 36.19 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.868 -0.606 . . . . 2.44 110.316 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' A' ' 215' ' ' SER . 17.5 t70 -61.71 117.9 6.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 3.47 109.921 177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.522 HG21 ' OG ' ' A' ' 180' ' ' SER . 5.8 tt -74.11 -16.32 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.455 . . . . 1.95 111.889 -173.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.496 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 20.7 t -67.54 -18.61 65.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.461 0.648 . . . . 2.91 109.94 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 20.0 t90 -77.83 -18.21 56.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.839 -0.618 . . . . 4.8 110.385 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 4.1 mt -102.79 14.04 32.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.091 -0.504 . . . . 2.13 111.211 -171.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 m -60.96 153.31 25.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 2.03 110.435 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 73.34 -4.72 24.63 Favored Glycine 0 C--N 1.32 -0.324 0 CA-C-N 115.977 -0.556 . . . . 2.12 113.576 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 157' ' ' VAL . 16.0 mm-40 -99.44 166.12 11.33 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 110.13 -0.322 . . . . 2.61 110.13 179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -112.92 126.61 55.66 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.065 -0.717 . . . . 3.06 109.065 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.402 HD12 HG22 ' A' ' 159' ' ' VAL . 26.9 mt -95.74 156.4 16.35 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.491 -0.777 . . . . 1.3 109.571 -177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.432 ' CD2' HD13 ' A' ' 200' ' ' ILE . 80.5 m-70 -132.65 117.25 17.66 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.036 -0.728 . . . . 3.31 109.036 177.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 45.9 t -101.31 133.37 44.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.585 0.707 . . . . 1.58 110.895 -176.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -108.3 174.4 5.89 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.326 -1.306 . . . . 2.74 108.033 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.485 HG12 ' HG3' ' A' ' 228' ' ' GLU . 16.4 t -114.3 116.27 52.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 110.276 -0.268 . . . . 2.61 110.276 177.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 196' ' ' ALA . 0.0 OUTLIER -81.15 97.97 7.83 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.888 0.375 . . . . 2.86 110.486 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.485 ' HG3' HG12 ' A' ' 226' ' ' VAL . 49.6 mt-10 -117.52 141.79 47.94 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.997 -0.547 . . . . 4.27 110.525 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.25 67.07 1.07 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.819 -0.628 . . . . 6.02 110.356 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.43 127.48 46.28 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.81 -0.632 . . . . 6.23 111.204 -177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -79.7 -15.29 12.24 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.762 2.308 . . . . 8.56 112.904 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 43.8 tp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.608 -0.71 . . . . 10.1 110.561 -176.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' 6FS . . . . . 0.548 ' C11' ' O2 ' ' A' ' 301' ' ' 6FS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_